0000896264-23-000004.txt : 20230228 0000896264-23-000004.hdr.sgml : 20230228 20230228143443 ACCESSION NUMBER: 0000896264-23-000004 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 96 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230228 DATE AS OF CHANGE: 20230228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: USANA HEALTH SCIENCES INC CENTRAL INDEX KEY: 0000896264 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 870500306 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35024 FILM NUMBER: 23684024 BUSINESS ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 BUSINESS PHONE: 8019547100 MAIL ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. STREET 2: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 FORMER COMPANY: FORMER CONFORMED NAME: USANA INC DATE OF NAME CHANGE: 19930125 10-K 1 usna-20221231.htm 10-K usna-20221231
0000896264FYfalse2022http://fasb.org/us-gaap/2022#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2022#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent00008962642022-01-022022-12-3100008962642022-07-01iso4217:USD00008962642023-02-24xbrli:shares00008962642022-12-3100008962642022-01-01iso4217:USDxbrli:shares00008962642021-01-032022-01-0100008962642019-12-292021-01-020000896264us-gaap:CommonStockMember2019-12-280000896264us-gaap:AdditionalPaidInCapitalMember2019-12-280000896264us-gaap:RetainedEarningsMember2019-12-280000896264us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-2800008962642019-12-280000896264us-gaap:CommonStockMember2019-12-292021-01-020000896264us-gaap:AdditionalPaidInCapitalMember2019-12-292021-01-020000896264us-gaap:RetainedEarningsMember2019-12-292021-01-020000896264us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-292021-01-020000896264us-gaap:CommonStockMember2021-01-020000896264us-gaap:AdditionalPaidInCapitalMember2021-01-020000896264us-gaap:RetainedEarningsMember2021-01-020000896264us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-0200008962642021-01-020000896264us-gaap:CommonStockMember2021-01-032022-01-010000896264us-gaap:AdditionalPaidInCapitalMember2021-01-032022-01-010000896264us-gaap:RetainedEarningsMember2021-01-032022-01-010000896264us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-032022-01-010000896264us-gaap:CommonStockMember2022-01-010000896264us-gaap:AdditionalPaidInCapitalMember2022-01-010000896264us-gaap:RetainedEarningsMember2022-01-010000896264us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-010000896264us-gaap:CommonStockMember2022-01-022022-12-310000896264us-gaap:AdditionalPaidInCapitalMember2022-01-022022-12-310000896264us-gaap:RetainedEarningsMember2022-01-022022-12-310000896264us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-022022-12-310000896264us-gaap:CommonStockMember2022-12-310000896264us-gaap:AdditionalPaidInCapitalMember2022-12-310000896264us-gaap:RetainedEarningsMember2022-12-310000896264us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000896264us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2022-12-310000896264us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2022-01-010000896264us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2021-01-020000896264us-gaap:OtherNoncurrentAssetsMember2022-12-310000896264us-gaap:OtherNoncurrentAssetsMember2022-01-010000896264us-gaap:OtherNoncurrentAssetsMember2021-01-02usna:region0000896264us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2022-12-310000896264us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2022-12-310000896264us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2022-12-310000896264us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Member2022-12-310000896264us-gaap:FairValueMeasurementsRecurringMember2022-12-310000896264us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-12-310000896264us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310000896264us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310000896264us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2022-01-010000896264us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2022-01-010000896264us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2022-01-010000896264us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Member2022-01-010000896264us-gaap:FairValueMeasurementsRecurringMember2022-01-010000896264us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-01-010000896264us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-01-010000896264us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-01-010000896264us-gaap:FairValueMeasurementsNonrecurringMember2022-12-310000896264us-gaap:FairValueMeasurementsNonrecurringMember2022-01-010000896264usna:AmountsReceivableFromCreditCardProcessorsMember2022-12-310000896264usna:AmountsReceivableFromCreditCardProcessorsMember2022-01-010000896264usna:RestrictedCashDepositsInChinaMember2022-12-310000896264usna:RestrictedCashDepositsInChinaMember2022-01-010000896264us-gaap:OtherAssetsMember2022-01-01xbrli:pure0000896264us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeOptionMember2022-01-010000896264us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeOptionMember2021-01-020000896264us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeOptionMember2022-01-022022-12-310000896264us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeOptionMember2019-12-292021-01-020000896264us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeOptionMember2021-01-032022-01-010000896264us-gaap:DesignatedAsHedgingInstrumentMember2022-01-010000896264us-gaap:DesignatedAsHedgingInstrumentMember2022-12-310000896264us-gaap:SubsequentEventMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-180000896264us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2022-04-032022-07-020000896264us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2022-07-020000896264us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2022-07-012022-12-310000896264us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2022-01-022022-12-310000896264us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2022-12-31usna:period0000896264us-gaap:ForeignCountryMemberus-gaap:ResearchMember2022-12-310000896264usna:MirroredDeferredTaxAssetsRecordedInTheUsToOffsetDeferredTaxLiabilitiesOfForeignDisregardedEntitiesMember2022-12-310000896264usna:UtahStateTaxCommissionMemberus-gaap:ResearchMemberus-gaap:StateAndLocalJurisdictionMember2022-12-310000896264us-gaap:DomesticCountryMemberus-gaap:ResearchMember2022-12-310000896264us-gaap:ForeignCountryMember2022-12-310000896264usna:ForeignOperatingLossCarryforwardsMember2022-12-310000896264usna:OtherForeignDeferredTaxAssetsMember2022-12-310000896264us-gaap:OtherCurrentLiabilitiesMember2022-12-310000896264us-gaap:OtherNoncurrentLiabilitiesMember2022-12-310000896264us-gaap:OtherCurrentLiabilitiesMember2022-01-010000896264us-gaap:OtherNoncurrentLiabilitiesMember2022-01-010000896264us-gaap:BuildingMember2022-01-022022-12-310000896264us-gaap:BuildingMember2022-12-310000896264us-gaap:BuildingMember2022-01-010000896264srt:MinimumMemberusna:LaboratoryAndProductionEquipmentMember2022-01-022022-12-310000896264srt:MaximumMemberusna:LaboratoryAndProductionEquipmentMember2022-01-022022-12-310000896264usna:LaboratoryAndProductionEquipmentMember2022-12-310000896264usna:LaboratoryAndProductionEquipmentMember2022-01-010000896264us-gaap:AirTransportationEquipmentMember2022-01-022022-12-310000896264us-gaap:AirTransportationEquipmentMember2022-12-310000896264us-gaap:AirTransportationEquipmentMember2022-01-010000896264us-gaap:ComputerEquipmentMembersrt:MinimumMember2022-01-022022-12-310000896264srt:MaximumMemberus-gaap:ComputerEquipmentMember2022-01-022022-12-310000896264us-gaap:ComputerEquipmentMember2022-12-310000896264us-gaap:ComputerEquipmentMember2022-01-010000896264srt:MinimumMemberus-gaap:FurnitureAndFixturesMember2022-01-022022-12-310000896264srt:MaximumMemberus-gaap:FurnitureAndFixturesMember2022-01-022022-12-310000896264us-gaap:FurnitureAndFixturesMember2022-12-310000896264us-gaap:FurnitureAndFixturesMember2022-01-010000896264us-gaap:AutomobilesMembersrt:MinimumMember2022-01-022022-12-310000896264us-gaap:AutomobilesMembersrt:MaximumMember2022-01-022022-12-310000896264us-gaap:AutomobilesMember2022-12-310000896264us-gaap:AutomobilesMember2022-01-010000896264srt:MinimumMemberus-gaap:LeaseholdImprovementsMember2022-01-022022-12-310000896264srt:MaximumMemberus-gaap:LeaseholdImprovementsMember2022-01-022022-12-310000896264us-gaap:LeaseholdImprovementsMember2022-12-310000896264us-gaap:LeaseholdImprovementsMember2022-01-010000896264us-gaap:LandImprovementsMember2022-01-022022-12-310000896264us-gaap:LandImprovementsMember2022-12-310000896264us-gaap:LandImprovementsMember2022-01-010000896264us-gaap:LandMember2022-12-310000896264us-gaap:LandMember2022-01-010000896264usna:DepositsAndProjectsInProcessMember2022-12-310000896264usna:DepositsAndProjectsInProcessMember2022-01-010000896264us-gaap:TrademarksAndTradeNamesMember2022-12-310000896264us-gaap:TrademarksAndTradeNamesMember2022-01-022022-12-310000896264us-gaap:TradeSecretsMember2022-12-310000896264us-gaap:TradeSecretsMember2022-01-022022-12-310000896264us-gaap:CustomerRelationshipsMember2022-12-310000896264us-gaap:CustomerRelationshipsMember2022-01-022022-12-310000896264us-gaap:NoncompeteAgreementsMember2022-12-310000896264us-gaap:NoncompeteAgreementsMember2022-01-022022-12-310000896264us-gaap:LicensingAgreementsMember2022-12-310000896264us-gaap:TrademarksAndTradeNamesMember2022-01-010000896264us-gaap:TrademarksAndTradeNamesMember2021-01-032022-01-010000896264us-gaap:TradeSecretsMember2022-01-010000896264us-gaap:TradeSecretsMember2021-01-032022-01-010000896264us-gaap:LicensingAgreementsMember2022-01-010000896264us-gaap:LineOfCreditMember2022-12-310000896264us-gaap:LineOfCreditMemberusna:AmendedAndRestatedCreditAgreementMember2022-12-310000896264us-gaap:LineOfCreditMemberusna:AmendedAndRestatedCreditAgreementMember2022-01-022022-12-31utr:Y0000896264usna:LiabilityAwardMember2022-01-022022-12-310000896264usna:LiabilityAwardMember2021-01-032022-01-010000896264usna:LiabilityAwardMember2019-12-292021-01-020000896264usna:The2015PlanMember2022-12-310000896264us-gaap:StockAppreciationRightsSARSMemberusna:The2015PlanMember2022-01-022022-12-310000896264usna:The2015PlanMemberus-gaap:RestrictedStockMember2022-01-022022-12-310000896264us-gaap:EmployeeStockMemberusna:The2015PlanMember2022-01-022022-12-310000896264us-gaap:StockAppreciationRightsSARSMember2022-01-022022-12-310000896264us-gaap:StockAppreciationRightsSARSMember2021-01-032022-01-010000896264us-gaap:StockAppreciationRightsSARSMember2019-12-292021-01-020000896264usna:VestingAnnuallyMemberus-gaap:StockAppreciationRightsSARSMember2022-01-022022-12-310000896264us-gaap:StockAppreciationRightsSARSMember2022-01-010000896264us-gaap:StockAppreciationRightsSARSMember2021-01-020000896264us-gaap:StockAppreciationRightsSARSMember2022-12-310000896264us-gaap:AdditionalPaidInCapitalMemberus-gaap:StockAppreciationRightsSARSMember2019-12-292021-01-020000896264us-gaap:AdditionalPaidInCapitalMemberus-gaap:StockAppreciationRightsSARSMember2021-01-032022-01-010000896264usna:VestingAnnuallyMemberus-gaap:RestrictedStockUnitsRSUMember2022-01-022022-12-310000896264us-gaap:ShareBasedPaymentArrangementNonemployeeMemberusna:VestingEachQuarterMemberusna:DeferredStockUnitsMember2022-01-022022-12-310000896264us-gaap:RestrictedStockMember2022-12-310000896264us-gaap:RestrictedStockUnitsRSUMember2022-01-010000896264us-gaap:RestrictedStockUnitsRSUMember2022-01-022022-12-310000896264us-gaap:RestrictedStockUnitsRSUMember2022-12-310000896264us-gaap:RestrictedStockUnitsRSUMemberus-gaap:AdditionalPaidInCapitalMember2022-01-022022-12-310000896264us-gaap:RestrictedStockUnitsRSUMemberus-gaap:AdditionalPaidInCapitalMember2021-01-032022-01-010000896264us-gaap:RestrictedStockUnitsRSUMemberus-gaap:AdditionalPaidInCapitalMember2019-12-292021-01-020000896264us-gaap:RestrictedStockUnitsRSUMember2021-01-032022-01-010000896264us-gaap:RestrictedStockUnitsRSUMember2019-12-292021-01-020000896264usna:CashSettledRestrictedStockUnitsMember2022-01-010000896264usna:CashSettledRestrictedStockUnitsMember2022-01-022022-12-310000896264usna:CashSettledRestrictedStockUnitsMember2022-12-310000896264usna:DeferredStockUnitsMember2022-01-022022-12-310000896264usna:DeferredStockUnitsMember2021-01-032022-01-010000896264usna:DeferredStockUnitsMember2019-12-292021-01-020000896264us-gaap:AdditionalPaidInCapitalMemberus-gaap:StockAppreciationRightsSARSMember2022-01-022022-12-310000896264usna:DirectSellingMemberus-gaap:OperatingSegmentsMember2022-01-022022-12-310000896264usna:DirectSellingMemberus-gaap:OperatingSegmentsMember2021-01-032022-01-010000896264usna:DirectSellingMemberus-gaap:OperatingSegmentsMember2019-12-292021-01-020000896264usna:AllOtherMemberus-gaap:OperatingSegmentsMember2022-01-022022-12-310000896264usna:AllOtherMemberus-gaap:OperatingSegmentsMember2021-01-032022-01-010000896264usna:AllOtherMemberus-gaap:OperatingSegmentsMember2019-12-292021-01-020000896264us-gaap:SalesRevenueNetMemberusna:USANANutritionalsMemberus-gaap:ProductConcentrationRiskMember2022-01-022022-12-310000896264us-gaap:SalesRevenueNetMemberusna:USANANutritionalsMemberus-gaap:ProductConcentrationRiskMember2021-01-032022-01-010000896264us-gaap:SalesRevenueNetMemberusna:USANANutritionalsMemberus-gaap:ProductConcentrationRiskMember2019-12-292021-01-020000896264us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMemberusna:USANAFoodsMember2022-01-022022-12-310000896264us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMemberusna:USANAFoodsMember2021-01-032022-01-010000896264us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMemberusna:USANAFoodsMember2019-12-292021-01-020000896264us-gaap:SalesRevenueNetMemberusna:PersonalCareAndSkincareMemberus-gaap:ProductConcentrationRiskMember2022-01-022022-12-310000896264us-gaap:SalesRevenueNetMemberusna:PersonalCareAndSkincareMemberus-gaap:ProductConcentrationRiskMember2021-01-032022-01-010000896264us-gaap:SalesRevenueNetMemberusna:PersonalCareAndSkincareMemberus-gaap:ProductConcentrationRiskMember2019-12-292021-01-020000896264usna:AllOtherMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-01-022022-12-310000896264usna:AllOtherMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-01-032022-01-010000896264usna:AllOtherMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2019-12-292021-01-020000896264usna:GreaterChinaMember2022-01-022022-12-310000896264usna:GreaterChinaMember2021-01-032022-01-010000896264usna:GreaterChinaMember2019-12-292021-01-020000896264usna:SoutheastAsiaPacificMember2022-01-022022-12-310000896264usna:SoutheastAsiaPacificMember2021-01-032022-01-010000896264usna:SoutheastAsiaPacificMember2019-12-292021-01-020000896264usna:NorthAsiaMember2022-01-022022-12-310000896264usna:NorthAsiaMember2021-01-032022-01-010000896264usna:NorthAsiaMember2019-12-292021-01-020000896264srt:AsiaPacificMember2022-01-022022-12-310000896264srt:AsiaPacificMember2021-01-032022-01-010000896264srt:AsiaPacificMember2019-12-292021-01-020000896264usna:AmericasAndEuropeMember2022-01-022022-12-310000896264usna:AmericasAndEuropeMember2021-01-032022-01-010000896264usna:AmericasAndEuropeMember2019-12-292021-01-020000896264usna:GreaterChinaMember2022-12-310000896264usna:GreaterChinaMember2022-01-010000896264usna:SoutheastAsiaPacificMember2022-12-310000896264usna:SoutheastAsiaPacificMember2022-01-010000896264usna:NorthAsiaMember2022-12-310000896264usna:NorthAsiaMember2022-01-010000896264srt:AsiaPacificMember2022-12-310000896264srt:AsiaPacificMember2022-01-010000896264usna:AmericasAndEuropeMember2022-12-310000896264usna:AmericasAndEuropeMember2022-01-010000896264country:CN2022-01-022022-12-310000896264country:CN2021-01-032022-01-010000896264country:CN2019-12-292021-01-020000896264country:KR2022-01-022022-12-310000896264country:KR2021-01-032022-01-010000896264country:KR2019-12-292021-01-020000896264country:US2022-01-022022-12-310000896264country:US2021-01-032022-01-010000896264country:US2019-12-292021-01-020000896264country:US2022-12-310000896264country:US2022-01-010000896264country:US2021-01-020000896264country:CN2022-12-310000896264country:CN2022-01-010000896264country:CN2021-01-020000896264usna:GullGlobalLtdMember2022-01-022022-12-310000896264usna:AmarevitaMember2019-12-292021-01-020000896264usna:SecSchedule1209AllowanceSalesReturnsMember2022-01-010000896264usna:SecSchedule1209AllowanceSalesReturnsMember2022-01-022022-12-310000896264usna:SecSchedule1209AllowanceSalesReturnsMember2022-12-310000896264us-gaap:AllowanceForCreditLossMember2022-01-010000896264us-gaap:AllowanceForCreditLossMember2022-01-022022-12-310000896264us-gaap:AllowanceForCreditLossMember2022-12-310000896264us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2022-01-010000896264us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2022-01-022022-12-310000896264us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2022-12-310000896264usna:SecSchedule1209AllowanceSalesReturnsMember2021-01-020000896264usna:SecSchedule1209AllowanceSalesReturnsMember2021-01-032022-01-010000896264us-gaap:AllowanceForCreditLossMember2021-01-020000896264us-gaap:AllowanceForCreditLossMember2021-01-032022-01-010000896264us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2021-01-020000896264us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2021-01-032022-01-010000896264usna:SecSchedule1209AllowanceSalesReturnsMember2019-12-280000896264usna:SecSchedule1209AllowanceSalesReturnsMember2019-12-292021-01-020000896264us-gaap:AllowanceForCreditLossMember2019-12-280000896264us-gaap:AllowanceForCreditLossMember2019-12-292021-01-020000896264us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2019-12-280000896264us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2019-12-292021-01-02
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________________
FORM 10-K
(Mark One)
x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2022
or
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ____________ to ____________
Commission file number: 001-35024
______________________________
USANA HEALTH SCIENCES, INC.
(Exact name of registrant as specified in its charter)
Utah87-0500306
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
3838 West Parkway Blvd., Salt Lake City, Utah 84120
(Address of principal executive offices, Zip Code)
(801) 954-7100
(Registrant’s telephone number, including area code)
______________________________
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, Par Value $0.001 per shareUSNANew York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None
______________________________
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes x No o
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes o No x
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer
xAccelerated filer o
Non-accelerated fileroSmaller reporting companyo
Emerging growth companyo
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☑
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements
of the registrant included in the filing reflect the correction of an error to previously issued financial statements. o

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o No x
The aggregate market value of common stock held by non-affiliates of the registrant as of July 1, 2022 was approximately $1,426,392,900 based on a closing market price of $75.00 per share.
There were 19,294,332 shares of the registrant’s common stock outstanding as of February 24, 2023.
DOCUMENTS INCORPORATED BY REFERENCE
The registrant incorporates by reference into Part III (Items 10, 11, 12, 13, and 14) of this report certain information contained in its Definitive Proxy Statement to be filed with the Securities and Exchange Commission no later than 120 days after the end of the registrant’s fiscal year ended December 31, 2022, in connection with the registrant’s 2023 Annual Meeting of Shareholders to be held May 10, 2023.
Auditor Name: KPMG LLP
Auditor Location: Salt Lake City, Utah
Auditor Firm ID: 185

USANA HEALTH SCIENCES, INC.
FORM 10-K
For the Fiscal Year Ended December 31, 2022
INDEX
Page
Item 11
Executive Compensation
Item 12
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Item 13
Certain Relationships and Related Transactions, and Director Independence
Item 14
Principal Accounting Fees and Services

Cautionary Note Regarding Forward-Looking Statements and Certain Risks
This report contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new products; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. Forward-looking statements may include, but are not limited to, statements regarding future financial results, long-term value creation goals, productivity, raw material prices and related costs, supply chain, asset impairment, litigation, sustainability and environmental, social and governance (“ESG”) efforts, and the impact of COVID-19, and the Russia/Ukraine conflict on our operations. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will” and similar references to future periods. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely unduly on forward-looking statements.
Although we believe that the expectations reflected in our forward-looking statements are reasonable, actual results could differ materially from those we project or assume in our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, such as those disclosed or incorporated by reference in our filings with the Securities and Exchange Commission (“SEC”). Any forward-looking statement made by us in this report is based only on information currently available to us and speaks only as of the date hereof. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments, the occurrence of unanticipated events or otherwise. Among the important factors that could cause our actual results, performance and achievements to differ materially from estimates or projections contained in our forward-looking statements in this report are the following:
•Our dependence upon the direct selling business model to distribute our products and the activities of our independent Associates;
•Extensive regulation of our business model and uncertainties relating to the interpretation and enforcement of applicable laws and regulations governing direct selling and anti-pyramiding, particularly in the United States and China;
•The operation and expansion of our business in China through our subsidiary, BabyCare Holdings, Ltd. (“BabyCare”), including risks related to (i) operating in China in general, (ii) engaging in direct selling in China, (iii) BabyCare’s business model in China, (iv) new and expanded data privacy and security laws and regulations in China, and (v) changes in the Chinese economy, marketplace or consumer environment;
•Unanticipated effects of changes to our Compensation Plan;
•Challenges associated with our planned expansion into new international markets, delays in commencement of sales or product offerings in such markets, delays in compliance with local marketing or other regulatory requirements, or changes in target markets;
•Macroeconomic conditions and other factors, including inflationary pressures, slower economic growth or recession, general conditions affecting consumer spending or discretionary income, or disruptions to our supply chain;
•The continuing effects of the COVID-19 pandemic and its impact, which are highly unpredictable and could be significant and could harm our business, operations, and financial results;
1
•Political events, natural disasters, pandemics, epidemics or other health crises including, and in addition to, COVID-19, or other events that may negatively affect economic conditions, consumer spending or consumer behavior;
•Changes in the legal and regulatory environment including environmental, health and safety regulations, data security and privacy, and trade policies and tariffs, the impact of customs, duties, taxation, and transfer pricing regulations, as well as regulations governing distinctions between and our responsibilities to employees and independent contractors;
•Geo-political tensions or conflicts, including impacts from the conflict involving Russia and Ukraine, deterioration in foreign relations, as well as disputes or tensions among other countries around the world in general or among the United States, China, and other countries;
•Volatile fluctuation in the value of foreign currencies against the U.S. dollar;
•Noncompliance by us or our Associates with any data privacy or security laws or any security breach by us or a third party involving the misappropriation, loss, destruction or other unauthorized use or disclosure of confidential information;
•Shortages of raw materials, disruptions in the business of our contract manufacturers, significant price increases of key raw materials, and other disruptions to our supply chain;
•Our continued compliance with debt covenants in our Credit Facility;
•Litigation, tax, and legal compliance risk and costs, especially if materially different from the amount we expect to incur or have accrued for, and any disruptions caused by the same;
•Information technology system failures, data security breaches, data security and privacy compliance, network disruptions, and cybersecurity attacks; and
•Acquisition, divestiture, and investment-related risks, including risks associated with past or future acquisitions;
Unless otherwise indicated or otherwise required by the context, the terms “we,” “our,” “it,” “its,” “Company,” and “USANA” refer to USANA Health Sciences, Inc. and its wholly owned subsidiaries.
2
PART I
Item 1. Business
General
USANA Health Sciences, Inc. is a global direct-selling nutrition, personal health and wellness company. In 2022, we generated $998.6 million in net sales and finished the year with approximately 490,000 active Customers worldwide. We were founded in 1992 by Myron W. Wentz, Ph.D. and since that time, we have developed and manufactured high quality, science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness. In so doing, we are committed to continuous product innovation and sound scientific research. We have operations in 24 geographic markets worldwide, where we distribute and sell our products by way of direct selling. Mainland China (“China”) is our largest market and single largest source of revenue, representing approximately 45.4% of net sales and approximately 45.9% of active Customers. We distribute our products through the direct selling channel, because we believe it is the most conducive sales channel to meeting our vision, which is improving the overall health and nutrition of individuals and families around the world. As a U.S.-based multi-national corporation with an expanding international presence, our operating results are sensitive to currency fluctuations, as well as economic and political conditions in markets throughout the world. Additionally, we are subject to the various laws and regulations in the United States, China, and the other markets in which we operate with respect to the products that we manufacture, and sell, and our method of distribution. We are a U.S. public company listed on the New York Stock Exchange ("NYSE") and subject to the rules of the SEC.
Our customer base is primarily comprised of two types of customers: “Associates” and “Preferred Customers” referred to collectively as “active Customers.” Our Associates also sell our products to retail customers. Associates share in our company vision by acting as independent distributors of our products, in addition to purchasing our products for their personal use. Preferred Customers purchase our products strictly for personal use and are not permitted to resell or to distribute the products. We only count as active Customers those Associates and Preferred Customers who have purchased from us at any time during the most recent three-month period.
This “Item 1. Business” provides detailed information about our world-wide business, including who we are, what we do and where we are headed. Unless otherwise specified, current information reported in this Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (this “report” or “Annual Report”) is as of or for the fiscal year ended December 31, 2022. We also discuss the development of our company and the geographic areas where we do business. For the year ended December 31, 2022, there were no material changes to our corporate structure or our method of conducting business.
Current Focus and Growth Strategy
In 2023, we plan to execute our global growth strategy which remains focused on increasing the number of active Customers in each of our markets. We plan to do this by (i) continuing to advance our digital commerce initiatives to support our business; (ii) executing market specific promotional and incentive strategies; (iii) continuing to pursue product development and further leveraging our foods manufacturing facility; (iv) focusing on our China market and our customer base in that market; (v) pursuing growth through international expansion; and (vi) advancing our business development strategy by growing the two companies we acquired in 2022, and evaluating new acquisition opportunities.
Digital Commerce Initiatives
In 2023, we will continue to focus on expanding, enhancing and leveraging our digital capabilities to create the best overall customer experience. Collaboration between our sales leaders and management team, combined with assessment of customer feedback, will continue to be utilized in connection with planned digital investments. Listed below are some of the digital initiatives we plan to advance in 2023.
•Onboarding program and digital tools: In 2022, we launched a new education and communication onboarding program for our new Associates. This program offers product education and utilizes a variety of our key online and app-based digital tools. In 2023, we will continue to promote and improve these digital tools to improve the onboarding process and experience for new Associates through targeted communications, notifications and orientation, which we believe will help drive customer acquisition and retention.
•Affiliate program, social selling and digital tools: In January 2023, we launched our Affiliate program in the United States, Canada, and Mexico. The Affiliate program offers a new, simplified way for individuals and
3
customers in these markets to share, market, sell, and earn compensation for selling our products. We developed and deployed a variety of digital tools in connection with the launch of this new program. In 2023, we will promote this program in these markets, promote and expand the digital tools for the program, and continue to evaluate offering the program in other markets.
Market-Specific Strategies
In 2023, we will continue to pursue market-specific strategies to facilitate customer growth and strengthen our business around the world. Listed below are some of the strategies we plan to execute on a market-specific basis.
•Shifting our focus from large, world-wide incentive offerings to strategically timed, market- and region-specific efforts to incent sales and customer growth.
•Continuing to offer product promotions to increase product demand and drive customer growth.
•Returning to in-person events and Associate incentive trips where possible. Examples of these events include our China National Meeting and Asia Pacific Convention, which are both scheduled for the second quarter of 2023.
•Increasing the number of in-person meetings and improving collaboration amongst our management team and Associate sales force.
•Refocusing our Associate sales force on promoting the science-based differentiation of USANA's products, which includes our proprietary InCelligence Technology®. InCelligence™ is our patented technology that supports the body's natural ability to nourish, protect and renew itself.

Product Development
In 2023, we plan to continue to invest in research and development and product innovation to ensure that USANA remains a leader in clinical nutrition. We also plan to roll-out new science-based products in 2023 and over the next several years. Our foods plant ("USANA North" facility) in Salt Lake City, UT, houses the manufacturing for our foods-related products. In 2023, we plan to move the production of more of our Active Nutrition products to USANA North. We also plan to move production of Rise Bar's products to USANA North to realize cost savings, increase production efficiency and provide Rise Bar with increased capacity to grow its customer base. Overall, we believe our investment in USANA North allows us to be more agile and cost efficient in responding to both current and future opportunities.
China Strategy
Notwithstanding the challenges we have experienced over the last several years in China related to the COVID-19 pandemic, we remain optimistic about the long-term growth potential of our China business. Listed below are some of the strategic initiatives in China that we executed in 2022 and plan to continue to advance in 2023:
•Advancing our research collaboration with Beijing University of Chinese Medicine (China).
•Investing in our branch office redesign strategy, which we believe will enhance the customer experience as well as contribute to increased customer activity and retention.
•Advancing and expanding our digital capabilities, which entails continued digital investments to improve the overall customer experience. These investments include: (i) improving the onboarding process through feedback, collaboration with our customers, and automation; (ii) simplifying and enhancing our shopping experience and app in China, which will help increase customer acquisition and retention; and (iii) enhancing our Associate-focused marketing content, which includes new videos and other training materials from our media studio in China.
•Continuing to advance and build upon collaborations and partnerships. We are continuing our partnership with the National Sports Training Bureau and we are looking for additional partnerships to promote our new Active Nutrition line. We also continue to work closely with Beijing University of Chinese Medicine (China) and we hope to have meaningful results from many of these projects and to start commercializing products as soon as possible.
4
International Expansion
We continue to believe that China represents a meaningful long-term growth opportunity for the Company, we also believe that growth opportunities exist in new international markets. Although we have not opened new markets during the COVID-19 pandemic, our team has continued to evaluate new market opportunities for USANA's business and has positioned USANA to announce and launch a new market in late 2023.
Business Development
Our strong balance sheet and our willingness to invest in growth continues to allow us to pursue a wide-range of opportunities that are additive to our long-term success. In 2022, we completed the acquisition of two companies, Rise Bar and Oola Global, LLC "(Oola"). Rise Bar manufactures and sells high-quality protein bars that are formulated to help customers achieve their health goals through clean and simple ingredients. Oola is an emerging direct selling company that offers a personal development framework that helps individuals create a life of balance, growth, and purpose. Although Rise Bar and Oola will continue to operate and grow independently of USANA, we plan to leverage their knowledge, experience, and technology to grow USANA’s core business. We are also utilizing USANA's assets and resources to generate growth for Rise Bar and Oola. For further details of these acquisitions, see Note B to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report, which is incorporated by reference. In 2023, we will continue to pursue acquisition opportunities in the health and wellness space that strengthen, diversify, and grow our world-wide business by focusing on: (i) overall nutrition, (ii) vertical integration, (iii) product and category expansion, and (iv) geographic expansion.
Products
The following table summarizes information concerning our principal product lines.
Product Line/CategoryDescriptionPercent of Product
Sales by Fiscal Year		Product examples
USANA® Nutritionals Optimizers
Consists of targeted supplements designed to meet individual health and nutritional needs. These products support needs such as cardiovascular health, skeletal/structural health, and digestive health and are intended to be used in conjunction with the Essentials/CellSentials2022 – 70%
2021 – 68%
2020 – 66%
Proflavanol®
CoQuinone® 30
BiOmega-3™
Essentials/CellSentials®(1)
Includes core vitamin and mineral supplements that provide a foundation of advanced total body nutrition for every age group beginning with children 13 months of age. 2022 – 17%
2021 – 18%
2020 – 19%		USANA CellSentials
Essentials
HealthPak 100™
Foods(2)
Includes meal replacement shakes, snack bars, and other related products that promote healthy weight management, digestive health, energy and hydration through a holistic approach. These products can be used along with Essentials and Optimizers to provide a complete and healthy diet and sustained energy throughout the day.2022 – 7%
2021 – 7%
2020 – 7%		Nutrimeal
Fibergy
RESET™ weight-management program
5
Product Line/CategoryDescriptionPercent of Product
Sales by Fiscal Year		Product examples
Personal care and Skincare
Includes our premium science-based personal care products and Celavive, our innovative skincare system formulated with our USANA InCelligence Technology®. Celavive offers a comprehensive skincare regimen benefiting multiple skincare types and ethnicities, upgraded science, and more noticeable user benefits.
2022 – 5%
2021 – 6%
2020 – 7%		Vitalizing Serum
Protective Day Cream
Replenishing Night Cream
Protective Day Cream
Perfecting Toner
All OtherIncludes materials and online tools that are designed to assist our Associates in building their businesses and in marketing our products.2022 – 1%
2021 – 1%
2020 – 1%		Associate Starter Kit
Product Brochures
Logo Merchandise
______________________________
(1)Represents a product line consisting of multiple products.
(2)Includes our new Active Nutrition line, which launched in five markets in 2021 and all but two of our remaining markets through the third quarter of 2022.
In addition to the products described above, we offer products designed specifically for prenatal, infant, and young-child age groups in China. As we continue to focus on innovation, we will look for innovative product opportunities such as our Celavive and Active Nutrition product lines.
Total product sales, as a percentage of net sales, represented by our top-selling products for the last three fiscal years is as follows:
Year Ended
202220212020
Key Product
USANA Essentials/CellSentials11 %12 %13 %
Proflavanol10 %10 %11 %
Probiotic10 %9 %9 %
Other top-selling products include our Hepasil, Soy Lecithin, and HealthPak™.
Geographic Presence
We have ongoing operations in the following markets, which are presented in two geographic regions: (1) Asia Pacific, and (2) Americas and Europe. Asia Pacific is further divided into three sub-regions: (i) Greater China, (ii) Southeast Asia Pacific, and (iii) North Asia. The countries included in these regions and sub-regions are described below:
Asia Pacific
(1)Asia Pacific is organized into three sub-regions: Greater China, Southeast Asia Pacific, and North Asia. Markets included in each of these sub-regions are as follows:
(i)Greater China - Hong Kong, Taiwan, and China. Our business in China is conducted by BabyCare
(ii)Southeast Asia Pacific – Australia, New Zealand, Singapore, Malaysia, the Philippines, Thailand, and Indonesia
(iii)North Asia – Japan and South Korea
6
Americas and Europe
(2)Americas and Europe – United States, Canada, Mexico, Colombia, and Europe (the United Kingdom, France, Germany, Spain, Italy, Romania, Belgium, and the Netherlands)
Impact of Foreign Currency Exchange
Because we have operations in multiple markets, with sales and expenses generated and incurred in multiple currencies, our reported U.S. dollar sales and earnings can be significantly affected by fluctuations in currency exchange rates. In general, our operating results are affected positively by a weakening of the U.S. dollar and negatively by a strengthening of the U.S. dollar. In 2022, net sales outside of the United States represented approximately 89.4% of consolidated net sales.
Research and Development
We focus our research and development (“R&D”) efforts on developing and bringing to market high quality, science-based products that promote long-term health and wellness. Our R&D activities include developing products that are new to USANA and new to the industry, updating existing USANA-brand formulas to keep them current with the latest science, and adapting existing formulas to meet ever-changing consumer preferences, and regulations in global markets.
Our scientific staff includes experts on human nutrition, cellular biology, biochemistry, genetics, the microbiome, natural product chemistry, foods and cosmetic science, and clinical research. These experts continually review the latest published research on nutrition, present their findings at scientific conferences, publish in scientific journals, and collaborate with third-party researchers and institutions to identify possible new products and product upgrade opportunities.
The R&D team is also involved in protecting our proprietary position with exclusive ingredients, proprietary formulations, product-specific scientific validation, and, in some cases, patent protection. In 2020, we announced the issuance of U.S. Patent 10,632,101 for our InCelligence complex formula. Research continues to support our proprietary InCelligence technology, advances in microbiome supplementation, immune system support, stress adaptation, and brain health.
Our in-house research team has established and maintained good working relationships with scientists at a number of universities and research institutes, including the University of Washington, the University of Utah, The Foods for Health Institute at The University of California Davis, Roseman University of Health Sciences, University of Memphis, Beijing University of Chinese Medicine (China), Peking University (China), Central Queensland University (Australia), University of Ghent (Belgium), and other academic institutions globally. These relationships help us continue to advance our knowledge, expertise and leadership in several areas of applied human nutrition. Working with these partners, we
select products at all stages of development for preclinical and clinical studies. While several studies were paused over the last few years due to the COVID-19 pandemic, in 2021we returned to conducting clinical studies and expect to accelerate the number of studies we conduct in the coming years.
When developing and manufacturing our products, we follow the highest applicable industry quality standards, as established by the U.S. Food and Drug Administration (“FDA”), U.S. Pharmacopeia (“USP”), other leading non-governmental agencies (“NGO”), and government agencies. Our ingredients are selected to meet a number of criteria, including, but not limited to safety, potency, purity, stability, bioavailability, and efficacy. We control the quality of our products throughout all our internal processes, beginning at the formulation stage. We maintain our quality control through controlled sourcing of raw ingredients, manufacturing, packaging and labeling, with testing occurring at several stages of manufacturing.
In fiscal years 2022, 2021, and 2020, we expended $11.6 million, $11.1 million, and $10.6 million, respectively, on product R&D activities. Going forward, we expect to continue to increase our spending and resources for R&D to advance our expertise and leadership in cellular nutrition, as well as overall health and wellness. We believe our attention to product quality is a sustainable competitive advantage that also provides a substantial barrier to entry for competitors who wish to enter our space.
Manufacturing and Quality Assurance
We conduct manufacturing, production and quality control operations for approximately 65% of our products in-house. We have established and maintain a manufacturing and quality control facility at our corporate headquarters in Salt
7
Lake City, Utah. In 2019, we added a 54,000 square foot manufacturing facility located adjacent to our corporate headquarters, which expanded our manufacturing capabilities to allow us to manufacture our food products in-house. This adjacent facility started to produce saleable product during the fourth quarter of 2020. BabyCare manufactures and produces a significant portion of its products in-house and maintains manufacturing and quality control facilities in Beijing, China and Tianjin, China. This section of this Annual Report gives you more information about our manufacturing, production and quality control operations.
Manufacturing
Our production process uses automatic and semi-automatic equipment and includes the following activities by type:
Tablet
Manufacturing		Foods
Manufacturing		Personal Care and Skincare
Manufacturing
Auditing and qualifying suppliers of raw materialsxxx
Acquiring raw materialsxxx
Analyzing raw material qualityxxx
Weighing or otherwise measuring raw materialsxxx
Mixing raw materials into batchesxxx
Forming mixtures into tabletsx
Converting batches into bars and/or finished powdersx
Coating and sorting the tabletsx
Analyzing tablet qualityx
Analyzing bars and/or finished powder qualityx
Analyzing liquid batch qualityx
Packaging finished productsxxx
Analyzing finished product qualityxxx
We conduct sample testing of raw materials, in-process materials, and finished products for purity, potency, and composition to determine whether our products conform to our internal specifications, and we maintain complete documentation for each of these tests. We employ a qualified staff of professionals to develop, implement and maintain a quality system designed to assure that our products are manufactured to our internal and applicable regulatory agency specifications.
Our Salt Lake City, Utah manufacturing facilities are registered, as required, with the FDA, Health Canada Natural Health Products Directorate, the Australian Therapeutic Goods Administration (“TGA”), and other governmental agencies. These and other various organizations and government agencies regularly audit this facility to assess, among other things, compliance with current Good Manufacturing Practices (“GMPs”) and with labeling claims. Additionally, our Salt Lake City, Utah manufacturing facilities are certified, through inspection and audits, with the Islamic Foods and Nutrition Counsel of America in compliance with Halal, The Organized Kashrus Laboratories in compliance with Kosher, NSF International in compliance with product testing and GMPs, and the TGA in compliance with the current Therapeutic Goods Act in Australia.
The manufacture of nutritional or dietary supplements and related products in the United States requires compliance with dietary supplement GMPs, which are based on the food-model GMPs and pharmaceutical GMPs, with additional requirements that are specific to dietary supplements. We are audited by the FDA, specifically for dietary supplements, and have historically been found to be in compliance with GMPs for dietary supplements. Although the FDA has not promulgated GMPs for personal care items, it has issued guidelines for manufacturing personal care products. We voluntarily maintain compliance with the guidance established by the FDA and the Personal Care Products Council.
Our Beijing, China manufacturing facility is registered with State Administration of Market Regulation (“SAMR”), which includes the China Food and Drug Administration. Our facility in Beijing is audited regularly by various organizations and government agencies to assess, among other things, compliance with applicable GMPs, and with labeling claims.
8
Third-Party Suppliers and Manufacturers
We contract with third-party suppliers and manufacturers for the production of certain of our products, which account for approximately 35% of our product sales. These third-party suppliers and manufacturers produce and, in most cases, package these products according to formulations that have been developed by or in conjunction with our in-house product development team. These products include most of our gelatin-capsulated supplements, Rev3 Energy® Drink, Probiotic, our powdered drink mixes, foods, and certain personal care and skincare products, including our Celavive line for markets outside of China. Products manufactured by third-party suppliers at their locations must also pass through quality control and assurance procedures to ensure they are manufactured in conformance with our specifications. As noted above, with the expansion of our manufacturing facility in Salt Lake City, Utah, we are able to manufacture our foods product line. Additionally, we plan to increase the proportion of the personal care and skincare products that we manufacture. This will reduce our reliance on third-party suppliers and manufacturers and add to our operating strengths, which are described below in this Annual Report.
Quality Control and Assurance
We have in-house microbiology and analytical chemistry labs in which we conduct quality control processes. In our microbiology laboratory, scientists test for biological contamination of raw materials and finished goods. In our analytical chemistry laboratory, scientists test for chemical contamination and accurate levels of active ingredients in both raw materials and finished products. Scientists also identify and confirm all raw materials used in the manufacturing process through scientifically valid means. Both laboratories conduct stability tests on finished products to determine the shelf life of our products. Our Salt Lake City, Utah laboratory staff also performs chemical assays on vitamin and mineral constituents, using USP methods and other internally validated methods. In addition to our quality control and clinical laboratories, both our headquarters and China facilities also house a laboratory designated for R&D.
Raw Materials
Most of the raw ingredients used in the manufacture of our products are available from a number of suppliers. Our raw material suppliers must demonstrate stringent process and quality control before we use their products in our manufacturing process. When supplies of certain raw materials have tightened, we have been able to find alternative sources of raw materials, and believe we will be able to do so in the future, if the need arises.
Distribution and Marketing
General
We distribute our products internationally through direct selling, which entails person-to-person marketing and selling of products. Direct selling is based on the strength of personal relationships and recommendations that frequently come from friends, neighbors, relatives, and close acquaintances. We believe that direct selling is an effective way to distribute our products because it allows person-to-person product education, as well as higher levels of customer service, all of which are not as readily available through other distribution channels.
Structure of Direct Selling Program
Overview. Although our direct selling philosophy and strategy are generally consistent in our markets around the world, certain aspects of our business may differ from market to market as a result of different legal and regulatory regimes, operational requirements or other factors. These differences may include how individuals join USANA, the compensation they are paid, the products they sell, and other components of their relationship with USANA. For example, China has enacted and maintains unique business laws and regulations governing direct selling that differ materially from our other markets around the world. Consequently, we have adjusted our direct selling program in China to comply with these laws and regulations. To do this, we operate our business in China through BabyCare. BabyCare utilizes a business model in China that is consistent with the philosophy of our world-wide business model, but different in structure from our other markets. These differences are explained below under “China Business.”
Associates. Outside of China, a person who wishes to sell USANA products must join our independent sales force as an Associate. A person becomes a USANA Associate by completing an application under the sponsorship of an existing Associate. The new Associate then becomes part of the sponsoring Associate’s sales organization. New Associates must agree to adhere to the USANA policies and procedures. Under our policies and procedures, Associates may not, among other things: (i) use deceptive or unlawful practices to sell USANA products; (ii) make deceptive or unlawful claims or representations concerning our products or Compensation Plan; or (iii) sell competitive products to other USANA
9
Associates or solicit USANA Associates to participate in other direct selling opportunities. Associates who violate our policies are subject to discipline, which may include the termination of their purchase and distribution rights. New Associates are required to purchase a starter kit that includes a detailed manual describing our business and products, as well as our policies and procedures. We sell these kits at a nominal price averaging approximately $19 in each of our markets and these kits are fully refundable under our return policy, which is described elsewhere in this report. No other direct investment is required to become an Associate.
Once a person becomes an Associate, she, he, or they may purchase products directly from us at wholesale prices for their personal use and for resale to customers. Our Associates are also entitled to build sales organizations by attracting, enrolling and selling product to new customers. Associates are not required to recruit or sponsor new Associates and we do not compensate Associates for sponsoring or recruiting Associates. The sponsoring of new Associates results in the creation of multiple levels within our direct sales structure. Sponsored Associates are referred to as part of the sales organization of the sponsoring Associate. New Associates in turn may sponsor new Associates and Preferred Customers, creating additional levels in their sales network, but also forming a part of the same sales organization as the original sponsoring Associate. As outlined below, Associates who are interested in earning income with USANA must successfully sell USANA products and establish a network of product consumers in order to qualify for commissions, including bonuses. Subject to payment of a minimal annual account renewal fee, Associates may continue to distribute or consume our products as long as they adhere to our policies and procedures.
Associate Compensation. This section describes our Associate Compensation Plan generally, except for our China operations, which are discussed separately below under the caption “China Business.” Our Compensation Plan provides several opportunities for Associates to earn compensation, provided they are willing to work consistently at (i) sharing, marketing and selling USANA products to consumers and (ii) building, training, and retaining their sales organizations. The purpose behind each form of compensation under our Compensation Plan is to reward committed Associates for generating product sales either directly or indirectly through their sales organization and network of product consumers.
Associates can earn compensation under the Compensation Plan in four ways:
•Commissions. The primary way an Associate is compensated is through earning commissions. Associates earn commissions by generating sales volume points, which are based on product sales of their sales organization. We have assigned each of our products a sales volume point value comprised of a certain percentage of the product price in U.S. dollars. To be eligible to earn commissions, an Associate must sell a certain amount of product each month. Associates do not earn commissions for simply recruiting and enrolling others in their organization. Commissions are paid only on the sale of products. In most markets, we pay Associates their commissions on a weekly basis.
•Bonuses. We offer Associates several bonus opportunities, including our leadership bonus, elite bonus, and lifetime matching bonus. These bonus opportunities are based on a pay-for-performance philosophy and, therefore, are paid out when the Associate achieves certain performance measures.
•Retail Mark-Ups. As discussed previously, in markets where retail mark-ups are permitted, our Associates purchase products from us at the Preferred Price and may resell them to consumers at higher retail prices. This allows the Associate to retain the retail mark-up as another form of compensation.
•Contests and Promotions. We regularly sponsor contests and promotions designed to incentivize Associates to generate sales, grow their active Customer base and ultimately increase the number of USANA product users. These promotions are also based on a pay-for-performance philosophy and, therefore, are only paid upon the achievement of certain objectives.
With the exception of our China market (discussed below), we endeavor to integrate our Compensation Plan seamlessly across all markets where legally permissible, allowing Associates to receive commissions for global product sales. This seamless sales organization structure is designed to allow Associates to build a global network by establishing or expanding their sales organization in any of the markets where we operate. We believe our Compensation Plan significantly enhances our ability to expand internationally, and we intend to continue to integrate new markets, where permitted, into our Compensation Plan.
Preferred Customers and Retail Customers. We also sell products directly to Preferred Customers and retail customers who purchase the products only for their personal use. Preferred Customers enroll with USANA, generally through an introduction by an Associate, and purchase product directly from the Company. Retail customers, however, generally purchase directly from Associates. Neither Preferred Customers nor retail customers may resell or distribute our
10
products, regardless of where they purchased them. To sell USANA products, a Preferred Customer or retail customer must become an Associate.
These various customer programs give us access to a customer market that would otherwise be missed, by targeting consumers who enjoy USANA products, but who prefer not to maintain a distribution relationship with us. Although our policies prohibit Preferred Customers and retail customers from engaging in retail sales of products, they may enroll as Associates at any time in the future, if they desire.
China Business. As explained above, the Chinese government maintains direct selling laws and regulations that differ materially from our other markets around the world. Although these laws and regulations permit direct selling, they impose a number of financial and operational restrictions, including a prohibition of pyramid selling and multi-level compensation systems. The Chinese government has also implemented a number of administrative and regulatory measures around direct selling to control these prohibited activities. To reduce the risk that the Chinese government might view BabyCare’s business model as conflicting with these laws and regulations, BabyCare utilizes a business model that is different from the model we use elsewhere in the world. BabyCare’s business model has been developed specifically for the China market and is based on, among other things: (i) BabyCare’s communications with the Chinese government, (ii) BabyCare’s interpretation of China's direct selling laws and regulations, as well as its understanding of how the government interprets and enforces these laws and regulations, and (iii) BabyCare’s understanding of how other multinational direct selling companies operate in China. Consequently, individuals who join BabyCare in China do not participate in our Compensation Plan outside of China; instead, they are compensated under BabyCare’s compensation plan, which has been established for China. Notwithstanding the foregoing, BabyCare has not received approval from the Chinese government that its business model, compensation plan or operations comply with applicable laws and regulations, including those pertaining to direct selling.
BabyCare sells products in China through a variety of methods, including: (a) online through its website; (b) at physical branch retail locations; (c) through direct sellers in provinces and municipalities where BabyCare has received a direct selling license granted by the local provincial government; and (d) through independent distributors who are considered independent business owners under Chinese law. Individuals who reside in China and who are interested in being part of our business in China may do so by enrolling with BabyCare. While the process for enrolling with BabyCare is similar to the process for joining our business in other markets, individuals must initially enroll with BabyCare as a China Preferred Customer ("CPC"). CPCs are similar to Preferred Customers in our other markets, but CPCs may also refer other CPCs in China and receive free product value from us on future product purchases based on the volume of product purchased by CPCs they have referred.
A CPC may become a direct seller or independent distributor (which we report collectively as Associates) in China by electing to do so and agreeing to adhere to BabyCare’s policies and procedures in China. Our direct sellers in China are permitted by our policies and the terms of our direct selling licenses to sell product away from fixed retail locations in the provinces and municipalities where BabyCare has been granted a local direct selling license. Direct sellers are compensated for their sales under BabyCare’s compensation plan and do not receive compensation for promotional, marketing, or sales services that independent distributors are eligible to receive (as described below). Independent distributors are independent business owners who sell BabyCare’s products in China and also provide promotional, marketing, and sales services for BabyCare in China. Under BabyCare’s compensation plan, independent distributors are compensated not only for their own product sales, but also for their productivity in providing promotional, marketing and sales services. BabyCare’s compensation to its independent distributors for these services is intended and designed to be business-to-business compensation under Chinese law. To calculate independent distributor compensation for these services, we (i) use our world-wide Compensation Plan to track sales volume, and other metrics for the group of CPCs, distributors and others in China to whom the independent distributor provides promotional, marketing and sales services on behalf of BabyCare; (ii) calculate the fee-based compensation for the various services performed by the distributor; and (iii) pay the corresponding service fee to the independent distributor in China on a monthly basis. The fee-based compensation we pay our China independent distributors is comparable to the compensation available to our Associates in other markets and competitive with other direct selling companies in China.
BabyCare’s business model, compensation plan, and operations in China involve certain risks and uncertainties, as discussed further in Item 1A. Risk Factors. We endeavor to mitigate these risks and uncertainties through various measures, including by seeking to understand and obey laws and regulations, training our employees and sales force, engaging in dialogue with government officials to better understand their goals and explain our plans, and cooperating in inquiries and other matters of interest to regulators. However, these efforts do not completely eliminate the significant risks associated with BabyCare’s operations in China.
11
Associate Training and Motivation. Initial training of Associates about USANA, our products and Compensation Plan, and global direct selling in general, is provided primarily by an Associate’s sponsor and others in the Associate’s sales organization. We develop and provide training materials and sales tools to assist Associates in building their businesses, and we provide reprints from commercial publications that feature USANA that may be used as sales tools. We also sponsor and conduct regional, national, and international Associate events, as well as intensive leadership training seminars. Attendance at these sessions is voluntary, and we undertake no generalized effort to provide individualized training to Associates, although experience shows that the most effective and successful Associates tend to be those who participate in such training activities. Although we provide leadership training and sales tools, we ultimately rely on our Associates to sell our products, attract new customers to purchase our products, and to educate and train new Associates regarding our products and Compensation Plan.
Operating Strengths
Our principal objective is to improve the overall health and nutrition of individuals and families around the world. We do this through developing and manufacturing high-quality, science-based nutritional, and personal care and skincare products that promote long-term health, and providing a global direct selling opportunity for our Associates who desire to distribute our products and earn supplemental income. Our strategy is to capitalize on our operating strengths, which include (i) a strong R&D program; (ii) significant in-house manufacturing capability; (iii) high quality science-based products; (iv) an equitable Associate Compensation Plan; (v) a scalable business model; and (vi) an experienced management team.
Emphasis on Research and Development. We have a technical team of experienced scientists, including several holding doctoral degrees, quality engineers, and regulatory specialists who contribute to our R&D activities. In our R&D laboratories, our scientists and researchers:
•Investigate activities of natural extracts and formulated products in laboratory and clinical settings;
•Identify and research combinations of nutrients that may be candidates for new products;
•Develop new nutritional ingredients for use in supplements;
•Study the metabolic activities of existing and newly identified nutritional ingredients;
•Enhance existing USANA brand products, as new discoveries in nutrition, personal care and skincare are made;
•Formulate products to meet diverse regulatory requirements across all of our markets; and
•Investigate processes for improving the production of our formulated products.
Our in-house research team also conducts double-blind, placebo-controlled, clinical studies, which are intended to further evaluate the efficacy of our products. In addition, we collaborate with outside research organizations to further support various aspects of our R&D efforts. Our in-house research team has funded clinical research programs and works closely with scientists at a number of universities and research institutes, including those listed under the caption “Research and Development” above, to maintain our leadership in clinical research in nutrition, oxidative stress, glycemic stress, chronic inflammation and health implications of the microbiome. It is through our internal R&D efforts, as well as our relationships with outside research organizations and health care providers, that we can provide what we believe to be some of the highest quality health products in the industry.
In-house Manufacturing. We manufacture products that account for approximately 65% of our product sales. We believe that our ability to manufacture our own products in-house is a significant competitive advantage for the following reasons:
•We can better control the quality of raw materials and finished products;
•We can more reliably monitor the manufacturing process to better guarantee potency and bioavailability and to reduce the risk of product contamination;
•We can better control production schedules to increase the likelihood of maintaining an uninterrupted supply of products for our customers;
12
•We are able to produce most of our own prototypes in the research phase of product development; and
•We are better able to manage the underlying costs associated with manufacturing our products.
Science-based Quality Products. As a result of our emphasis on R&D and our in-house manufacturing capabilities, we have developed a line of high quality products that we believe provide health benefits to our customers. Our products have been developed based on a combination of published research, in-house laboratory and third-party clinical studies, and sponsored research.
Equitable Associate Compensation Plan and Support. We are committed to increasing our product sales by providing a competitive compensation plan that attracts and retains Associates who constitute our sales force. We motivate our Associates by paying incentives on a weekly basis, in most markets. Where permissible, our Compensation Plan is implemented as a global-seamless plan, meaning that Associates can be compensated each week for their business success in any market in which they have product consumers and/or a sales organization where we conduct business. Our China operations maintain their own compensation plan, which is structured differently than our plan in other markets. In China, we pay Associates on a monthly basis.
To support our Associates, we sponsor virtual and in-person meetings and events throughout the year, where we offer information about our products and our global direct selling system. These meetings are designed to assist Associates in business development and to provide a forum for interaction with some of our Associate leaders and with members of our management team. Throughout the COVID-19 pandemic, we held meetings and events with our Associates using a predominantly virtual meeting strategy; however, in markets where health and safety best practices have allowed us to safely do so, we have held in-person meetings. Our strategy in 2023, and going forward, is to return to in-person meeting and events with our Associates to the extent health and safety practices make it possible. Our plan is to continue to leverage a virtual meeting element as a component of our in-person meetings. We also provide low-cost sales tools and resources, which we believe are an integral part of building and maintaining a successful home-based business for our Associates.
In addition to company-sponsored meetings, sales tools and resources, we maintain a website exclusively for our Associates, where they can access the latest USANA news, obtain training materials, manage their personal information, enroll new customers, shop for products, and register for company-sponsored events. Additionally, through this website, Associates can access other online services to which they may subscribe. For example, we offer an online business management service, which includes a tool that helps Associates track and manage their business activity, a personal webpage to which prospects or retail customers can be directed, and e-cards for advertising.
We also believe that recognition is an important factor in supporting and retaining our Associates. We understand that being a successful USANA Associate requires hard work and dedication, and we celebrate key achievements and rank advancements of our Associates. We believe that our recognition programs greatly contribute to our ability to retain our Associates.
Business Model. We believe that our direct-selling business model provides, among others, the following advantages:
•No requirement for a company-employed sales force to sell our products, with a relatively low incremental cost to add a new active Customer;
•Commissions paid to our Associates are tied to sales performance;
•Accounts receivable are minimal because payment is required at the time an active Customer purchases product;
•A stream of recurring revenue generated from our monthly product subscription program known as “Auto Order,” which we utilize in all of our markets (this program offers a 10% price discount and represented 65% of our product sales volume for the year ended December 31, 2022); and
•The ability to expand into new international markets with moderate investment because we generally maintain only warehouse facilities, customer support, and minimal administrative facilities in those international markets. Larger markets, including China, however, require more significant local investment.
Experienced Management Team. Our management team includes individuals with expertise in various scientific and managerial disciplines, including global direct selling, nutrition, product research and development, international
13
development, marketing, sales, information technology, manufacturing, finance, legal, regulatory, and operations. This team is responsible for supporting growth, R&D, international expansion, strengthening our financial condition, and improving our internal controls.
Competition
Our industry is very competitive and the barriers to entry are not significant. We compete with manufacturers, distributors, and retailers of nutritional products in many channels, including global direct selling, specialty retail stores, wholesale stores, and the internet generally. We also compete with other public and privately owned global network marketers for distributor talent, including for example Amway, Herbalife, and Nu Skin. On both fronts, compared to USANA, some of our competitors are significantly larger, have a longer operating history, higher visibility and name recognition, and greater financial resources. We compete with these entities by emphasizing to our Associates, Preferred Customers, and potential customers the strengths of our business, as described in the "Operating Strengths" section above.
Product Returns
Product returns have not been a material factor in our business, totaling approximately 0.7%, 0.6%, and 0.7% of net sales in 2022, 2021, and 2020, respectively. Customer satisfaction has always been and will continue to be a hallmark of our business. We believe that we have always offered a generous product return policy. Our standard return policy allows customers to receive a 100% refund on the purchase price on all product orders that are unused and returned within the first 30 days following purchase. Additionally, we offer a 100% refund of the sales price on all product orders that are unused and resalable up to one year from the date of purchase. This standard policy differs slightly in a few of our international markets due to applicable regulations in those markets. To avoid manipulation of our Compensation Plan, return of product when the purchase amount exceeds $100 and the product was not damaged at the time of receipt by the Associate may result in cancellation of an Associate’s distributorship.
Major Customers
We sell product to independent Associates and Preferred Customers. No single Associate or Preferred Customer accounted for 10% or more of net sales in any of the last three fiscal years. Notwithstanding the foregoing, the nature of our business model results in a significant amount of sales to several different Associate leaders and their sales organizations. Although no single Associate accounted for 10% or more of our annual net sales, the loss of a key Associate leader or that Associate’s sales organization could adversely affect our net sales and our overall operating results. See “Item 1A. Risk Factors.”
Associate Compliance
Our reputation depends upon the quality of our products and the integrity of our Associates. We continually monitor and review our Associates’ compliance with our policies and procedures as well as the laws and regulations applicable to our business around the world. Part of this review entails an assessment of our Associates’ sales activities to ensure that they are actually selling products to consumers. Our policies and procedures require Associates to present our products and the USANA opportunity ethically and honestly. Associates are not permitted to make claims about our products or Compensation Plan that are not consistent with our policies and procedures and applicable laws and regulations. The majority of our Associates use marketing and promotional materials provided by USANA. Associates are permitted to produce their own marketing and promotional materials. However, prior to doing so, Associates are required to complete an Advertising Certification to help educate them and prevent them from making unapproved product and business claims.
In the ordinary course of our business, we encounter Associates who fail to adhere to our policies and procedures. We systematically review reports of alleged Associate misbehavior. Infractions of the policies and procedures are reported to our Ethics and Education group, who determine what, if any, disciplinary action is warranted in each case. More serious infractions are also reported to our Ethics Committee, which includes USANA executives. If we determine that an Associate has violated any of our policies and procedures, we may take a number of disciplinary actions, including warnings, fines or probation. Among other measures, we may also withdraw or deny awards, suspend privileges, withhold commissions until specific conditions are satisfied, or take other appropriate actions in our discretion, including termination of the Associate’s purchase and distribution rights.
Because we believe that Associate compliance is critical to the integrity of our business, we are aggressive in ensuring that our Associates comply with our policies and procedures. When an Associate fails to comply with our policies and procedures, we may terminate the Associate’s purchase and distribution rights. From time to time, we become involved
14
in litigation with Associates whose purchase and distribution rights have been terminated. We consider such litigation to be routine and incidental to our business and we will continue to be aggressive in ensuring that our Associates comply with our policies and procedures.
Information Technology
We believe that the ability to efficiently manage sales, active Customer data, distribution, compensation, manufacturing, inventory, accounting and finance, and communication functions through the use of secure, sophisticated, and dependable information processing systems is critical to our success. We continually evaluate changes in the information technology environment in connection with our efforts to capitalize on new technologies, keep pace with regulatory standards, and secure our systems and data. Over the last several years, we have meaningfully invested in technology systems and infrastructure to create a better overall customer experience for our customers and we will continue to invest in this area going forward.
Our information technology resources are maintained primarily by our in-house staff to optimally support our customer base and core business processes. Our IT staff manages an array of systems and processes that support our global operations 24 hours a day and 365 days a year. Three of our most critical applications include:
•A web-based application that provides online services to Associates, such as training sessions and presentations, online shopping, enrollment, a real-time reporting engine, USANA and product information, web hosting, email, and other tools to help Associates effectively manage their business and sales organizations;
•A web-based order-entry system that handles order entry, customer information, compensation, Associate business structure, returns, invoices, and other transactional-based processes; and
•A fully integrated world-wide Enterprise Resource Planning (“ERP”) system that handles accounting, human resources, inventory management, production processes, quality assurance, and reporting requirements in a multinational environment.
Our web applications are supported by a clustered environment providing high availability. All production systems are fully backed up and stored off-site to mitigate the risk of significant interruption of our business in the event of a disaster at the locations of our primary servers.
For information regarding technology-related risks, see the information in “Item 1A: Risk Factors.”
Regulatory Matters
General. In every jurisdiction in which we operate, our business is subject to extensive governmental regulation. These regulations exist at various national and local levels and pertain to our products, direct selling, and other aspects of our business. In this section, we describe the material regulations that are applicable to our business.
Product Regulation. Numerous governmental agencies regulate the formulation, manufacturing, holding, packaging, labeling, advertising, promoting, importing, distributing, shipping, and selling of health supplements, cosmetics, and foods. In the United States, these agencies include the Federal Trade Commission (“FTC”) under the FTC Act, as amended, the FDA, under the Food, Drug, and Cosmetic Act, as amended (“FDCA”) and related regulations, the Consumer Product Safety Commission, the U.S. Department of Agriculture, the Environmental Protection Agency, the United States Customs and Border Patrol, and the United States Postal Service.
Our largest selling product group includes products that are regulated as dietary supplements under the FDCA. Dietary supplements are also regulated in the United States under the Dietary Supplement Health and Education Act of 1994, as amended (“DSHEA”), which we believe is generally favorable to the dietary supplement industry. Some of our powdered drink, food bar, and other nutrition products are regulated as foods under the Nutrition Labeling and Education Act of 1990, as amended (“NLEA”). The NLEA establishes requirements for ingredient and nutritional labeling including product labeling claims. The manufacture of nutritional or dietary supplements and related products in the United States requires compliance with dietary supplement GMPs, which are based on the food-model GMPs and Pharmaceutical GMPs, with additional requirements that are specific to dietary supplements. We are audited annually by the FDA, specifically for dietary supplements and have been found in compliance with GMPs for dietary supplements. The Dietary Supplement & Nonprescription Drug Consumer Protection Act requires manufacturers of dietary supplements and over-the-counter (“OTC”) products to notify the FDA when they receive reports of serious adverse events occurring within the United
15
States. We have an internal adverse event reporting system that has been in place for several years, and we believe that we comply with this law.
In general, our personal care and skincare products, which are regulated as cosmetic products by the FDA, are not subject to pre-market approval by that agency. Cosmetics, however, are subject to regulation by the FDA under the adulteration and misbranding provisions of the FDCA. Cosmetics also are subject to specific labeling regulations, including warning statements, if the safety of a cosmetic is not adequately substantiated or if the product may be hazardous, as well as ingredient statements and other packaging requirements under The Fair Packaging and Labeling Act. Cosmetics that meet the definition of a drug, such as sunscreens, are regulated as drugs. OTC drug products, including cosmetics, may be marketed if they conform to the requirements of the OTC monograph that is applicable to that drug. Drug products not conforming to monograph requirements require an approved New Drug Application (“NDA”) before marketing may begin. Under these provisions, if the agency were to find that a product or ingredient of one of our OTC drug products is not generally recognized as safe and effective or is not included in a final monograph that is applicable to one of our OTC drug products, we would be required to reformulate or cease marketing that product until it is the subject of an approved NDA or until the time, if ever, that the monograph is amended to include such product.
Advertising of our products in the United States is subject to regulation by the FTC under the FTC Act. Claims by us or our Associates about our products that cannot be adequately substantiated may be considered unfair or deceptive acts or practices and may expose us to liability under the FTC Act. In recent years, the FTC has initiated numerous investigations of and actions against companies that sell dietary supplement, weight-management, and cosmetic products. We believe that we have adequate substantiation for all material advertising claims that we make for our products in the United States, and we believe that we have organized the documentation to support our advertising and promotional practices. However, no assurance can be given that the FTC would reach the same conclusion if it were to review or question our substantiation for our advertising claims in the United States.
The FTC may enforce compliance with the law in a variety of ways both administratively and judicially, using compulsory process, cease and desist orders, and injunctions. FTC enforcement can result in orders requiring, among other things, limits on advertising, corrective advertising, consumer redress, divestiture of assets, rescission of contracts, and such other relief as the agency deems necessary to protect the public. During 2020, for example, the FTC sent warning letters to several nutrition companies and direct-selling companies in connection with advertising claims that the companies and/or their distributor sales people were making about the respective company's products ability to prevent or treat COVID-19. Failure to adhere to FTC warning letters or other orders can result in substantial financial or other penalties. Although, to our knowledge, we have not been the subject of any action by the FTC, no assurance can be given that the FTC will not question our advertising or other operations in the United States in the future. Any action in the future by the FTC could materially and adversely affect our ability to market our products successfully in the United States.
The manufacturing, labeling, and advertising of our products are also regulated by various governmental agencies outside the United States in each country where they are distributed. In China, our nutritional products are typically classified as “health functional foods” and our personal care and skincare products are classified typically as “non-special use cosmetics.” The registration process for health functional foods in China is complex and can be unpredictable. It generally requires extensive analysis and approval by the SAMR. As a result, it can take several years to register a product as a health functional food in China. While all products currently sold by BabyCare in China have been registered with the SAMR, we continue to work through the registration process for other health functional food products, which we also hope to begin selling through BabyCare in the future. SAMR and other governmental agencies also enforce advertising and other regulations that restrict the ability of health products companies to advertise the benefits of their products in China.
In Australia, the TGA regulates product registration, labeling and manufacturing. In Japan, the Ministry of Health, Labor and Welfare regulates these activities. Upon entering a new market, prior to commencing operations or marketing products, we may be required to obtain approvals, licenses, or certifications from that country’s Food Administration, Ministry of Health or comparable agency. Approvals or licensing may be conditioned on reformulation of USANA products for the particular market or approval or licensing otherwise may be unavailable with respect to certain products or product ingredients in a given market.
We cannot predict the nature of any future laws, regulations, interpretations, or applications, nor can we determine what effect additional governmental regulations or administrative orders, when and if promulgated, would have on our business. Future changes could include requirements for the reformulation of certain products to meet new standards, the recall or discontinuation of certain products that cannot be reformulated, additional record keeping, expanded documentation of the properties of certain products, expanded or different labeling, and additional scientific substantiation.
16
Any or all of these requirements could have a material adverse effect on our business, financial condition, and operating results.
Direct Selling Regulation. Various laws and regulations in all of our markets regulate direct selling. These laws and regulations exist at many levels of government in many different forms, including statutes, rules, regulations, judicial decisions, and administrative orders. Direct selling regulations are inherently fact-based and often do not include “bright line” rules. In most of our markets, these regulations are subject to discretionary interpretation by regulators and respective legal authorities. Consequently, the regulations, or a regulator’s interpretation and enforcement of the regulations, could change at any time. If that were to occur, we may be required to change our business model in the respective market in an effort to comply.
In the United States, the FTC has jurisdiction to regulate direct selling companies under the FTC Act. The FTC’s interpretation of the applicable direct selling laws and regulations has evolved over the last several years as represented in various consent orders between the FTC and certain direct selling companies, guidance issued by the FTC to the direct selling industry and informal communications from the FTC to the industry. The FTC, through these consent orders, guidance and communications, has addressed a variety of consumer protection issues, including misleading earnings representations by a company or its independent distributors, as well as the fairness and legal compliance of a company’s business model and distributor compensation plan. For example, in 2020, the FTC sent warning letters to several direct-selling companies in connection with income claims allegedly made by the companies and/or their distributor sales forces in the context of the respective company's business opportunity during the COVID-19 pandemic. The consent orders, guidance and communication from the FTC have also created a degree of ambiguity and uncertainty regarding how the FTC and other regulators will interpret the laws, regulations and judicial precedent applicable to direct selling in the United States. In October 2021, the FTC, pursuant to its Penalty Offense Authority under the FTC Act, sent letters to over 1,100 companies, including USANA, warning them that the FTC could seek penalties of up to $43,792 per violation for conduct determined to be unfair, deceptive, or otherwise unlawful in certain prior FTC actions. The letter did not accuse any recipient company, including USANA, of engaging in unlawful conduct. But if the FTC later alleges that we have engaged in acts or practices found to be unfair, deceptive, or unlawful in the actions referenced in the letters, we could be at risk of penalties and other potential liability.
As noted above, the Chinese government has adopted direct selling laws and regulations that contain a number of financial and operational restrictions on direct selling companies, as well as prohibitions on pyramid selling and multi-level compensation. These regulations are subject to discretionary interpretation and enforcement by various municipal, provincial and state officials in China. Departments within the Chinese government that regulate direct selling include the Ministry of Commerce (“MOFCOM”), the Ministry of Public Security (“MPS”) and their regional and local counterparts. BabyCare’s business model has been developed specifically for China based on, among other things: (i) BabyCare’s communications with the Chinese government, (ii) BabyCare’s interpretation of the direct selling laws and regulations, as well as its understanding of how the government interprets and enforces the regulations, and (iii) BabyCare’s understanding of how other multinational direct selling companies operate in China.
Notwithstanding the foregoing, the direct selling industry in China, as well as the regulatory environment for the industry, continues to evolve and receive significant attention and scrutiny from the Chinese government and the Chinese media. In 2019, following unfavorable media coverage of certain health product companies and direct selling companies, several departments of the Chinese government, including SAMR, MPS, and MOFCOM, initiated a review of health product and direct selling companies. This review required direct-selling companies in China such as BabyCare to conduct a self-assessment of the regulatory compliance of their business (including product regulatory compliance and direct selling regulatory compliance) and to provide information to the Chinese government regarding that assessment. The review also entailed a review of direct sellers' regulatory compliance by various departments of the Chinese government. During this review, the Chinese government, among other things, instructed direct selling companies not to hold large distributor meetings, and suspended its application review process for direct sales licenses and authorizations. The Chinese government has yet to re-open the application review process for direct sales licenses and authorizations or indicate if or when it plans to do so. The Chinese government's scrutiny of the direct selling industry has been higher following the 2019 review.
The Chinese government has taken action historically against direct selling companies that it believes have violated the government’s direct selling regulations and anti-pyramiding laws. The government’s action in this regard has entailed investigating direct selling companies and their distributors, imposing significant fines and, in some cases, shutting down companies it believed to be in violation. Historically, there have been instances when inquiries or complaints about BabyCare’s business resulted in warnings from the Chinese government, as well as the payment of fines by BabyCare or its distributors.
17
BabyCare has obtained direct selling licenses in certain provinces and municipalities in China, but must obtain others from additional provinces and municipalities if it is to continue to expand its direct selling business model in China. As of the date of this Annual Report, BabyCare has been granted licenses to engage in direct selling in the provinces and municipalities of Beijing, Jiangsu, Shaanxi, and Tianjin.
Direct selling companies, and the industry in general, continue to experience significant media and public scrutiny. Several companies similar to USANA recently have been scrutinized and penalized in several markets where we operate, including the United States, Canada, China, Japan, and South Korea. This scrutiny, along with the uncertainty of the laws and regulations pertaining to direct selling in many countries, can affect how a regulator or member of the public, including investors, perceives us. For instance, there has been significant media and short-seller attention given to the viability and legality of direct selling in the United States and China over the past few years. This attention has led to intense public scrutiny of our industry, as well as volatility in our stock price and the stock prices of other direct selling companies who operate in the same markets. We cannot predict the impact that this scrutiny may have on our business or industry in the future.
We detail more of the various risks associated with the regulation of our overall business, direct selling business model and Compensation Plan in this Annual Report in “Item 1A. “Risk Factors.”
Transfer Pricing Regulation. In the United States and many other countries, we are subject to transfer pricing and other tax regulations designed to ensure that appropriate levels of income are reported by our United States or international entities and taxed accordingly. We have adopted transfer prices, which are supported by formal transfer pricing studies for the sale of products to our subsidiaries in accordance with applicable transfer pricing laws. In addition, we have entered into agreements with our subsidiaries for services and other contractual obligations, such as the payment of Associate incentives that are also supported by the same formal transfer pricing studies. We have experienced instances in the past where international taxing authorities have successfully challenged our transfer pricing calculations and agreements and assessed us additional tax. Going forward, if the U.S. Internal Revenue Service (“IRS”) or the taxing authorities of any other jurisdiction successfully challenge these agreements or require changes in our standard transfer pricing practices for products, we could become subject to higher taxes and our earnings could be adversely affected. The tax treaties between the United States and most countries provide competent authority for relief to avoid any double taxation. We believe that we operate in compliance with all applicable transfer pricing regulations. There can be no assurance, however, that we will continue to be found to be operating in compliance with transfer pricing regulations or that those laws will not be modified, which may require that we change our operating procedures.
Intellectual Property
Trademarks. We have developed and use registered trademarks in our business, particularly relating to our product names. We own 28 trademarks that are registered with the U.S. Patent and Trademark Office. Federal registration of a trademark enables the registered owner of the mark to bar the unauthorized use of the registered mark by a third party in connection with a similar product in similar channels of trade anywhere in the United States, regardless of whether the registered owner has ever used the trademark in the area where the unauthorized use occurs. We have filed applications and own trademark registrations, and we intend to register additional trademarks in countries outside the United States where USANA products are or may be sold in the future. Protection of registered trademarks in some jurisdictions may not be as extensive as the protection in the United States.
We also claim ownership and protection of certain product names, unregistered trademarks, and service marks under common law. Common law trademark rights do not provide the same level of protection that is afforded by the registration of a trademark. In addition, common law trademark rights are limited to the geographic area in which the trademark is actually used. We believe these trademarks, whether registered or claimed under common law, constitute valuable assets, adding to recognition of USANA and the effective marketing of USANA products. Trademark registration once obtained is essentially perpetual, subject to the payment of a renewal fee and continue usage of the trademark. We therefore believe that these proprietary rights have been and will continue to be important in enabling us to compete.
Patent. We own U.S. Patent 10,632,101 for our InCelligence complex formula. This patent was issued in 2020.
Trade Secrets. We own certain intellectual property, including trade secrets that we seek to protect, in part, through operational protections and confidentiality agreements with employees, consultants, vendors and other parties. Even where these agreements exist, there can be no assurance that these agreements will not be breached, that we would have adequate remedies for any breach, or that our trade secrets will not otherwise become known to or independently developed by competitors. Our proprietary product formulations are generally considered trade secrets, but are not otherwise protected under intellectual property laws.
18
We intend to protect our legal rights concerning intellectual property by all appropriate legal action. Consequently, we may become involved from time to time in litigation to determine the enforceability, scope, and validity of any of the foregoing proprietary rights. Any intellectual property litigation could result in substantial cost and divert the efforts of management and technical personnel.
Seasonality
Although we are not significantly affected by seasonality, we do experience variations in the activity of our customers in many of our markets in the first and fourth quarters around major cultural events such as Chinese New Year and Christmas.
Backlog
Our products are typically shipped within 72 hours after receipt of an order. As of February 24, 2023, we had no significant backlog of orders.
Working Capital Practices
Due to our dual role as manufacturer and distributor, we require substantial inventories, as such, we strive to maintain sufficient amounts of inventory in order to provide a high level of service to our customers. We also watch seasonal commodity markets and may buy ahead of normal demand to hedge against cost increases and supply risks.
Environment Laws
We are not aware of any instance in which we have contravened federal, state, or local laws relating to protection of the environment or in which we otherwise may be subject to liability for environmental conditions that could materially affect operations.
Our Values and Culture
Our business is driven by our four Core Values:
•Excellence: We rely on scientific research to provide innovative, healthy living solutions, and we empower all individuals to continually improve each day.
•Community: We support, care for, and encourage one another, and the world, to live happier, healthier lives.
•Integrity: We demonstrate honesty, responsibility, and accountability through our individual actions and corporate decision-making.
•Health: We cultivate a holistic view of wellness that supports a healthy body and a strong mind.
Corporate Sustainability
In 2021, our Board of Directors formed a separate Sustainability Committee to oversee and advise on all matters related to corporate sustainability, including ESG. The Sustainability Committee is composed of directors Peggie Pelosi, Chair; John Fleming; Frederic Winssinger; Tim Wood; and Scott Nixon. In the United States and abroad there are an increasing number of sustainability-related rules and regulations that have been adopted or proposed. Such regulations may subject us to new disclosure requirements, which could result in risks to our reputation or consumer demand for our products if we do not meet increasingly demanding stakeholder expectations and standards. We will continue to incorporate and advance sustainability-related best practices across all of our markets as part of our commitment to improving the health and wellness of individuals, families and communities around the world.
19
Our ESG strategy centers on three main pillars - products, people, and planet - that encompass where we are focusing our sustainability efforts now and in the future. To achieve our goals, we plan to continue fortifying each pillar, to deliver meaningful progress while evolving our efforts to ensure our business becomes more sustainable day by day.
Strategic PillarsTier One TopicsTier Two Topics
Products
•Product quality and safety
•Responsible Sourcing
•Health and nutrition
•Affordable and accessible products
People
•Talent Management and development
•Employee health, safety, and well-being
•Diversity, equity, and inclusion
•Human rights
Planet
•Sustainable packaging
•Waste management
•Greenhouse gas management
•Biodiversity and environmental conservation
•Energy management
•Water management
We encourage you to review our most recent Sustainability Report available on our investor relations website https://ir.usana.com/ for more detailed information regarding our human capital programs and initiatives. Nothing on our website, including our Sustainability Report or sections thereof, is deemed incorporated by reference into this Report.
Human Capital
We believe that "creating the healthiest family on earth by empowering the individual" starts with our employees. Key to our ambition is giving our employees the skills and development they need to build a meaningful career and tools to support their total health and wellness and enhancing our diverse and inclusive workplace culture to help employees thrive. We also believe that the manner in which we address issues related to workforce demographics, diversity and inclusion, community involvement, talent management, and employee health and safety directly correlates to our success as a business.
As of February 24, 2023, we had approximately 1,900 employees working in 23 countries worldwide, as measured by full-time equivalency. The majority of our employee population resides in the United States (46%) and China (28%). Approximately 58% of our world-wide employee population is female. We are actively working through initiatives such as our Women in Leadership Program, along with formal and informal mentorship programs, to continue promoting and hiring talented and capable women into management roles. We have also increased the number of women in senior leadership roles over the past several years.
Our employees are not currently represented by a collective bargaining agreement, and we have not experienced work stoppages as a result of labor disputes. We believe that we have a good relationship with our employees.
We are committed to fostering a diverse, inclusive and equitable workplace. Our diversity, equity and inclusion (“DEI”) program is designed to promote representation and engagement at all levels of the organization. Through our mentorship program and Women in Leadership initiative, we are working to increase representation of underrepresented groups in leadership positions. Our DEI council focuses on education and awareness, access to developmental programs, and community engagement.

One of the key elements of our DEI program is our commitment to volunteerism and charitable action. In 2022 we have spent more than 2,600 hours volunteering, working with local organizations to help promote diversity, equity and inclusion in the communities where we operate. Additionally, we have launched new programs that foster career development and help to ensure that all employees have the opportunity to reach their full potential.

In addition to these internal initiatives, we also partner with other organizations to help achieve our DEI goals. By working together with other companies, community groups, and non-profits, we are able to amplify our impact and create a more inclusive and equitable society for all.

Our DEI program is a key component of our company culture. By fostering diversity and inclusion, we are able to create a more vibrant and innovative workplace that benefits all of our employees, customers, and stakeholders. We will continue to invest in this program, and strive to make our company an inclusive, equitable and welcoming place for all.
20
We understand the value of developing employees at every level. Our leaders actively participate in leadership development programs that include mentorship and coaching, online learning, and regular company and industry specific training programs. Additionally, our global employee population is engaged in online learning platforms and, more than 350 participants have completed our mentorship and coaching program. All employees are encouraged to attend training specific to their role, as well as, utilize our tuition reimbursement program, which has provided additional monetary support to employees at all levels as they pursue bachelor and advanced college degrees.
The health and safety of employees is also a key element in providing return to all stakeholders. In addition to following mandatory government requirements for health and safety, we have established a wellness program that includes free nutritional products to employees.
Employees in our corporate headquarters have access to an on-site gym, exercise classes, free access to massages, and chiropractic care. A health clinic located on the campus of our corporate headquarters provides medical and mental health care, and is actively engaged in the health of about 46% of our eligible employees.
The health and safety of our employees around the world remains our top priority. We remain committed to being socially responsible as a corporate leader in each of our markets and doing our part to reduce the spread of COVID-19. As such, we continue to utilize a modified operating model in each of our markets as necessary to follow applicable guidelines from government and health officials. Although a significant portion of our non-manufacturing and non-distribution employees continued with remote working arrangements, we began efforts during the second quarter of 2021 to bring these employees back to our offices, in markets where health and safety best practices have allowed us to safely do so. In connection with this effort, permit most of our employees to utilize a hybrid work schedule, which allows them to split their time working at the office and remotely. Employees working on site are required to follow applicable health and safety guidelines. We continue to utilize flexible shift schedules, time and attendance policies, and sick-leave policies to promote health, wellness and safety. Where necessary in our international markets, we have temporarily closed product will-call centers and continue to offer curbside delivery and subsidized shipping to customers. We will continue to monitor the situation surrounding the pandemic and implement additional risk mitigation actions where necessary.
We recognize that a strong commitment to community is essential to all stakeholders. In 2012, we established the USANA Foundation, which operates independently to provide nutrition to under-privileged children and families worldwide. In 2022, the USANA Foundation:
•Provided over 12 million meals;
•Provided over $500,000 in aid and grants to partner charities around the world;
•Distributed weekly backpacks of food for children in 42 schools to take home on the weekend;
•Supported 44 additional schools by providing large packs of food for children to take home during long holiday breaks; and
•Gifted approximately 6,000 bottles of children's vitamins to some of the most malnourished children around the world.
A discussion of the risks relating to our ability to attract and retain active Associates and Preferred Customers, and the loss of key management, is included in Item 1A. Risk Factors.
21
Information About Our Executive Officers and Directors
Executive Officers
The following table sets forth certain information regarding our Executive Officers as of the date of this Annual Report.
NameAgePosition
Kevin G. Guest60Chief Executive Officer and Chairman of the Board
Jim Brown54President
G. Douglas Hekking53Chief Financial Officer
Paul A. Jones59Chief People Officer
P. Joshua Foukas47Chief Legal Officer, General Counsel and Corporate Secretary
Daniel A. Macuga53Chief Communications and Marketing Officer
Robert Sinnott58Chief Scientific Officer
Walter Noot57Chief Operating Officer
David Mulham62Chief Sales Officer
Brent Neidig39Chief Officer and Managing Director of China
Kevin G. Guest was appointed Chief Executive Officer in 2016 and Chairman of the Board and Chief Executive Officer in May 2020. Mr. Guest's important role as the leading force of our management and sales efforts, and his talent as a motivating leader, qualify him to serve as a member of the Board. Mr. Guest earned a B.A. in Communications from Brigham Young University.
Jim Brown has been President of the Company since 2016. From 2016 to 2019 he served as President and Chief Operating Officer. Mr. Brown received a bachelor’s degree with a double major in computer science and math, and an M.B.A. from Francis Marion University in Florence, South Carolina.
G. Douglas Hekking became our Chief Financial Officer in May 2017. Mr. Hekking received a B.S. in accounting from the University of Utah and an M.B.A. from Brigham Young University.
Paul A. Jones has been our Chief People Officer since 2021. From 2015 to 2021, Mr. Jones was Chief Leadership Development Officer. Mr. Jones received a B.S. in finance from Utah State University and M.A. in organizational management from the University of Phoenix.
P. Joshua Foukas has served as our Chief Legal Officer and Corporate Secretary since 2018. Mr. Foukas received a B.A. from the University of Utah and a J.D. from the University of Idaho.
Daniel A. Macuga, Jr. became Chief Communications and Marketing Officer of USANA in 2017. Mr. Macuga received a B.A. in communications from the University of California, San Diego.
Robert A. Sinnott, M.N.S., Ph.D. joined USANA as Chief Scientific Officer in August 2016. Dr. Sinnott holds a B.S. in Biological Sciences, an M.S. in Natural Science, and a Ph.D. in Plant Sciences from Arizona State University, in Tempe, Arizona. His focus was on applied biological sciences, including biotechnology and plant medicinal chemistry.
Walter Noot joined USANA as Chief Information Officer in December 2016 and served in that role until he was promoted to Chief Operating Officer in October 2019. He holds a B.S. in mechanical engineering from Brigham Young University.
David Mulham was appointed Chief Field Development Officer in 2017. Mr. Mulham has a postgraduate diploma from Macquarie Graduate School of Management, Sydney.
Brent L. Neidig was appointed Executive Vice President of China in February 2017, and in April 2019 was named Chief Officer and Managing Director of China. Mr. Neidig received a B.S. in accounting and M.B.A. from the University of Utah.
22
As announced on February 13, 2023, our Board of Directors has appointed Jim Brown as the Company's Chief Executive Officer effective July 1, 2023, at that time, Kevin Guest will transition to Executive Chairman.
Board of Directors
The following table sets forth certain information regarding our Directors as of the date of this Annual Report.
NameAgePosition
Kevin Guest60Chief Executive Officer and Chairman of the Board
Gilbert A. Fuller82Director
Xia Ding52Director
Peggie J. Pelosi 67Director
Frederick J. Winssinger54Director
Timothy Wood74Director
John T. Fleming79Director
Scott Nixon63Director
Additional Available Information
We maintain our corporate headquarters, executive offices, and principal facilities at 3838 West Parkway Boulevard, Salt Lake City, Utah 84120. Our telephone number is (801) 954-7100. Our website address is www.usanahealthsciences.com. The information on our website should not be considered part of and is not incorporated into this Annual Report by reference.
We make available, free of charge at our corporate website, copies of our reports filed with the SEC under the Exchange Act, including our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, proxy statements, and all amendments to such reports, as soon as reasonably practicable after such reports or other material have been electronically filed with or furnished to the SEC pursuant to Section 13(a) or 15(d) of the Exchange Act. This information may also be obtained from the SEC via its on-line database, which is located at www.sec.gov.
You may also obtain, free of charge on our website, a copy of our Corporate Governance Guidelines, our Code of Ethics for Directors and Employees, and the charters of the Audit Committee, Governance, Risk and Nominating Committee, Compensation Committee, and Sustainability Committee of our Board of Directors.
Item 1A. Risk Factors
We have listed below the most material risk factors applicable to us. These risk factors are not necessarily in the order of importance or probability of occurrence: You should consider the following risk factors, in addition to the information presented elsewhere in this Annual Report, particularly under the heading “Cautionary Note Regarding Forward-Looking Statements,” on page 1, and the disclosures contained in Part I, “Item 1. Business,” and Part II, “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” of this report, as well as in the other filings we make from time to time with the SEC, in evaluating us, our business and an investment in our securities.
Risk Associated with Direct Selling
Direct selling is subject to intense government scrutiny, and regulation and changes in the law, or the interpretation and enforcement of the law, might adversely affect our business.
Various laws and regulations in the United States and other countries regulate direct selling. These laws and regulations exist at many levels of government in many different forms, are inherently fact-based, and often do not include “bright line” rules. We are also subject to the risk that the laws and regulations, or a regulator’s interpretation and enforcement of the laws and regulations, could change.
In the United States, the FTC is one of many regulators who regulate direct selling. The FTC has actively warned various direct selling companies and the industry as a whole about certain business practices associated with direct selling and entered into settlements with several direct selling companies that required those companies to modify their compensation plans and business models. Those settlements resulted from enforcement actions brought by the FTC involving a variety of alleged violations of consumer protection laws, including misleading earnings representations and
23
legal compliance of those companies’ business models and distributor compensation plans. For example, in 2016, the FTC entered into a settlement with another direct selling company following an enforcement action in which the FTC alleged that the company’s distributors were making misleading earnings representations and that the company was utilizing an illegal business model. Also in 2016, the FTC entered into a settlement with another direct selling company following an enforcement action in which the FTC alleged that the company’s distributors had made misleading income representations and that the company was utilizing an unfair and deceptive compensation plan.
In 2019, the FTC entered into a settlement with a direct selling company following an FTC enforcement action, which included the alleged violations noted above. Pursuant to this settlement, the company is permanently prohibited from using a multilevel compensation plan in the United States. Following this settlement, the FTC initiated litigation with another direct selling company for similar alleged violations and is seeking similar remedies, including a prohibition of multilevel compensation in the United States. This case remains in litigation. Settlements, such as those described in the cases above, may require a direct selling company to pay a significant fine, revise its U.S. business model and compensation plan to comply with various restrictions on how it can compensate distributors and change its marketing practices to avoid misleading product or income representations, among other things. Although a settlement between the FTC and a specific company does not generally have force of law or binding effect on other companies, FTC officials have indicated that the direct selling industry should look to these settlements, and the principles contained therein, for guidance.
In 2020, the FTC sent warning letters to several direct-selling companies regarding product and/or income claims that the companies and/or their distributors were making related to the COVID-19 pandemic. In 2021, the FTC, pursuant to its Penalty Offense Authority under the FTC Act, sent letters to over 1,100 companies, including USANA, warning them that the FTC could seek penalties of up to $43,792 per violation for conduct determined to be unfair, deceptive, or otherwise unlawful in certain prior FTC actions. The letter did not accuse any recipient company, including USANA, of engaging in unlawful conduct. But if the FTC later alleges that we have engaged in acts or practices found to be unfair, deceptive, or unlawful in the actions referenced in the letters, we could be at risk of penalties and other potential liability.
The FTC is currently advocating and considering certain legal and regulatory changes that, if implemented, could have a material adverse effect on our business. For example, in 2022 the FTC issued an Advanced Notice of Proposed Rulemaking for a proposed rule concerning deceptive earnings claims that would further regulate how companies like USANA advertise and represent their business. The FTC is also currently reviewing the Business Opportunity Rule, which requires business opportunity sellers to give prospective buyers specific information to help them evaluate a business opportunity or work-at-home program. Direct sellers like USANA are currently exempt from the Business Opportunity Rule, but the FTC could include direct sellers within the scope of the rule as a result of the review. If direct sellers become subject to the rule, we will have to comply with disclosure requirements that could significantly increase the cost of doing business and have other material adverse effects on our business.
We regularly analyze our business model in response to settlements between the FTC and other direct selling companies, as well as guidance and other communications issued by the FTC, and from time to time we refine aspects of our business model where appropriate. Although we strive to ensure that our business model and compensation plan are compliant with applicable laws and regulations, as well as regulatory guidance, in each of our markets, we cannot assure you that a regulator, if it were to review our business, would agree with our assessment and would not require us to change one or more aspects of our operations. Any action against us in the future by the FTC or another regulator could materially and adversely affect our operations.
We are also subject to various direct selling laws and regulations in our other markets, including China (as explained below). We cannot predict the nature of any future law, regulation, or guidance, nor can we predict what effect additional governmental regulations, judicial decisions, or administrative orders would have on our business. Failure by us, or our Associates, to comply with these laws, regulations, or guidance, could have a material adverse effect on our business in a particular market or in general. Finally, the continuation of regulatory challenges, investigations and litigation against other direct selling companies could harm our business and industry if the laws and regulations are interpreted in a way that results in additional restrictions on direct selling companies in general.
The violation of marketing or advertising laws by Associates in connection with the sale of our products or the improper promotion of our Compensation Plan could adversely affect our business.
All Associates contractually agree to adhere to our policies. Although these policies prohibit Associates from making false, misleading and other improper claims regarding products or income potential from the sale of the products, from time to time Associates, without our knowledge and in violation of our policies, create promotional materials or otherwise provide information that does not accurately describe USANA, our products or the Compensation Plan. They
24
also may make statements regarding potential earnings, product claims, or other matters in violation of our policies or applicable laws and regulations concerning these matters. These violations may result in legal action against us in our various markets by regulatory agencies, state attorneys general, or private parties – and in China by the Chinese government. Legal actions against us or our Associates or others who are associated with us could lead to increased regulatory scrutiny of our business, including our business model. We take what we believe to be commercially reasonable steps to (i) regularly train our Associates, and (ii) monitor the activities of our Associates to guard against misrepresentation and other illegal or unethical conduct by Associates and to assure compliance with our policies. There can be no assurance, however, that our efforts in this regard will be sufficient to accomplish this objective. In the past, we have experienced adverse publicity both within and outside of our sales force for enforcing our Associate policies and procedures. This type of adverse publicity has made, and will continue to make, it difficult for us to attract and retain Associates and Preferred Customers and may have an adverse effect on our business, financial condition, and results of operations.
We may have or could incur obligations relating to the activities of our Associates.
Our Associates are subject to taxation, and, in some instances, legislation or governmental agencies may impose an obligation on us to collect taxes, such as sales taxes or value added taxes, and to maintain appropriate records of such transactions. In addition, we are subject to the risk in some jurisdictions of being responsible for social security and similar taxes as well as employee benefits with respect to our Associates. In particular, the laws regarding independent contractor status in certain jurisdictions, including the United States, continue to evolve and, in some cases, authorities have sought to apply these laws unfavorably against gig economy, platform and direct selling companies, including USANA. In 2020, we were named as a defendant in a private lawsuit in California by a plaintiff’s firm that is seeking to reclassify our California Associates from independent contractors to employees under California state law. While we do not believe this litigation is material to our business, and we believe we have legally and appropriately classified our Associates as independent contractors, it is possible that this lawsuit or potential future laws, could negatively impact the independent contractor status of our Associates or distributors in direct selling companies in general. For example, in 2022, the U.S. Department of Labor proposed a regulation that, if adopted, would alter the employee vs. independent contractor analysis in a way that could potentially cause more workers to be classified as employees.
If federal, state or local laws and regulations or the interpretation of such laws and regulations change to require us to treat our Associates as employees, or if our Associates are deemed by local regulatory authorities in one or more of the jurisdictions in which we operate to be our employees rather than independent contractors, under existing laws and interpretations, we may be deemed to be responsible for a variety of obligations that are imposed upon employers relating to their employees, including social security and related taxes in those jurisdictions, wages, employee benefits, plus any related assessments and penalties, which could harm our financial condition and operating results.
Our Associate Compensation Plan, or changes we make to it, may be viewed negatively by some Associates, could fail to achieve our desired objectives, and could have a negative impact on our business.
From time to time, we modify our Compensation Plan to (i) keep it competitive and attractive, (ii) cause or address a change in Associate behavior, (iii) conform to legal and regulatory requirements, or (iv) address other business needs. It is difficult to predict how any changes to the plan will be viewed by Associates and whether such changes will achieve their desired results. For example, in 2023 we launched our Affiliate program in three markets and this program creates a new and different element of our Compensation Plan. There can be no assurance that changes to our Associate Compensation Plan will allow us to successfully attract new Associates or retain existing Associates, nor can we assure that any changes we make to our Compensation Plan will achieve our desired results. Additionally, the payment of Associate incentives under our Compensation Plan is our most significant expense. Modifying our Compensation Plan directly affects the incentives we pay as a percentage of net sales. There can be no assurance that changes to the Compensation Plan will be successful in achieving target levels of Associate incentives as a percentage of net sales. Furthermore, such changes may make it difficult to attract and retain qualified and motivated Associates.
Changes we are required to make to our Associate Compensation Plan in certain markets, including limits on the amount of Associate compensation we can pay, may hurt our ability to attract and retain Associates, result in regulatory risk and affect our operating results.
We have been required to modify our Associate Compensation Plan in certain markets to comply with the laws and regulations in these markets or the interpretation of the same by authorities in these markets. For example, we have been required to use a different compensation plan for our BabyCare operations in China (as noted elsewhere in this report) and have been required to modify our Compensation Plan in South Korea, Malaysia, and Indonesia to comply with
25
applicable laws and regulations. We obtain regulatory approval of our Compensation Plan when required or, when not required, we may seek a legal opinion regarding compliance. We may also be prohibited from distributing products through direct selling or paying multilevel compensation in some countries. Several markets, including China, South Korea, and Indonesia also impose limits on the amount of compensation we can pay to our Associate sales force.

If we fail to comply with the legal requirements for our Compensation Plan in our various markets, including the limits on compensation we are legally permitted to pay, we may incur fines or other sanctions, including the loss of applicable licenses to conduct our business. These required changes to Compensation Plan, including compensation limits, may also be viewed as limiting the incentive for people to join our Associate sales force and may reduce the competitive advantage of our Associate Compensation Plan.
Risks Related to Our China Business
Our Greater China region accounts for a significant part of our business and expected growth. A decline in sales or customers in this region would harm our business, financial condition and results of operations.
Our Greater China region consists of China, Hong Kong, and Taiwan and has been our largest region for sales over the last several years and China has been our largest market. Our international growth strategy has focused largely on growing our China business. For the last three years, health officials in Greater China have responded to the COVID-19 pandemic, which has created a challenging operating environment for our business in China and has negatively impacted our sales and customer results. Additionally, in 2019, our sales and active Customer counts in both the Greater China region and our China market declined, largely because of a challenging operating environment in China, following the China’s governments inquiry into and review of the health foods industry in China. If we are not successful in growing BabyCare’s sales and customer base in China, our consolidated growth as a company will be negatively affected and our business, financial condition, results of operations and cash flows may be harmed.
BabyCare must comply with significant operational, financial, and other regulatory requirements to engage in direct selling in China. Although we believe that we will be successful in growing BabyCare’s business in China, it is difficult to assess the extent to which BabyCare’s business model and compensation plan will be successful or deemed to be compliant with applicable Chinese laws and regulations. In light of the factors listed above, and the other risks to our business, there can be no assurance that we will be successful in increasing sales and customers in China through BabyCare.
Our operations in China are subject to significant government regulation, as well as a variety of legal, political, and economic risks. If the Chinese government modifies its direct selling laws and regulations, or interprets and enforces these laws and regulations in a manner that is adverse to our business in China, our consolidated business and results of operations may be materially harmed.
Our operations in China are conducted by BabyCare, our China subsidiary. BabyCare operates in China pursuant to direct selling laws and regulations that are uncertain and evolving. These regulations contain a number of financial and operational restrictions for direct selling companies, including prohibitions on pyramid selling and multi-level compensation. The laws and regulations are also subject to discretionary interpretation and enforcement by various state, provincial and municipal level officials in China. Regulators in China may modify current direct selling laws and regulations or change how they interpret and enforce them. As a result, there can be no assurance that the Chinese government’s current or future interpretation and application of existing and new regulations will not negatively impact our business in China, result in regulatory investigations or lead to fines or penalties against us or our Associates.
The Chinese government also exercises significant control over the Chinese economy, including through controlling capital, foreign currency exchange, foreign exchange rates, and tax regulations, providing preferential treatment to certain industry segments or companies and issuing required licenses to conduct business. We also face additional risks resulting from new and expanded China data privacy and security laws and regulations. Accordingly, any adverse change in the Chinese governmental, economic or other policies could have a material adverse effect on BabyCare’s business in China and our consolidated results of operations.
In addition to BabyCare's direct selling business in China, we periodically offer and sell certain U.S. products in China through a cross-border e-commerce sales channel by utilizing one of our separate China subsidiaries that is registered to engage in cross-border e-commerce. This cross-border e-commerce channel is legally required to be separate from BabyCare's direct selling business in China. The products that we offer and sell through this channel are neither registered for retail sale in China nor registered as direct selling products under BabyCare's direct sales license.
26
Consequently, products sold via our cross-border e-commerce channel can only be sold to China customers for their personal consumption and cannot be sold through BabyCare's direct selling channel. BabyCare's direct selling business in China could be negatively impacted if China regulatory authorities (i) attribute our cross-border e-commerce sales and related product claims to BabyCare's direct selling business, and (ii) make a determination that the same are in violation of direct selling or other applicable laws and regulations.
Although BabyCare utilizes a business model that has been developed specifically for China’s laws and regulations, the Chinese government has not approved BabyCare’s model, compensation plan, and operations.
BabyCare’s business model has been designed specifically for China’s laws and regulations based on, among other things, BabyCare’s (i) communications with the Chinese government, (ii) interpretation of the direct selling laws and regulations, as well as its understanding of how the government interprets and enforces the regulations, and (iii) understanding of how other multinational direct selling companies operate in China. Many of the components of BabyCare’s business model are unique to China and are not part of our business model in our markets outside of China. For example, BabyCare sells products in China through a variety of methods, including: (a) online through its website; (b) at physical branch retail locations in China; (c) through direct sellers in provinces and municipalities where BabyCare has received a direct sales license; and (d) through independent distributors who are considered independent business owners under Chinese law. BabyCare has not received confirmation from the Chinese government that its business model and operations in China comply with applicable laws and regulations, including those pertaining to direct selling. We cannot assure that Chinese regulatory authorities would deem BabyCare's business model, compensation plan or the activities of its employees, direct sellers or independent distributors to be compliant with current or future laws and regulations. If BabyCare’s model were deemed to be in violation of applicable regulations, as they are now or may in the future be interpreted or enforced, BabyCare could be subject to fines, penalties or suspension of its business in China or, ultimately, have its direct selling license revoked by the Chinese government, all of which could have a material adverse impact on our business in China.
BabyCare’s operations in China, and direct selling companies in general, are subject to significant government oversight, scrutiny and monitoring.
Chinese regulators regularly monitor and make inquiries about the business activities of direct sellers in China and have done so with BabyCare. For example, following adverse media coverage of certain health product companies and direct selling companies in 2019, several departments of the Chinese government, including SAMR, MPS, and MOFCOM, initiated a review of health product and direct selling companies in China. The review required applicable companies such as BabyCare to conduct a self-assessment of the regulatory compliance of their business and to provide information to the government regarding the same. The review also entailed a review of a company’s regulatory compliance by various departments of the Chinese government. During this review, the Chinese government, among other things, (i) instructed direct selling companies not to hold large distributor meetings, and (ii) suspended its application review process for direct sales licenses and authorizations. The Chinese government has yet to re-open the application review process for direct sales licenses and authorizations or indicate if or when it plans to do so.
Direct selling regulations in China prevent persons who are not Chinese nationals from engaging in direct selling in China. We have implemented internal policies that are designed to promote our Associates’ compliance with these regulations, however, we cannot guarantee that any of our Associates residing outside of China or any of BabyCare’s Associates in China have not engaged or will not engage in activities that violate our policies in this market or that violate Chinese law or other applicable laws and regulations, which might result in regulatory action and adverse publicity and potential harm to our business in China.
The Chinese government has investigated and imposed significant fines on companies and their distributors believed to have violated direct selling and anti-pyramiding regulations. In some cases, it has even shut such companies down. There have been instances where inquiries or complaints about BabyCare’s business have resulted in warnings from the Chinese government as well as the payment of fines by BabyCare or its distributors. We expect that BabyCare will continue to face the risk of government inquiries, complaints or investigations. Any determination that BabyCare’s business or the activities of its Associates are not in compliance with applicable regulations could result in additional fines, disruption of business, or the suspension or termination of BabyCare’s licenses, including its direct selling licenses, all of which could have a material adverse effect on our business and operations. There can be no assurance that the Chinese government’s interpretation and enforcement of applicable laws and regulations will not negatively impact BabyCare’s business, result in regulatory investigations or lead to fines or penalties against BabyCare, USANA or our Associates in China.
27
BabyCare must apply for and receive government approval to expand its business in China and the failure to obtain such approvals could negatively impact its ability to expand and grow its business.
BabyCare has obtained direct selling licenses in certain provinces and municipalities and it must obtain various licenses and approvals from additional municipalities and provinces within China if it is to operate its direct selling business model in China. Although direct selling licenses are centrally issued, the licenses are generally valid only in the jurisdictions within which related approvals have been obtained. Those approvals are generally awarded on local and provincial bases, and the approval process requires involvement of multiple ministries at each level.
BabyCare also will be required to obtain licenses from municipalities and provinces within China where it currently does not hold a license. The Chinese government has not reopened its application review process for direct sales licenses and approvals since suspending the process in 2019. If BabyCare is unable to obtain additional direct selling licenses and approvals as quickly as we would like, or at all, it would negatively impact our ability to expand and grow our business in China. Ultimately, there can be no assurance that BabyCare will be successful in maintaining its current direct selling licenses or obtaining additional direct selling licenses or the required approvals to expand into additional locations in China that are important to its business.
Risk Associated with Our International Operations
Risks associated with operating in international markets could restrict our ability to expand globally and harm our business and prospects.
We currently conduct our business in various foreign countries, and we expect to expand the number of countries in which we operate in the future. Economic conditions, including those resulting from wars, civil unrest, political unrest, acts of terrorism and other conflicts or volatility in the global markets, may adversely affect our customers, their demand for our products and their ability to pay for our products. In addition, there are numerous risks inherent in conducting our business internationally, including, but not limited to, potential instability in international markets, changes in regulatory requirements applicable to international operations, currency fluctuations in foreign countries, political, economic and social conditions in foreign countries and complex U.S. and foreign laws and treaties.
We believe that our ability to achieve future growth is dependent in part on our ability to continue our international expansion efforts. There can be no assurance, however, that we will be able to grow in our existing international markets or enter new international markets on a timely basis, or that new markets will be profitable. We must overcome significant regulatory and legal barriers before we can begin marketing in any international market. In addition, before marketing commences in a new country or market, it is difficult to assess the extent to which our products and sales techniques will be accepted or successful in any given country. In addition to significant regulatory barriers, we may also encounter problems conducting operations in new markets with different cultures and legal systems from those encountered elsewhere. We may be required to reformulate certain of our products before commencing sales in a given country. Once we have entered a market, we must adhere to the regulatory and legal requirements of that market. No assurance can be given that we will be able to successfully reformulate our products in any of our current or potential international markets to meet local regulatory requirements or to attract local customers. Our failure to do so could have a material adverse effect on our business, financial condition, or results of operations.
In many market areas, other direct selling companies already have significant market penetration, the effect of which could be to desensitize the local population to a new opportunity, such as USANA, or to make it more difficult for us to attract qualified Associates or sell to customers generally. Even if we are able to commence operations in new markets, there may not be a sufficient population of persons who are interested in our business.
Trade policies, disputes, tariffs or other international disputes could harm our business and operating results.
Trade policies and actions which have been, or in the future may be, implemented by the United States against other countries, including China, relating to the import and export of certain products, and negotiations with respect thereto, may have a negative effect on our business, financial condition, and results of operations in China and other markets. There have been consistent, ongoing discussions and activities that raise concern in this regard.
Additionally, any actions taken by the Chinese government, or the government in our other markets, to implement further trade policy changes, financial restrictions, or increased regulatory scrutiny on U.S. companies could negatively impact our business, financial condition, and results of operations. For instance, China has previously taken or threatened to take trade and other actions in retaliation against U.S. policies, and is likely to continue to do so. Past or future
28
developments in this regard may have a material adverse effect on the economies, financial markets, and currency exchange rates in China and the United States.
Tensions between the United States and China have increased over the past few years as a result of disputes in areas including trade policy, intellectual property, cybersecurity and data privacy. China is our largest market and the United States is one of our largest markets and the location of our corporate headquarters. Our business could be harmed if relations between the United States and China worsen or if either government imposes additional policies, tariffs or sanctions and our business could encounter increased regulatory scrutiny in China, as well as adverse media or public attention in China, as a result of the deteriorating bilateral relationship.
Fluctuation in the value of currency exchange rates with the U.S. dollar affects our operations and our net sales and earnings.
For the year ended December 31, 2022, 89.4% of our total net sales were generated in markets outside of the United States. Consequently, exchange rate fluctuations have, and will continue to have, a significant effect on our sales and earnings. If exchange rates fluctuate dramatically, it may become uneconomical for us to establish or to continue activities in certain countries. For instance, changes in currency exchange rates may affect the relative prices at which we and our competitors sell similar products in the same market. As our business expands outside the United States, an increasing share of our net sales and operating costs is transacted in currencies other than the U.S. dollar. Accounting practices require that our non-U.S. financial results be converted to U.S. dollars for reporting purposes. Consequently, our reported net earnings may be significantly affected by fluctuations in currency exchange rates, with earnings generally increasing with a weaker U.S. dollar and decreasing with a strengthening U.S. dollar.
Currently our strategy for reducing our exposure to currency fluctuation includes the timely and efficient repatriation of earnings from international markets where such earnings are not considered to be indefinitely reinvested, and settlement of intercompany transactions. We also enter into currency exchange contracts to offset foreign currency exposure in various international markets. We do not use derivative instruments for speculative purposes. A foreign government may impose, and some have imposed, foreign currency remittance restrictions. For example, several markets in which we conduct business, including China, require that we file the necessary statutory financial statements for the relevant period as a prerequisite to repatriating cash in the form of a dividend. Any government restrictions on transfers of cash out of the country and control of exchange rates may have a materially adverse effect on our business, financial condition, liquidity and cash flows. There can be no assurance that we will be successful in protecting our operating results or cash flows from potentially adverse effects of currency exchange fluctuations. Any such adverse effects could also adversely affect our business, financial condition, or results of operations.
Inflationary pressures and persistently high prices and uncertain availability of commodities, raw materials or other inputs used by us and our suppliers, or instability in logistics and related costs, could negatively impact our profitability.
Increases in prices, including as a result of inflation and rising interest rates, for commodities, raw materials or other inputs that we and our suppliers use in manufacturing products, systems, components and ingredients or other similar raw materials, or increases in logistics and related costs, have led and may continue to lead to higher production costs for our products. In addition, any increase in the cost, or reduced availability, of critical materials for our products could lead to higher production costs and could impede our ability to successfully deliver on business strategy. Further, increasing global demand for, and uncertain supply of, such materials could disrupt us or our suppliers’ ability to obtain such materials in a timely manner and/or could lead to increased costs. Geopolitical risk, fluctuations in supply and demand, fluctuations in interest rates, any weakening of the U.S. dollar and other economic and political factors have created and may continue to create pricing pressure for commodities, raw materials and other inputs. These inflationary pressures could, in turn, negatively impact our profitability because we may not be able to pass all of those costs on to our customers or require our suppliers to absorb such costs. Additionally, any price increases we impose on our products as a result of the inflationary environment may result in decreased demand of our products, which could adversely affect our business, financial condition, or results of operations.
Risks Related to Our Products, Manufacturing and Operations
Our products and manufacturing activities are subject to extensive government regulation, which could limit or prevent the sale of our products in some markets.
The manufacture, packaging, labeling, advertising, promotion, distribution, and sale of our products are subject to regulation by numerous national and local governmental agencies in the United States and other countries, including the FDA and the FTC. Failure to comply with FDA regulatory requirements may result in, among other things, injunctions,
29
product withdrawals, recalls, product seizures, fines, and criminal prosecutions. Any action of this type by the FDA could materially adversely affect our ability to market our products successfully. The manufacture of nutritional or dietary supplements and related products in the United States requires compliance with dietary supplement GMPs, which are based on the food-model GMPs, with additional requirements that are specific to dietary supplements. We believe our manufacturing processes comply with these GMPs for dietary supplements. Nevertheless, any FDA action determining that our processes were non-compliant with dietary supplement GMPs, could materially adversely affect our ability to manufacture and market our products. In addition, the Dietary Supplement & Nonprescription Drug Consumer Protection Act requires manufacturers of dietary supplement and over-the-counter products to notify the FDA when they receive reports of serious adverse events occurring within the United States. Potential FDA responses to any such report could include injunctions, product withdrawals, recalls, product seizures, fines, or criminal prosecutions. We have an internal adverse event reporting system that has been in place for several years and believe that we comply with this new law. Nevertheless, any action by the FDA in response to a serious adverse event report that may be filed by us could materially and adversely affect our ability to market our products successfully.
In markets outside the United States, prior to commencing operations or marketing our products, we may be required to obtain approvals, licenses, or certifications from a country’s ministry of health or a comparable agency. Approvals or licensing may be conditioned on reformulation of products or may be unavailable with respect to certain products or product ingredients. We must also comply with product labeling and packaging regulations that vary from country to country. These activities are also subject to regulation by various agencies of the countries in which our products are sold.
We cannot predict the nature of any future laws, regulations, interpretations, or applications, nor can we determine what effect additional governmental regulations or administrative orders, when and if promulgated, could have on our business. These potential effects could include, however, requirements for the reformulation of certain products to meet new standards, the recall or discontinuance of certain products, additional record keeping and reporting requirements, expanded documentation of the properties of certain products, expanded or different labeling, or additional scientific substantiation. Any or all of these requirements could have a material adverse effect on our business, financial condition, or results of operations.
Our in-house manufacturing activity is subject to certain risks.
We manufacture approximately 65% of the products sold to our customers. Additionally, over the past several years we have increased self-manufacturing of our foods, personal care and skincare products, which has increased the percentage of products we manufacture in-house. Because of our self-manufacturing practices, we are dependent upon the uninterrupted and efficient operation of our manufacturing facilities. Those operations are subject to power failures, the breakdown, failure, or substandard performance of equipment, the improper installation or operation of equipment, natural or other disasters, and the need to comply with the requirements or directives of government agencies, including the FDA and CFDA. There can be no assurance that the occurrence of these or any other operational problems at our facilities would not have a material adverse effect on our business, financial condition, or results of operations.
We are subject to a variety of environmental laws relating to the storage, discharge, handling, emission, generation, manufacture, use and disposal of chemicals, solid and hazardous waste, and other toxic and hazardous materials. Our manufacturing operations presently do not result in the generation of material amounts of hazardous or toxic substances. Nevertheless, complying with new or more stringent laws or regulations, or more vigorous enforcement of current or future policies of regulatory agencies, could require substantial expenditures by us that could have a material adverse effect on our business, financial condition, or results of operations. Environmental laws and regulations require us to maintain and comply with a number of permits, authorizations, and approvals and to maintain and update training programs and safety data regarding materials used in our processes. Violations of those requirements could result in financial penalties and other enforcement actions and could require us to halt one or more portions of our operations until a violation is cured. The combined costs of curing incidents of non-compliance, resolving enforcement actions that might be initiated by government authorities, or of satisfying new legal requirements could have a material adverse effect on our business, financial condition, or results of operations.
Our reliance on third parties to manufacture and supply certain of our products may harm our business, financial condition and operating results.
We contract with third-party suppliers and manufacturers for the production of certain of our products, which accounted for approximately 35% of our product sales for the year ended December 31, 2022. These third-party suppliers and manufacturers produce and, in most cases, package the products according to formulations and specifications that have
30
been developed by or in conjunction with our in-house product development team. These products include most of our gelatin-capsulated supplements, Rev3 Energy Drink, Probiotic, our powdered drink mixes, foods, and certain of our personal care products, including our Celavive line for markets outside of China. Products manufactured by third-party suppliers at their locations must also pass through quality control and assurance procedures to ensure they are manufactured in conformance with our specifications. We cannot assure you that our outside contract manufacturers will continue to reliably supply products to us at the levels of quality, or the quantities, we require, and in compliance with our specifications or applicable laws, including under the FDA’s GMP regulations. We have encountered situations in the past where we have had disagreements with contract manufacturers about the overall quality of products they have produced for us, and specifically whether such products conform to our specifications. We have also suspended and terminated relationships with contract manufacturers for quality issues and non-conforming products. While our business continuation plan contemplates events such as these, identifying and obtaining acceptable replacement manufacturing sources, on a timely basis or at all, is challenging. Additionally, transferring our third-party manufacturing business to another contract manufacturer can be expensive, time-consuming, result in delays in our production or shipping, reduce our net sales, damage our relationship with customers and damage our reputation in the marketplace.
The inability to obtain adequate supplies of raw materials for products at favorable prices, or at all, could have a material adverse effect on our business, financial condition, or operating results.
We acquire all of our raw materials for the manufacture of our products from third-party suppliers. Materials used in manufacturing our products are purchased through purchase order, often invoking pre-negotiated annual supply agreements. We have very few long-term agreements for the supply of these materials. There is a risk that any of our suppliers could discontinue selling raw materials to us. Although we believe that we could establish alternate sources for most of our products, any delay in locating and establishing relationships with other sources could result in product shortages or back orders for products, with a resulting loss of net sales. In certain situations, we may be required to alter our products or to substitute different products from another source. There can be no assurance that suppliers will provide the raw materials that are needed by us in the quantities that we request or at the prices that we are willing to pay. Because we do not control the actual production of certain raw materials, we are also subject to delays caused by any interruption in the production of these materials, based on conditions not within our control, including those related to the COVID-19 pandemic, weather, crop conditions, transportation interruptions, strikes by supplier employees, and natural disasters or other catastrophic events.
In the past, we have experienced temporary shortages of the raw materials used in certain of our nutritional products. Although we had identified multiple sources to supply such raw material ingredients, quantities of the materials we purchased during these shortages were at higher prices, which had a negative impact on our gross margins for those products. While we periodically experience price increases due to unexpected raw material shortages and other unanticipated events, we have been able to manage this by increasing the price at which we sell our products, therefore, this has historically not resulted in a material effect on our gross margin. Supply chain interruptions, including as a result of shortages and transportation issues or unexpected increases in demand, and price increases can adversely affect us as well as our suppliers and Associates, whose performance may have a significant impact on our results. Such shortages or disruptions could be caused by factors beyond the control of our suppliers, Associates or us. Any of these events, if they were to occur, could harm our business, results of operations and financial condition.
Delays and disruptions to transporting and distributing our products may adversely affect our results.
We may experience delays and disruptions in shipping, transporting and otherwise distributing our products, including increased airport and shipping port congestion, a lack of transportation capacity, increased expenses, import or export controls or delays, and labor disputes or shortages. Disruptions in transportation and shipments may result in increased costs, including the additional use of airfreight to meet demand. Congestion to ports can affect previously negotiated contracts with shipping companies, resulting in unexpected increases in shipping costs and reduction in our profitability. For example, the COVID-19 pandemic has resulted in several delays, cost increases, and disruptions in our global distribution channel.
We may incur liability with respect to our products.
As a manufacturer and a distributor of products for human consumption and topical application, we could become exposed to product liability claims and litigation. Additionally, the manufacture and sale of these products involves the risk of injury to consumers due to tampering by unauthorized third parties or product contamination. To date, we have not been a party to any product liability litigation, although, like any dietary supplement company, we have received reports from individuals who have asserted that they suffered adverse consequences as a result of using our products. The number of
31
reports we have received to date is nominal. These matters historically have been settled to our satisfaction and have not resulted in material payments. We are aware of no instance in which any of our products are or have been defective in any way that could give rise to material losses or expenditures related to product liability claims. Although we maintain product liability insurance, which we believe to be adequate for our needs, there can be no assurance that we will not be subject to such claims in the future or that our insurance coverage will be adequate.
Nutritional supplement products may be supported by only limited availability of conclusive clinical studies.
Our products include nutritional supplements that are made from vitamins, minerals, herbs, and other substances for which there is a long history of human consumption. Some of our products contain innovative ingredients or combinations of ingredients. Although we believe that all of our products are safe when taken as directed, there is little long-term experience with human consumption of certain of these product ingredients or combinations of ingredients in concentrated form. We conduct research and test the formulation and production of our products, but we have performed or sponsored only limited clinical studies. Furthermore, because we are highly dependent on consumers’ perception of the efficacy, safety, and quality of our products, as well as similar products distributed by other companies, we could be adversely affected in the event that those products prove or are asserted to be ineffective or harmful to consumers or in the event of adverse publicity associated with any illness or other adverse effects resulting from consumers’ use or misuse of our products or similar products of our competitors.
Legal, Regulatory, Compliance and Tax Risks
Legal action by former Associates or third parties against us could harm our business.
We continually monitor and review our Associates’ compliance with our policies and procedures as well the laws and regulations applicable to our business. In the ordinary course of our business, Associates occasionally fail to adhere to our policies and procedures. If this happens, we may take disciplinary action against the breaching Associate. This disciplinary action is based on the facts and circumstances of the particular case and may include anything from warnings for minor violations to termination of the Associate’s purchase and distribution rights for more serious violations. From time to time, we become involved in litigation with an Associate whose purchase and distribution rights have been terminated. We consider this type of litigation to be routine and incidental to our business. While neither the existence nor the outcome of this type of litigation is typically material to our business, in the past we have been involved in litigation of this nature that resulted in a large cash award against us.
Our competitors have also been involved in this type of litigation, and more and more of these cases have resulted in class action litigation, where the result has been a large cash award against the competitor or a large cash settlement by the competitor. These types of challenges, awards or settlements could provide incentives for similar actions by other former Associates against us in the future, which could result in class action litigation against us. Any such challenge involving others in our industry or us, could harm our business by resulting in fines or damages against us, creating adverse publicity about us or our industry, or hurting our ability to attract and retain customers.
We believe that Associate compliance is critical to the integrity of our business, and, therefore, we will continue to be assertive in ensuring that our Associates comply with our policies and procedures. As such, there can be no assurance that this type of litigation will not occur again in the future or result in an award or settlement that has a materially adverse effect on our business. We could also be subject to challenges by private parties in civil actions. We are aware of recent civil litigation against various direct selling companies in the United States, which have already resulted in settlements and may result in additional significant settlements in the future by these companies. There can be no assurance that we will not be challenged by private parties in litigation.
We may incur liability under our “Athlete Guarantee” program.
We believe that our nutritional supplement products are free from substances that have been banned by world-class training and competitive athletic programs. We retain independent testing agencies to conduct periodic checks for banned substances. We further believe that, while our products promote good health, they are not otherwise considered “performance enhancing” as that term has been used in defining substances that are banned from use in international competition by the World Anti-Doping Agency (“WADA”). For many years, we have been a sponsor of Olympic level athletes and professional competitors around the world. These athletes have been tested on many occasions and have never tested positive for banned substances as a result of taking USANA nutritional products. To back up our claim that athletes who use USANA products as part of their training regimen will not be consuming banned substances, we have offered to enter into agreements with select athletes, some of whom have high-profiles and are highly compensated. These agreements provide that, during the term of the agreement, should the athlete test positive for a banned substance included
32
in the WADA, and should such positive result be caused by taking USANA nutritional products, we will compensate that athlete at an amount equal to two times their current annual earnings, up to $1.0 million, based on the athlete’s personal level of competition, endorsement, and other income, as well as other factors. Although we believe that the pool of current and potential participants in the program is small and that the procedures and safeguards implemented by us in connection with the program are sound, there is no guarantee that an athlete who is accepted in the program will not successfully make a claim against us. We currently have no insurance to protect us from potential claims under this program.
Failure to comply with anti-corruption laws could adversely affect our business.
We currently conduct our business in various foreign countries and expect to expand the number of countries in which we operate in the future. Our international business is subject to various anti-corruption laws, including principally the U.S. Foreign Corrupt Practices Act. In recent years, there have been an increasing number of investigations and other enforcement activities under these laws, including a voluntary investigation we recently concluded concerning our China operations. The FCPA prohibits U.S.-based companies and their intermediaries from making improper payments to government officials for the purpose of obtaining or retaining business. Other anti-corruption laws prohibit both domestic and international bribery as well as bribery across both public and private sectors. We pursue opportunities in certain parts of the world that experience government corruption and in certain circumstances compliance with anti-bribery laws may conflict with local customs and practices. Our policies mandate compliance with all applicable anti-bribery laws. Further, we require our partners, subcontractors, agents and others who work for us or on our behalf to comply with these and other anti-bribery laws.
Although we have policies and procedures and a compliance program designed to ensure that we comply with the FCPA and other anti-bribery laws, there is no assurance that such policies or procedures will protect us against liability under the FCPA or other laws for actions taken by our agents, employees and intermediaries. If we are found to be liable for violations of these acts (either due to our own acts or our inadvertence or due to the acts or inadvertence of others), we could incur severe criminal or civil penalties or other sanctions, which could have a material adverse effect on our reputation, business, results of operations or cash flows. In addition, detecting, investigating and resolving actual or alleged violations of these acts is expensive and could consume significant time and attention of our senior management.
We could be subject to adverse changes in tax laws, regulations and interpretations or challenges to our tax positions.
We are subject to tax laws and regulations in the United States and numerous other foreign jurisdictions. Tax laws, regulations, and interpretations in various jurisdictions may change, with or without notice, due to social, economic, political and other considerations. As a result, our evaluation and estimates for our provision for income taxes may change perhaps negatively. Our future effective tax rates could be affected by numerous factors, including changes in the market mix for our net sales, the amount of our earnings and where earned, intercompany transactions, the inability to realize tax benefits, changes in currency exchange rates, tax positions, allocation and apportionment of state taxes, changes in our deferred tax assets and liabilities and their valuation, changes in our business operations, acquisitions, and entry into new markets. There can be no assurance that additional changes in tax laws or regulations, both within the United States and the other jurisdictions in which we operate, will not materially and adversely affect our effective tax rate, tax payments, financial condition and results of operations. Similarly, changes in tax laws and regulations that impact our customers and counterparties or the economy generally may also impact our financial condition and results of operations.
We are also subject to examination by tax authorities, including state revenue agencies and foreign governments. While we regularly assess the likelihood of favorable or unfavorable outcomes resulting from examinations by tax authorities to determine the adequacy of our provision for income taxes, there can be no assurance that the actual outcome resulting from these examinations will not materially adversely affect our financial condition and operating results. The IRS and several foreign tax authorities have also increasingly focused attention on intercompany transfer pricing. Tax authorities, in certain instances, have disagreed with our transfer pricing calculations and agreements and assessed us with additional taxes. Going forward, tax authorities could continue to disagree with our intercompany charges, cross-jurisdictional transfer pricing or other matters and assess additional taxes. If we do not prevail in any such disagreements, our profitability may be affected. Tax laws and regulations are complex and subject to varying interpretations and any significant failure to comply with applicable tax laws and regulations in all relevant jurisdictions could give rise to substantial penalties and liabilities. Any changes in enacted tax laws, rules or regulatory or judicial interpretations; any adverse outcome in connection with tax audits in any jurisdiction; or any change in the pronouncements relating to accounting for income taxes could materially and adversely impact our effective tax rate, tax payments, financial condition and results of operations.
33
Failure to maintain effective internal controls could negatively impact our business.
We are required by federal securities laws to document and test our internal control over financial reporting and are required to have management annually assess the effectiveness of such internal controls. Effective internal controls are necessary for us to provide reliable financial reports and to effectively prevent fraud. In addition, our independent registered public accounting firm must report on the effectiveness of our internal controls. If we fail to maintain effective internal controls we could be required to take costly and time-consuming corrective measures, to remedy any number of deficiencies, significant deficiencies or material weaknesses, be required to restate the affected historical financial statements, be subjected to investigations and/or sanctions by federal and state securities regulators, and be subjected to civil lawsuits by security holders. Any of the foregoing could also cause investors to lose confidence in our reported financial information and in our company and would likely result in a decline in the market price of our stock and in our ability to raise additional financing if needed in the future.
ESG issues may have an adverse effect on our reputation, business, financial condition or results of operations.
Companies across all industries are facing increasing scrutiny relating to their ESG policies. If we are unable to meet our ESG goals or evolving regulator, investor, industry or stakeholder expectations and standards, or if we are perceived to have not responded appropriately to the growing concern for ESG issues, customers may choose to stop purchasing our products and our reputation, business or financial condition may be adversely affected. In particular, these constituencies are increasingly focusing on environmental issues, including climate change, water use, plastic waste, and other sustainability concerns. These factors could cause us to incur additional costs, to make changes to our operations to make additional commitments, set targets or establish additional goals and take actions to meet them, which could expose us to market, operational and execution costs or risk.
In addition to environmental issues these constituencies are also focused on social and other governance issues, including matters such as, but not limited to, human capital and social issues. We also have established diversity, equity and inclusion goals as part of our ESG initiative.
Concern over climate change, including plastics and packaging materials, in particular, may result in new or increased legal and regulatory requirements. Increased regulatory requirements related to environmental causes, and related ESG disclosure rules, including the SEC's recent disclosure proposal on climate change, may result in increased compliance costs or increased costs of energy, raw materials or compliance with emissions standards, which may cause disruptions in the manufacture of our products or an increase in operating costs. Any failure to achieve our ESG goals or a perception (whether or not valid) of our failure to act responsibly with respect to the environmental, human capital, or social issues, or to effectively respond to new, or changes in, legal or regulatory requirements concerning environmental or other ESG matters, or increased operating or manufacturing costs due to increased regulation or environmental causes could adversely affect our business and reputation and increase risk of litigation.
Risk Associated with Information Technology, Data Security and Data Privacy
A failure or interruption of our information technology systems would harm our business.
The global nature of our business, shopping and our global compensation plan requires the development and implementation of robust and efficiently functioning information technology systems. Such systems are vulnerable to a variety of potential risks, including damage or interruption resulting from natural disasters, power outages, certain aging system architecture, systems failures, hardware or software corruption, human error or hacking, malware, ransomware, phishing or other similar acts. We rely on both self-developed and third-party developed and supported information technology systems. Although we have adopted and implemented a business continuity and disaster recovery plan and a variety of other operational safeguards, the occurrence of any of these events could result in costly interruptions or failures adversely affecting our business and the results of our operations.
We rely on information technology to support our operations and reporting environments. A data breach involving that technology or the data stored in it, could disrupt our ability to operate our businesses effectively, adversely affect our reported financial results and our reputation, and expose us to significant potential liability, government investigations, fines or litigation.
In the ordinary course of our global business, we collect and store in our data centers and on our networks, including cloud systems, significant amounts of data, including personally identifiable information (PII), intellectual property, and our proprietary business information The secure collection, storage and other processing of this information is critical to our operations, regulatory compliance and business strategy. Although we strive to frequently analyze and
34
improve our data security measures, our information technology and infrastructure are subject to persistent attacks of varying degrees and types and we may be vulnerable to attacks by hackers. Such attacks could include viruses, ransomware attacks, computer denial of service attacks, or phishing schemes. In some instances, despite our reasonable efforts, it could take us some time to discover that our networks have been breached.
Any such breach of our networks and the information and PII stored therein could cause such information and PII to be accessed, publicly disclosed, altered, damaged, held ransom, lost or stolen. In any such event, we could suffer significant loss or incur significant liability, including: damage to our reputation; increased cyber insurance premiums; loss of customer confidence or goodwill; and significant expenditures of time and money to address and remediate the resulting damage (including notification and credit monitoring costs, as well as fines and penalties imposed by regulators) to affected individuals or business partners, or to defend ourselves in resulting litigation or other legal proceedings, by affected individuals, business partners or regulators.
Likewise, a failure to adhere to the payment card industry’s data security standards could lead to significant penalties from payment card associations, termination of our ability to receive credit or debit card payments, any of which could have a material adverse effect on our business and financial condition. Furthermore, such data breach could result in significant disruption of our operations, which could adversely affect our business, revenues and competitive position.
We are subject to data privacy and security laws and regulations, and our actual or perceived failure to comply with them could adversely affect our business and operating results.
Compliance with data privacy and security laws and regulations is a significant effort for us in all of our markets because we collect, store and otherwise process significant amounts of customer and employee personal information for business (including for transactional and marketing purposes) and legal purposes. The governments of our various markets have adopted, or are adopting, complex and strict laws and regulations governing data privacy and security, and these areas are still rapidly evolving . These laws and regulations have resulted in greater compliance risk and cost for us.
These laws and regulations often require us to take a variety of actions, including: implementing new data privacy and security policies; granting individuals a wide variety of rights with respect to their PII, including access, correction and deletion rights; informing individuals of security breaches that affect their PII; disclosing to individuals how we process their PII and obtaining their written consent to such processing; and localizing individuals' PII within national borders and complying with cross border PII transfer assessments and requirements, among other things. Examples of significant, recent data privacy and security laws affecting our various markets include the European Union General Data Protection Regulation, ("GDPR"), China’s national Data Privacy Law and Personal Information Protection Law, China's Cybersecurity Law, the California Consumer Privacy Act, ("CCPA"), and the California Privacy Rights Act. Virginia, Colorado, Connecticut and Utah all have adopted laws introducing new privacy obligations and many other states are considering similar legislation. A broad range of legislative measures also have been introduced at the federal level. There also is a wide range of enforcement agencies at both the state and federal levels that can review companies for privacy and data security concerns based on general consumer protection laws. The FTC and state Attorneys General all are aggressive in reviewing privacy and data security protections for consumers.
We have incurred, and will continue to incur, substantial costs in striving to comply with these various data privacy and security laws and regulations. Compliance with these laws and regulations may limit our ability to provide products and services to our customers that they may find valuable or otherwise require us to change our business practices in a manner that is ultimately adverse to our business objectives. As such, we cannot assure ongoing compliance with all such laws or regulations, industry standards, contractual obligations and other legal obligations. Any failure or perceived failure by us to comply with data security and privacy laws and regulations may result in governmental enforcement actions and prosecutions, private litigation, significant fines and penalties, adverse publicity, or reputation damage, which could have an adverse effect our business and operating results.
Human Capital Risks Associated with our Business
If we are unable to attract and retain active Associates and Preferred Customers, our business may be harmed.
Our consumer base includes Associates who personally consume and sell our products, Preferred Customers who join USANA and simply consume our products, and retail customers who do not join USANA but purchase products directly from us or one of our Associates and consume our products. We refer to Associates, and Preferred Customers in this Annual Report together as active Customers. We rely largely on our Associates to market and sell our products and to generate active Customer growth. Our ability to maintain and increase sales in the future will depend in large part upon our success in increasing our number of active Customers. Our success will also depend on our ability to retain and motivate
35
our existing Associates and attract new Associates to sell our products. Associates typically market and sell our products on a part-time basis and often engage in other business activities, some of which may compete with us. Our ability to continue to attract and retain active Customers can be affected by a number of factors, some of which are beyond our control, including each of the other risks identified in this Annual Report. Our Associates may terminate their services at any time and, like most direct selling companies, we experience a high turnover among new active Customers from year to year. Customers may also stop buying from us at any time and it is challenging to determine why a customer actually stops buying. In 2022, most of our markets, including China, experienced active Customer declines. If our strategies, including our customer experience strategy, do not generate growth in our active Customer base, our operating results could be harmed.
We also rely on the successful efforts of our Associates who become leaders with our Company. Our Compensation Plan is designed to permit Associates to sponsor new Associates and Preferred Customers, thereby creating sales organizations. As a result, Associates develop business and personal relationships with other Associates and Preferred Customers. The loss of a key Associate or group of Associates, large turnover or decreases in the size of the key Associate force, seasonal or other decreases in product purchases, sales volume reduction, the costs associated with training new Associates, and other related expenses may adversely affect our business, financial condition, or results of operations.
The loss of key management personnel could adversely affect our business.
Our executive officers are primarily responsible for our day-to-day operations, and we believe our success depends in part on our ability to retain our executive officers, to compensate our executive officers at attractive levels, and to continue to attract additional qualified individuals to our management team. We depend upon the services of our Chairman and Chief Executive Officer, Kevin Guest; our President, Jim Brown; and our Chief Financial Officer, Douglas Hekking, as well as other key members of our executive team. We disclosed in February 2023 that, effective July 1, 2023, Mr. Guest will be transitioning from the role of Chief Executive Officer to the role of Executive Chairman and that Jim Brown will succeed him as the Chief Executive Officer. We cannot guarantee continued service by our key executive officers. We do not maintain key man life insurance on any of our executive officers, nor do we have an employment agreement with any of our executive officers. The loss or limitation of the services of any of our executive officers or the inability to attract additional qualified management personnel could have a material adverse effect on our business, financial condition, or results of operations.
Risks Associated with Business Development Activities and Acquisitions
In 2022, we acquired two businesses and our growth strategy contemplates acquiring additional businesses in the future to the extent that we find prospects that meet our acquisition criteria. Our acquisition criteria includes, but is not limited to: vertical integration; product and category expansion; geographic expansion; and other opportunities that strengthen, diversify and grow our world-wide business. Our completed and potential future acquisitions entail a variety risks and uncertainties, including: (i) potential disruption to our direct selling business; (ii) failure to achieve our strategic objectives, efficiencies, and growth strategies for the acquisition; (iii) potential loss of key employees, customers, or other stakeholders of an acquired businesses, particularly given that our strategy contemplates our acquired businesses operating and growing independently of USANA; (iv) general risks associated with owning and overseeing businesses and industries where we have limited or no prior experience; (v) expense and indebtedness, including unanticipated liabilities and litigation; (vi) shareholder dilution; (vii) difficulty in implementing an effective control environment for acquired companies, in a timely and efficient manner; or (viii) the failure to consummate transactions in a timely or efficient manner or at all.
The occurrence of any of the foregoing risks or others, or our inability to effectively execute our business development strategy, could have a material adverse effect on our business, financial condition and operating results. We cannot assure you that we will be able to identify suitable acquisition prospects, consummate acquisitions on favorable terms or at all, or accomplish the objectives of an acquisition.
General Economic, Publicity, Competitive, and Intellectual Property Risks Associated with our Business
Difficult economic conditions may adversely affect our business.
Over the past few years, economic conditions in many of the markets where we sell our products have resulted in challenges to our business and economies around the world have been negatively impacted by the COVID-19 pandemic. We cannot predict whether world or market-specific economies will improve or deteriorate in the future. If difficult economic conditions continue or worsen as a result of the COVID-19 pandemic, or otherwise, we could experience declines in net sales, profitability and cash flow due to lower demand for our products or other factors caused by economic
36
challenges faced by our customers, potential customers or suppliers. Additionally, these conditions may result in a material adverse effect on our liquidity and capital resources or otherwise negatively impact our operations or overall financial condition.
Our business is subject to the effects of adverse publicity and negative public perception.
Our ability to attract and retain active Customers and to sustain and enhance sales through our Associates can be affected by adverse publicity or negative public perception regarding our industry, our competition, or our business generally. Our business prospects, financial condition and results of operations could be adversely affected if our public image or reputation were tarnished by negative publicity. This negative public perception may include publicity regarding the legality of direct selling, the quality or efficacy of nutritional supplement products or ingredients in general or our products or ingredients specifically, data privacy or security concerns, and regulatory investigations, regardless of whether those investigations involve us or our Associates or the business practices or products of our competitors or other direct selling companies.
There has been significant media and short-seller attention regarding the viability and legality of direct selling in the United States, China, and internationally over the past several years. This attention has led to intense public scrutiny of the industry, as well as volatility in our stock price and the stock price of companies similar to ours. There can be no assurance that we will not be subject to adverse publicity or negative public perception in the future or that such adverse publicity will not have a material adverse effect on our business, financial condition, or results of operations.
Our business is subject to the risks associated with intense competition from larger, wealthier, and more established competitors.
We face intense competition in the business of distributing and marketing nutritional supplements, vitamins and minerals, personal care products, and other nutritional products, as described in greater detail in “Business — Competition.” Numerous manufacturers, distributors, and retailers compete actively for consumers and, in the case of other direct selling companies, for Associates. There can be no assurance that we will be able to compete in this intensely competitive environment. In addition, nutrition and personal care products can be purchased in a wide variety of channels of distribution, including retail stores. Entry to market is not particularly capital intensive or otherwise subject to high barriers and as a result, new competitors can enter easily and compete with us for customers and distributors, including our Associates. Our product offerings in each product category are also relatively small, compared to the wide variety of products offered by many of our competitors.
Our business is subject to particular intellectual property risks.
Most of our products are not protected by patents. The labeling regulations governing our nutritional supplements require that we indicate ingredients of such products precisely and accurately on product containers. Accordingly, patent protection for nutritional supplements often is impractical given the large number of manufacturers who produce nutritional supplements having many active ingredients in common. Additionally, the nutritional supplement industry is characterized by rapid change and frequent reformulations of products, as the body of scientific research and literature refines current understanding of the application and efficacy of certain substances and the interactions among various substances. We protect our investment in research, as well as the techniques we use to improve the purity and effectiveness of our products, by relying on trade secret laws. We have also entered into confidentiality agreements with certain of our employees involved in research and development activities. Additionally, we endeavor to seek, to the fullest extent permitted by applicable law, trademark and trade dress protection for our products, which protection has been sought in many of our existing and potential future markets. Notwithstanding our efforts, there can be no assurance that our efforts to protect our trade secrets and trademarks will be successful. Nor can there be any assurance that third parties will not assert claims against us for infringement of their intellectual proprietary rights. If an infringement claim is asserted, we may be required to obtain a license of such rights, pay royalties on a retrospective or prospective basis, or terminate our manufacturing and marketing of our infringing products. Litigation with respect to such matters could result in substantial costs and diversion of management and other resources and could have a material adverse effect on our business, financial condition, or operating results.
37
Global Pandemic
Pandemics, epidemics, disease outbreaks and other public health crises, such as the COVID-19 pandemic, have disrupted our business and operations, and future public health crises could materially adversely impact our business, financial condition, liquidity and results of operations.
Pandemics, epidemics or disease outbreaks in the United States or globally, including the COVID-19 pandemic, have disrupted, and may in the future disrupt, our business, which could materially affect our results of operations, financial condition, liquidity and future expectations. Any such events may adversely impact our global supply chain and global manufacturing operations and cause us to again limit or suspend our operations in the United States, China and elsewhere. To address the pandemic, many governments issued various restrictive orders that affected businesses and consumers. During the pandemic, government-imposed restrictions, health and safety mandated best practices, and public hesitance regarding in-person gatherings reduced our ability and the ability of our Associates to hold sales meetings, required our Associates to share and sell our products in a predominantly virtual environment, resulted in cancellations of key Company events and trips, required us to utilize a work-from-home strategy for all non-manufacturing and non-distribution employees, and required us to temporarily close our walk-in and fulfillment locations we maintain in some markets. The pandemic also affected the availability and cost of several of our raw materials, packaging materials and shipping resources to transport our product to our various markets around the world. Our supply chain and logistics have incurred some disruption and we could experience more significant disruptions or face more significant closures in the future.
These factors and others related to the COVID-19 pandemic, including the spread of new variants of the virus, will likely continue to negatively affect our business and our financial results in a number of ways. Any new pandemic or other public health crises, or future public health crises, could have a material impact on our business, financial condition and results of operations going forward.
Risks Related to Our Common Stock
The beneficial ownership of a significant percentage of our common stock gives our founder and parties related to or affiliated with him effective control, and limits the influence of other shareholders on important policy and management issues.
Gull Global, Ltd., an entity that is solely owned and controlled by our founder, Dr. Myron Wentz, owned approximately 41.6% of our outstanding common stock at December 31, 2022. Dr. Wentz is no longer active in the management of USANA and is an emeritus member of our Board of Directors. By virtue of this stock ownership, Dr. Wentz is able to exert significant influence and control over the election of the members of our Board of Directors and our business affairs. This concentration of ownership could also have the effect of delaying, deterring, or preventing a change in control that might otherwise be beneficial to shareholders. There can be no assurance that conflicts of interest will not arise with respect to these relationships or that conflicts will be resolved in a manner favorable to our other shareholders.
Sales by our shareholders of a substantial number of shares of our common stock in the public market could adversely affect the market price of our common stock.
A large number of outstanding shares of our common stock are held by several of our principal shareholders, including Gull Global, Ltd. If any of these principal shareholders were to decide to sell large amounts of stock over a short period of time such sales could cause the market price of our common stock to decline.
The market price of our common stock may be influenced by many factors, some of which are beyond our control.
There can be no assurance that an active market in our stock will be sustained. We have a relatively small public float compared to the number of our shares outstanding. Accordingly, we cannot predict the extent to which investors’ interest in our common stock will provide an active and liquid trading market. We are also vulnerable to investors taking a “short position” in our common stock, which has the effect of depressing the price of our common stock and adding volatility to our trading market. The price of our common stock also may fluctuate in the future in response to quarter-to-quarter variations in operating results, material announcements by us or our competitors, governmental regulatory action, conditions in the nutritional supplement industry, negative publicity, or other events or factors, many of which are beyond our control. In addition, the stock market has historically experienced significant price and volume fluctuations, which have particularly affected the market prices of many dietary and nutritional supplement companies and which have not had a strong correlation in certain cases to the operating performance of these companies. Our operating results in future quarters
38
may be below the expectations of securities analysts and investors. If that were to occur, the price of our common stock, and accordingly, the value of a shareholder’s investment in our company, would likely decline, perhaps substantially.
Item 1B. Unresolved Staff Comments
There are no unresolved comments that were received from the SEC staff relating to our periodic or current reports under the Securities Exchange Act of 1934.
Item 2. Properties
Corporate Headquarters
Our world-wide corporate headquarters is a 354,000 square foot company-owned facility located in Salt Lake City, Utah. In addition to executive offices, this facility includes space for manufacturing and quality control, distribution, administrative functions, and research and development. This facility manufactures inventories for all global markets, excluding China. Additionally, we own a 54,000 square foot manufacturing facility, located adjacent to the corporate headquarters facility, where we began in-house manufacturing of our foods product line during the fourth quarter of 2020.
China Manufacturing
We own a 350,000 square foot state-of-the-art facility in Beijing, China similar in potential capacity and nature to our corporate headquarters to manufacture products sold in China. Additionally, we own a 31,000 square foot manufacturing facility in Tianjin, China, where we manufacture our skincare products for sale in China.
Other Office and Distribution Warehouse Facilities
We own a 45,000 square foot office and warehouse building in Sydney, Australia.
In other markets, we lease regional offices and distribution warehouses. Additionally, we lease retail centers for our operations in China and a packaging facility in Singapore, which fulfills orders for our MyHealthPak™ product in our Asia Pacific markets.
We believe that the facilities referenced above are in good condition and are adequately utilized. Further, we believe that our current and planned manufacturing facilities provide for the productive capacity to meet our foreseeable needs.
Item 3. Legal Proceedings
We are a party to litigation and other proceedings that arise in the ordinary course of conducting business, including matters involving our products, intellectual property, supplier relationships, distributors, competitor relationships, employees and other matters.
Information with respect to legal proceedings may be found in Note K to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report, which is incorporated herein by reference.
Item 4. Mine Safety Disclosures
Not applicable.
39
PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Market Information
Our common stock trades on the NYSE under the symbol “USNA.” As of February 24, 2023, we had approximately 244 holders of record of our common stock. We have never declared or paid cash dividends on our common stock. Future cash dividends, if any, will be determined by our Board of Directors and will be based on earnings, available capital, our financial condition, and other factors that the Board of Directors deems to be relevant.
Information regarding securities authorized for issuance under equity compensation plans is included in Item 12. “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.”
Share Repurchases
Our share repurchase plan has been ongoing since the fourth quarter of 2000, with our Board of Directors periodically approving additional dollar amounts for share repurchases under the plan. There were no share repurchases made during the quarter ended December 31, 2022. As of December 31, 2022, the remaining authorized repurchase amount under the stock repurchase plan was $82.8 million. There is no expiration date on the remaining approved repurchase amount and no requirement for future share repurchases.
Stock Performance Graph
The following graph and table compare the performance of our common stock to the Russell 2000 Index ("Index") and to a market-weighted index of six companies selected in good faith from our industry (the “Peer Group”) over the last five years. The data shown assumes an investment on December 31, 2016, of $100 in our common stock and each of the other equities and reinvestment of all dividends into additional shares of the same class of equity, if applicable to the stock or index.
Each of the companies included in the Peer Group markets or manufactures products similar to our products or markets its products through a similar marketing channel. The Peer Group includes the following companies: Nu Skin Enterprises, Inc., Herbalife Nutrition Ltd., LifeVantage Corporation, Medifast, Inc., Nature's Sunshine Products, Inc., and Mannatech, Inc. The change to the Index and the Peer Group was made to address changes in the external market and to better reflect our business.
40
usna-20221231_g1.jpg
USNARussell 2000Peer Group
Dec 17$100 $100 $100 
Dec 18$159 $88 $97 
Dec 19$106 $109 $80 
Dec 20$104 $129 $116 
Dec 21$137 $146 $131 
Dec 22$72 $115 $81 
Item 6. Reserved
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of USANA’s financial condition and results of operations is presented in 10 sections:
•Overview
•Impact of the COVID-19 Pandemic
•Customers
•Presentation
•Non-GAAP Financial Measures
•Results of Operations
•Liquidity and Capital Resources
•Contractual Obligations and Commercial Contingencies
•Inflation
41
•Critical Accounting Policies and Estimates
This discussion and analysis from management's perspective should be read in conjunction with the Consolidated Financial Statements and notes thereto appearing elsewhere in this report.
Overview
We develop and manufacture high quality, science-based nutritional and personal care and skincare products that are distributed internationally through direct selling. We use this distribution method because we believe it is more conducive to meeting our vision as a company, which is to improve the overall health and nutrition of individuals and families around the world. Our customer base is primarily comprised of two types of customers: “Associates” and “Preferred Customers” referred to together as “active Customers.” Our Associates also sell our products to retail customers. Associates share in our company vision by acting as independent distributors of our products in addition to purchasing our products for their personal use. Preferred Customers purchase our products strictly for personal use and are not permitted to resell or to distribute the products. We only count as active Customers those Associates and Preferred Customers who have purchased from us at any time during the most recent three-month period. As of December 31, 2022, we had approximately 490,000 active Customers worldwide.
Impact of the COVID-19 Pandemic
The COVID-19 pandemic, including the spread of new variants of the virus, has negatively impacted our business in various markets around the world. The ongoing COVID-19 pandemic has created an unpredictable operating environment for us in many of our markets around the world and caused meaningful disruptions in both sales and operations. Government-imposed restrictions, health and safety mandated best practices, and public hesitance regarding in-person gatherings have reduced our ability, and the ability of our Associates to hold sales meetings, required our Associates to share and sell our products in a predominantly virtual environment, resulted in cancellations of key Company events and trips, required us to modify our workforce strategies, and required us, at times, to temporarily close our walk-in and fulfillment locations in some markets where we have such properties. The pandemic has also affected the availability and cost of various of our raw materials, packaging material, and shipping resources to transport our product to our various markets around the world. Our supply chain and logistics have incurred some disruption and we could experience more significant disruptions or closures in the future. These factors and others related to the COVID-19 pandemic will likely continue to negatively affect our business throughout 2023 in a number of ways.
Customers
Because we sell our products to a customer base of independent Associates and Preferred Customers, we increase our sales by increasing the number of our active Customers, the amount they spend on average, or both. Our primary focus continues to be increasing the number of active Customers. We believe this focus is consistent with our vision of improving the overall health and nutrition of individuals and families around the world. Sales to Associates accounted for approximately 53.4% of product sales during 2022 with the remainder of our sales being to Preferred Customers. Increases or decreases in product sales are typically the result of variations in the volume of product sold relating to fluctuations in the number of active Customers purchasing our products. The number of active Associates and Preferred Customers is therefore used by management as a key non-financial indicator to evaluate our operational performance.
The table below summarizes the change in our active Customer base by geographic region, rounded to the nearest thousand, as of the dates indicated.
Total Active Customers by RegionChange from
Prior Year		Percent
Change
As of
December 31, 2022		As of
January 1, 2022
Asia Pacific:
Greater China244,00049.8 %255,00045.5 %(11,000)(4.3 %)
Southeast Asia Pacific87,00017.8 %115,00020.5 %(28,000)(24.3 %)
North Asia53,00010.8 %58,00010.4 %(5,000)(8.6 %)
Asia Pacific Total384,00078.4 %428,00076.4 %(44,000)(10.3 %)
Americas and Europe106,00021.6 %132,00023.6 %(26,000)(19.7 %)
490,000100.0 %560,000100.0 %(70,000)(12.5 %)
42
Presentation
Product sales along with the shipping and handling fees billed to our customers are recorded as revenue net of applicable sales discounts when, or as control of, the promised product is transferred to the customer, which is at the time of delivery to the third party carrier for shipment. Payments received for unshipped products are recorded as deferred revenue and are included in the "Other current liabilities" line item in the consolidated balance sheet. Also reflected in net sales is a provision for a refund liability for sales returns, which is estimated based on our historical experience. Additionally, other types of revenue include fees, which are paid by the customer at the beginning of the service period, for access to online customer service applications and annual account renewal fees for Associates, for which control is transferred over time as services are delivered and are recognized as revenue on a straight-line basis over the term of the respective contracts.
Cost of sales primarily consists of expenses related to raw materials, labor, quality assurance, and overhead costs that are all directly associated with the production and distribution of our products and sales materials, as well as duties and taxes that are associated with the import and export of our products. As international sales increase as a percentage of net sales, cost of sales are increasingly affected by additional duties, freight, and other factors, such as changes in currency exchange rates.
Associate incentives expense includes all forms of commissions, and other incentives paid to our Associates. Incentives paid to Associates include bonuses earned, rewards from contests and promotions, and base commissions, which makes up the majority of our Associate incentives expense. We pay bonuses to Associates based on certain business-related criteria, total base commission earnings, and leadership level. Contests and promotions are offered as an incentive and reward to our Associates and are typically paid out only after an Associate achieves specific criteria. Base commissions are paid out on the sale of products. Associates earn their commissions based on sales volume points that are generated in their sales organization. Sales volume points are assigned to each commissionable product and comprise a certain percent of the product price. Items such as our starter kits and sales tools have no sales volume point value, and commissions are not paid on the sale of these items. Although insignificant to our financial statements, an Associate may earn commissions on sales volume points that are generated from personal purchases that are not considered part of their “Qualifying Sales.” To be eligible to earn commissions, an Associate must reach a certain level of Qualifying Sales each month, which may include product that they use personally or that they resell to consumers. Associates do not earn commissions on their Qualifying Sales. Commissions paid to Associates on personal purchases are considered a sales discount and are reported as a reduction to our net sales.
Selling, general and administrative expenses include wages and benefits, depreciation and amortization, lease costs and utilities, Associate event costs, advertising, professional fees, marketing, and research and development expenses. Wages and benefits represent the largest component of selling, general and administrative expenses. Significant depreciation and amortization expense is incurred as a result of investments in physical facilities, computer and information technology infrastructure to support our international operations.
Sales to customers outside the United States are transacted in the respective local currencies and translated to U.S. dollars at weighted-average currency exchange rates for each monthly accounting period to which they relate. With the exception of China, our raw material purchases from suppliers and product purchases from third-party manufacturers are transacted in U.S. dollars. Consequently, our net sales and earnings are affected by changes in currency exchange rates. In general, our operating results are affected positively by a weakening U.S. dollar and negatively by a strengthening U.S. dollar. In our net sales discussions that follow, we approximate the impact of currency fluctuations on net sales by translating current year net sales at the average exchange rates in effect during the comparable prior-year periods.
Non-GAAP Financial Measures
We believe that presentation of certain non-GAAP financial information is meaningful and useful in understanding the activities and business metrics of our operations. Management believes these measures reflect an additional way of viewing aspects of our business that, when viewed with our GAAP results, provide a more complete understanding of factors and trends affecting our business. This non-GAAP financial information may be determined or calculated differently by other companies, limiting the usefulness of those measures for comparative purposes. We provide such non-GAAP financial information for informational purposes only. Readers should consider the information in addition but not instead of or superior to, our Consolidated Financial Statements prepared in accordance with GAAP, accompanying this report.
In analyzing business trends and performance, management uses “constant currency” net sales, “local currency” net sales, and other currency-related financial information terms to discuss our financial results in a way we believe is
43
helpful in understanding the impact of fluctuations in foreign-currency exchange rates and facilitating period-to-period comparisons of results of operations and providing investors an additional perspective on trends and underlying business results. Changes in our reported revenue and profits in this report include the impacts of changes in foreign currency exchange rates. As additional information to the reader, we provide constant currency assessments in the tables and the narrative information in this MD&A to remove or quantify the impact of the fluctuation in foreign exchange rates and utilize constant currency results in our analysis of performance. Our constant currency financial results are calculated by translating the current period’s financial results at the same average exchange rates in effect during the applicable prior-year period and then comparing this amount to the prior-year period’s financial results.
Results of Operations
Summary of 2022 Financial Results
Our discussion and analysis is focused on our 2022 and 2021 financial results, including comparisons of our year-over-year performance between these years. Discussion and analysis of our 2020 fiscal year specifically, as well as the year-over-year comparison of our 2021 financial performance to 2020, are located in Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended January 1, 2022, filed with the SEC on March 1, 2022, which is available on our investor relations website at https://ir.usana.com or the SEC’s website at www.sec.gov. That information is incorporated by reference into this report.
Net sales in 2022 decreased 15.8%, or $187.9 million, to $998.6 million, compared with 2021. Current year sales programs and market specific promotions have performed below expectations, largely due to disruptions attributable to COVID-19 related lockdowns, and inflationary and economic challenges in many of our markets, particularly in our Asia Pacific markets. These disruptions have contributed to a 12.5% decline in active Customers compared to the prior year. Additionally, unfavorable changes in currency exchange rates decreased net sales for the year by an estimated $49.7 million.
Net earnings decreased 40.5% to $69.4 million in 2022, when compared with 2021. The decrease in net earnings was primarily the result of decreased sales and higher relative operating expenses.
Fiscal Year 2022 compared to Fiscal Year 2021
Net Sales
The following table summarizes the changes in our net sales by geographic region for the fiscal years ended December 31, 2022, and January 1, 2022:
Net Sales by Region
(in thousands)		Change from prior
year		Percent changeCurrency impact on
sales		Percent change
excluding currency
impact
Twelve Months Ended
December 31, 2022January 1, 2022
Asia Pacific
Greater China$502,486 50.3 %$563,469 47.5 %$(60,983)(10.8)%$(18,892)(7.5)%
Southeast Asia Pacific190,478 19.1 %269,803 22.7 %(79,325)(29.4)%(13,994)(24.2)%
North Asia108,952 10.9 %129,920 11.0 %(20,968)(16.1)%(13,809)(5.5)%
Asia Pacific Total801,916 80.3 %963,192 81.2 %(161,276)(16.7)%(46,695)(11.9)%
Americas and Europe196,685 19.7 %223,272 18.8 %(26,587)(11.9)%(3,033)(10.5)%
$998,601 100.0 %$1,186,464 100.0 %$(187,863)(15.8)%$(49,728)(11.6)%
Asia Pacific: The decline in this region is largely the result of the challenging operating environment as discussed above. As a result, there were local currency sales declines in all markets in this region. The decrease in constant currency net sales in Greater China was most notable in China, where local currency net sales decreased 7.0%. The decrease in constant currency net sales in Southeast Asia Pacific was most notable in the Philippines, and Malaysia, which had local
44
currency net sales declines of 33.2%, and 27.8%, respectively. The decrease in constant currency net sales in North Asia was most notable in South Korea, which had a local currency net sales decline of 4.9%.
Americas and Europe: The decline in this region is largely the result of the challenging operating environment as discussed above, as a result, there were local currency sales declines in all markets in this region, most notable among these markets, Canada and the United States, where local currency net sales decreased 14.8% and 7.1%, respectively.
Gross Profit
Gross profit decreased 100 basis points to 80.6% of net sales, down from 81.6% in 2021. The decrease in gross profit margin can be attributed to unfavorable changes in currency exchange rates, higher scrap and inventory valuation, increased product costs, and loss of leverage on lower sales. These decreases were partially offset by favorable changes in market and product sales mix, and increased transportation costs in the prior-year period related to the strategic buildup of inventory due to COVID-19 related disruptions to our supply chain and logistics.
Associate Incentives
Associate incentives decreased 30 basis points to 43.5% of net sales in 2022, compared with 43.8% in the prior year. The relative decrease can primarily be attributed to a decrease in promotional incentives, as described above, and decreased spend on miscellaneous associate incentives.
Selling, General and Administrative Expenses
Selling, general and administrative expenses increased 280 basis points relative to net sales and decreased $16.8 million in absolute terms. The relative increase can be attributed to leverage lost on lower net sales. The decreased expense in absolute terms can be primarily attributed to lower costs on variable expenses, as well as lower employee related costs.
Income Taxes
Income taxes increased to 36.2% of pre-tax earnings in 2022, up from 31.7% of pre-tax earnings in 2021. The effective tax rate increase is due primarily to a change in the market mix of pre-tax book income.
Diluted Earnings Per Share
Diluted EPS decreased to $3.59 in 2022 from $5.73 in 2021. This decrease can be attributed to lower net earnings, partially offset by lower diluted share count.
Liquidity and Capital Resources
We have historically met our working capital and capital expenditure requirements by using both net cash flow from operations and by drawing on our line of credit. Our principal source of liquidity is our operating cash flow. Although we are required to maintain cash deposits with banks in certain of our markets, there are currently no material restrictions on our ability to transfer and remit funds among our international markets. In China, however, our compliance with Chinese accounting and tax regulations promulgated by the State Administration of Foreign Exchange (“SAFE”) results in transfer and remittance of our profits and dividends from China to the United States on a delayed basis. If SAFE or other Chinese regulators introduce new regulations, or change existing regulations, which allow foreign investors to remit profits and dividends earned in China to other countries, our ability to remit profits or pay dividends from China to the United States may be limited in the future.
We believe we have sufficient liquidity to satisfy our cash needs and expect to continue to fund our business with cash flow from operations. We continue, however, to evaluate and take action, as necessary, to preserve adequate liquidity and ensure that our business can continue to operate during these uncertain times. Additionally, we continually evaluate opportunities to repurchase shares of our common stock and will, from time to time, consider the acquisition of, or investment in complementary businesses, products, services and technologies, which has the potential to affect our liquidity.
Cash and Cash Equivalents
Cash and cash equivalents increased to $288.4 million at December 31, 2022, from $239.8 million at January 1, 2022. Cash flow provided by operating activities generated $103.9 million partially offset by cash used in financing activities of $30.1 million, and cash used in investing activities of $12.4 million primarily to acquire property and
45
equipment and assets in business combinations, partially offset by proceeds from the settlement of our net investment hedge. Additionally, unfavorable changes in currency exchange rates, have impacted cash and cash equivalents, and restricted cash by an estimated $13.8 million.
The following table below presents concentrations of cash and cash equivalents by market for the periods indicated:
Cash and cash equivalents
(in Millions)
As of
December 31, 2022		As of
January 1, 2022
China$129.8 $139.9 
United States114.151.9
All other markets44.548.0
Total Cash and cash equivalents$288.4 $239.8 
Cash Flows Provided by Operations and Significant Uses of Cash
As discussed above, our principal source of liquidity comes from cash flows provided by operating activities, which results from a strong operating margin. Net cash flow provided by operating activities totaled $103.9 million in 2022. Net earnings combined with adjustments of non-cash items contributed positively to our net cash flow provided by operating activities, partially offset by cash used to payout the annual employee bonus, reduce accruals related to inventories, and a reduction in trade payables. Additionally, cash used to repurchase and retire shares was $25.4 million for 2022.
Net cash flow provided by operating activities totaled $121.2 million in 2021. Net earnings combined with adjustments of non-cash items contributed positively to our net cash flow provided by operating activities, partially offset by purchase of inventories, the payout of the annual employee bonus, and a reduction in trade payables. Additionally, cash used to repurchase and retires shares was $177.8 million for 2021.
Line of Credit
Information with respect to our line of credit may be found in Note J to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report, which is incorporated by reference.
Share Repurchase
Information with respect to our share repurchases may be found in Note N to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report, which is incorporated by reference.
Off-Balance Sheet Arrangements
None.
Summary
We believe that current cash balances, future cash provided by operations, and amounts available under our line of credit will be sufficient to cover our operating and capital needs in the ordinary course of business for the foreseeable future. If we experience an adverse operating environment or unanticipated and unusual capital expenditure requirements, additional financing may be required. No assurance can be given, however, that additional financing, if required, would be available at all or on favorable terms. We might also require or seek additional financing for the purpose of expanding into new markets, growing our existing markets, or for other reasons. Such financing may include the use of additional debt or the sale of additional equity securities. Any financing which involves the sale of equity securities or instruments that are convertible into equity securities could result in immediate and possibly significant dilution to our existing shareholders.
46
Contractual Obligations and Commercial Contingencies
The following table summarizes our contractual obligations and commitments as of December 31, 2022 and the effect such obligations and commitments are expected to have on our liquidity and cash flow in future periods:
Payments Due By Period
(in thousands)
Contractual ObligationsTotalLess than 1 year1 - 3 years3 - 5 yearsMore than 5 years
Operating Leases$15,064 $7,214 $7,233 $617 $— 
Other Commitments32,690 23,544 7,583 1,563 — 
Total Contractual Obligations$47,754 $30,758 $14,816 $2,180 $— 
“Operating Leases” generally provide that property taxes, insurance, and maintenance expenses are our responsibility. Such expenses are not included in the operating lease amounts in the table above. Information with respect to our Operating Leases may be found in Note G to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report, which is incorporated by reference.
“Other Commitments” generally include consulting- and IT-related services, investments in brand awareness through corporate and athlete sponsorships, facility maintenance, and services related to the events that we hold for our Associates both locally and internationally. Additionally, throughout the year we will enter into various short-term contracts, mostly for services related to events that we hold for our Associates. Information with respect to our Unconditional Purchase Obligations may be found in Note K to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report, which is incorporated by reference.
Inflation
We do not believe that inflation has had a material impact on our historical operations or profitability. Like many other global companies, we are facing significant inflationary pressures in the world economy. Inflationary pressures are growing as we renew pricing arrangements, notably for certain direct materials, wages, energy, and transportation costs. These inflationary pressures, including margin pressure from inflation as well as the cost of capital could continue to grow in 2023.
Critical Accounting Policies and Estimates
Our Consolidated Financial Statements included in this report have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). Our significant accounting policies are described in Consolidated Financial Statements included herein. The preparation of financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and accompanying notes. Those estimates and assumptions are derived and are continually evaluated based on our historical experiences, current facts and circumstances, and on changes in the business environment. Actual results, however, may sometimes differ materially from estimates under different conditions. Critical accounting estimates are defined as both those that are material to the portrayal of our financial condition and results of operations and those that require management’s most subjective judgments. We believe that our most critical accounting policies and estimates are described in this section.
Revenue Recognition. Revenue is recognized when, or as, control of a promised product or service transfers to a customer, in an amount that reflects the consideration to which we expect to be entitled in exchange for transferring those products or services. Revenue recognition is evaluated through the following five-step process:
1)identification of the contract with a customer;
2)identification of the performance obligations in the contract;
3)determination of the transaction price;
4)allocation of the transaction price to the performance obligations in the contract; and
5)recognition of revenue when or as a performance obligation is satisfied.
A majority of our sales are for products sold at a point in time and shipped to customers, for which control is transferred to the customer as goods are delivered to the third-party carrier for shipment. We receive payment, primarily via credit card, for the sale of products at the time customers place orders and payment is required prior to shipment. Our
47
product sales contracts include terms that could cause variability in the transaction price for items such as discounts, credits, or sales returns. Accordingly, the transaction price for product sales includes estimates of variable consideration to the extent it is probable that a significant reversal of revenue recognized will not occur. At the time of sale, we estimate a refund liability for the variable consideration based on historical experience.
Initial product orders with a new customer may include multiple performance obligations related to sales discounts earned under our initial order reward program. Under this program, the customer receives an option to apply the discounts earned on the initial order to two subsequent Auto Orders, which conveys a material right to the customer. As such, the initial order transaction price is allocated to each separate performance obligation based on its relative standalone selling price and recognized as revenue as each performance obligation is satisfied.
Associate incentives represent consideration paid and include all forms of commissions, and other incentives paid to our Associates. With the exception of commissions paid to Associates on personal purchases, which are considered a sales discount and are reported as a reduction to net sales, the incentives are paid for distinct services related to our product sales and are recorded as an expense when revenue for the goods is recognized.
Shipping and handling activities are performed upon delivery to the third-party carrier for shipment. We account for these activities as fulfillment costs. Therefore, we recognize the costs of these activities when revenue for the goods is recognized. Shipping and handling costs are included in cost of sales for all periods presented.
Contract liabilities relate to deferred revenue for product sales for customer payments received in advance of shipment, for outstanding material rights under the initial order program, and for services where the performance obligations are satisfied over time as services are delivered. Contract liabilities are recorded as deferred revenue within the “Other current liabilities” line item in the consolidated balance sheet. Deferred revenue is recognized when or as the related performance obligation is satisfied. On the occasion that will-call orders are not picked up by customers, we periodically assess the likelihood that customers will exercise their contractual right to pick up orders and recognize revenue when the likelihood that customers will pick up orders is remote.
Inventory Valuation. Inventories are stated at the lower of cost or net realizable value. Cost is determined using a standard costing system, which approximates the first-in, first-out method. The components of inventory cost include raw materials, labor, and overhead. Net realizable value is determined using various assumptions with regard to excess or slow-moving inventories, non-conforming inventories, expiration dates, current and future product demand, production planning, and market conditions. The forecasted future product demand for excess or slow-moving inventories is based on judgment and available information. A change in any valuation assumptions could result in an adjustment to inventory. However, the reported carrying value of inventory is not highly sensitive to reasonable changes in individual assumptions.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
Our earnings, cash flows, and financial position are affected by fluctuations in currency exchange rates, interest rates, and other uncertainties that are inherent in doing business and selling product in more than one currency. In addition, our operations are exposed to risks that are associated with changes in social, political, and economic conditions in our international operations. This includes changes in the laws and policies that govern investment in international countries where we have operations, as well as, to a lesser extent, changes in U.S. laws and regulations relating to international trade and investment.
Foreign Currency Risks. Because a significant portion of our sales are generated outside the United States, currency exchange rate fluctuations may have a significant effect on our sales and earnings. The local currency of each international subsidiary is considered the functional currency, with all revenue and expenses being translated at weighted-average currency exchange rates for the applicable periods. In general, our reported sales and gross profit are affected positively by a weakening of the U.S. dollar and negatively by a strengthening of the U.S. dollar because we manufacture the majority of our products in the United States and sell them to our international subsidiaries in their respective functional currencies. Currency fluctuations, however, have the opposite effect on our Associate incentives and selling, general and administrative expenses. We are unable to reasonably estimate the effect that currency fluctuations may have on our future business, results of operations, or financial condition. This is due to the uncertainty in, and the varying degrees and type of exposure that we face from, fluctuation of various currencies.
Currently our strategy for reducing our exposure to currency fluctuation includes the timely and efficient repatriation of earnings from international markets, and settlement of intercompany transactions. Additionally, we may enter into short-term foreign currency credit arrangements in our international markets, primarily as a way to reduce our exposure to negative effects of changes in foreign currency exchange rates. We also enter into currency exchange contracts
48
to offset foreign currency exposure in various international markets. We do not use derivative financial instruments for trading or speculative purposes. There can be no assurance that our practices will be successful in eliminating all or substantially all of the risks that we may encounter in connection with our currency transactions.
Interest Rate Risks. As of December 31, 2022, we had no outstanding debt and therefore, we had no direct exposure to interest rate risk. It may become necessary to borrow in the future in order to meet our financing needs. In the event that it becomes necessary to borrow, there can be no assurance that we will be able to borrow, or at favorable rates.
Item 8. Financial Statements and Supplementary Data
The Financial Statements and Supplementary Data required by this Item are set forth at the pages indicated at Part IV, Item 15, below.
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
Not applicable.
Item 9A. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures that are designed to ensure that information that is required to be disclosed in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods that are specified in the SEC’s rules and forms and that such information is accumulated and communicated to management, including our Principal Executive Officer and Principal Financial Officer, as appropriate, to allow timely decisions regarding any required disclosure. In designing and evaluating these disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.
As of the end of the period covered by this report, our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial and Accounting Officer) evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act). Based on this evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures were effective to provide reasonable assurance as of December 31, 2022.
Management’s Report on Internal Control over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting, (as defined in Rule 13a- 15(f) under the Exchange Act). Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our Financial Statements for external purposes in accordance with generally accepted accounting principles. Internal control over financial reporting includes those policies and procedures that:
•Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company;
•Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and
•Provide reasonable assurance regarding the prevention or timely detection of any unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.
Internal control over financial reporting is a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures. Internal control over financial reporting also can be circumvented by collusion or improper override of a control. Because of its inherent limitations, internal control over financial reporting may not prevent or detect all errors or fraud or ensure that all material information will be made known to management in a timely manner. However, these inherent limitations are known features of the financial reporting process, and it is possible to design into the process safeguards to reduce, though not eliminate, this risk. Projections of any
49
evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.
Our management, including our Chief Executive Officer and our Chief Financial Officer, assessed the effectiveness of our internal control over financial reporting as of December 31, 2022. In making this assessment, management used the criteria that have been set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal Control-Integrated Framework (2013). Based on its assessment, using those criteria, management concluded that, as of December 31, 2022, our internal control over financial reporting was effective.
The effectiveness of the Company’s internal control over financial reporting, as of December 31, 2022, has been audited by KPMG LLP, an independent registered public accounting firm, as stated in their report which appears herein.
Changes in Control over Financial Reporting
There were no changes in our internal control over financial reporting during the fiscal quarter ended December 31, 2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
50
Report of Independent Registered Public Accounting Firm
To the Stockholders and Board of Directors
USANA Health Sciences, Inc.:
Opinion on Internal Control Over Financial Reporting
We have audited USANA Health Sciences, Inc. and subsidiaries' (the Company) internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2022 and January 1, 2022, the related consolidated statements of comprehensive income, stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2022, and the related notes and financial statement schedule II - valuation and qualifying accounts (collectively, the consolidated financial statements), and our report dated February 28, 2023 expressed an unqualified opinion on those consolidated financial statements.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/ KPMG LLP
Salt Lake City, Utah
February 28, 2023
51
Item 9B. Other Information
Not applicable.
Item 9C. Disclosure regarding Foreign Jurisdictions that Prevent Inspections
Not applicable.
PART III
Items 10, 11, 12, 13 and 14
Information required by Items 10, 11, 12, 13, and 14 of this Form 10-K is incorporated by reference from our definitive Proxy Statement for our 2023 Annual Meeting of Shareholders, which will be filed with the SEC, pursuant to Regulation 14A, not later than 120 days after the end of the 2022 fiscal year, all of which information is hereby incorporated by reference in, and made part of, this Form 10-K, except disclosure of our executive officers, which is included in Part I, Item 1 of this report.
PART IV
Item 15. Exhibits, Financial Statement Schedules
(a)The following documents are filed as part of this report:
1.Financial Statements
2.Financial Statement Schedules.
For the years ended December 31, 2022, January 1, 2022, and January 2, 2021
Schedule II – Valuation and Qualifying Accounts
3.Exhibits.
The exhibits identified below are filed or incorporated by reference as part of this Annual Report, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K). We have identified below each management contract and compensation plan filed as an exhibit to this Annual Report in response to Item 15(a)(3) of Form 10-K.

Exhibit
Number
Description
3.1
3.2
4.1
4.6
10.1
52
10.2
10.3
10.4
10.5
10.6
10.7
10.8
10.9
10.10
10.11
10.12
10.13
10.14
10.15
10.16
10.17
10.18
10.19
10.20
14
53
21
23.1
31.1
31.2
32.1
32.2
101.INSInline XBRL Instance Document
101.SCHInline XBRL Taxonomy Extension Schema Document
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document
101.LABInline XBRL Taxonomy Extension Label Linkbase Document
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
______________________________
*Denotes a management contract or compensatory plan or arrangement.
54
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
USANA Health Sciences, Inc.
By:/s/ Kevin G. Guest
Kevin G. Guest
Chief Executive Officer and Chairman of the Board
Date: February 28, 2023
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
SignatureTitleDate
/s/ Kevin G. GuestChairman and Chief Executive OfficerFebruary 28, 2023
Kevin G. Guest(Principal Executive Officer)
/s/ Gilbert A. FullerDirectorFebruary 28, 2023
Gilbert A. Fuller
/s/ John T. FlemingDirectorFebruary 28, 2023
John Fleming
/s/ Scott NixonDirectorFebruary 28, 2023
Scott Nixon
/s/ Frederic J. WinssingerDirectorFebruary 28, 2023
Frederic J. Winssinger
/s/ Xia DingDirectorFebruary 28, 2023
Xia Ding
/s/ Timothy E. WoodDirectorFebruary 28, 2023
Timothy E. Wood
/s/ Peggie PelosiDirectorFebruary 28, 2023
Peggie Pelosi
/s/ G. Douglas HekkingChief Financial OfficerFebruary 28, 2023
G. Douglas Hekking(Principal Financial and Accounting Officer)
55
Report of Independent Registered Public Accounting Firm
To the Stockholders and Board of Directors
USANA Health Sciences, Inc.:
Opinion on the Consolidated Financial Statements
We have audited the accompanying consolidated balance sheets of USANA Health Sciences, Inc. and subsidiaries (the Company) as of December 31, 2022 and January 1, 2022, the related consolidated statements of comprehensive income, stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2022, and the related notes and financial statement schedule II - valuation and qualifying accounts (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and January 1, 2022, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2022, in conformity with U.S. generally accepted accounting principles.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated February 28, 2023 expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting.
Basis for Opinion
These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Assessment of lower of cost or net realizable value of certain inventories
As discussed in Notes A and C to the consolidated financial statements, inventories of $67,089,000 in current assets and noncurrent inventories of $3,479,000 in other assets as of December 31, 2022 are stated at the lower of cost or net realizable value. The Company performs analyses to identify and estimate the net realizable value of excess or slow-moving inventories, which includes the evaluation of inventory that does not conform to product specifications, expiration dates, current and future product demand, production planning and market conditions. The Company manufactures inventories in the United States for all global markets, excluding China.
We identified the assessment of lower of cost or net realizable value of inventories, excluding inventories manufactured and held in China, as a critical audit matter. The forecasted future product demand for excess or slow-moving inventories is difficult to assess and results in the application of greater auditor judgment.
F-1
The following are the primary procedures we performed to address the critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls over the Company’s inventory valuation process, including controls related to the assessment of the lower of cost or net realizable value and the determination of the forecasted future product demand. We performed a retrospective review to assess the Company’s ability to accurately forecast. We evaluated the Company’s determination of lower of cost or net realizable value of excess or slow-moving inventories utilizing current year sales by product and comparing it to product inventory on hand as of December 31, 2022. We also analyzed a sample of inventory items to evaluate the forecasted future product demand by comparison of that forecast to historical demand and any known changes that would impact future demand.
/s/ KPMG LLP
We have served as the Company’s auditor since 2013.
Salt Lake City, Utah
February 28, 2023
F-2
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(in thousands, except par value)

As of
December 31,
2022		As of
January 1,
2022
ASSETS
Current assets
Cash and cash equivalents$288,420 $239,832 
Inventories67,089 98,318 
Prepaid expenses and other current assets28,873 26,967 
Total current assets384,382 365,117 
Property and equipment, net97,773 101,780 
Goodwill17,368 17,668 
Intangible assets, net32,432 30,442 
Deferred tax assets9,799 4,839 
Other assets54,795 57,894 
$596,549 $577,740 
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable$11,049 $13,508 
Other current liabilities132,784 147,282 
Total current liabilities143,833 160,790 
Deferred tax liabilities4,071 7,497 
Other long-term liabilities14,173 14,329 
Stockholders' equity
Common stock, $0.001 par value; Authorized -- 50,000 shares, issued and outstanding 19,206 as of December 31, 2022 and 19,393 as of January 1, 2022
19 19 
Additional paid-in capital55,604 50,010 
Retained earnings391,636 344,637 
Accumulated other comprehensive income (loss)(12,787)458 
Total stockholders' equity434,472 395,124 
$596,549 $577,740 
The accompanying notes are an integral part of these statements.
F-3
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands, except per share data)

Fiscal Year
202220212020
Net sales$998,601 $1,186,464 $1,134,644 
Cost of sales193,890 217,898 209,111 
Gross profit804,711 968,566 925,533 
Operating expenses:
Associate incentives434,793 519,267 487,856 
Selling, general and administrative262,304 279,107 261,186 
Total operating expenses697,097 798,374 749,042 
Earnings from operations107,614 170,192 176,491 
Other income (expense):
Interest income3,789 2,515 2,535 
Interest expense(192)(57)(507)
Other, net(2,590)(2,008)(571)
Other income (expense), net1,007 450 1,457 
Earnings before income taxes108,621 170,642 177,948 
Income taxes39,271 54,137 53,284 
Net earnings$69,350 $116,505 $124,664 
Earnings per common share
Basic$3.60 $5.78 $5.89 
Diluted$3.59 $5.73 $5.86 
Weighted average common shares outstanding
Basic19,254 20,146 21,156 
Diluted19,310 20,343 21,256 
Comprehensive income:
Net earnings$69,350 $116,505 $124,664 
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment(15,126)2,203 13,327 
Tax benefit (expense) related to foreign currency translation adjustment1,881 1,880 (3,051)
Other comprehensive income (loss), net of tax(13,245)4,083 10,276 
Comprehensive income$56,105 $120,588 $134,940 
The accompanying notes are an integral part of these statements.
F-4
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in thousands)

Common StockAdditional
Paid-in
Capital		Retained
Earnings		Accumulated
Other
Comprehensive
Income (Loss)		Total
SharesValue
Balance at December 28, 201921,655$22 $59,445 $306,146 $(13,901)$351,712 
Net earnings124,664 124,664 
Other comprehensive income (loss), net of tax10,276 10,276 
Equity-based compensation expense14,394  14,394 
Common stock repurchased and retired(785)(1)(9,012)(48,016)(57,029)
Common stock issued under equity award plans168—  — 
Tax withholding for net-share settled equity awards(2,367)(2,367)
Balance at January 2, 202121,03821 62,460 382,794 (3,625)441,650 
Net earnings116,505 116,505 
Other comprehensive income (loss), net of tax4,083 4,083 
Equity-based compensation expense14,298 14,298 
Common stock repurchased and retired(1,844)(2)(23,173)(154,662)(177,837)
Common stock issued under equity award plans199—   — 
Tax withholding for net-share settled equity awards(3,575) (3,575)
Balance at January 1, 202219,39319 50,010 344,637 458 395,124 
Net earnings69,350 69,350 
Other comprehensive income (loss), net of tax(13,245)(13,245)
Equity-based compensation expense13,331 13,331 
Common stock repurchased and retired(288)— (3,031)(22,351)(25,382)
Common stock issued under equity award plans101—  — 
Tax withholding for net-share settled equity awards (4,706)(4,706)
Balance at December 31, 202219,206$19 $55,604 $391,636 $(12,787)$434,472 
The accompanying notes are an integral part of these statements.
F-5
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

Year Ended
202220212020
Cash flows from operating activities
Net earnings$69,350 $116,505 $124,664 
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities
Depreciation and amortization13,393 13,036 13,747 
Right-of-use asset amortization8,017 9,157 8,762 
(Gain) loss on sale of property and equipment141 61 191 
Equity-based compensation expense13,331 14,298 14,394 
Deferred income taxes(7,183)(2,970)(2,423)
(Gain) loss on impairment on other assets— — 510 
Changes in operating assets and liabilities, net of acquisitions:
Inventories21,879 (10,501)(16,784)
Prepaid expenses and other assets(3,304)(2,331)(5,192)
Accounts payable(2,656)(4,572)6,076 
Other liabilities(9,066)(11,456)16,456 
Net cash provided by (used in) operating activities103,902 121,227 160,401 
Cash flows from investing activities
Receipts on notes receivable— 116 281 
Proceeds from the settlement of net investment hedges4,555 — 1,935 
Payments for net investment hedge— (1,555)(1,089)
Payments for investment in equity securities— — (20,000)
Payments to acquire businesses(6,532)— — 
Proceeds from sale of property and equipment7 15 6 
Purchases of property and equipment(10,400)(12,763)(15,094)
Net cash provided by (used in) investing activities(12,370)(14,187)(33,961)
Cash flows from financing activities
Repurchase of common stock(25,382)(177,837)(57,029)
Borrowings on line of credit11,000 — 60,000 
Payments on line of credit(11,000)— (60,000)
Payments related to tax withholding for net-share settled equity awards(4,706)(3,575)(2,367)
Payments for debt issuance costs— — (46)
Net cash provided by (used in) financing activities(30,088)(181,412)(59,442)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash(13,777)2,088 11,251 
Net increase (decrease) in cash, cash equivalents, and restricted cash47,667 (72,284)78,249 
Cash, cash equivalents, and restricted cash at beginning of period243,653 315,937 237,688 
Cash, cash equivalents, and restricted cash at end of period$291,320 $243,653 $315,937 
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets
Cash and cash equivalents$288,420 $239,832 $311,917 
Restricted cash included in prepaid expenses and other current assets— — 958 
Restricted cash included in other assets2,900 3,821 3,062 
Total cash, cash equivalents, and restricted cash$291,320 $243,653 $315,937 
F-6
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS - CONTINUED
(in thousands)
Year Ended
202220212020
Supplemental disclosures of cash flow information
Cash paid during the period for:
Interest$49 $10 $711 
Income taxes45,863 59,524 53,015 
Cash received during the period for:
Income tax refund113 191 847 
Non-cash investing and financing activities:
Right-of-use assets obtained in exchange for lease obligations5,641 5,322 6,632 
Non-cash change in right-of-use assets— — (3,182)
Accrued purchases of property and equipment679 383 375 
Contingent consideration given to acquire assets886 — — 
The accompanying notes are an integral part of these statements.
F-7
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)

NOTE A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
COVID-19
The COVID-19 pandemic, including the spread of new variants of the virus, has negatively impacted our business in various markets around the world. The ongoing COVID-19 pandemic has created an unpredictable operating environment for us in many of our markets around the world and caused meaningful disruptions in both sales and operations for fiscal 2022, 2021, and 2020. At this time, the Company is unable to predict the impact that COVID-19 will have on its business, financial position and operating results in future periods due to numerous uncertainties and is closely monitoring the impact of the pandemic on all aspects of its business.
The Company
USANA Health Sciences, Inc. is a global direct-selling, personal health and wellness company that develops and manufactures high quality, science-based nutritional and personal care products.
The Consolidated Financial Statements (the “Financial Statements”) include the accounts and operations of the Company, which are grouped and presented in two geographic regions: (1) Asia Pacific and (2) Americas and Europe. Asia Pacific is further divided into three sub-regions: (i) Greater China, (ii) Southeast Asia Pacific, and (iii) North Asia.
Asia Pacific
(1)Asia Pacific is organized into three sub-regions: Greater China, Southeast Asia Pacific, and North Asia. Markets included in each of these sub-regions are as follows:
(i)Greater China - Hong Kong, Taiwan, and China. Our business in China is conducted by BabyCare
(ii)Southeast Asia Pacific – Australia, New Zealand, Singapore, Malaysia, the Philippines, Thailand, and Indonesia
(iii)North Asia – Japan and South Korea
Americas and Europe
(2)Americas and Europe – United States, Canada, Mexico, Colombia, and Europe (the United Kingdom, France, Germany, Spain, Italy, Romania, Belgium, and the Netherlands)
Principles of Consolidation and Basis of Presentation
The accompanying Consolidated Financial Statements include the accounts and operations of the Company. All inter-company accounts and transactions have been eliminated in consolidation. The accounting and reporting policies of the Company conform with accounting principles generally accepted in the United States of America (“US GAAP”).
Use of Estimates
The preparation of Consolidated Financial Statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. These estimates may be adjusted as more current information becomes available, and any adjustment could be significant.
Fiscal Year
The Company operates on a 52/53-week year, ending on the Saturday closest to December 31. Fiscal years 2022 and 2021 were 52-week years. Fiscal year 2020 was a 53-week year. Fiscal year 2022 covered the period January 2, 2022
F-8
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
to December 31, 2022 (hereinafter 2022). Fiscal year 2021 covered the period January 3, 2021 to January 1, 2022 (hereinafter 2021). Fiscal year 2020 covered the period December 29, 2019 to January 2, 2021 (hereinafter 2020).
Fair Value Measurements
The Company measures at fair value certain of its financial and non-financial assets and liabilities by using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price, based on the highest and best use of the asset or liability. The levels of the fair value hierarchy are:
•Level 1 inputs are quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date.
•Level 2 inputs are from other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly.
•Level 3 inputs are unobservable and are used to measure fair value in situations where there is little, if any, market activity for the asset or liability at the measurement date.
As of December 31, 2022 and January 1, 2022, the following financial assets and liabilities were measured at fair value on a recurring basis using the type of inputs shown:
December 31,
2022		Fair Value Measurements Using
Inputs
Level 1Level 2Level 3
Money market funds included in cash equivalents$211,539 $211,539 $— $— 
Foreign currency contracts included in other current liabilities(3,150)— (3,150)— 
Deferred compensation liabilities
(1,632)— (1,632)— 
Contingent consideration included in other current liabilities of $(338) and other long-term liabilities of $(548)
(886)— — (886)
$205,871 $211,539 $(4,782)$(886)
January 1,
2022		Fair Value Measurements Using
Inputs
Level 1Level 2Level 3
Money market funds included in cash equivalents$163,619 $163,619 $— $— 
Foreign currency contracts included in other current liabilities(461)— (461)— 
$163,158 $163,619 $(461)$— 
There were no transfers of financial assets or liabilities between levels of the fair value hierarchy for the periods indicated.
The majority of the Company’s non-financial assets, which include long-lived assets, are not required to be carried at fair value on a recurring basis. However, if an impairment charge is required, a non-financial asset would be written down to fair value. As of December 31, 2022 and January 1, 2022, there were no non-financial assets measured at fair value on a non-recurring basis.
F-9
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
Fair Value of Financial Instruments
As of December 31, 2022 and January 1, 2022, the Company’s financial instruments include cash equivalents, restricted cash, other liabilities, and foreign currency contracts. The recorded values of cash equivalents and restricted cash approximate their fair values, based on their short-term nature.
Translation of Foreign Currencies
The functional currency of the Company’s foreign subsidiaries is the local currency of their country of domicile. Assets and liabilities of the foreign subsidiaries are translated into U.S. dollar amounts at month-end exchange rates. Revenue and expense accounts are translated at the weighted-average rates for the monthly accounting period to which they relate. Equity accounts are translated at historical rates. Foreign currency translation adjustments are accumulated as a component of other comprehensive income. Gains and losses from foreign currency transactions are included in the “Other, net” component of Other income (expense) in the Company’s consolidated statements of comprehensive income.
Business Combinations
The Company allocates the purchase price consideration of the assets acquired and liabilities assumed based on the acquisition date fair values. Additionally, the Company records goodwill for the excess of the total consideration given for the acquired business over the fair value of the identifiable net assets of the acquired business. Transaction costs attributable to the acquisition are expensed as incurred.
Cash and Cash Equivalents
The Company considers all highly liquid investments with an original maturity of three months or less from the date of purchase to be cash equivalents. Cash equivalents as of December 31, 2022 and January 1, 2022 consisted primarily of money market fund investments and amounts receivable from credit card processors.
Amounts receivable from credit card processors and other forms of electronic payment are considered cash equivalents because they are both short-term and highly liquid in nature and are typically converted to cash within three days of the sales transaction. Amounts receivable from credit card processors as of December 31, 2022 and January 1, 2022 totaled $8,904 and $11,123, respectively.
Restricted Cash
The Company is required to maintain cash deposits with banks in certain subsidiary locations for various operating purposes. The most significant of these cash deposits relates to a deposit held at a bank in China, the balance of which was $2,900 as of December 31, 2022, and $3,146 as of January 1, 2022. This deposit is required for the application of direct sales licenses by the Ministry of Commerce and the State Administration of Market Regulation (“SAMR”) of the People’s Republic of China, and will continue to be restricted during the periods while the Company holds these licenses.
Inventories
Inventories are stated at the lower of cost or net realizable value. Cost is determined using a standard costing system, which approximates the first-in, first-out method. The components of inventory cost include raw materials, labor, and overhead. Net realizable value is determined using various assumptions with regard to excess or slow-moving inventories, non-conforming inventories, expiration dates, current and future product demand, production planning, and market conditions. A change in any of these variables could result in an adjustment to inventory.

Noncurrent inventory are inventories not expected to be sold within the normal operating cycle. The Company has defined the operating cycle as 52-weeks. Noncurrent inventory is classified in the "Other assets" line item in the Company's consolidated balance sheets.
Accounts Receivable
Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company maintains an allowance for doubtful accounts for estimated losses inherent in its accounts receivable portfolio. In establishing the
F-10
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
required allowance, management considers historical losses adjusted to take into account current market conditions and our customers’ financial condition, the amount of receivables in dispute, and the current receivables aging and current payment patterns. The Company reviews its allowance for doubtful accounts regularly. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Accounts Receivable is included in the “Prepaid expenses and other current assets” line item in the Company’s consolidated balance sheets.
Income Taxes
The Company accounts for income taxes using the asset and liability method, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of the differences between the financial statement assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates that are expected to apply to taxable income in the year in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax law is recognized in income in the period that includes the enactment date. Deferred tax expense or benefit is the result of changes in deferred tax assets and liabilities.
The Company evaluates the probability of realizing the future benefits of its deferred tax assets and provides a valuation allowance for the portion of any deferred tax assets where the likelihood of realizing an income tax benefit in the future does not meet the “more-likely-than-not” criteria for recognition. The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the Financial Statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. The Company recognizes interest and penalties related to unrecognized tax benefits in income taxes.
Property and Equipment
Property and equipment are recorded at cost. Maintenance, repairs, and renewals, which neither materially add to the value of the property nor appreciably prolong its life, are charged to expense as incurred. Depreciation is provided in amounts sufficient to relate the cost of depreciable assets to operations over the estimated useful lives of the related assets. The straight-line method of depreciation and amortization is followed for financial statement purposes. Leasehold improvements are amortized over the shorter of the life of the respective lease or the useful life of the improvements. Property and equipment are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When property and equipment are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period.
Leases
With the exception of the Company’s headquarters in Salt Lake City, Utah, and its facilities in New South Wales, Australia, and in Beijing and Tianjin, China, the Company leases its facilities. Each of the facility lease agreements is a non-cancelable operating lease generally structured with renewal options and expires prior to or during 2027. In connection with the production facilities in Beijing and Tianjin, China, the Company has prepaid land use rights, which represents a lease with the associated prepayment recorded as a Right-of-Use (“ROU”) asset. The Company also utilizes equipment under non-cancelable operating leases, expiring through 2026.
At contract inception, the Company determines whether an arrangement is or contains a lease and whether the lease should be classified as an operating or a financing lease. A contract is or contains a lease if the contract conveys the right to control the use of the identified asset for a period of time in exchange for consideration. Control is determined based on the right to obtain all of the economic benefits from use of the identified asset and the right to direct the use of the identified asset. ROU assets for operating leases represent the right to use an underlying asset for the lease term, and operating lease liabilities represent the obligation to make lease payments.
Lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date for leases exceeding 12 months. Minimum lease payments include only the fixed lease component of the agreement, as well as any variable rate payments that depend on an index, initially measured using the
F-11
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
index at the lease commencement date. Non-lease components are accounted for separately from the fixed lease component for all leases. Most of the Company’s leases do not provide an implicit rate that can readily be determined. Therefore, the applied discount rate is based on the Company’s incremental borrowing rate, which is determined using its credit rating and other information available as of the commencement date and is the rate of interest it would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. Lease terms may include options to renew, which the Company factors into the determination of the lease term when it is reasonably certain that the Company will exercise that option. The ROU asset is measured at the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received.
Operating lease expense is recognized on a straight-line basis over the lease term and is included in “Cost of sales” and “Selling, general and administrative” line items in the Company’s consolidated statements of comprehensive income. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases is recognized on a straight-line basis over the lease term.
The Company monitors for events or changes in circumstances that require a reassessment of its leases. When a reassessment results in the remeasurement of a lease liability, a corresponding adjustment is made to the carrying amount of the ROU asset unless doing so would reduce the ROU asset to an amount less than zero, in which case the remaining adjustment would be recorded in the consolidated statements of comprehensive income.
Goodwill
Goodwill represents the excess of the purchase price over the fair market value of identifiable net assets of acquired companies. Goodwill is not amortized, but rather is tested at the reporting unit level at least annually for impairment or more frequently if triggering events or changes in circumstances indicate impairment. Initially, qualitative factors are considered to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Some of these qualitative factors may include macroeconomic conditions, industry and market considerations, a change in financial performance, entity-specific events, a sustained decrease in share price, and consideration of the difference between the fair value and carrying amount of a reporting unit as determined in the most recent quantitative assessment. If, through this qualitative assessment, the conclusion is made that it is more likely than not that a reporting unit’s fair value is less than its carrying amount, a quantitative impairment analysis is performed. This analysis involves estimating the fair value of a reporting unit using widely accepted valuation methodologies including the income and market approaches, which requires the use of estimates and assumptions. These estimates and assumptions include revenue growth rates, discount rates, and determination of appropriate market comparables. If the fair value of the reporting unit is less than its carrying amount, an impairment loss is recognized in an amount equal to the excess of the carrying amount over the fair value of the reporting unit, not to exceed the carrying amount of the goodwill. During 2022, 2021, and 2020, no impairment of goodwill was recorded.
Intangible Assets
Intangible assets represent amortized and indefinite-lived intangible assets primarily acquired in connection with business combinations. Amortized intangible assets are amortized over their related useful lives, using a straight-line or accelerated method consistent with the underlying expected future cash flows related to the specific intangible asset. Amortized intangible assets are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When indicators of impairment exist, an estimate of undiscounted net cash flows is used in measuring whether the carrying amount of the asset or related asset group is recoverable. Measurement of the amount of impairment, if any, is based upon the difference between the asset or asset group’s carrying value and fair value. Fair value is determined through various valuation techniques, including market and income approaches as considered necessary.
Indefinite-lived intangible assets are not amortized; however, they are tested at least annually for impairment or more frequently if events or changes in circumstances exist that may indicate impairment. Initially, qualitative factors are considered to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. If, through this qualitative assessment, the conclusion is made that it is more likely than not that an indefinite-lived intangible asset’s fair value is less than its carrying amount, a quantitative impairment analysis is performed by comparing the indefinite-lived intangible asset’s carrying amount to its fair value. The fair value for
F-12
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
indefinite-lived intangible assets is determined through various valuation techniques, including market and income approaches as considered necessary. The amount of any impairment is measured as the difference between the carrying amount and the fair value of the impaired asset. During 2022, 2021, and 2020, no impairment of indefinite-lived intangible assets was recorded.
Investment in Equity Securities
Equity securities (“securities”) without readily determinable fair value that are not eligible to be measured in accordance with the net asset value practical expedient qualify for an election to initially estimate fair value using the measurement alternative at its cost. During 2020, the Company entered into a strategic collaboration and made a minority investment in a privately held company, which totaled $20,000 and is included in the “Other assets” line item on the Company’s consolidated balance sheets. The Company, at the time of the investment, elected to apply the measurement alternative, which may be applied to an equity interest on an instrument-by-instrument basis. Dividends received are reported in earnings.
The initial value of the securities are remeasured to fair value if the securities are impaired or if observable price changes occur. These events are continually monitored and assessed at each reporting period. If a readily determinable fair value becomes available for the securities or observable price changes for the identical or a similar investment of the same issuer occur, the securities are measured at fair value as of the date the observable change occurred. Any resulting gains or losses on the securities for which the observable price changes occur will be recorded in net earnings. During 2022 and 2021, no such observable price changes occurred.
At each reporting period a qualitative assessment is made to consider impairment indicators to determine whether the securities are impaired. Impairment indicators may include but are not limited to earnings performance, business prospects by the investee, cash flows from operations, working capital, and noncompliance with debt covenants. If this qualitative assessment indicates impairment, fair value is determined and an impairment loss equal to the difference between the fair value of the investment and its carrying amount is recognized in net income. During 2022 and 2021, no impairment of securities was recorded.
Nonqualified Deferred Compensation
In 2021, the Company created a non-qualified deferred compensation plan for a select group of management and highly compensated individuals. The plan permits the deferral of up to 50% of a participant's base salary and/or 80% of a participant's annual incentive bonus. The deferrals are held in an irrevocable rabbi trust (the "Rabbi Trust"), which has been established to administer the plan. The Rabbi Trust is intended to be used as a source of funds to match respective funding obligations to participants. The assets of the trust are subject to the claims of the Company's creditors in the event that the Company becomes insolvent. Consequently, the Rabbi Trust qualifies as a grantor trust for income tax purposes. The Company makes periodic payments into company-owned life insurance policies held in this Rabbi trust to fund the expected obligations arising under this plan. There are no contractual restrictions on the Company's ability to surrender a policy. The assets and liabilities of the plan are included in "Other assets" and "Other long-term liabilities" respectively in the Consolidated Balance Sheets. Changes in the deferred compensation balances are recorded to compensation expense and reflected within the "Selling, general and administrative" line in the Consolidated Statements of Comprehensive Income. As of December 31, 2022 and January 1, 2022, the trustee held total assets of $1,622 and $382, and deferred compensation liabilities of $1,632, and, $390, respectively.
Self-Insurance
The Company is self-insured, up to certain limits, for employee group health claims. The Company has purchased stop-loss insurance on both an individual and an aggregate basis, which will reimburse the Company for individual claims in excess of $175 and aggregate claims that are greater than $13,515. A liability is accrued for all unpaid claims. Total expense under this self-insurance program was $13,413, $12,349, and $11,798 in 2022, 2021, and 2020, respectively.
Derivative Financial Instruments
The Company’s risk management strategy includes the select use of derivative instruments to reduce the effects of volatility in foreign currency exchange exposure on operating results and cash flows. In accordance with the Company’s
F-13
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
risk management policies, the Company does not hold or issue derivative instruments for trading or speculative purposes. The Company recognizes all derivative instruments as either assets or liabilities in the balance sheet at their respective fair values. When the Company becomes a party to a derivative instrument and intends to apply hedge accounting, the Company formally documents the hedge relationship and the risk management objective for undertaking the hedge, the nature of risk being hedged, and the hedged transaction, which includes designating the instrument for financial reporting purposes as a fair value hedge, a cash flow hedge, or a net investment hedge. The Company also documents how the hedging instrument’s effectiveness in offsetting the hedged risk will be assessed prospectively and retrospectively, and a description of the method used to measure ineffectiveness.
The Company periodically uses derivative instruments to hedge the foreign currency exposure of its net investment in foreign subsidiaries into U.S. dollars. Initially, the Company records derivative assets on a gross basis in its consolidated balance sheets. Subsequently the fair value of derivatives is measured for each reporting period. The effective portion of gains and losses attributable to these net investment hedges is recorded to foreign currency translation adjustment (“FCTA”) within accumulated other comprehensive income (loss) (“AOCI”) to offset the change in the carrying value of the net investment being hedged, and will subsequently be reclassified to net earnings in the period in which the hedged investment is either sold or substantially liquidated.
During 2022, the Company settled a forward contract with a notional amount of $98,930. During 2021 and 2020, the Company settled European options with notional amounts of $98,684 and $90,000, respectively. Both the forward contract and the European options were designated as net investment hedges. The Company realized a gain of $4,555 and $846 in 2022 and 2020, respectively, and realized a loss of $1,555 in 2021, recorded to FCTA within AOCI. The Company assessed hedge effectiveness under the forward rate method, determining the hedging instruments were highly effective. As of December 31, 2022 and January 1, 2022, there were no derivatives outstanding for which the Company has applied hedge accounting.
Subsequent to December 31, 2022, on January 18, 2023 the Company entered into an option contract designated as a net investment hedge with a notional amount of $81,343.
Common Stock Share Repurchases
The Company has a stock repurchase plan in place that has been authorized by the Board of Directors. As of December 31, 2022, $82,839 is available to repurchase shares under this plan. The excess of the repurchase price over par value is allocated between additional paid-in capital and retained earnings on a pro-rata basis. There currently is no expiration date on the remaining approved repurchase amount and no requirement for future share repurchases.
Revenue Recognition
Revenue is recognized when, or as, control of a promised product or service transfers to a customer, in an amount that reflects the consideration to which the Company expects to be entitled in exchange for transferring those products or services. Revenue excludes taxes that have been assessed by governmental authorities and that are directly imposed on revenue-producing transactions between the Company and its customers, including sales, use, value-added, and some excise taxes. Revenue recognition is evaluated through the following five-step process:
1)identification of the contract with a customer;
2)identification of the performance obligations in the contract;
3)determination of the transaction price;
4)allocation of the transaction price to the performance obligations in the contract; and
5)recognition of revenue when or as a performance obligation is satisfied.
Product Revenue
A majority of the Company’s sales are for products sold at a point in time and shipped to customers, for which control is transferred to the customer as goods are delivered to the third party carrier for shipment. The Company receives payment, primarily via credit card, for the sale of products at the time customers place orders and payment is required prior to shipment. The Company does not recognize assets associated with costs to obtain or fulfill a contract with a customer.
F-14
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
The Company’s product sales contracts include terms that could cause variability in the transaction price for items such as discounts, product promotions, credits, or sales returns, which are a reduction of revenue. Accordingly, the transaction price for product sales includes estimates of variable consideration to the extent it is probable that a significant reversal of revenue recognized will not occur. At the time of sale, the Company estimates a refund liability for the variable consideration based on historical experience, which is recorded within the “Other current liabilities” line item in the consolidated balance sheets.
Initial product orders with a new customer may include multiple performance obligations related to sales discounts earned under the Company’s initial order reward program. Under this program, the customer receives an option to apply the discounts earned on the initial order to two subsequent Auto Orders, which conveys a material right to the customer. As such, the initial order transaction price is allocated to each separate performance obligation based on its relative standalone selling price and is recognized as revenue as each performance obligation is satisfied.
Associate incentives represent consideration paid to an Associate for distinct services provided in the sale of the Company's products and include all forms of commissions, and other incentives paid to our Associates. The Company may provide Associate incentive promotions which are earned by Associates for distinct services rendered. Associate incentive promotions are recorded as the incentives are earned by the Associates. With the exception of commissions paid to Associates on personal purchases, which are considered a sales discount and are reported as a reduction to net sales, Associate incentives are recorded as an operating expense. The amounts paid to Associates are commensurate with the fair value received for the distinct services rendered by Associates and are recorded as an operating expense when revenue for the goods is recognized.
Shipping and handling activities are performed upon delivery to the third party carrier for shipment. The Company accounts for these activities as fulfillment costs. Therefore, the Company recognizes the costs of these activities when revenue for the goods is recognized. Shipping and handling costs are included in cost of sales for all periods presented.
With respect to will-call orders, the Company periodically assesses the likelihood that customers will exercise their contractual right to pick up orders and revenue is recognized when the likelihood that customers will pick up orders is remote.
Other Revenue
Other types of revenue include fees, which are paid by the customer at the beginning of the service period, for access to online customer service applications and annual account renewal fees for Associates, for which control is transferred over time as services are delivered and are recognized as revenue on a straight-line basis over the term of the respective contracts.
The following table presents Other Revenue for the periods indicated:
Year Ended
202220212020
Other Revenue$3,452 $3,825 $3,805 
Revenue Disaggregation
Disaggregation of revenue by geographical region and major product line is included in Note M – Segment Information.
Contract Balances
When the timing of our provision of goods or services is different from the timing of the payments made by our customers, we recognize either a contract asset (performance precedes contractual due date) or a contract liability (customer payment precedes performance).
F-15
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
Contract liabilities relate to deferred revenue for product sales for customer payments received in advance of shipment, for outstanding material rights under the initial order program, and for services where the performance obligations are satisfied over time as services are delivered. Contract liabilities are recorded as deferred revenue within the "Other current liabilities" line item in the consolidated balance sheets. The Company typically does not have contract assets based on the payment terms included in the Company’s contracts and the balance of contract assets was $0 at December 31, 2022 and January 1, 2022.
The following table provides information about contract liabilities from contracts with customers, including significant changes in the contract liabilities balances during the period.
December 31,
2022		January 1,
2022
Contract liabilities at beginning of period$19,635 $15,952 
Increase due to deferral of revenue at period end20,875 19,635 
Decrease due to beginning contract liabilities recognized as revenue(19,635)(15,952)
Contract liabilities at end of period$20,875 $19,635 
Product Return Policy
All product orders that are unused and returned within the first 30 days following purchase are refunded at 100% of the sales price. All product orders that are unused and resalable are refunded up to one year from the date of purchase at 100% of the sales price. This standard policy differs in a few of our international markets due to the regulatory environment in those markets. Depending upon the conditions under which product was returned, customers may either receive a refund based on their original form of payment, or credit on account for a product exchange. The Company monitors Associate activity to ensure that all such practices are in line with established Company policies. Product returns totaled approximately 0.7%, 0.6%, and 0.7% of net sales in 2022, 2021, and 2020, respectively.
Associate Incentives
Associate incentives expenses include all forms of commissions, and other incentives paid to our Associates, less commissions paid to Associates on personal purchases, which are considered a sales discount and are reported as a reduction to net sales.
Selling, General and Administrative
Selling, general and administrative expenses include wages and benefits, depreciation and amortization, rents and utilities, Associate event costs, advertising and professional fees, marketing, and research and development expenses.
Equity-Based Compensation
The Company records compensation expense in the Financial Statements for equity-based awards based on the grant date fair value, which for restricted stock units is the closing market value of the Company’s common stock on the date of the grant. The grant date fair value of each stock-settled stock appreciation right is based upon the Black-Scholes option pricing model. Equity-based compensation expense is recognized under the straight-line method over the period that service is provided, which is generally the vesting term. Further information regarding equity awards can be found in Note L – Equity-Based Compensation.
Advertising
Advertising costs are charged to expense as incurred and are presented as part of the “Selling, general and administrative” line item. Advertising expense totaled $5,053, $12,399, and $9,853, in 2022, 2021, and 2020, respectively.
F-16
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
Research and Development
Research and development costs are charged to expense as incurred and are presented as part of the “Selling, general and administrative” line item. Research and development expense totaled $11,563, $11,112, and $10,633 in 2022, 2021, and 2020, respectively.
Earnings Per Share
Basic earnings per common share ("EPS") are based on the weighted-average number of common shares that were outstanding during each period. Diluted EPS include the effect of potentially dilutive common shares calculated using the treasury stock method, which include in-the-money, equity-based awards that have been granted but have not been issued. When there is a loss, potential common shares are not included in the computation of diluted EPS, because to do so would be anti-dilutive.
Recent Accounting Pronouncements
Issued Accounting Pronouncements Not Yet Adopted
In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. ASU 2021-08 requires an acquirer to recognize and measure contract assets and contract liabilities (deferred revenue) acquired in a business combination in accordance with Revenue from Contracts with Customers (Topic 606). Under this approach, the acquirer applies the revenue model as if it had originated the contracts. This is a departure from the current requirement to measure contract assets and contract liabilities at fair value at the acquisition date. ASU 2021-08 is effective for annual periods beginning after December 15, 2022 and interim periods within those annual periods. ASU 2021-08 should be applied prospectively to business combinations occurring on or after the date of adoption. Evaluation of this new standard is dependent on multiple circumstances including the timing and complexity of completed business combinations. As a result, the Company intends to adopt the provisions of ASU 2021-08 in the first quarter of 2023.
No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements.
NOTE B— BUSINESS COMBINATIONS
During the second quarter, the Company acquired assets in business combinations for an aggregate purchase consideration of $6,532 in cash and $886 in contingent consideration. The preliminary purchase price allocations were $964 to tangible assets, $6,065 to intangible assets, and $389 to goodwill. The primary reasons for the business combinations are to augment and expand the Company's core competencies. The amount of revenue and earnings related to the business combinations since the acquisition date is immaterial.
Subsequent to the acquisition date, the Company made certain measurement period adjustments to the preliminary purchase price allocation, which resulted in an increase to goodwill of $193. The increase was due to a $105 decrease of certain tangible assets acquired, an increase to assumed liabilities of $147, and a $59 decrease in the aggregate consideration in connection with post close net working capital adjustments that were finalized in the fourth quarter of 2022.
The contingent consideration liability is based on the achievement of certain milestones over a three-year period. Under the terms of the purchase agreement, the contingent consideration consists of three earn-out periods capped at $500 per earn-out period. The maximum earn-out is $1,500 per the asset purchase agreement. As of the acquisition date, the contingent consideration had a fair value of $886. The estimated fair value of the contingent consideration liability as of the date of acquisition was determined using an option pricing method based upon available information and certain assumptions known and contains key inputs that are unobservable in the market, which represents a Level 3 measurement within the fair value hierarchy. Contingent consideration is included in Fair Value Measures above.
Pro forma results of operations have not been presented because the effects of the acquisitions were not material to the Company’s Consolidated Financial Statements.
F-17
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(in thousands, except per share data)
NOTE C—INVENTORIES
December 31,
2022		January 1,
2022
Raw materials$21,776 $30,280 
Work in progress4,285 9,586 
Finished goods41,028 58,452 
$67,089 $98,318 
Noncurrent inventories$3,479 $— 
Noncurrent inventory consists of $1,711 of raw materials and $1,768 of finished goods inventory and is included in the “Other assets” line item on the Company’s Consolidated Balance Sheets.
NOTE D—PREPAID EXPENSES AND OTHER CURRENT ASSETS
Prepaid expenses and other current assets consists of the following:
December 31,
2022		January 1,
2022
Prepaid insurance$2,293 $3,734 
Other prepaid expenses9,089 10,119 
Income taxes receivable2,030 1,579 
Miscellaneous receivables, net5,183 5,584 
Deferred commissions3,157 2,270 
Other current assets7,121 3,681 
$28,873 $26,967 
NOTE E—INCOME TAXES
Consolidated earnings before income taxes consists of the following for 2022, 2021, and 2020:
Year Ended
202220212020
U.S.$(23,996)$13,017 $18,838 
Foreign132,617 157,625 159,110 
Total earnings before income taxes$108,621 $170,642 $177,948 
F-18
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(in thousands, except per share data)
NOTE E—INCOME TAXES - CONTINUED
Income tax expense (benefit) included in income from continuing operations consists of the following:
Year Ended
202220212020
Current
Federal$42 $(264)$306 
State297 567 303 
Foreign45,869 56,668 55,147 
Total Current46,208 56,971 55,756 
Deferred
Federal(9,180)(4,088)1,317 
State(331)(40)(47)
Foreign2,574 1,294 (3,742)
Total Deferred(6,937)(2,834)(2,472)
$39,271 $54,137 $53,284 
The effective tax rate for 2022, 2021, and 2020 reconciled to the statutory U.S. Federal tax rate is as follows:
Year Ended
202220212020
Statutory U.S. federal income tax rate21.0 %21.0 %21.0 %
State income taxes, net of federal tax benefit0.4 0.4 0.3 
Permanent tax differences0.3 0.1 0.2 
Excess foreign tax credits(16.6)(10.9)(9.9)
Net increase in valuation allowance11.9 10.6 8.2 
Foreign income tax rate differences9.5 1.8 1.7 
Foreign withholding taxes9.7 7.9 7.7 
Uncertain tax position reserve0.5 (0.3)0.8 
All other, net(0.5)1.1 (0.1)
36.2 %31.7 %29.9 %
The effective tax rate for the year ended December 31, 2022 increased compared to the year ended January 1, 2022. The effective tax rate increase is due primarily to a change in the market mix of pre-tax book income.
F-19
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(in thousands, except per share data)
NOTE E—INCOME TAXES - CONTINUED
The significant categories of deferred taxes are as follows:
December 31,
2022		January 1,
2022
Deferred tax assets
Inventory$5,872 $5,106 
Accruals not currently deductible8,627 11,634 
Equity-based compensation expense2,746 2,355 
Property and equipment922 1,143 
Intangible assets6,680 7,545 
Foreign currency translation1,448 — 
Capitalized R&D Expenses9,618 2,337 
Tax credit carry forwards115,539 96,635 
Net operating losses1,720 1,401 
Other3,223 4,824 
Gross deferred tax assets156,395 132,980 
Valuation allowance(118,136)(99,958)
Net deferred tax assets38,259 33,022 
Deferred tax liabilities
Property and equipment(5,723)(5,268)
Foreign currency translation— (126)
Prepaid expenses(2,990)(3,596)
Intangible assets(6,680)(7,545)
Withholding tax on unremitted earnings(11,639)(13,556)
Other(5,499)(5,589)
Gross deferred tax liabilities(32,531)(35,680)
Net deferred taxes$5,728 $(2,658)
The components of net deferred taxes on a jurisdiction basis are as follows:
December 31,
2022		January 1,
2022
Net deferred tax assets$9,799 $4,839 
Net deferred tax liabilities(4,071)(7,497)
Net deferred taxes$5,728 $(2,658)
As of December 31, 2022, the Company had foreign tax credit carryforwards of approximately $111,948. If unused, these carryforwards will expire between 2026 and 2032. The Company has generated excess foreign tax credits since the Tax Cuts and Jobs Act of 2017 was enacted on December 22, 2017. This is due to the U.S. tax rate being lower than most foreign taxing jurisdiction rates where the Company operates. Although the Company can claim foreign tax credits against U.S. source income due to overall domestic losses generated in previous years, the Company does not believe it will be able to use more foreign tax credits than it generates in a single year. The Company believes these foreign tax credit carryforwards will expire unused based on available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, available tax planning strategies, and available carryback opportunities. Similar with prior years, the Company continues to maintain a full valuation allowance on its
F-20
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(in thousands, except per share data)
NOTE E—INCOME TAXES - CONTINUED
foreign tax credit carryforwards. Valuation allowances are determined using a more-likely-than-not realization criteria and are based upon all facts and circumstances.
The Company recorded a $1,390 valuation allowance on mirrored deferred tax assets recorded in the United States, which offset deferred tax liabilities of foreign disregarded entities. These mirrored deferred tax assets represent future foreign tax credits. This valuation allowance is necessary because the Company is limited in its ability to utilize future foreign tax credits due to the U.S. tax rate being lower than most foreign taxing jurisdiction rates where the Company operates.
The Company also had $1,568 of Utah research credit carryforwards, and $2,023 of Federal research credit carryforwards as of December 31, 2022. If unused, the Utah research credit carryforwards expire between 2027 and 2036, and the Federal research credits expire between 2036 and 2042. Utah research credits are limited to Utah tax due and the Company has a history of generating more credits than it can use. Federal research credit carryforwards can only be used in a year when U.S. taxes are owed after foreign tax credits have been applied. Due to the lack of sufficient evidence to the contrary, the Company has placed a full valuation allowance on these credit carryforwards.
In addition, the Company had $5,296 of foreign operating loss carry forwards, $2,808 of which have an unlimited carryforward period. The deferred tax asset associated with these losses was $1,666 and a valuation allowance of $1,174 has been applied against this deferred tax asset. The 2022 deferred tax asset for state-tax-loss carryforwards was $54. If unused, some of the state-tax-loss carryforwards will expire between 2032 and 2041 and others can be carried forward indefinitely.
The total combined valuation allowance was $118,136 as of December 31, 2022. The 2022 valuation allowance represents a $18,178 net increase from 2021. If the Company determines that there is sufficient evidence to remove the valuation allowances addressed above, the valuation allowance will be released and the provision for income taxes will be reduced.
As of December 31, 2022, the cumulative amount of undistributed earnings of the Company’s non-U.S. subsidiaries held for indefinite reinvestment is approximately $4,000. If this amount were repatriated to the United States, the amount of incremental taxes would be approximately $400.
As of December 31, 2022, the Company reported $66 of unrecognized tax benefits in "Other current liabilities" and $1,384 in "Other long-term liabilities" for a combined total of $1,450 in unrecognized tax benefits that would impact the effective tax rate if recognized. This compares to $199 of unrecognized tax benefits in "Other current liabilities" and $809 in "Other long-term liabilities" for a combined total of $1,008 reported as of January 1, 2022.
The following reconciliation provides the changes in unrecognized tax benefits for the years presented:
Year Ended
202220212020
Beginning balance of unrecognized tax benefits$1,008 $1,528 $560 
Increases related to prior year tax positions107 21 775 
Decreases related to prior year tax positions— (330)— 
Increases related to current year tax positions468 424 753 
Decreases for settlements with taxing authorities(133)(635)(560)
Ending balance of unrecognized tax benefits$1,450 $1,008 $1,528 
The Company accounts for interest and penalties associated with unrecognized tax benefits as a component of income tax expense. For the period ended December 31, 2022 and January 1, 2022, the Company reported $201 and $91, respectively, as income tax expense related to interest and penalties. As of December 31, 2022, the Company recorded $64 of "Other current liabilities" and $239 of "Other long-term liabilities" associated with interest and penalties for
F-21
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(in thousands, except per share data)
NOTE E—INCOME TAXES - CONTINUED
unrecognized tax benefits. This compares to $162 of "Other current liabilities" and $63 of "Other long-term liabilities" associated with interest and penalties reported as of January 1, 2022.
The Company files income tax returns in the United States and foreign jurisdictions. In general, the Company's tax filings are subject to examination for years ended on or after December 31, 2018. However, statutes of limitations in some markets may be as long as ten years for transfer pricing related issues.
NOTE F—PROPERTY AND EQUIPMENT
Cost of property and equipment and their estimated useful lives is as follows:
YearDecember 31,
2022		January 1,
2022
Buildings39.5$78,071 $80,820 
Laboratory and production equipment
5-7
50,679 47,552 
Air transportation equipment52,952 2,952 
Computer equipment and software
3-5
53,436 53,562 
Furniture and fixtures
3-5
6,198 6,636 
Automobiles
3-5
722 767 
Leasehold improvements
3-5
14,388 15,212 
Land improvements153,271 3,382 
209,717 210,883 
Less accumulated depreciation and amortization124,748 121,590 
84,969 89,293 
Land6,723 6,992 
Deposits and projects in process6,081 5,495 
$97,773 $101,780 
Depreciation of property and equipment was $11,351, $11,661, and $12,242, for the years ended 2022, 2021, and 2020, respectively.
F-22
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(in thousands, except per share data)
NOTE G—OPERATING LEASES
The following table summarizes the classification of ROU assets and lease liabilities in the Company’s consolidated balance sheet:
LeasesClassificationDecember 31,
2022		January 1,
2022
Assets
ROU operating lease assets, netOther assets$19,997 $23,789 
Total ROU assets$19,997 $23,789 
Liabilities
Current:
Operating lease liabilitiesOther current liabilities$6,892 $7,080 
Noncurrent:
Operating lease liabilitiesOther long-term liabilities7,680 10,215 
Total lease liabilities$14,572 $17,295 
The following table presents supplemental lease information:
Year Ended
20222021
Lease cost
Operating lease cost$8,606 $9,585 
Total lease cost$8,606 $9,585 
Year Ended
20222021
Other information
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases$7,924 $9,506 
ROU assets obtained in exchange for new operating lease liabilities$5,641 $5,322 
Weighted-average remaining lease term—operating leases
2.39 yrs.
2.76 yrs.
Weighted-average discount rate—operating leases3.04 %3.11 %
F-23
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(in thousands, except per share data)
NOTE G—OPERATING LEASES - CONTINUED
The following table presents the maturity of the Company’s lease liabilities as of December 31, 2022:
Year ending
2023$7,214 
20245,383 
20251,850 
2026497 
2027120 
Thereafter— 
15,064 
Less: imputed interest(492)
Present value$14,572 
These leases generally provide that property taxes, insurance, and maintenance expenses are the responsibility of the Company. Such expenses are not included in the operating lease amounts outlined in the table above or in the rent expense amounts that follow. The total rent expense was approximately $8,258, $9,830, and $11,199 for the years ended 2022, 2021, and 2020, respectively.
NOTE H—INTANGIBLE ASSETS
The Company performed its annual goodwill impairment test during the third quarter of 2022. The Company performed a qualitative assessment of each reporting unit and determined that it was not more-likely-than-not that the fair value of any reporting unit was less than its carrying amount. As a result, no impairments of goodwill were recognized in 2022 and 2021.
The Company also performed its annual indefinite-lived intangible asset impairment test during the third quarter of 2022. The Company performed a qualitative assessment of the indefinite-lived intangible assets and determined that it was not more-likely-than-not that the fair value of any indefinite-lived intangible asset was less than the carrying amount. As a result, no impairments of indefinite-lived intangible assets were recognized in 2022 and 2021.
The changes in the carrying amount of goodwill are as follows:
December 31,
2022		January 1,
2022
Balance at beginning of year:
Gross goodwill$17,668 $17,367 
Goodwill as of beginning of year17,668 17,367 
  
Goodwill acquired during the year582 — 
Currency translation adjustment(882)301 
Balance as of end of year
Gross goodwill17,368 17,668 
Goodwill as of end of year$17,368 $17,668 
F-24
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(in thousands, except per share data)
NOTE H—INTANGIBLE ASSETS - CONTINUED
Intangible assets consist of the following:
As of December 31, 2022
Gross carrying
amount		Accumulated
 amortization		Net carrying
amount		Weighted-average
amortization
period (years)
Amortized intangible assets
Trade name and trademarks$2,285 $(114)$2,171 10
Product formulas8,701 (7,983)718 8
Customer relationships3,313 (414)2,899 4
Non-compete agreements467 (61)406 4
Indefinite-lived intangible assets
Direct sales license26,238 26,238 
   
$41,004 $32,432 
Estimated Amortization Expense: 
 
2023$1,843 
20241,224 
20251,154 
2026692 
2027253 
Thereafter1,028 
 
$6,194 
As of January 1, 2022
Gross carrying
amount		Accumulated
amortization 		Net carrying
amount		Weighted-average
amortization
period (years)
Amortized intangible assets
Trade name and trademarks$4,173 $(4,173)$— 10
Product formulas9,440 (7,462)1,978 8
Indefinite-lived intangible assets
Direct sales license28,464 28,464 
  
$42,077 $30,442 
F-25
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(in thousands, except per share data)
NOTE H—INTANGIBLE ASSETS - CONTINUED
Aggregate amortization of intangible assets was $1,723, $1,182, and $1,326 for the years ended 2022, 2021, and 2020, respectively.
NOTE I—OTHER CURRENT LIABILITIES
Other current liabilities consist of the following:
December 31,
2022		January 1,
2022
Associate incentives$55,688 $53,929 
Accrued employee compensation17,334 32,366 
Deferred revenue20,875 19,635 
Sales taxes11,234 11,330 
Operating lease liabilities6,892 7,080 
Income taxes4,973 5,193 
All other15,788 17,749 
$132,784 $147,282 
NOTE J—LINE OF CREDIT
On August 25, 2020, the Company as borrower, and certain of its material subsidiaries as guarantors, entered into the Second Amended and Restated Credit Agreement (the “Credit Agreement”) with Bank of America, N.A. (“Bank of America”) as Administrative Agent, Swingline Lender and Letter of Credit Issuer, and the other lenders party thereto. On August 10, 2022, the Company entered into the Second Amendment to the Second Amended and Restated Credit Agreement ("Restated Credit Agreement"), which replaces the Eurodollar Rate, and LIBOR terms and provisions with the Bloomberg Short-Term Bank Yield Index rate ("BSBY").
The Credit Agreement provides for a revolving credit limit for loans to the Company up to $75,000 (the “Credit Facility”). In addition, at the option of the Company, and subject to certain conditions, the Company may request to increase the aggregate commitment under the Credit Facility up to an additional $200,000.
There was no outstanding debt on the Credit Facility as of December 31, 2022. The obligations of the Company under the Credit Agreement are secured by the pledge of the capital stock of certain subsidiaries of the Company, pursuant to a Security and Pledge Agreement.
Interest on revolving borrowings under the Credit Facility are computed at BSBY, adjusted by features specified in the Credit Agreement. The Credit Agreement covenants require the Company’s rolling four-quarter consolidated EBITDA of $100,000 or greater and its ratio of consolidated funded debt to consolidated EBITDA of equal to or less than 2.0 to 1.0 at the end of each quarter. The Credit Agreement does not include any restrictions on the payment of cash dividends or share repurchases by the Company. Consolidated EBITDA and consolidated funded debt are non-GAAP terms specified in the Credit Agreement.
The Company will be required to pay any balance on this Credit Facility in full at the time of maturity in August 2025.
F-26
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(in thousands, except per share data)

NOTE K—COMMITMENTS AND CONTINGENCIES
Unconditional Purchase Obligations
The Company’s unconditional purchase obligations relating to IT-related services and advertising agreements were $7,163 and $6,151, as of December 31, 2022 and January 1, 2022, respectively that are generally paid within one year.
Contingencies
The Company is involved in various lawsuits, claims, and other legal matters from time to time that arise in the ordinary course of conducting business, including matters involving its products, intellectual property, supplier relationships, distributors, competitor relationships, employees and other matters. The Company records a liability when a particular contingency is probable and estimable. The Company faces contingencies that are reasonably possible to occur; however, they cannot currently be estimated. While complete assurance cannot be given as to the outcome of these proceedings, management does not currently believe that any of these matters, individually or in the aggregate, will have a material adverse effect on the Company’s financial condition, liquidity or results of operations. It is reasonably possible that a change in the contingencies could result in a change in the amount recorded by the Company in the future.
Employee Benefit Plan
In the United States, the Company sponsors an employee benefit plan under Section 401(k) of the Internal Revenue Code. This plan covers employees who are at least 18 years of age and have met a one-month service requirement. The Company makes a matching contribution equal to 100 percent of the first one percent of a participant’s compensation that is contributed by the participant, and 50 percent of that deferral that exceeds one percent of the participant’s compensation, not to exceed six percent of the participant’s compensation, subject to the limits of ERISA. In addition, the Company may make a discretionary contribution based on earnings. The Company’s matching contributions cliff vest at two years of service. Contributions made by the Company to the plan in the United States were $2,589, $2,509, and $2,322 for the years ended 2022, 2021, and 2020, respectively.
The Company has employees in international countries that are covered by various defined contribution plans. These plans are administered based upon the legal requirements in the countries in which they are established.
NOTE L—EQUITY-BASED COMPENSATION
Total equity-based compensation expense was $13,485, $14,706, and $14,633 for fiscal years 2022, 2021, and 2020, of which, $154, $408, and $239, was related to liability-classified awards, respectively. The related tax benefit for these periods was $2,556, $2,813, and $2,472, respectively.
The following table shows the remaining unrecognized compensation expense on a pre-tax basis for all types of unvested equity awards outstanding as of December 31, 2022. This table does not include an estimate for future grants that may be issued.
2023$11,273 
20247,781 
20254,117 
2026408 
$23,579 
The remaining unrecognized compensation expense above is expected to be recognized over a weighted-average period of 1.7 years.
The Company's 2015 Equity Incentive Award Plan (the "2015 Plan") is currently the only plan under which equity awards are issued. The 2015 Plan allows for the grant of various equity awards including stock-settled stock
F-27
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(in thousands, except per share data)
NOTE L—EQUITY-BASED COMPENSATION - CONTINUED
appreciation rights, stock options, restricted stock units, deferred stock units, and other types of equity-based awards to the Company’s officers, key employees, and non-employee directors.
Since the inception of the 2015 Plan, 1,750 shares have been authorized. As of December 31, 2022, 3,877 awards had been granted under the 2015 Plan, of which 2,924 were stock-settled stock appreciation rights, and 953 were restricted stock awards. Also, as of December 31, 2022, a total of 1,088 options and grants had been forfeited, of which 59 awards have been added back to the number of shares available for issuance under the 2015 Plan.
Stock-Settled Stock Appreciation Rights
The Company uses the Black-Scholes option pricing model to estimate the fair value of its stock-settled stock appreciation rights. There were no stock-settled stock appreciation rights granted in 2022. The weighted-average fair value of stock-settled stock appreciation rights granted in 2021 and 2020 was $27.12 and $17.65, respectively.
Stock-settled stock appreciation rights granted to officers and key employees upon hire or promotion to such a position, or annually for existing participants, generally vest 25% each year on the anniversary of the grant date and expire 4.5 years from the date of grant.
Following is a table that includes the weighted-average assumptions that the Company used to calculate fair value of stock-settled stock appreciation rights that were granted during the periods indicated.
Year Ended
202220212020
Expected volatility (1)N/A43.28 %35.23 %
Risk-free interest rate (2)N/A0.33 %1.66 %
Expected life (3)N/A
3.5 yrs
3.5 yrs.
Expected dividend yield (4)N/A0.00 %0.00 %
Weighted-average exercise price (5)N/A$85.19 $63.02 
(1)The Company utilizes historical volatility of the trading price of its common stock.
(2)Risk-free interest rate is based on the U.S. Treasury yield curve with respect to the expected life of the award.
(3)Depending upon the terms of the award, one of two methods will be used to calculate expected life:
(i)a weighted-average that includes historical settlement data of the Company’s equity awards and a hypothetical holding period, or (ii) the simplified method.
(4)The Company historically has not paid and currently has no plan to pay dividends.
(5)Exercise price is the closing price of the Company's common stock on the date of grant.
F-28
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(in thousands, except per share data)
NOTE L—EQUITY-BASED COMPENSATION - CONTINUED
A summary of the Company’s stock-settled stock appreciation right activity is as follows:
Shares Weighted-average exercise priceWeighted-average remaining
contractual term		Aggregate intrinsic value*
Outstanding at January 1, 2022150 $82.22 2.3$3,596 
Granted— — 
Exercised(2)63.02 
Forfeited— — 
Expired(1)116.06 
Outstanding at December 31, 2022147 $82.16 1.3$— 
Exercisable at December 31, 202272 $90.63 1.1$— 
* Aggregate intrinsic value is defined as the difference between the current market value at the reporting date (the closing price of the Company’s common stock on the last trading day of the period) and the exercise price of awards that were in-the-money. The closing price of the Company’s common stock at December 31, 2022 and January 1, 2022 was $53.20 and $101.20, respectively.
The total intrinsic value of stock-settled stock appreciation rights exercised was $50, $10,337, and $7,881, for the years ended 2022, 2021, and 2020, respectively. The total fair value of stock-settled stock appreciation rights that vested was $983, $3,868, and $3,532, for the years ended 2022, 2021, and 2020, respectively.
During the years ended December 31, 2022, January 1, 2022, and January 2, 2021, certain employees elected to receive a net amount of shares upon the exercise of stock-settled stock appreciation rights in order to satisfy the Company’s tax withholding obligation. There was no reduction to additional paid-in capital for the years ended 2022, 2021, and 2020.
Restricted Stock Awards
Restricted stock awards include stock-settled and cash-settled restricted stock units granted to the Company’s officers and key employees, and deferred stock units granted to non-employee directors. Restricted stock units are granted to officers and key employees upon hire or promotion to such a position, or annually for existing participants, and generally vest 25% each year on the anniversary of the grant date. Awards of deferred stock units granted to non-employee directors generally vest 25% each quarter, commencing on the first vest date anniversary following the final vesting of the previous award. Upon vesting, holders of stock-settled restricted stock units and deferred stock units are entitled to receive shares of the Company’s common stock on a one-for-one basis. Holders of cash-settled restricted stock units are entitled to receive cash payments equivalent to the number of awards held, valued at the closing market price on the vest date. The fair value of restricted stock awards is determined based on the Company’s closing stock price on the date of grant. Cash-settled restricted stock units are accounted for as liability-classified awards and fair value is remeasured to the current fair value, which is the Company's closing stock price, at each reporting date until the award is settled at vesting. Restricted stock awards are full-value shares at the date of grant, vesting over the periods of service, and do not have expiration dates.
F-29
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(in thousands, except per share data)
NOTE L—EQUITY-BASED COMPENSATION - CONTINUED
A summary of the Company’s stock-settled restricted stock unit activity is as follows:
Shares Weighted-average grant date fair value
Outstanding at January 1, 2022366$80.87 
Granted17091.67 
Vested(142)81.11 
Forfeited(9)83.11 
Outstanding at December 31, 2022385$85.50 
During the year ended December 31, 2022, certain employees elected to receive a net amount of shares upon the release of restricted stock units in order to satisfy the Company’s tax withholding obligation. This resulted in a reduction to additional paid-in capital of $4,706, $3,575, and $2,367 for the years ended 2022, 2021, and 2020, respectively, reflected as a financing activity in the Company’s consolidated statements of cash flows.
The total fair value of restricted stock units that vested was $12,808, $11,378, and $7,732, for the years ended 2022, 2021, and 2020, respectively.
A summary of the Company’s cash-settled restricted stock unit activity is as follows:
Shares Weighted-average grant date fair value
Nonvested at January 1,202212$78.66 
Granted691.53 
Vested(3)79.22 
Forfeited(3)79.67 
Nonvested at December 31,202212$84.72 
The weighted-average fair value of liability-classified awards outstanding was $85, $79, and $76 for the years ended 2022, 2021, and 2020, respectively.
The number of deferred stock units vested and unreleased totaled 8, 19, and 23 for the years ended 2022, 2021, and 2020, respectively. There were no deferred stock units that vested in 2022, 2021, and 2020.
NOTE M—SEGMENT INFORMATION

The Company primarily operates as a global direct-selling nutrition, personal health and wellness company that develops and manufactures high quality, science-based nutritional, and personal care products.
The Company’s operating segments are identified according to how business activities are managed and evaluated by the chief operating decision maker (“CODM”), our CEO. The CODM manages the business, allocates resources, makes operating decisions, and evaluates performance for a geographic region or market based on net sales. The Company aggregates its direct-selling operating segments (“Direct-selling”) into one reportable segment, as management believes that the Company’s Direct-selling segments exhibit similar long-term financial performance and have similar economic characteristics. The CODM does not evaluate operating segments using asset information, accordingly, the Company does not report asset information by segment.
F-30
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(in thousands, except per share data)
NOTE M—SEGMENT INFORMATION - CONTINUED
As a result of the Company’s acquisitions during 2022, the Company has operating segments that are not material to the Company’s net sales. These operating segments are included as a component of (“All other”) and are included for purposes of reconciliation of net sales to the Company’s Consolidated Statements of Comprehensive Income.

Year Ended
202220212020
Net sales:
Direct-selling$995,043 $1,186,464 $1,134,644 
All other3,558 — — 
Consolidated Total$998,601 $1,186,464 $1,134,644 
No single Associate accounted for 10% or more of net sales for the periods presented. The table below summarizes the approximate percentage of total product revenue that has been contributed by the Company’s nutritionals, foods, and personal care and skincare products for the periods indicated.
Year Ended
202220212020
USANA Nutritionals87%86%85%
USANA Foods (1)7%7%7%
Personal care and Skincare5%6%7%
All Other1%1%1%
______________________________
(1)Includes the Company’s new Active Nutrition line, which launched in five markets in 2021 and all but two of the remaining markets through the end of 2022.
Selected Financial Information
Financial information, presented by geographic region is listed below:
Year Ended
202220212020
Net Sales to External Customers
Asia Pacific
Greater China$502,486 $563,469 $530,505 
Southeast Asia Pacific190,478 269,803 269,555 
North Asia108,952 129,920 114,964 
Asia Pacific Total801,916 963,192 915,024 
Americas and Europe196,685 223,272 219,620 
Consolidated Total$998,601 $1,186,464 $1,134,644 
F-31
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(in thousands, except per share data)
NOTE M—SEGMENT INFORMATION - CONTINUED
December 31,
2022		January 1,
2022
Long-lived Assets
Asia Pacific
Greater China$86,051 $95,965 
Southeast Asia Pacific15,226 15,394 
North Asia3,617 7,395 
Asia Pacific Total104,894 118,754 
Americas and Europe92,373 89,030 
Consolidated Total$197,267 $207,784 
Total Assets
Asia Pacific
Greater China$250,786 $274,002 
Southeast Asia Pacific51,880 62,332 
North Asia22,952 25,592 
Asia Pacific Total325,618 361,926 
Americas and Europe270,931 215,814 
Consolidated Total$596,549 $577,740 
The following table provides further information on markets representing ten percent or more of consolidated net sales and long-lived assets, respectively:
Year Ended
202220212020
Net sales:
China$453,134 $506,103 $470,177 
South Korea$106,391 $125,835 $110,807 
United States$106,087 $110,379 $107,323 
Long-lived Assets:
United States$89,150 $85,350 
China$83,938 $91,530 
F-32
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(in thousands, except per share data)
NOTE N—COMMON STOCK AND EARNINGS PER SHARE
Basic earnings per share (“EPS”) are based on the weighted-average number of shares outstanding for each period. Shares that have been repurchased and retired during the periods specified below have been included in the calculation of the number of weighted-average shares that are outstanding for the calculation of basic EPS based on the time they were outstanding in any period. Diluted EPS are based on shares that are outstanding (computed under basic EPS) and on potentially dilutive shares. Shares that are included in the diluted EPS calculations under the treasury stock method include equity awards that are in-the-money but have not yet been exercised.
The following is a reconciliation of the numerator and denominator used to calculate basic EPS and diluted EPS for the periods indicated:
Year Ended
202220212020
Net earnings available to common shareholders$69,350 $116,505 $124,664 
Weighted average common shares outstanding - basic19,254 20,146 21,156 
Dilutive effect of in-the-money equity awards56 197 100 
Weighted average common shares outstanding - diluted19,310 20,343 21,256 
Earnings per common share from net earnings - basic$3.60 $5.78 $5.89 
Earnings per common share from net earnings - diluted$3.59 $5.73 $5.86 
Equity awards for the following shares were not included in the computation of diluted EPS due to the fact that their effect would be anti-dilutive:
Year Ended
202220212020
35460359
During the years ended 2022, 2021, and 2020, the Company repurchased and retired 288 shares, 1,844 shares, and 785 shares for an aggregate price of $25,382, $177,837, and $57,029, respectively.
F-33
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(in thousands, except per share data)
NOTE O—RELATED-PARTY TRANSACTIONS
The Company's Founder and Chairman Emeritus of the Board, Myron W. Wentz, PhD is the sole beneficial owner of the largest shareholder of the Company, Gull Global, Ltd. As of December 31, 2022, Gull Global, Ltd. owned 41.6% of the Company’s issued and outstanding shares. Dr. Wentz retired from the position of Board Chairman and director at the Company's Annual Shareholder Meeting on May 1, 2020. Dr. Wentz devotes much of his personal time, expertise, and resources to a number of business and professional activities outside of USANA. The most significant of these is the Sanoviv Medical Institute, which is a unique, fully integrated health and wellness center located near Rosarito, Mexico that Dr. Wentz founded in 1998. Dr. Wentz’s private entity, Sanoviv S.A. de C.V. (“Sanoviv”), contracts with Amarevita S DE RL DE CV (“Amarevita”), an entity that is owned and operated independently of Dr. Wentz, to conduct the operations of the Sanoviv Medical Institute. Sanoviv leases the medical building to Amarevita and Amarevita carries out all of the operations of the medical institute, which include employing all of the medical and healthcare professionals who provide services at the medical institute. The Amarevita medical and healthcare professionals possess expertise in the fields of human health, digestive health, nutritional medicine, lifestyle medicine and other medical fields that are important to USANA.
Amarevita performs research and development of novel product formulations for future development and production by USANA, and they also perform research and development of improvements in existing USANA product formulations. In addition to providing contract research services, Amarevita provides physicians and other medical staff to speak at USANA Associate events. Finally, Amarevita performs health assessments and physical examinations for the Company’s Executives. In consideration for these services, USANA paid Amarevita an immaterial amount in 2022 and 2021, and $175 in 2020. The Company’s agreements with Amarevita were approved by the Audit Committee in advance of the Company’s entry into the agreements. USANA’s collaboration with Amarevita is terminable at will by USANA at any time, without any continuing commitment by USANA.
F-34

USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS
(in thousands)
DescriptionBalance at beginning of periodCharged to costs and expensesDeductionsBalance at end of period
December 31, 2022
Allowance for sales returns$547 $6,562 $6,537 $572 
Allowance for doubtful accounts$504 $6 $147 $363 
Valuation allowance - deferred tax assets$99,958 $18,178 $— $118,136 
January 1, 2022
Allowance for sales returns$819 $7,213 $7,485 $547 
Allowance for doubtful accounts$372 $148 $16 $504 
Valuation allowance - deferred tax assets$81,401 $18,557 $— $99,958 
January 2, 2021
Allowance for sales returns$772 $115 $68 $819 
Allowance for doubtful accounts$261 $131 $20 $372 
Valuation allowance - deferred tax assets$64,285 $17,116 $— $81,401 
F-35
 EX-21 2 subsidiaries-exhibit21.htm EX-21 Document
EXHIBIT 21
SUBSIDIARIES

Set forth below is a list of all active subsidiaries of the Registrant, the state or other jurisdiction of incorporation or organization of each, and the names under which subsidiaries do business as of February 24, 2023.

Name
Jurisdiction of Incorporation
USANA Canada Holding, Inc.
Delaware
USANA Health Sciences, China, Inc.
Delaware
USANA Health Sciences New Zealand, Inc.
Delaware
International Holdings, Inc.
Delaware
FMG Productions, Inc. (dba USANA Studios)
Utah
UHS Essential Health Philippines, Inc.
Utah
USANA Sense Company, Inc.
Utah
Pet Lane Inc.
Delaware
USANA Acquisition Corporation
Utah
USANA Canada Co.
Canada
USANA Australia Pty, Ltd.
Australia
USANA Health Sciences (NZ) Corporation
New Zealand
USANA Hong Kong Limited
Hong Kong
USANA Health Sciences Japan, LLC.
Japan
USANA Health Sciences Korea Ltd.
South Korea
USANA Health Sciences Singapore Pte, Ltd.
Singapore
USANA Mexico S.A. de C.V.
Mexico
Mercadotecnia Nutricional S de R.L. de C.V.
Mexico
UHS Essential Health Malaysia SND BHD
Malaysia
BabyCare Holdings Ltd.
Utah / Cayman Islands
BabyCare Ltd.
People’s Republic of China
Tianjin BabyCare Biological Science and Technology Ltd
People’s Republic of China
Tianjin Health Resources Sales Co., Ltd
People’s Republic of China
USANA Health Sciences (Thailand) Ltd
Thailand
USANA Health Sciences (France) SAS
France
USANA Asia Holding Ltd.
Singapore
USANA Health Sciences (Colombia) SAS
Colombia
PT. USANA Health Sciences Indonesia
Indonesia
OOLA Life, Inc.
Utah
Rise Bar Wellness, Inc.
Utah

Except as noted above, each subsidiary listed above is doing business under its corporate name.


 EX-23.1 3 exhibit231.htm EX-23.1 Document
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (Nos. 333-96645, 333-128103, 333-133385, 333-174695, and 333-206070) on Form S-8 and (No. 333-169946) on Form S-3 of our reports dated February 28, 2023, with respect to the consolidated financial statements and financial statement schedule II of USANA Health Sciences, Inc. and the effectiveness of internal control over financial reporting.
/s/ KPMG LLP
Salt Lake City, Utah
February 28, 2023

 EX-31.1 4 usna-20221231xex311.htm EX-31.1 Document
EXHIBIT 31.1
CHIEF EXECUTIVE OFFICER CERTIFICATION
I, Kevin G. Guest, certify that:
1.I have reviewed this Annual Report on Form 10-K of USANA Health Sciences, Inc. (the “Registrant”);
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
4.The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
5.The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions)::
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.
Date: February 28, 2023
/s/ Kevin G. Guest
 Kevin G. Guest
 Chief Executive Officer
(Principal Executive Officer)

 EX-31.2 5 usna-20221231xex312.htm EX-31.2 Document
EXHIBIT 31.2
CHIEF EXECUTIVE OFFICER CERTIFICATION
I, G. Douglas Hekking, certify that:
1.I have reviewed this Annual Report on Form 10-K of USANA Health Sciences, Inc. (the “Registrant”);
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
4.The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
5.The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions)::
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.
Date: February 28, 2023
/s/ G. Douglas Hekking
 G. Douglas Hekking
 Chief Financial Officer
(Principal Accounting and Financial Officer)

 EX-32.1 6 usna-20221231xex321.htm EX-32.1 Document
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

The undersigned hereby certifies that the Annual Report on Form 10-K of USANA Health Sciences, Inc. for the period ended December 31, 2022 as filed February 28, 2023 with the Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or 15(d) of The Securities Exchange Act of 1934 (15 U.S.C. 78m) and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of USANA Health Sciences, Inc.

Date: February 28, 2023
/s/ Kevin G. Guest
 Kevin G. Guest
 Chief Executive Officer
(Principal Executive Officer)

 EX-32.2 7 usna-20221231xex322.htm EX-32.2 Document
EXHIBIT 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

The undersigned hereby certifies that the Annual Report on Form 10-K of USANA Health Sciences, Inc. for the period ended December 31, 2022 as filed February 28, 2023 with the Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or 15(d) of The Securities Exchange Act of 1934 (15 U.S.C. 78m) and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of USANA Health Sciences, Inc.

Date: February 28, 2023
/s/ G. Douglas Hekking
 G. Douglas Hekking
 Chief Financial Officer
(Principal Accounting and Financial Officer)



 EX-101.SCH 8 usna-20221231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Consolidated Balance Sheets (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Consolidated Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 0000007 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 0000008 - Disclosure - Business Combinations link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Prepaid Expenses and Other Current Assets link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Operating Leases link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Other Current Liabilities link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Line of Credit link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Equity-Based Compensation link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Common Stock and Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Related-Party Transactions link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Schedule II - Valuation and Qualifying Accounts link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 0000027 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 0000028 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 0000029 - Disclosure - Operating Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 0000030 - Disclosure - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 0000031 - Disclosure - Other Current Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 0000032 - Disclosure - Equity-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 0000033 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 0000034 - Disclosure - Common Stock and Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 0000035 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000036 - Disclosure - Summary of Significant Accounting Policies - Schedule of Assets And Liabilities Measured At Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 0000037 - Disclosure - Summary of Significant Accounting Policies - Schedule of Other Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 0000038 - Disclosure - Summary of Significant Accounting Policies - Schedule of Contract Liabilities From Contract With Customers (Details) link:presentationLink link:calculationLink link:definitionLink 0000039 - Disclosure - Business Combinations and Asset Acquisitions (Details) link:presentationLink link:calculationLink link:definitionLink 0000040 - Disclosure - Inventories - Schedule of Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 0000041 - Disclosure - Inventories - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000042 - Disclosure - Prepaid Expenses and Other Current Assets - Prepaid Expenses and Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000043 - Disclosure - Income Taxes - Consolidated Earnings Before Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 0000044 - Disclosure - Income Taxes - Income Tax Expense (Benefit) Included in Income from Continuing Operations (Details) link:presentationLink link:calculationLink link:definitionLink 0000045 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 0000046 - Disclosure - Income Taxes - Significant Categories of Deferred Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 0000046 - Disclosure - Income Taxes - Significant Categories of Deferred Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 0000047 - Disclosure - Income Taxes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000048 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details) link:presentationLink link:calculationLink link:definitionLink 0000049 - Disclosure - Property and Equipment - Cost of Property and Equipment and Estimated Useful Lives (Details) link:presentationLink link:calculationLink link:definitionLink 0000050 - Disclosure - Property and Equipment - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000051 - Disclosure - Operating Leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000052 - Disclosure - Operating Leases - Classification of Lease Assets and Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000053 - Disclosure - Operating Leases - Supplemental Lease Information (Details) link:presentationLink link:calculationLink link:definitionLink 0000054 - Disclosure - Operating Leases - Maturity of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000054 - Disclosure - Operating Leases - Maturity of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000055 - Disclosure - Intangible Assets - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000056 - Disclosure - Intangible Assets - Changes in Carrying Amounts of Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 0000057 - Disclosure - Intangible Assets - Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000058 - Disclosure - Intangible Assets - Estimated Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 0000059 - Disclosure - Other Current Liabilities - Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000060 - Disclosure - Line of Credit - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000061 - Disclosure - Commitments and Contingencies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000062 - Disclosure - Equity-Based Compensation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000063 - Disclosure - Equity-Based Compensation - Remaining Unrecognized Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 0000064 - Disclosure - Equity-Based Compensation - Weighted-average Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 0000065 - Disclosure - Equity-Based Compensation - Summary of Stock-settled Stock Appreciation Right Activity (Details) link:presentationLink link:calculationLink link:definitionLink 0000066 - Disclosure - Equity-Based Compensation - Summary of Stock-settled Restricted Stock Unit Activity (Details) link:presentationLink link:calculationLink link:definitionLink 0000067 - Disclosure - Equity-Based Compensation - Summary of Cash-settled Restricted Stock Unit Activity (Details) link:presentationLink link:calculationLink link:definitionLink 0000068 - Disclosure - Segment Information - Schedule of Segment Reporting Information, by Operating Segment (Details) link:presentationLink link:calculationLink link:definitionLink 0000069 - Disclosure - Segment Information - Schedule of Revenue Percentage By Product (Details) link:presentationLink link:calculationLink link:definitionLink 0000070 - Disclosure - Segment Information - Consolidated Net Sales and Long Lived Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000071 - Disclosure - Segment Information - Markets Representing Ten Percent Or More Of Consolidated Net Sales and Long-Lived Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000072 - Disclosure - Common Stock and Earnings Per Share - Schedule of Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 0000073 - Disclosure - Common Stock and Earnings Per Share - Schedule of Shares not Included in the Computation of Diluted EPS (Details) link:presentationLink link:calculationLink link:definitionLink 0000074 - Disclosure - Common Stock and Earnings Per Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000075 - Disclosure - Related-Party Transactions - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000076 - Disclosure - Schedule II - Valuation and Qualifying Accounts - Valuation and Qualifying Accounts (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 usna-20221231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 10 usna-20221231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 11 usna-20221231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Business Acquisition [Axis] Business Acquisition [Axis] Inventory [Axis] Inventory [Axis] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Total operating lease, liability Lessee, Operating Lease, Liability, to be Paid Foreign Current Foreign Tax Expense (Benefit) Translation of Foreign Currencies Foreign Currency Transactions and Translations Policy [Policy Text Block] Related Party Transactions [Abstract] Deferred tax assets Net deferred tax assets Deferred Income Tax Assets, Net Entity Address, Postal Zip Code Entity Address, Postal Zip Code Product return, percentage refunded Product Return Percentage Refunded The percentage of refund on product returns. Cash paid for amounts included in the measurement of lease liabilities Cash Paid For Amounts Included In The Measurement Of Lease Liabilities [Abstract] Cash Paid For Amounts Included In The Measurement Of Lease Liabilities Property, Plant and Equipment [Abstract] Deferred Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Business Combinations Business Combinations Policy [Policy Text Block] Debt Instrument [Axis] Debt Instrument [Axis] Property, plant and equipment, gross Property, Plant and Equipment, Gross Related party transaction, expenses from transactions with related party Related Party Transaction, Expenses from Transactions with Related Party Line of credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Income Tax Disclosure [Abstract] Property and equipment Deferred Tax Liabilities, Property, Plant and Equipment Deductions SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction Withholding tax on unremitted earnings Deferred Tax Liabilities Withholding Tax On Unremitted Earnings Amount of deferred tax liability attributable to taxable temporary differences from withholding tax on unremitted earnings. Prepaid Expense and Other Assets, Current [Abstract] Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Personal care and Skincare Personal Care And Skincare [Member] Related to personal care and skincare. Statistical Measurement [Domain] Statistical Measurement [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Depreciation Depreciation Net deferred taxes Deferred Tax Assets, Net Associate Incentives Associate Incentives [Policy Text Block] Disclosure of accounting policy for associate incentives. Weighted-average discount rate—operating leases Operating Lease, Weighted Average Discount Rate, Percent Schedule of Markets Representing Ten Percent Or More of Consolidated Net Sales and Long-Lived Assets Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Product Return Policy Product Return [Policy Text Block] Disclosure of accounting policy for product returns. Share-Based Payment Arrangement [Abstract] Additional paid-in capital Additional Paid in Capital, Common Stock Long-lived Assets Long-Lived Assets Weighted-average exercise price (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price Domestic Tax Authority Domestic Tax Authority [Member] Effect of exchange rate changes on cash, cash equivalents, and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Incremental taxes Incremental Taxes The amount of incremental taxes for the reporting period. State Current State and Local Tax Expense (Benefit) Income taxes Income Taxes Paid Associate incentives Associate Incentives Expenses related to commissions and other incentives earned by independent associates. Commissions are earned based on direct and indirect commissionable product sales. Other incentives including bonuses and contests and promotions are based on pay-for-performance and earned when associates achieve the required performance measures. Total fair value, net asset (liability) Fair Value, Net Asset (Liability) Foreign currency contracts included in other current liabilities Foreign Currency Contracts, Liability, Fair Value Disclosure Net earnings Net earnings Net Income (Loss) Attributable to Parent Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive securities excluded from computation of earnings per share, amount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Subsequent Event Type [Axis] Subsequent Event Type [Axis] Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five All other, net Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Prepaid insurance Prepaid Insurance Equity Component [Domain] Equity Component [Domain] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Fair Value, Nonrecurring Fair Value, Nonrecurring [Member] Non-qualified deferred compensation plan, annual incentive bonus deferral, percentage Non-Qualified Deferred Compensation Plan, Annual Incentive Bonus Deferred, Percentage Non-Qualified Deferred Compensation Plan, Annual Incentive Bonus Deferred, Percentage Share-based compensation arrangement by share-based payment award, award vesting rights, percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Increases related to current year tax positions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Operating Leases Lessee, Operating Leases [Text Block] Weighted average exercise price, outstanding (in dollars per share) Share-based Compensation Arrangement By Share-based Payment Award Equity Instruments Other Than Options Weighted Average Exercise Price Per share or unit weighted-average exercise price of award under share-based payment arrangement. Excludes share and unit options. Related Party [Domain] Related Party [Domain] Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] 2026 Share-based Payment Arrangement Nonvested Award Cost Not Yet Recognized Amount Due Year Four Amount of cost not yet recognized for nonvested award under share-based payment arrangement to be recognized in year four. Plan Name [Axis] Plan Name [Axis] Equity securities without readily determinable fair value, impairment loss, annual amount Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount Contract with customer, asset, after allowance for credit loss, total Contract with Customer, Asset, after Allowance for Credit Loss Hedging Designation [Domain] Hedging Designation [Domain] Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Name [Domain] Line of Credit Facility [Abstract] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Payments for net investment hedge Payments for Hedge, Investing Activities Amortized intangible assets Finite-Lived Intangible Assets, Net [Abstract] Supplemental disclosures of cash flow information Supplemental Cash Flow Information [Abstract] Derivative Instrument [Axis] Derivative Instrument [Axis] Valuation Allowance by Deferred Tax Asset [Axis] Valuation Allowance by Deferred Tax Asset [Axis] Plan Name [Domain] Plan Name [Domain] Deferred tax assets, operating loss carryforwards, state and local Deferred Tax Assets, Operating Loss Carryforwards, State and Local Expired, weighted-average exercise price (in dollars per share) Expired, Weighted-Average Exercise Price (In Dollars Per Share) Per share or unit weighted-average exercise price of award expired during the period under share-based payment arrangement. Excludes share and unit options. Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Long-term line of credit, total Long-Term Line of Credit Entity Address, State or Province Entity Address, State or Province Level 1 Fair Value, Inputs, Level 1 [Member] Schedule of Other Current Liabilities Other Current Liabilities [Table Text Block] Employee Stock Employee Stock [Member] Deferred Tax Liabilities, Unrealized Currency Transaction Gains Deferred Tax Liabilities, Unrealized Currency Transaction Gains Award Type [Axis] Award Type [Axis] Decreases for settlements with taxing authorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities USANA Foods USANA Foods [Member] Related to USANA Foods. Operating lease liabilities Operating Lease, Liability, Current SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Defined contribution plan, maximum annual contributions per employee, percent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent 2023 Share-based Payment Arrangement Nonvested Award Cost Not Yet Recognized Amount Due Year One Amount of cost not yet recognized for nonvested award under share-based payment arrangement to be recognized in year one Excess foreign tax credits Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent Document Annual Report Document Annual Report Contingent consideration given to acquire assets Noncash or Part Noncash Acquisition, Value of Assets Acquired Defined benefit plan, cliff vesting period (year) Defined Benefit Plan Cliff Vesting Period Minimum amount of service time before matching contributions will cliff vest. Movement in Contract Liabilities [Roll Forward] Movement In Contract Liabilities [Roll Forward] Movement In Contract Liabilities Weighted-average remaining lease term—operating leases Operating Lease, Weighted Average Remaining Lease Term Geographical [Axis] Geographical [Axis] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Product return, first time order, duration of return (day) Product Return First Time Order Duration Of Return The duration of the return on first-time product orders. Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Schedule of Property and Equipment Property, Plant and Equipment [Table Text Block] Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Current Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Document Type Document Type Weighted-average exercise price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] 2024 Share-based Payment Arrangement Nonvested Award Cost Not Yet Recognized Amount Due Year Two Amount of cost not yet recognized for nonvested award under share-based payment arrangement to be recognized in year two. Useful life Property, Plant and Equipment, Useful Life Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Cash paid during the period for: Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect [Abstract] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Segments [Axis] Segments [Axis] Beginning balance outstanding, weighted-average grant date fair value (in dollars per share) Ending balance outstanding, weighted-average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Line of Credit Debt Disclosure [Text Block] Deferred Stock Units Deferred Stock Units [Member] Represents deferred stock units. Product and Service [Domain] Product and Service [Domain] Entity Shell Company Entity Shell Company Total Deferred Deferred Income Tax Expense (Benefit) Decreases related to prior year tax positions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 2023 Lessee, Operating Lease, Liability, to be Paid, Year One Other Current Liabilities Other Liabilities Disclosure [Text Block] Number of sub geographical regions Number Of Sub Geographical Regions The number of sub-geographical regions the company operates in. Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] Revenue Benchmark Revenue Benchmark [Member] Consolidation Items [Domain] Consolidation Items [Domain] Subsequent Event Subsequent Event [Member] Share-based Payment Arrangement, Nonemployee Share-Based Payment Arrangement, Nonemployee [Member] Contract with Customer, Contract Asset, Contract Liability, and Receivable Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Document Period End Date Document Period End Date Number of geographic regions Number Of Geographic Regions The number of geographic regions in which the company operates. Gull Global, Ltd. Gull Global, Ltd. [Member] Represents Gull Global, Ltd. Prepaid Expenses And Other Current Assets Other Current Assets [Text Block] Total assets Total Assets Assets Earnings per common share Earnings Per Share [Abstract] Accounts Receivable Accounts Receivable [Policy Text Block] COVID-19 COVID-19 Policy [Policy Text Block] COVID-19 Policy Sales taxes Sales and Excise Tax Payable, Current Fair Value Measurements, Recurring and Nonrecurring Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Foreign Exchange Option Foreign Exchange Option [Member] 2027 Lessee, Operating Lease, Liability, to be Paid, Year Five Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Accounting Policies [Abstract] Accounting Policies [Abstract] Accrued employee compensation Employee-related Liabilities, Current Line of Credit Line of Credit [Member] Other Foreign Deferred Tax Assets Other Foreign Deferred Tax Assets [Member] Represents other foreign deferred tax assets. Earnings before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Stockholders' equity Stockholders' Equity Attributable to Parent [Abstract] Prepaid expenses and other current assets Total prepaid expense and other current assets Prepaid Expense and Other Assets, Current Segments [Domain] Segments [Domain] Foreign income tax rate differences Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Deferred income taxes Deferred Income Taxes and Tax Credits Common Stock and Earnings Per Share Earnings Per Share [Text Block] Current: Other Liabilities, Current [Abstract] Other Deferred Tax Liabilities, Other Other Noncurrent Liabilities Other Noncurrent Liabilities [Member] Schedule of Weighted-Average Assumptions Used to Calculate Fair Value of Stock Settled Stock Appreciation Rights Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Gross goodwill Gross goodwill Goodwill, Gross Deferred compensation liability, classified, noncurrent, total Deferred Compensation Liability, Classified, Noncurrent Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Schedule of Income Tax Expense (Benefit) Included in Income From Continuing Operations Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Award Type [Domain] Award Type [Domain] Grantee Status [Axis] Grantee Status [Axis] Net increase in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition (year) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Total ROU assets Lease Right Of Use Asset Amount of lessee's right to use underlying asset under lease. Income Tax Contingency [Table] Income Tax Contingency [Table] Income taxes receivable Income Taxes Receivable, Current Computer equipment and software Computer Equipment [Member] Payments to acquire businesses Payments to Acquire Businesses, Gross Derivative Contract [Domain] Derivative Contract [Domain] Gross profit Gross Profit Entity Registrant Name Entity Registrant Name China CHINA Goodwill Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Currency translation adjustment Goodwill, Foreign Currency Translation Gain (Loss) Series of Individually Immaterial Business Acquisitions Series of Individually Immaterial Business Acquisitions [Member] Customer relationships Customer Relationships [Member] Entity Address, City or Town Entity Address, City or Town Accounting Policies [Table] Accounting Policies [Table] Accounting Policies Operating expenses: Operating Expenses [Abstract] Net operating losses Deferred Tax Assets, Operating Loss Carryforwards Principles of Consolidation and Basis of Presentation Consolidation, Policy [Policy Text Block] Minimum Minimum [Member] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Common stock, par or stated value per share (in dollars per share) Common Stock, Par or Stated Value Per Share Raw materials Inventory, Raw Materials, Net of Reserves Purchase price allocations to intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] Deferred tax assets, operating loss carryforwards, foreign Deferred Tax Assets, Operating Loss Carryforwards, Foreign Commitments and Contingencies Disclosure [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Mirrored Deferred Tax Assets Recorded in the U.S. to Offset Deferred Tax Liabilities of Foreign Disregarded Entities Mirrored Deferred Tax Assets Recorded in the U.S. to Offset Deferred Tax Liabilities of Foreign Disregarded Entities [Member] Represents mirrored deferred tax assets recorded in the U.S. to offset deferred tax liabilities of foreign disregarded entities. Auditor Name Auditor Name Air transportation equipment Air Transportation Equipment [Member] Share price (in dollars per share) Share Price Operating loss carryforwards, total Operating Loss Carryforwards Trading Symbol Trading Symbol Entity File Number Entity File Number Nonqualified Deferred Compensation Nonqualified Deferred Compensation Plan Policy [Policy Text Block] Disclosure of accounting policy related to the Company's nonqualified deferred compensation plan. Exercisable, aggregate intrinsic value Exercisable, Aggregate Intrinsic Value Intrinsic value of exercisable award under share-based payment arrangement. Excludes share and unit options. 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Four Research and development expense, total Research and Development Expense Increases related to prior year tax positions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Deferred revenue Deferred Revenue, Current Foreign Deferred Foreign Income Tax Expense (Benefit) Derivatives Financial Instruments Derivatives, Policy [Policy Text Block] Restricted cash Restricted Cash and Cash Equivalents Granted, shares (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Research Tax Credit Carryforward Research Tax Credit Carryforward [Member] Total effective income tax rate reconciliation, percent Effective Income Tax Rate Reconciliation, Percent Exercised, shares (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Borrowings on line of credit Proceeds from Lines of Credit Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Share-based compensation arrangement by share-based payment award, equity instruments other than options, exercises in period, intrinsic value Share-based Compensation Arrangement By Share-based Payment Award Equity Instruments Other Than Options Exercises In Period Intrinsic Value The intrinsic value of award exercised under share-based payment arrangement. Excludes share and unit options. Use of Estimates Use of Estimates, Policy [Policy Text Block] Money market funds included in cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Business Combinations Business Combination Disclosure [Text Block] Accounts payable Increase (Decrease) in Accounts Payable Concentration risk, percentage Concentration Risk, Percentage Share-based compensation arrangement by share-based payment award, number of additional shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Income Taxes Income Tax Disclosure [Text Block] Aggregate intrinsic value, outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Granted, shares (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted State Deferred State and Local Income Tax Expense (Benefit) Finished goods Inventory, Finished Goods, Net of Reserves Credit Facility [Domain] Credit Facility [Domain] Intangible assets, gross (excluding goodwill) Intangible Assets, Gross (Excluding Goodwill) Amortization of intangible assets, total Amortization of Intangible Assets Schedule of Goodwill Schedule of Goodwill [Table Text Block] Interest Interest Paid, Excluding Capitalized Interest, Operating Activities Forfeited, shares (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures Earnings per share, basic (in dollars per share) Earnings per common share from net earnings - basic (in dollars per share) Earnings Per Share, Basic 2025 Lessee, Operating Lease, Liability, to be Paid, Year Three Share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period, fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Other Assets Other Assets [Member] Land improvements Land Improvements [Member] Deferred compensation liabilities Deferred compensation liabilities Deferred Compensation Liability, Current and Noncurrent Inventories - Current and Noncurrent Inventory, Policy [Policy Text Block] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Indefinite-lived Intangible Assets [Axis] Indefinite-Lived Intangible Assets [Axis] Total stockholders' equity Beginning balance Ending balance Stockholders' Equity Attributable to Parent Cash, cash equivalents, and restricted cash at beginning of period Cash, cash equivalents, and restricted cash at end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Tax credit carryforward, amount Tax Credit Carryforward, Amount Contingent consideration milestone period Contingent Consideration Milestone Period Contingent Consideration Milestone Period Forfeited, weighted-average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Vesting [Domain] Vesting [Domain] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Tax credit carry forwards Deferred Tax Assets, Tax Credit Carryforwards Other Deferred Tax Assets, Other Entity Interactive Data Current Entity Interactive Data Current Finite-lived intangible assets, accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Deferred Tax Asset [Domain] Deferred Tax Asset [Domain] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Prepaid Expenses and Other Current Assets Prepaid Expenses and Other Current Assets [Member] Changes in operating assets and liabilities, net of acquisitions: Increase (Decrease) in Operating Capital [Abstract] Weighted-average remaining contractual term Weighted-Average Remaining Contractual Term [Abstract] Weighted-Average Remaining Contractual Term 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Three Decrease in tangible assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment Uncertain tax position reserve Effective Income Tax Rate Reconciliation, Tax Contingency, Percent Money Market Funds Money Market Funds [Member] Retained Earnings Retained Earnings [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Total lease cost Lease, Cost Common Stock Common Stock [Member] Other comprehensive income (loss), net of tax Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Common stock issued under equity award plans Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Schedule of Supplemental Lease Information Lease, Cost [Table Text Block] Repurchase of common stock Payments for repurchase of common stock Payments for Repurchase of Common Stock Contingent consideration included in other current liabilities of $(338) and other long-term liabilities of $(548) Contingent consideration Business Combination, Contingent Consideration, Liability Income Taxes Income Tax, Policy [Policy Text Block] Statement [Table] Statement [Table] Vested, weighted-average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Share-based compensation arrangement by share-based payment award, shares issued per award exercised (in shares) Share-based Compensation Arrangement By Share-based Payment Award Shares Issued Per Award Exercised The number of shares issued per each one award upon exercise of award under share based payment arrangement. Purchase price allocations to tangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Furniture and fixtures Furniture and Fixtures [Member] Current assets Assets, Current [Abstract] Operating lease liabilities Operating Lease, Liability, Noncurrent Income tax expense related to interest and penalties Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Statistical Measurement [Axis] Statistical Measurement [Axis] Indefinite-lived intangible assets (excluding goodwill), direct sales license Indefinite-Lived Intangible Assets (Excluding Goodwill) Leasehold improvements Leasehold Improvements [Member] Proceeds from the settlement of net investment hedges Proceeds from Hedge, Investing Activities Grantee Status [Domain] Grantee Status [Domain] Retained earnings Retained Earnings (Accumulated Deficit) Forfeited, weighted-average exercise price (in dollars per share) Forfeited, Weighted-Average Exercise Price (In Dollars Per Share) Per share or unit weighted-average exercise price of award forfeited during the period under share-based payment arrangement. Excludes share and unit options. Cash equivalents, at carrying value, total Cash Equivalents, at Carrying Value Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Equity Components [Axis] Equity Components [Axis] Fair Value, Recurring Fair Value, Recurring [Member] Related-Party Transactions Related Party Transactions Disclosure [Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Schedule of Amortization Expense Finite-Lived Intangible Assets Amortization Expense [Table Text Block] Tax Credit Carryforward [Axis] Tax Credit Carryforward [Axis] Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Statement [Line Items] Statement [Line Items] Beginning balance outstanding, shares (in shares) Ending balance outstanding, shares (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Capitalized R&D Expenses Deferred Tax Assets, in Process Research and Development Business combination, contingent consideration, liability, current Business Combination, Contingent Consideration, Liability, Current Increase in goodwill Goodwill, Period Increase (Decrease) Other income (expense), net Nonoperating Income (Expense) Deferred commissions Deferred Costs, Current Other comprehensive income (loss), net of tax: Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Finite-lived intangible assets, gross carrying amount Finite-Lived Intangible Assets, Gross Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Accounting Policies [Line Items] Accounting Policies [Line Items] Accounting Policies Selling, general and administrative Selling, General and Administrative Expense ROU operating lease assets, net Operating Lease, Right-of-Use Asset Total Current Current Income Tax Expense (Benefit) Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Investment in Equity Securities Equity Securities without Readily Determinable Fair Value [Policy Text Block] Property and equipment, net, excluding non-depreciable Property Plant And Equipment Net Excluding Nondepreciable Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale, excluding non-depreciable amounts. Auditor Firm ID Auditor Firm ID The Company The Company [Policy Text Block] The Company Deferred tax liabilities Deferred Tax Liabilities, Gross [Abstract] Rent expense Operating Lease, Expense Document Transition Report Document Transition Report Foreign Tax Authority Foreign Tax Authority [Member] Local Phone Number Local Phone Number Life insurance, corporate or bank owned, amount Life Insurance, Corporate or Bank Owned, Amount Earnings from operations Operating Income (Loss) Inventory Deferred Tax Assets, Inventory Inventories Increase (Decrease) in Inventories Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Liability Award Liability Award [Member] Represents liability award. Equity-based compensation expense Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Equity securities without readily determinable fair value, amount Equity Securities without Readily Determinable Fair Value, Amount Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets State and Local Jurisdiction State and Local Jurisdiction [Member] Common stock, shares, outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Product return, percentage of net sales Product Return Percentage Of Net Sales The percentage of net sales that had product returns during the period. Goodwill Goodwill as of beginning of year Goodwill as of end of year Goodwill Other Current Liabilities Other Current Liabilities [Member] Non-qualified deferred compensation plan, salary deferred, percentage Non-Qualified Deferred Compensation Plan, Salary Deferred, Percentage Non-Qualified Deferred Compensation Plan, Salary Deferred, Percentage Exercisable, weighted-average remaining contractual term (years) Exercisable, Weighted-Average Remaining Contractual Term (Year) Weighted average remaining contractual term for equity-based awards excluding options that are exercisable, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Adjustments to reconcile net earnings to net cash provided by (used in) operating activities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Income taxes Total income tax expense (benefit) Income Tax Expense (Benefit) Geographical [Domain] Geographical [Domain] Valuation allowance Valuation allowance Deferred Tax Assets, Valuation Allowance Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Deferred tax liabilities Net deferred tax liabilities Deferred Income Tax Liabilities, Net 2026 Lessee, Operating Lease, Liability, to be Paid, Year Four Income Statement [Abstract] Income Statement [Abstract] Entity Public Float Entity Public Float Federal Deferred Federal Income Tax Expense (Benefit) Additional Paid-in Capital Additional Paid-in Capital [Member] Cash received during the period for: Income Taxes Paid, Net [Abstract] Direct sales license Licensing Agreements [Member] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Document Fiscal Period Focus Document Fiscal Period Focus Increase in assumed liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assumed Liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assumed Liabilities Cost of sales Cost of Goods and Services Sold Prepaid expenses Deferred Tax Liabilities, Prepaid Expenses Diluted (in shares) Weighted average common shares outstanding - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Less accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Intangible Assets Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block] Derivative assets (liabilities), at fair value, net, total Derivative Assets (Liabilities), at Fair Value, Net Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Expected life Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Foreign currency translation Deferred Tax Assets, Unrealized Currency Losses ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Foreign withholding taxes Foreign Withholding Taxes Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax withholdings. Common stock, $0.001 par value; Authorized -- 50,000 shares, issued and outstanding 19,206 as of December 31, 2022 and 19,393 as of January 1, 2022 Common Stock, Value, Issued Defined contribution plan, employer contribution amount Defined Contribution Plan Employer Contribution Amount Amount of contributions made by an employer to a defined contribution plan. Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Deferred tax assets Deferred Tax Assets, Gross [Abstract] Right-of-use assets obtained in exchange for lease obligations Right-Of-Use Assets Obtained In Exchange For Lease Obligations The amount of right of use asset obtained in exchange for operating lease liability classified as a noncash transaction. Granted, weighted-average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Asia Pacific Total Asia Pacific [Member] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Operating Segments Operating Segments [Member] Payments for investment in equity securities Payments to Acquire Trading Securities Held-for-investment Other Revenue Other Income Southeast Asia Pacific Southeast Asia Pacific [Member] Related to Southeast Asia Pacific. Product Concentration Risk Product Concentration Risk [Member] Total cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Restricted Cash Deposits in China Restricted Cash Deposits in China [Member] Represents restricted cash deposits in China. Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Current liabilities Liabilities, Current [Abstract] Net earnings available to common shareholders Net Income (Loss) Available to Common Stockholders, Basic 2025 Share-based Payment Arrangement Nonvested Award Cost Not Yet Recognized Amount Due Year Three Amount of cost not yet recognized for nonvested award under share-based payment arrangement to be recognized in year three. Common stock, shares, issued (in shares) Common Stock, Shares, Issued Accrued purchases of property and equipment Capital Expenditures Incurred but Not yet Paid Defined contribution plan, employer matching contribution, percent of employees' gross pay Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Weighted-average remaining contractual term, outstanding (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Amendment Flag Amendment Flag Finite-lived intangible asset, weighted-average amortization period (years) Finite-Lived Intangible Asset, Useful Life Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Operating lease cost Operating Lease, Cost South Korea KOREA, REPUBLIC OF Undistributed earnings Undistributed Earnings, Basic SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] Comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Goodwill acquired during the year Goodwill, Acquired During Period Schedule of Segment Reporting Information, by Operating Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Entity Current Reporting Status Entity Current Reporting Status Goodwill and Intangible Assets Disclosure [Abstract] Other current liabilities Total other current liabilities Other Liabilities, Current Other assets Other Assets, Noncurrent Schedule of Stock-Settled Appreciation Right Activity Share-Based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block] Depreciation and amortization Depreciation, Depletion and Amortization Statutory U.S. federal income tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Thereafter Finite-Lived Intangible Asset, Expected Amortization, after Year Five Utah State Tax Commission Utah State Tax Commission [Member] Represents the Utah state tax commission. Charged to costs and expenses SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code State income taxes, net of federal tax benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Liabilities Liabilities [Abstract] Property and equipment, net Property, Plant and Equipment, Net Line of credit facility, additional increase in maximum borrowing capacity Line Of Credit Facility Additional Increase In Maximum Borrowing Capacity Maximum borrowing capacity due to additional increase under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility Operating cash flows from operating leases Operating Lease, Payments Income tax refund Proceeds from Income Tax Refunds Unrecorded unconditional purchase obligation, to be paid, year one Unrecorded Unconditional Purchase Obligation, to be Paid, Year One Maximum amount of earnouts total Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Associate incentives Associate Incentives Payable Carrying value as of the balance sheet date of liabilities incurred and payable for associate incentives. Defined contribution plan, requisite service period (month) Defined Contribution Plan Requisite Service Period The requisite service period of the defined contribution plan. Amounts Receivable from Credit Card Processors Amounts Receivable From Credit Card Processors [Member] Represents amounts receivable from credit card processors. Forfeited, shares (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Other, net Other Nonoperating Income (Expense) Balance Sheet Location [Axis] Balance Sheet Location [Axis] Summary of Significant Accounting Policies Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Business combination, contingent consideration, liability, noncurrent Business Combination, Contingent Consideration, Liability, Noncurrent Common stock, shares authorized (in shares) Common Stock, Shares Authorized Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Business Combination, Separately Recognized Transactions [Table] Business Combination, Separately Recognized Transactions [Table] Income taxes Accrued Income Taxes, Current Total operating expenses Operating Expenses Maximum Maximum [Member] Revenue from External Customers by Products and Services Revenue from External Customers by Products and Services [Table Text Block] Accumulated other comprehensive income (loss) Accumulated Other Comprehensive Income (Loss), Net of Tax Schedule of Revenue by Geographic Region Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block] Inventory [Domain] Inventory [Domain] Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Restricted cash and cash equivalents, noncurrent, total Restricted Cash and Cash Equivalents, Noncurrent Common stock repurchased and retired Stock Repurchased and Retired During Period, Value Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Fiscal Year Fiscal Period, Policy [Policy Text Block] Total current assets Assets, Current Designated as Hedging Instrument Designated as Hedging Instrument [Member] Minimum amount of projected aggregate claims before insurance reimbursement Minimum Amount Of Projected Aggregate Claims Before Insurance Reimbursement The minimum amount of projected aggregate claims required before insurance will reimburse. Decrease due to beginning contract liabilities recognized as revenue Contract with Customer, Liability, Revenue Recognized Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Entity Small Business Entity Small Business Raw Materials Raw Materials [Member] Measurement Frequency [Domain] Measurement Frequency [Domain] Right-of-use asset amortization Operating Lease, Right-of-Use Asset, Amortization Expense Finite-lived intangible assets, net carrying amount Total estimated amortization expense Finite-Lived Intangible Assets, Net Common Stock Share Repurchases Stockholders' Equity, Policy [Policy Text Block] Line of Credit Facility [Table] Line of Credit Facility [Table] Amended and Restated Credit Agreement Amended And Restated Credit Agreement [Member] Related to amended and restated credit agreement. Total remaining unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Property and Equipment Property, Plant and Equipment Disclosure [Text Block] The 2015 Plan The 2015 Plan [Member] Represents the 2015 Equity Incentive Award Plan. Share-based payment arrangement, expense, tax benefit Share-Based Payment Arrangement, Expense, Tax Benefit Allowance for sales returns SEC Schedule, 12-09, Allowance, Sales Returns [Member] Allowance for sales returns. Amarevita Amarevita [Member] Represents Amarevita. Common stock repurchased and retired (in shares) Stock repurchased and retired during period, shares (in shares) Stock Repurchased and Retired During Period, Shares Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Title of 12(b) Security Title of 12(b) Security Schedule of Unrecognized Tax Benefits Reconciliation Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Payments on line of credit Repayments of Lines of Credit Business Combination and Asset Acquisition [Abstract] Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] Increase due to deferral of revenue at period end Increase Due To Deferral Of Revenue At Period End The amount of increase (decrease) in contract with customer liability due to deferred revenue. Common stock issued under entity award plans (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Payments for debt issuance costs Payments of Debt Issuance Costs Total lease liabilities Present value Operating Lease, Liability Segment Information Segment Reporting Disclosure [Text Block] Balance at beginning of period Balance at end of period SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount Equity-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Adjustments to additional paid in capital Adjustments to Additional Paid in Capital, Other 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Two Derivative, gain (loss) on derivative, net Derivative, Gain (Loss) on Derivative, Net Net deferred taxes Deferred Tax Liabilities, Net LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Weighted average common shares outstanding Weighted Average Number of Shares Outstanding, Diluted [Abstract] Accruals not currently deductible Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals Inventories Total inventory, net Inventory, Net Accounts payable Accounts Payable, Current Direct-selling Direct Selling [Member] Direct Selling Comprehensive income: Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Income Tax Authority [Axis] Income Tax Authority [Axis] Hedging Designation [Axis] Hedging Designation [Axis] Auditor Location Auditor Location Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] Schedule of Intangible Assets Schedule Of Finite And Indefinite Lived Intangible Assets [Table Text Block] Tabular disclosure for finite lived and indefinite lived intangible assets. Entity Filer Category Entity Filer Category Basic (in shares) Weighted average common shares outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Federal Current Federal Tax Expense (Benefit) China UNITED STATES Americas and Europe Americas And Europe [Member] Related to Americas and Europe. Deposits and projects in process Deposits and Projects In Process [Member] Represents deposits and projects in process. Laboratory and production equipment Laboratory And Production Equipment [Member] Represents laboratory and production equipment. Schedule of Remaining Unrecognized Compensation Expense Share-Based Payment Arrangement, Nonvested Award, Cost [Table Text Block] Non-cash investing and financing activities: Noncash Investing and Financing Items [Abstract] Security Exchange Name Security Exchange Name Indefinite-lived intangible assets Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract] Related party transaction, ownership percentage Related Party Transaction Ownership Percentage The ownership percentage by the related party. Other Liabilities Disclosure [Abstract] Derivative, notional amount Derivative, Notional Amount North Asia North Asia [Member] Related to north Asia. Restricted Stock Restricted Stock [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Net sales Net Sales to External Customers Revenue from Contract with Customer, Excluding Assessed Tax Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Defined contribution plan, employer matching contribution, percent of match Defined Contribution Plan, Employer Matching Contribution, Percent of Match Finished Goods Finished Goods [Member] Finished Goods Valuation allowance - deferred tax assets SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Cover [Abstract] Nonfinancial assets, fair value disclosure Nonfinancial Assets Fair Value Disclosure The amount of nonfinancial assets measured at fair value. Leases Lessee, Leases [Policy Text Block] Debt instrument, covenant ratio of consolidated funded debt to adjusted earnings before interest, taxes, depreciation, and amortization Debt Instrument Covenant Ratio Of Consolidated Funded Debt To Adjusted Earnings Before Interest Taxes Depreciation And Amortization The covenant ratio of consolidated debt to adjusted earnings before interest, taxes, depreciation, and amortization for a debt instrument. Level 3 Fair Value, Inputs, Level 3 [Member] Entity Voluntary Filers Entity Voluntary Filers Goodwill, impairment loss Goodwill, Impairment Loss Equity-Based Compensation Share-Based Payment Arrangement [Text Block] Work in progress Inventory, Work in Process, Net of Reserves Segment Reporting [Abstract] Greater China Greater China [Member] Related to Greater China. Foreign Operating Loss Carryforwards Foreign Operating Loss Carryforwards [Member] Represents foreign operating loss carryforwards. Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Permanent tax differences Permanent Tax Differences Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to permanent tax differences. Payments related to tax withholding for net-share settled equity awards Payment, Tax Withholding, Share-Based Payment Arrangement Total liabilities and equity Liabilities and Equity Share-based compensation arrangement by share-based payment award, grants in period, gross (in shares) Share-based Compensation Arrangement By Share-based Payment Award Grants In Period Gross Gross number of awards granted during the period. Schedule of Deferred Taxes Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Related Party [Axis] Related Party [Axis] Goodwill [Roll Forward] Goodwill [Roll Forward] Land Land [Member] Stock repurchase program, remaining authorized repurchase amount Stock Repurchase Program, Remaining Authorized Repurchase Amount Dilutive effect of in-the-money equity awards (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Intangible assets Deferred Tax Assets, Goodwill and Intangible Assets SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] Gross deferred tax assets Deferred Tax Assets, Gross Schedule of Consolidated Income Before Income Taxes Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Payments to acquire businesses Payments to Acquire Businesses, Net of Cash Acquired Receipts on notes receivable Proceeds from Collection of Notes Receivable Level 2 Fair Value, Inputs, Level 2 [Member] Current Fiscal Year End Date Current Fiscal Year End Date Unrecognized tax benefits, income tax penalties and interest accrued, total Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Vesting [Axis] Vesting [Axis] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Earnings per share, diluted (in dollars per share) Earnings per common share from net earnings - diluted (in dollars per share) Earnings Per Share, Diluted Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Inventory [Line Items] Inventory [Line Items] Maximum amount per earnout Business Combination, Contingent Consideration Arrangements, Range Of Outcomes, Value Per Arrangement, High Amount of maximum earn-out per period. Proceeds from sale of property and equipment Proceeds from Sale of Property, Plant, and Equipment Trade name and trademarks Trademarks and Trade Names [Member] (Gain) loss on sale of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Product return, first time order, percentage refunded Product Return First Time Order Percentage Refunded The percentage refunded on first-time orders for product returns. Equity-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Consolidation Items [Axis] Consolidation Items [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Share based compensation arrangement by share based payment award, equity instruments other than options, vested and unreleased in period (in shares) Share-based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Unreleased In Period The number of shares vested and unreleased in the period of non-option equity instruments under share based payment arrangement. Total current liabilities Liabilities, Current Exercised, weighted-average exercise price (in dollars per share) Exercised, Weighted-Average Exercise Price (In Dollars Per Share) Per share or unit weighted-average exercise price of award exercised in period under share-based payment arrangement. Excludes share and unit options. 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two Other current assets Other Assets, Current Inventory, Current [Table] Inventory, Current [Table] Granted, weighted-average exercise price (in dollars per share) Granted, Weighted-Average Exercise Price (In Dollars Per Share) Per share or unit weighted-average exercise price of award granted during the period under share-based payment arrangement. Excludes share and unit options. Self-Insurance Self Insurance Reserve [Policy Text Block] All other Other Sundry Liabilities, Current Exercisable, shares (in shares) Exercisable, Shares (In Shares) Number of equity instruments other than options exercisable. Unrecognized tax benefits Beginning balance of unrecognized tax benefits Ending balance of unrecognized tax benefits Unrecognized Tax Benefits Net deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Intangible assets Deferred Tax Liabilities, Intangible Assets Schedule of Stock-Settled Restricted Stock Unit Activity Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] (Gain) loss on impairment on other assets Other Asset Impairment Charges Share-based compensation arrangement by share-based payment award, forfeitures (in shares) Share-based Compensation Arrangement By Share-based Payment Award Forfeitures Number of shares under equity instrument agreements that were cancelled as a result of occurrence of a terminating event. U.S. Income (Loss) from Continuing Operations before Income Taxes, Domestic Share-based compensation arrangement by share-based payment award, expiration period (year) Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Noncurrent: Other Liabilities, Noncurrent [Abstract] Other income (expense): Nonoperating Income (Expense) [Abstract] Schedule of Maturity of Lease Liabilities Lessee, Operating Lease, Liability, Maturity [Table Text Block] Entity Address, Address Line One Entity Address, Address Line One Vesting Annually Vesting Annually [Member] Represents vesting annually. Income Tax Authority [Domain] Income Tax Authority [Domain] Share-based payment arrangement, amount capitalized Share-Based Payment Arrangement, Amount Capitalized Contract liabilities at beginning of period Contract liabilities at end of period Contract with Customer, Liability Product and Service [Axis] Product and Service [Axis] Impairment of intangible assets, indefinite-lived (excluding goodwill) Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill) Valuation allowance, deferred tax asset, increase (decrease), amount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Interest expense Interest Expense Credit Facility [Axis] Credit Facility [Axis] Noncurrent inventories Inventory, Noncurrent Inventories Inventory Disclosure [Text Block] Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Buildings Building [Member] Vested, shares (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Miscellaneous receivables, net Other Receivables, Net, Current Decrease in consideration, post close net working capital adjustments Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Working Capital Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Working Capital Inventory Disclosure [Abstract] Entity Tax Identification Number Entity Tax Identification Number Share-based compensation arrangement by share-based payment award, number of shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract] Other Noncurrent Assets Other Noncurrent Assets [Member] Cash-settled Restricted Stock Units Cash-Settled Restricted Stock Units [Member] Represents cash-settled restricted stock units. Business Combination, Separately Recognized Transactions [Line Items] Business Combination, Separately Recognized Transactions [Line Items] Schedule of Cash-Settled Restricted Stock Unit Activity Schedule of Nonvested Share Activity [Table Text Block] Beginning balance outstanding, shares (in shares) Ending balance outstanding, shares (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Defined contribution plan, employer matching contribution, match percent exceeding initial match Defined Contribution Plan Employer Matching Contribution Match Percent Exceeding Initial Match The percent exceeding the initial matching percent that the employer matches contributions under the defined contribution plan. Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Self-insurance expense Self Insurance Expense The expense in the period incurred for claims for which no insurance coverage exists. Advertising expense Advertising Expense Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Gross deferred tax liabilities Deferred Tax Liabilities, Gross Non-compete agreements Noncompete Agreements [Member] Schedule of Effective Income Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Vesting Each Quarter Vesting Each Quarter [Member] Represents vesting each quarter. Net increase (decrease) in cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Debt instrument covenant, adjusted earnings before interest taxes, depreciation, and amortization Debt Instrument Covenant Adjusted Earnings Before Interest Taxes Depreciation And Amortization The amount of debt instrument covenant for adjusted earnings before interest taxes, depreciation, and amortization. Schedule II - Valuation And Qualifying Accounts SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Property and equipment Deferred Tax Assets, Property, Plant and Equipment 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Five Entity Central Index Key Entity Central Index Key Number of earnout periods Number Of Earnout Periods Number of earn-out periods. Interest income Investment Income, Interest Measurement Frequency [Axis] Measurement Frequency [Axis] Research and Development Research and Development Expense, Policy [Policy Text Block] Allowance for doubtful accounts SEC Schedule, 12-09, Allowance, Credit Loss [Member] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Tax withholding for net-share settled equity awards Share-based payment arrangement, decrease for tax withholding obligation Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Exercisable, weighted-average exercise price (in dollars per share) Exercisable, Weighted-Average Exercise Price (In Dollars Per Share) Per share or unit weighted-average exercise price of exercisable award under share-based payment arrangement. Excludes share and unit options. City Area Code City Area Code ASSETS Assets Assets [Abstract] Defined contribution plan, minimum age of employee Defined Contribution Plan Minimum Age Of Employee The minimum age of employee required to participate in the defined contribution plan Schedule of Classification of ROU Assets and Lease Liabilities Assets And Liabilities, Lessee [Table Text Block] Tabular disclosure of lessee's assets and liabilities. Selling, General and Administrative Selling, General and Administrative Expenses, Policy [Policy Text Block] Product formulas Trade Secrets [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Other prepaid expenses Other Prepaid Expense, Current Advertising Advertising Cost [Policy Text Block] Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Schedule of Prepaid Expenses Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax Earnings Per Share Earnings Per Share, Policy [Policy Text Block] Equity-based compensation expense Share-Based Payment Arrangement, Noncash Expense Leases, Operating [Abstract] Other long-term liabilities Other Liabilities, Noncurrent Minimum amount of individual claims before insurance reimbursement Minimum Amount Of Individual Claims Before Insurance Reimbursement The minimum amount of individual claims required before insurance will reimburse. Other liabilities Increase (Decrease) in Other Operating Liabilities Operating loss carryforwards, not subject to expiration Operating Loss Carryforwards Not Subject To Expiration Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws, that are not subject to expiration. Non-cash change in right-of-use assets Non-Cash Change In Right-Of-Use Assets Amount of noncash change in right-of-use asset. Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment USANA Nutritionals USANA Nutritionals [Member] Related to USANA Nutritionals. Expired, shares (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations 2023 Finite-Lived Intangible Asset, Expected Amortization, Year One Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Tax benefit (expense) related to foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax ROU assets obtained in exchange for new operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Automobiles Automobiles [Member] All Other All Other [Member] Related to all other. Equity based compensation expense Equity Based Compensation Expense The value of equity based compensation expenses under share-based payment arrangement. EX-101.PRE 12 usna-20221231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 13 usna-20221231_g1.jpg CUMULITIVE SHAREHOLDER RETURN begin 644 usna-20221231_g1.jpg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Ö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end XML 14 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Document And Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2022
Feb. 24, 2023
Jul. 01, 2022
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2022    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-35024    
Entity Registrant Name USANA HEALTH SCIENCES, INC.    
Entity Incorporation, State or Country Code UT    
Entity Tax Identification Number 87-0500306    
Entity Address, Address Line One 3838 West Parkway Blvd.    
Entity Address, City or Town Salt Lake City    
Entity Address, State or Province UT    
Entity Address, Postal Zip Code 84120    
City Area Code 801    
Local Phone Number 954-7100    
Title of 12(b) Security Common Stock, Par Value $0.001 per share    
Trading Symbol USNA    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Entity Shell Company false    
Entity Public Float     $ 1,426,392,900
Entity Common Stock, Shares Outstanding   19,294,332  
Auditor Name KPMG LLP    
Auditor Location Salt Lake City, Utah    
Auditor Firm ID 185    
Entity Central Index Key 0000896264    
Document Fiscal Period Focus FY    
Amendment Flag false    
Document Fiscal Year Focus 2022    
XML 15 R2.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Jan. 01, 2022
Current assets    
Cash and cash equivalents $ 288,420 $ 239,832
Inventories 67,089 98,318
Prepaid expenses and other current assets 28,873 26,967
Total current assets 384,382 365,117
Property and equipment, net 97,773 101,780
Goodwill 17,368 17,668
Intangible assets, net 32,432 30,442
Deferred tax assets 9,799 4,839
Other assets 54,795 57,894
Total assets 596,549 577,740
Current liabilities    
Accounts payable 11,049 13,508
Other current liabilities 132,784 147,282
Total current liabilities 143,833 160,790
Deferred tax liabilities 4,071 7,497
Other long-term liabilities 14,173 14,329
Stockholders' equity    
Common stock, $0.001 par value; Authorized -- 50,000 shares, issued and outstanding 19,206 as of December 31, 2022 and 19,393 as of January 1, 2022 19 19
Additional paid-in capital 55,604 50,010
Retained earnings 391,636 344,637
Accumulated other comprehensive income (loss) (12,787) 458
Total stockholders' equity 434,472 395,124
Total liabilities and equity $ 596,549 $ 577,740
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets (Parentheticals) - $ / shares
shares in Thousands
Dec. 31, 2022
Jan. 01, 2022
Statement of Financial Position [Abstract]    
Common stock, par or stated value per share (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 50,000 50,000
Common stock, shares, issued (in shares) 19,206 19,393
Common stock, shares, outstanding (in shares) 19,206 19,393
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Comprehensive Income - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Jan. 02, 2021
Income Statement [Abstract]      
Net sales $ 998,601 $ 1,186,464 $ 1,134,644
Cost of sales 193,890 217,898 209,111
Gross profit 804,711 968,566 925,533
Operating expenses:      
Associate incentives 434,793 519,267 487,856
Selling, general and administrative 262,304 279,107 261,186
Total operating expenses 697,097 798,374 749,042
Earnings from operations 107,614 170,192 176,491
Other income (expense):      
Interest income 3,789 2,515 2,535
Interest expense (192) (57) (507)
Other, net (2,590) (2,008) (571)
Other income (expense), net 1,007 450 1,457
Earnings before income taxes 108,621 170,642 177,948
Income taxes 39,271 54,137 53,284
Net earnings $ 69,350 $ 116,505 $ 124,664
Earnings per common share      
Earnings per share, basic (in dollars per share) $ 3.60 $ 5.78 $ 5.89
Earnings per share, diluted (in dollars per share) $ 3.59 $ 5.73 $ 5.86
Weighted average common shares outstanding      
Basic (in shares) 19,254 20,146 21,156
Diluted (in shares) 19,310 20,343 21,256
Comprehensive income:      
Net earnings $ 69,350 $ 116,505 $ 124,664
Other comprehensive income (loss), net of tax:      
Foreign currency translation adjustment (15,126) 2,203 13,327
Tax benefit (expense) related to foreign currency translation adjustment 1,881 1,880 (3,051)
Other comprehensive income (loss), net of tax (13,245) 4,083 10,276
Comprehensive income $ 56,105 $ 120,588 $ 134,940
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Jan. 02, 2021
Cash flows from operating activities      
Net earnings $ 69,350 $ 116,505 $ 124,664
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities      
Depreciation and amortization 13,393 13,036 13,747
Right-of-use asset amortization 8,017 9,157 8,762
(Gain) loss on sale of property and equipment 141 61 191
Equity-based compensation expense 13,331 14,298 14,394
Deferred income taxes (7,183) (2,970) (2,423)
(Gain) loss on impairment on other assets 0 0 510
Changes in operating assets and liabilities, net of acquisitions:      
Inventories 21,879 (10,501) (16,784)
Prepaid expenses and other assets (3,304) (2,331) (5,192)
Accounts payable (2,656) (4,572) 6,076
Other liabilities (9,066) (11,456) 16,456
Net cash provided by (used in) operating activities 103,902 121,227 160,401
Cash flows from investing activities      
Receipts on notes receivable 0 116 281
Proceeds from the settlement of net investment hedges 4,555 0 1,935
Payments for net investment hedge 0 (1,555) (1,089)
Payments for investment in equity securities 0 0 (20,000)
Payments to acquire businesses (6,532) 0 0
Proceeds from sale of property and equipment 7 15 6
Purchases of property and equipment (10,400) (12,763) (15,094)
Net cash provided by (used in) investing activities (12,370) (14,187) (33,961)
Cash flows from financing activities      
Repurchase of common stock (25,382) (177,837) (57,029)
Borrowings on line of credit 11,000 0 60,000
Payments on line of credit (11,000) 0 (60,000)
Payments related to tax withholding for net-share settled equity awards (4,706) (3,575) (2,367)
Payments for debt issuance costs 0 0 (46)
Net cash provided by (used in) financing activities (30,088) (181,412) (59,442)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (13,777) 2,088 11,251
Net increase (decrease) in cash, cash equivalents, and restricted cash 47,667 (72,284) 78,249
Cash, cash equivalents, and restricted cash at beginning of period 243,653 315,937 237,688
Cash, cash equivalents, and restricted cash at end of period 291,320 243,653 315,937
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets      
Cash and cash equivalents 288,420 239,832 311,917
Total cash, cash equivalents, and restricted cash 291,320 243,653 315,937
Cash paid during the period for:      
Interest 49 10 711
Income taxes 45,863 59,524 53,015
Cash received during the period for:      
Income tax refund 113 191 847
Non-cash investing and financing activities:      
Right-of-use assets obtained in exchange for lease obligations 5,641 5,322 6,632
Non-cash change in right-of-use assets 0 0 (3,182)
Accrued purchases of property and equipment 679 383 375
Contingent consideration given to acquire assets 886 0 0
Prepaid Expenses and Other Current Assets      
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets      
Restricted cash 0 0 958
Other Noncurrent Assets      
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets      
Restricted cash $ 2,900 $ 3,821 $ 3,062
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 28, 2019   21,655      
Beginning balance at Dec. 28, 2019 $ 351,712 $ 22 $ 59,445 $ 306,146 $ (13,901)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings 124,664 124,664
Other comprehensive income (loss), net of tax 10,276 10,276
Equity-based compensation expense $ 14,394 14,394
Common stock repurchased and retired (in shares) (785) (785)      
Common stock repurchased and retired $ (57,029) $ (1) (9,012) (48,016)
Common stock issued under entity award plans (in shares)   168      
Common stock issued under equity award plans 0 $ 0
Tax withholding for net-share settled equity awards (2,367) (2,367)
Ending balance (in shares) at Jan. 02, 2021   21,038      
Ending balance at Jan. 02, 2021 441,650 $ 21 62,460 382,794 (3,625)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings 116,505 116,505
Other comprehensive income (loss), net of tax 4,083 4,083
Equity-based compensation expense $ 14,298 14,298
Common stock repurchased and retired (in shares) (1,844) (1,844)      
Common stock repurchased and retired $ (177,837) $ (2) (23,173) (154,662)
Common stock issued under entity award plans (in shares)   199      
Common stock issued under equity award plans 0 $ 0
Tax withholding for net-share settled equity awards $ (3,575) (3,575)
Ending balance (in shares) at Jan. 01, 2022 19,393 19,393      
Ending balance at Jan. 01, 2022 $ 395,124 $ 19 50,010 344,637 458
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings 69,350 69,350
Other comprehensive income (loss), net of tax (13,245) (13,245)
Equity-based compensation expense $ 13,331 13,331
Common stock repurchased and retired (in shares) (288) (288)      
Common stock repurchased and retired $ (25,382) $ 0 (3,031) (22,351)
Common stock issued under entity award plans (in shares)   101      
Common stock issued under equity award plans 0 $ 0
Tax withholding for net-share settled equity awards $ (4,706) (4,706)
Ending balance (in shares) at Dec. 31, 2022 19,206 19,206      
Ending balance at Dec. 31, 2022 $ 434,472 $ 19 $ 55,604 $ 391,636 $ (12,787)
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
COVID-19
The COVID-19 pandemic, including the spread of new variants of the virus, has negatively impacted our business in various markets around the world. The ongoing COVID-19 pandemic has created an unpredictable operating environment for us in many of our markets around the world and caused meaningful disruptions in both sales and operations for fiscal 2022, 2021, and 2020. At this time, the Company is unable to predict the impact that COVID-19 will have on its business, financial position and operating results in future periods due to numerous uncertainties and is closely monitoring the impact of the pandemic on all aspects of its business.
The Company
USANA Health Sciences, Inc. is a global direct-selling, personal health and wellness company that develops and manufactures high quality, science-based nutritional and personal care products.
The Consolidated Financial Statements (the “Financial Statements”) include the accounts and operations of the Company, which are grouped and presented in two geographic regions: (1) Asia Pacific and (2) Americas and Europe. Asia Pacific is further divided into three sub-regions: (i) Greater China, (ii) Southeast Asia Pacific, and (iii) North Asia.
Asia Pacific
(1)Asia Pacific is organized into three sub-regions: Greater China, Southeast Asia Pacific, and North Asia. Markets included in each of these sub-regions are as follows:
(i)Greater China - Hong Kong, Taiwan, and China. Our business in China is conducted by BabyCare
(ii)Southeast Asia Pacific – Australia, New Zealand, Singapore, Malaysia, the Philippines, Thailand, and Indonesia
(iii)North Asia – Japan and South Korea
Americas and Europe
(2)Americas and Europe – United States, Canada, Mexico, Colombia, and Europe (the United Kingdom, France, Germany, Spain, Italy, Romania, Belgium, and the Netherlands)
Principles of Consolidation and Basis of Presentation
The accompanying Consolidated Financial Statements include the accounts and operations of the Company. All inter-company accounts and transactions have been eliminated in consolidation. The accounting and reporting policies of the Company conform with accounting principles generally accepted in the United States of America (“US GAAP”).
Use of Estimates
The preparation of Consolidated Financial Statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. These estimates may be adjusted as more current information becomes available, and any adjustment could be significant.
Fiscal Year
The Company operates on a 52/53-week year, ending on the Saturday closest to December 31. Fiscal years 2022 and 2021 were 52-week years. Fiscal year 2020 was a 53-week year. Fiscal year 2022 covered the period January 2, 2022
to December 31, 2022 (hereinafter 2022). Fiscal year 2021 covered the period January 3, 2021 to January 1, 2022 (hereinafter 2021). Fiscal year 2020 covered the period December 29, 2019 to January 2, 2021 (hereinafter 2020).
Fair Value Measurements
The Company measures at fair value certain of its financial and non-financial assets and liabilities by using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price, based on the highest and best use of the asset or liability. The levels of the fair value hierarchy are:
•Level 1 inputs are quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date.
•Level 2 inputs are from other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly.
•Level 3 inputs are unobservable and are used to measure fair value in situations where there is little, if any, market activity for the asset or liability at the measurement date.
As of December 31, 2022 and January 1, 2022, the following financial assets and liabilities were measured at fair value on a recurring basis using the type of inputs shown:
December 31,
2022		Fair Value Measurements Using
Inputs
Level 1Level 2Level 3
Money market funds included in cash equivalents$211,539 $211,539 $— $— 
Foreign currency contracts included in other current liabilities(3,150)— (3,150)— 
Deferred compensation liabilities
(1,632)— (1,632)— 
Contingent consideration included in other current liabilities of $(338) and other long-term liabilities of $(548)
(886)— — (886)
$205,871 $211,539 $(4,782)$(886)
January 1,
2022		Fair Value Measurements Using
Inputs
Level 1Level 2Level 3
Money market funds included in cash equivalents$163,619 $163,619 $— $— 
Foreign currency contracts included in other current liabilities(461)— (461)— 
$163,158 $163,619 $(461)$— 
There were no transfers of financial assets or liabilities between levels of the fair value hierarchy for the periods indicated.
The majority of the Company’s non-financial assets, which include long-lived assets, are not required to be carried at fair value on a recurring basis. However, if an impairment charge is required, a non-financial asset would be written down to fair value. As of December 31, 2022 and January 1, 2022, there were no non-financial assets measured at fair value on a non-recurring basis.
Fair Value of Financial Instruments
As of December 31, 2022 and January 1, 2022, the Company’s financial instruments include cash equivalents, restricted cash, other liabilities, and foreign currency contracts. The recorded values of cash equivalents and restricted cash approximate their fair values, based on their short-term nature.
Translation of Foreign Currencies
The functional currency of the Company’s foreign subsidiaries is the local currency of their country of domicile. Assets and liabilities of the foreign subsidiaries are translated into U.S. dollar amounts at month-end exchange rates. Revenue and expense accounts are translated at the weighted-average rates for the monthly accounting period to which they relate. Equity accounts are translated at historical rates. Foreign currency translation adjustments are accumulated as a component of other comprehensive income. Gains and losses from foreign currency transactions are included in the “Other, net” component of Other income (expense) in the Company’s consolidated statements of comprehensive income.
Business Combinations
The Company allocates the purchase price consideration of the assets acquired and liabilities assumed based on the acquisition date fair values. Additionally, the Company records goodwill for the excess of the total consideration given for the acquired business over the fair value of the identifiable net assets of the acquired business. Transaction costs attributable to the acquisition are expensed as incurred.
Cash and Cash Equivalents
The Company considers all highly liquid investments with an original maturity of three months or less from the date of purchase to be cash equivalents. Cash equivalents as of December 31, 2022 and January 1, 2022 consisted primarily of money market fund investments and amounts receivable from credit card processors.
Amounts receivable from credit card processors and other forms of electronic payment are considered cash equivalents because they are both short-term and highly liquid in nature and are typically converted to cash within three days of the sales transaction. Amounts receivable from credit card processors as of December 31, 2022 and January 1, 2022 totaled $8,904 and $11,123, respectively.
Restricted Cash
The Company is required to maintain cash deposits with banks in certain subsidiary locations for various operating purposes. The most significant of these cash deposits relates to a deposit held at a bank in China, the balance of which was $2,900 as of December 31, 2022, and $3,146 as of January 1, 2022. This deposit is required for the application of direct sales licenses by the Ministry of Commerce and the State Administration of Market Regulation (“SAMR”) of the People’s Republic of China, and will continue to be restricted during the periods while the Company holds these licenses.
Inventories
Inventories are stated at the lower of cost or net realizable value. Cost is determined using a standard costing system, which approximates the first-in, first-out method. The components of inventory cost include raw materials, labor, and overhead. Net realizable value is determined using various assumptions with regard to excess or slow-moving inventories, non-conforming inventories, expiration dates, current and future product demand, production planning, and market conditions. A change in any of these variables could result in an adjustment to inventory.

Noncurrent inventory are inventories not expected to be sold within the normal operating cycle. The Company has defined the operating cycle as 52-weeks. Noncurrent inventory is classified in the "Other assets" line item in the Company's consolidated balance sheets.
Accounts Receivable
Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company maintains an allowance for doubtful accounts for estimated losses inherent in its accounts receivable portfolio. In establishing the
required allowance, management considers historical losses adjusted to take into account current market conditions and our customers’ financial condition, the amount of receivables in dispute, and the current receivables aging and current payment patterns. The Company reviews its allowance for doubtful accounts regularly. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Accounts Receivable is included in the “Prepaid expenses and other current assets” line item in the Company’s consolidated balance sheets.
Income Taxes
The Company accounts for income taxes using the asset and liability method, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of the differences between the financial statement assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates that are expected to apply to taxable income in the year in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax law is recognized in income in the period that includes the enactment date. Deferred tax expense or benefit is the result of changes in deferred tax assets and liabilities.
The Company evaluates the probability of realizing the future benefits of its deferred tax assets and provides a valuation allowance for the portion of any deferred tax assets where the likelihood of realizing an income tax benefit in the future does not meet the “more-likely-than-not” criteria for recognition. The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the Financial Statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. The Company recognizes interest and penalties related to unrecognized tax benefits in income taxes.
Property and Equipment
Property and equipment are recorded at cost. Maintenance, repairs, and renewals, which neither materially add to the value of the property nor appreciably prolong its life, are charged to expense as incurred. Depreciation is provided in amounts sufficient to relate the cost of depreciable assets to operations over the estimated useful lives of the related assets. The straight-line method of depreciation and amortization is followed for financial statement purposes. Leasehold improvements are amortized over the shorter of the life of the respective lease or the useful life of the improvements. Property and equipment are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When property and equipment are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period.
Leases
With the exception of the Company’s headquarters in Salt Lake City, Utah, and its facilities in New South Wales, Australia, and in Beijing and Tianjin, China, the Company leases its facilities. Each of the facility lease agreements is a non-cancelable operating lease generally structured with renewal options and expires prior to or during 2027. In connection with the production facilities in Beijing and Tianjin, China, the Company has prepaid land use rights, which represents a lease with the associated prepayment recorded as a Right-of-Use (“ROU”) asset. The Company also utilizes equipment under non-cancelable operating leases, expiring through 2026.
At contract inception, the Company determines whether an arrangement is or contains a lease and whether the lease should be classified as an operating or a financing lease. A contract is or contains a lease if the contract conveys the right to control the use of the identified asset for a period of time in exchange for consideration. Control is determined based on the right to obtain all of the economic benefits from use of the identified asset and the right to direct the use of the identified asset. ROU assets for operating leases represent the right to use an underlying asset for the lease term, and operating lease liabilities represent the obligation to make lease payments.
Lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date for leases exceeding 12 months. Minimum lease payments include only the fixed lease component of the agreement, as well as any variable rate payments that depend on an index, initially measured using the
index at the lease commencement date. Non-lease components are accounted for separately from the fixed lease component for all leases. Most of the Company’s leases do not provide an implicit rate that can readily be determined. Therefore, the applied discount rate is based on the Company’s incremental borrowing rate, which is determined using its credit rating and other information available as of the commencement date and is the rate of interest it would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. Lease terms may include options to renew, which the Company factors into the determination of the lease term when it is reasonably certain that the Company will exercise that option. The ROU asset is measured at the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received.
Operating lease expense is recognized on a straight-line basis over the lease term and is included in “Cost of sales” and “Selling, general and administrative” line items in the Company’s consolidated statements of comprehensive income. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases is recognized on a straight-line basis over the lease term.
The Company monitors for events or changes in circumstances that require a reassessment of its leases. When a reassessment results in the remeasurement of a lease liability, a corresponding adjustment is made to the carrying amount of the ROU asset unless doing so would reduce the ROU asset to an amount less than zero, in which case the remaining adjustment would be recorded in the consolidated statements of comprehensive income.
Goodwill
Goodwill represents the excess of the purchase price over the fair market value of identifiable net assets of acquired companies. Goodwill is not amortized, but rather is tested at the reporting unit level at least annually for impairment or more frequently if triggering events or changes in circumstances indicate impairment. Initially, qualitative factors are considered to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Some of these qualitative factors may include macroeconomic conditions, industry and market considerations, a change in financial performance, entity-specific events, a sustained decrease in share price, and consideration of the difference between the fair value and carrying amount of a reporting unit as determined in the most recent quantitative assessment. If, through this qualitative assessment, the conclusion is made that it is more likely than not that a reporting unit’s fair value is less than its carrying amount, a quantitative impairment analysis is performed. This analysis involves estimating the fair value of a reporting unit using widely accepted valuation methodologies including the income and market approaches, which requires the use of estimates and assumptions. These estimates and assumptions include revenue growth rates, discount rates, and determination of appropriate market comparables. If the fair value of the reporting unit is less than its carrying amount, an impairment loss is recognized in an amount equal to the excess of the carrying amount over the fair value of the reporting unit, not to exceed the carrying amount of the goodwill. During 2022, 2021, and 2020, no impairment of goodwill was recorded.
Intangible Assets
Intangible assets represent amortized and indefinite-lived intangible assets primarily acquired in connection with business combinations. Amortized intangible assets are amortized over their related useful lives, using a straight-line or accelerated method consistent with the underlying expected future cash flows related to the specific intangible asset. Amortized intangible assets are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When indicators of impairment exist, an estimate of undiscounted net cash flows is used in measuring whether the carrying amount of the asset or related asset group is recoverable. Measurement of the amount of impairment, if any, is based upon the difference between the asset or asset group’s carrying value and fair value. Fair value is determined through various valuation techniques, including market and income approaches as considered necessary.
Indefinite-lived intangible assets are not amortized; however, they are tested at least annually for impairment or more frequently if events or changes in circumstances exist that may indicate impairment. Initially, qualitative factors are considered to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. If, through this qualitative assessment, the conclusion is made that it is more likely than not that an indefinite-lived intangible asset’s fair value is less than its carrying amount, a quantitative impairment analysis is performed by comparing the indefinite-lived intangible asset’s carrying amount to its fair value. The fair value for
indefinite-lived intangible assets is determined through various valuation techniques, including market and income approaches as considered necessary. The amount of any impairment is measured as the difference between the carrying amount and the fair value of the impaired asset. During 2022, 2021, and 2020, no impairment of indefinite-lived intangible assets was recorded.
Investment in Equity Securities
Equity securities (“securities”) without readily determinable fair value that are not eligible to be measured in accordance with the net asset value practical expedient qualify for an election to initially estimate fair value using the measurement alternative at its cost. During 2020, the Company entered into a strategic collaboration and made a minority investment in a privately held company, which totaled $20,000 and is included in the “Other assets” line item on the Company’s consolidated balance sheets. The Company, at the time of the investment, elected to apply the measurement alternative, which may be applied to an equity interest on an instrument-by-instrument basis. Dividends received are reported in earnings.
The initial value of the securities are remeasured to fair value if the securities are impaired or if observable price changes occur. These events are continually monitored and assessed at each reporting period. If a readily determinable fair value becomes available for the securities or observable price changes for the identical or a similar investment of the same issuer occur, the securities are measured at fair value as of the date the observable change occurred. Any resulting gains or losses on the securities for which the observable price changes occur will be recorded in net earnings. During 2022 and 2021, no such observable price changes occurred.
At each reporting period a qualitative assessment is made to consider impairment indicators to determine whether the securities are impaired. Impairment indicators may include but are not limited to earnings performance, business prospects by the investee, cash flows from operations, working capital, and noncompliance with debt covenants. If this qualitative assessment indicates impairment, fair value is determined and an impairment loss equal to the difference between the fair value of the investment and its carrying amount is recognized in net income. During 2022 and 2021, no impairment of securities was recorded.
Nonqualified Deferred Compensation
In 2021, the Company created a non-qualified deferred compensation plan for a select group of management and highly compensated individuals. The plan permits the deferral of up to 50% of a participant's base salary and/or 80% of a participant's annual incentive bonus. The deferrals are held in an irrevocable rabbi trust (the "Rabbi Trust"), which has been established to administer the plan. The Rabbi Trust is intended to be used as a source of funds to match respective funding obligations to participants. The assets of the trust are subject to the claims of the Company's creditors in the event that the Company becomes insolvent. Consequently, the Rabbi Trust qualifies as a grantor trust for income tax purposes. The Company makes periodic payments into company-owned life insurance policies held in this Rabbi trust to fund the expected obligations arising under this plan. There are no contractual restrictions on the Company's ability to surrender a policy. The assets and liabilities of the plan are included in "Other assets" and "Other long-term liabilities" respectively in the Consolidated Balance Sheets. Changes in the deferred compensation balances are recorded to compensation expense and reflected within the "Selling, general and administrative" line in the Consolidated Statements of Comprehensive Income. As of December 31, 2022 and January 1, 2022, the trustee held total assets of $1,622 and $382, and deferred compensation liabilities of $1,632, and, $390, respectively.
Self-Insurance
The Company is self-insured, up to certain limits, for employee group health claims. The Company has purchased stop-loss insurance on both an individual and an aggregate basis, which will reimburse the Company for individual claims in excess of $175 and aggregate claims that are greater than $13,515. A liability is accrued for all unpaid claims. Total expense under this self-insurance program was $13,413, $12,349, and $11,798 in 2022, 2021, and 2020, respectively.
Derivative Financial Instruments
The Company’s risk management strategy includes the select use of derivative instruments to reduce the effects of volatility in foreign currency exchange exposure on operating results and cash flows. In accordance with the Company’s
risk management policies, the Company does not hold or issue derivative instruments for trading or speculative purposes. The Company recognizes all derivative instruments as either assets or liabilities in the balance sheet at their respective fair values. When the Company becomes a party to a derivative instrument and intends to apply hedge accounting, the Company formally documents the hedge relationship and the risk management objective for undertaking the hedge, the nature of risk being hedged, and the hedged transaction, which includes designating the instrument for financial reporting purposes as a fair value hedge, a cash flow hedge, or a net investment hedge. The Company also documents how the hedging instrument’s effectiveness in offsetting the hedged risk will be assessed prospectively and retrospectively, and a description of the method used to measure ineffectiveness.
The Company periodically uses derivative instruments to hedge the foreign currency exposure of its net investment in foreign subsidiaries into U.S. dollars. Initially, the Company records derivative assets on a gross basis in its consolidated balance sheets. Subsequently the fair value of derivatives is measured for each reporting period. The effective portion of gains and losses attributable to these net investment hedges is recorded to foreign currency translation adjustment (“FCTA”) within accumulated other comprehensive income (loss) (“AOCI”) to offset the change in the carrying value of the net investment being hedged, and will subsequently be reclassified to net earnings in the period in which the hedged investment is either sold or substantially liquidated.
During 2022, the Company settled a forward contract with a notional amount of $98,930. During 2021 and 2020, the Company settled European options with notional amounts of $98,684 and $90,000, respectively. Both the forward contract and the European options were designated as net investment hedges. The Company realized a gain of $4,555 and $846 in 2022 and 2020, respectively, and realized a loss of $1,555 in 2021, recorded to FCTA within AOCI. The Company assessed hedge effectiveness under the forward rate method, determining the hedging instruments were highly effective. As of December 31, 2022 and January 1, 2022, there were no derivatives outstanding for which the Company has applied hedge accounting.
Subsequent to December 31, 2022, on January 18, 2023 the Company entered into an option contract designated as a net investment hedge with a notional amount of $81,343.
Common Stock Share Repurchases
The Company has a stock repurchase plan in place that has been authorized by the Board of Directors. As of December 31, 2022, $82,839 is available to repurchase shares under this plan. The excess of the repurchase price over par value is allocated between additional paid-in capital and retained earnings on a pro-rata basis. There currently is no expiration date on the remaining approved repurchase amount and no requirement for future share repurchases.
Revenue Recognition
Revenue is recognized when, or as, control of a promised product or service transfers to a customer, in an amount that reflects the consideration to which the Company expects to be entitled in exchange for transferring those products or services. Revenue excludes taxes that have been assessed by governmental authorities and that are directly imposed on revenue-producing transactions between the Company and its customers, including sales, use, value-added, and some excise taxes. Revenue recognition is evaluated through the following five-step process:
1)identification of the contract with a customer;
2)identification of the performance obligations in the contract;
3)determination of the transaction price;
4)allocation of the transaction price to the performance obligations in the contract; and
5)recognition of revenue when or as a performance obligation is satisfied.
Product Revenue
A majority of the Company’s sales are for products sold at a point in time and shipped to customers, for which control is transferred to the customer as goods are delivered to the third party carrier for shipment. The Company receives payment, primarily via credit card, for the sale of products at the time customers place orders and payment is required prior to shipment. The Company does not recognize assets associated with costs to obtain or fulfill a contract with a customer.
The Company’s product sales contracts include terms that could cause variability in the transaction price for items such as discounts, product promotions, credits, or sales returns, which are a reduction of revenue. Accordingly, the transaction price for product sales includes estimates of variable consideration to the extent it is probable that a significant reversal of revenue recognized will not occur. At the time of sale, the Company estimates a refund liability for the variable consideration based on historical experience, which is recorded within the “Other current liabilities” line item in the consolidated balance sheets.
Initial product orders with a new customer may include multiple performance obligations related to sales discounts earned under the Company’s initial order reward program. Under this program, the customer receives an option to apply the discounts earned on the initial order to two subsequent Auto Orders, which conveys a material right to the customer. As such, the initial order transaction price is allocated to each separate performance obligation based on its relative standalone selling price and is recognized as revenue as each performance obligation is satisfied.
Associate incentives represent consideration paid to an Associate for distinct services provided in the sale of the Company's products and include all forms of commissions, and other incentives paid to our Associates. The Company may provide Associate incentive promotions which are earned by Associates for distinct services rendered. Associate incentive promotions are recorded as the incentives are earned by the Associates. With the exception of commissions paid to Associates on personal purchases, which are considered a sales discount and are reported as a reduction to net sales, Associate incentives are recorded as an operating expense. The amounts paid to Associates are commensurate with the fair value received for the distinct services rendered by Associates and are recorded as an operating expense when revenue for the goods is recognized.
Shipping and handling activities are performed upon delivery to the third party carrier for shipment. The Company accounts for these activities as fulfillment costs. Therefore, the Company recognizes the costs of these activities when revenue for the goods is recognized. Shipping and handling costs are included in cost of sales for all periods presented.
With respect to will-call orders, the Company periodically assesses the likelihood that customers will exercise their contractual right to pick up orders and revenue is recognized when the likelihood that customers will pick up orders is remote.
Other Revenue
Other types of revenue include fees, which are paid by the customer at the beginning of the service period, for access to online customer service applications and annual account renewal fees for Associates, for which control is transferred over time as services are delivered and are recognized as revenue on a straight-line basis over the term of the respective contracts.
The following table presents Other Revenue for the periods indicated:
Year Ended
202220212020
Other Revenue$3,452 $3,825 $3,805 
Revenue Disaggregation
Disaggregation of revenue by geographical region and major product line is included in Note M – Segment Information.
Contract Balances
When the timing of our provision of goods or services is different from the timing of the payments made by our customers, we recognize either a contract asset (performance precedes contractual due date) or a contract liability (customer payment precedes performance).
Contract liabilities relate to deferred revenue for product sales for customer payments received in advance of shipment, for outstanding material rights under the initial order program, and for services where the performance obligations are satisfied over time as services are delivered. Contract liabilities are recorded as deferred revenue within the "Other current liabilities" line item in the consolidated balance sheets. The Company typically does not have contract assets based on the payment terms included in the Company’s contracts and the balance of contract assets was $0 at December 31, 2022 and January 1, 2022.
The following table provides information about contract liabilities from contracts with customers, including significant changes in the contract liabilities balances during the period.
December 31,
2022		January 1,
2022
Contract liabilities at beginning of period$19,635 $15,952 
Increase due to deferral of revenue at period end20,875 19,635 
Decrease due to beginning contract liabilities recognized as revenue(19,635)(15,952)
Contract liabilities at end of period$20,875 $19,635 
Product Return Policy
All product orders that are unused and returned within the first 30 days following purchase are refunded at 100% of the sales price. All product orders that are unused and resalable are refunded up to one year from the date of purchase at 100% of the sales price. This standard policy differs in a few of our international markets due to the regulatory environment in those markets. Depending upon the conditions under which product was returned, customers may either receive a refund based on their original form of payment, or credit on account for a product exchange. The Company monitors Associate activity to ensure that all such practices are in line with established Company policies. Product returns totaled approximately 0.7%, 0.6%, and 0.7% of net sales in 2022, 2021, and 2020, respectively.
Associate Incentives
Associate incentives expenses include all forms of commissions, and other incentives paid to our Associates, less commissions paid to Associates on personal purchases, which are considered a sales discount and are reported as a reduction to net sales.
Selling, General and Administrative
Selling, general and administrative expenses include wages and benefits, depreciation and amortization, rents and utilities, Associate event costs, advertising and professional fees, marketing, and research and development expenses.
Equity-Based Compensation
The Company records compensation expense in the Financial Statements for equity-based awards based on the grant date fair value, which for restricted stock units is the closing market value of the Company’s common stock on the date of the grant. The grant date fair value of each stock-settled stock appreciation right is based upon the Black-Scholes option pricing model. Equity-based compensation expense is recognized under the straight-line method over the period that service is provided, which is generally the vesting term. Further information regarding equity awards can be found in Note L – Equity-Based Compensation.
Advertising
Advertising costs are charged to expense as incurred and are presented as part of the “Selling, general and administrative” line item. Advertising expense totaled $5,053, $12,399, and $9,853, in 2022, 2021, and 2020, respectively.
Research and Development
Research and development costs are charged to expense as incurred and are presented as part of the “Selling, general and administrative” line item. Research and development expense totaled $11,563, $11,112, and $10,633 in 2022, 2021, and 2020, respectively.
Earnings Per Share
Basic earnings per common share ("EPS") are based on the weighted-average number of common shares that were outstanding during each period. Diluted EPS include the effect of potentially dilutive common shares calculated using the treasury stock method, which include in-the-money, equity-based awards that have been granted but have not been issued. When there is a loss, potential common shares are not included in the computation of diluted EPS, because to do so would be anti-dilutive.
Recent Accounting Pronouncements
Issued Accounting Pronouncements Not Yet Adopted
In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. ASU 2021-08 requires an acquirer to recognize and measure contract assets and contract liabilities (deferred revenue) acquired in a business combination in accordance with Revenue from Contracts with Customers (Topic 606). Under this approach, the acquirer applies the revenue model as if it had originated the contracts. This is a departure from the current requirement to measure contract assets and contract liabilities at fair value at the acquisition date. ASU 2021-08 is effective for annual periods beginning after December 15, 2022 and interim periods within those annual periods. ASU 2021-08 should be applied prospectively to business combinations occurring on or after the date of adoption. Evaluation of this new standard is dependent on multiple circumstances including the timing and complexity of completed business combinations. As a result, the Company intends to adopt the provisions of ASU 2021-08 in the first quarter of 2023.
No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements
XML 21 R8.htm IDEA: XBRL DOCUMENT v3.22.4
Business Combinations
 12 Months Ended
Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]  
Business Combinations BUSINESS COMBINATIONS
During the second quarter, the Company acquired assets in business combinations for an aggregate purchase consideration of $6,532 in cash and $886 in contingent consideration. The preliminary purchase price allocations were $964 to tangible assets, $6,065 to intangible assets, and $389 to goodwill. The primary reasons for the business combinations are to augment and expand the Company's core competencies. The amount of revenue and earnings related to the business combinations since the acquisition date is immaterial.
Subsequent to the acquisition date, the Company made certain measurement period adjustments to the preliminary purchase price allocation, which resulted in an increase to goodwill of $193. The increase was due to a $105 decrease of certain tangible assets acquired, an increase to assumed liabilities of $147, and a $59 decrease in the aggregate consideration in connection with post close net working capital adjustments that were finalized in the fourth quarter of 2022.
The contingent consideration liability is based on the achievement of certain milestones over a three-year period. Under the terms of the purchase agreement, the contingent consideration consists of three earn-out periods capped at $500 per earn-out period. The maximum earn-out is $1,500 per the asset purchase agreement. As of the acquisition date, the contingent consideration had a fair value of $886. The estimated fair value of the contingent consideration liability as of the date of acquisition was determined using an option pricing method based upon available information and certain assumptions known and contains key inputs that are unobservable in the market, which represents a Level 3 measurement within the fair value hierarchy. Contingent consideration is included in Fair Value Measures above.
Pro forma results of operations have not been presented because the effects of the acquisitions were not material to the Company’s Consolidated Financial Statements.
XML 22 R9.htm IDEA: XBRL DOCUMENT v3.22.4
Inventories
 12 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
Inventories INVENTORIES
December 31,
2022		January 1,
2022
Raw materials$21,776 $30,280 
Work in progress4,285 9,586 
Finished goods41,028 58,452 
$67,089 $98,318 
Noncurrent inventories$3,479 $— 
Noncurrent inventory consists of $1,711 of raw materials and $1,768 of finished goods inventory and is included in the “Other assets” line item on the Company’s Consolidated Balance Sheets.
XML 23 R10.htm IDEA: XBRL DOCUMENT v3.22.4
Prepaid Expenses and Other Current Assets
 12 Months Ended
Dec. 31, 2022
Prepaid Expense and Other Assets, Current [Abstract]  
Prepaid Expenses And Other Current Assets PREPAID EXPENSES AND OTHER CURRENT ASSETS
Prepaid expenses and other current assets consists of the following:
December 31,
2022		January 1,
2022
Prepaid insurance$2,293 $3,734 
Other prepaid expenses9,089 10,119 
Income taxes receivable2,030 1,579 
Miscellaneous receivables, net5,183 5,584 
Deferred commissions3,157 2,270 
Other current assets7,121 3,681 
$28,873 $26,967 
XML 24 R11.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Income Taxes
Consolidated earnings before income taxes consists of the following for 2022, 2021, and 2020:
Year Ended
202220212020
U.S.$(23,996)$13,017 $18,838 
Foreign132,617 157,625 159,110 
Total earnings before income taxes$108,621 $170,642 $177,948 
Income tax expense (benefit) included in income from continuing operations consists of the following:
Year Ended
202220212020
Current
Federal$42 $(264)$306 
State297 567 303 
Foreign45,869 56,668 55,147 
Total Current46,208 56,971 55,756 
Deferred
Federal(9,180)(4,088)1,317 
State(331)(40)(47)
Foreign2,574 1,294 (3,742)
Total Deferred(6,937)(2,834)(2,472)
$39,271 $54,137 $53,284 
The effective tax rate for 2022, 2021, and 2020 reconciled to the statutory U.S. Federal tax rate is as follows:
Year Ended
202220212020
Statutory U.S. federal income tax rate21.0 %21.0 %21.0 %
State income taxes, net of federal tax benefit0.4 0.4 0.3 
Permanent tax differences0.3 0.1 0.2 
Excess foreign tax credits(16.6)(10.9)(9.9)
Net increase in valuation allowance11.9 10.6 8.2 
Foreign income tax rate differences9.5 1.8 1.7 
Foreign withholding taxes9.7 7.9 7.7 
Uncertain tax position reserve0.5 (0.3)0.8 
All other, net(0.5)1.1 (0.1)
36.2 %31.7 %29.9 %
The effective tax rate for the year ended December 31, 2022 increased compared to the year ended January 1, 2022. The effective tax rate increase is due primarily to a change in the market mix of pre-tax book income.
The significant categories of deferred taxes are as follows:
December 31,
2022		January 1,
2022
Deferred tax assets
Inventory$5,872 $5,106 
Accruals not currently deductible8,627 11,634 
Equity-based compensation expense2,746 2,355 
Property and equipment922 1,143 
Intangible assets6,680 7,545 
Foreign currency translation1,448 — 
Capitalized R&D Expenses9,618 2,337 
Tax credit carry forwards115,539 96,635 
Net operating losses1,720 1,401 
Other3,223 4,824 
Gross deferred tax assets156,395 132,980 
Valuation allowance(118,136)(99,958)
Net deferred tax assets38,259 33,022 
Deferred tax liabilities
Property and equipment(5,723)(5,268)
Foreign currency translation— (126)
Prepaid expenses(2,990)(3,596)
Intangible assets(6,680)(7,545)
Withholding tax on unremitted earnings(11,639)(13,556)
Other(5,499)(5,589)
Gross deferred tax liabilities(32,531)(35,680)
Net deferred taxes$5,728 $(2,658)
The components of net deferred taxes on a jurisdiction basis are as follows:
December 31,
2022		January 1,
2022
Net deferred tax assets$9,799 $4,839 
Net deferred tax liabilities(4,071)(7,497)
Net deferred taxes$5,728 $(2,658)
As of December 31, 2022, the Company had foreign tax credit carryforwards of approximately $111,948. If unused, these carryforwards will expire between 2026 and 2032. The Company has generated excess foreign tax credits since the Tax Cuts and Jobs Act of 2017 was enacted on December 22, 2017. This is due to the U.S. tax rate being lower than most foreign taxing jurisdiction rates where the Company operates. Although the Company can claim foreign tax credits against U.S. source income due to overall domestic losses generated in previous years, the Company does not believe it will be able to use more foreign tax credits than it generates in a single year. The Company believes these foreign tax credit carryforwards will expire unused based on available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, available tax planning strategies, and available carryback opportunities. Similar with prior years, the Company continues to maintain a full valuation allowance on its
foreign tax credit carryforwards. Valuation allowances are determined using a more-likely-than-not realization criteria and are based upon all facts and circumstances.
The Company recorded a $1,390 valuation allowance on mirrored deferred tax assets recorded in the United States, which offset deferred tax liabilities of foreign disregarded entities. These mirrored deferred tax assets represent future foreign tax credits. This valuation allowance is necessary because the Company is limited in its ability to utilize future foreign tax credits due to the U.S. tax rate being lower than most foreign taxing jurisdiction rates where the Company operates.
The Company also had $1,568 of Utah research credit carryforwards, and $2,023 of Federal research credit carryforwards as of December 31, 2022. If unused, the Utah research credit carryforwards expire between 2027 and 2036, and the Federal research credits expire between 2036 and 2042. Utah research credits are limited to Utah tax due and the Company has a history of generating more credits than it can use. Federal research credit carryforwards can only be used in a year when U.S. taxes are owed after foreign tax credits have been applied. Due to the lack of sufficient evidence to the contrary, the Company has placed a full valuation allowance on these credit carryforwards.
In addition, the Company had $5,296 of foreign operating loss carry forwards, $2,808 of which have an unlimited carryforward period. The deferred tax asset associated with these losses was $1,666 and a valuation allowance of $1,174 has been applied against this deferred tax asset. The 2022 deferred tax asset for state-tax-loss carryforwards was $54. If unused, some of the state-tax-loss carryforwards will expire between 2032 and 2041 and others can be carried forward indefinitely.
The total combined valuation allowance was $118,136 as of December 31, 2022. The 2022 valuation allowance represents a $18,178 net increase from 2021. If the Company determines that there is sufficient evidence to remove the valuation allowances addressed above, the valuation allowance will be released and the provision for income taxes will be reduced.
As of December 31, 2022, the cumulative amount of undistributed earnings of the Company’s non-U.S. subsidiaries held for indefinite reinvestment is approximately $4,000. If this amount were repatriated to the United States, the amount of incremental taxes would be approximately $400.
As of December 31, 2022, the Company reported $66 of unrecognized tax benefits in "Other current liabilities" and $1,384 in "Other long-term liabilities" for a combined total of $1,450 in unrecognized tax benefits that would impact the effective tax rate if recognized. This compares to $199 of unrecognized tax benefits in "Other current liabilities" and $809 in "Other long-term liabilities" for a combined total of $1,008 reported as of January 1, 2022.
The following reconciliation provides the changes in unrecognized tax benefits for the years presented:
Year Ended
202220212020
Beginning balance of unrecognized tax benefits$1,008 $1,528 $560 
Increases related to prior year tax positions107 21 775 
Decreases related to prior year tax positions— (330)— 
Increases related to current year tax positions468 424 753 
Decreases for settlements with taxing authorities(133)(635)(560)
Ending balance of unrecognized tax benefits$1,450 $1,008 $1,528 
The Company accounts for interest and penalties associated with unrecognized tax benefits as a component of income tax expense. For the period ended December 31, 2022 and January 1, 2022, the Company reported $201 and $91, respectively, as income tax expense related to interest and penalties. As of December 31, 2022, the Company recorded $64 of "Other current liabilities" and $239 of "Other long-term liabilities" associated with interest and penalties for
unrecognized tax benefits. This compares to $162 of "Other current liabilities" and $63 of "Other long-term liabilities" associated with interest and penalties reported as of January 1, 2022.
The Company files income tax returns in the United States and foreign jurisdictions. In general, the Company's tax filings are subject to examination for years ended on or after December 31, 2018. However, statutes of limitations in some markets may be as long as ten years for transfer pricing related issues.
XML 25 R12.htm IDEA: XBRL DOCUMENT v3.22.4
Property and Equipment
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
Property and Equipment PROPERTY AND EQUIPMENT
Cost of property and equipment and their estimated useful lives is as follows:
YearDecember 31,
2022		January 1,
2022
Buildings39.5$78,071 $80,820 
Laboratory and production equipment
5-7
50,679 47,552 
Air transportation equipment52,952 2,952 
Computer equipment and software
3-5
53,436 53,562 
Furniture and fixtures
3-5
6,198 6,636 
Automobiles
3-5
722 767 
Leasehold improvements
3-5
14,388 15,212 
Land improvements153,271 3,382 
209,717 210,883 
Less accumulated depreciation and amortization124,748 121,590 
84,969 89,293 
Land6,723 6,992 
Deposits and projects in process6,081 5,495 
$97,773 $101,780 
Depreciation of property and equipment was $11,351, $11,661, and $12,242, for the years ended 2022, 2021, and 2020, respectively.
XML 26 R13.htm IDEA: XBRL DOCUMENT v3.22.4
Operating Leases
 12 Months Ended
Dec. 31, 2022
Leases, Operating [Abstract]  
Operating Leases OPERATING LEASES
The following table summarizes the classification of ROU assets and lease liabilities in the Company’s consolidated balance sheet:
LeasesClassificationDecember 31,
2022		January 1,
2022
Assets
ROU operating lease assets, netOther assets$19,997 $23,789 
Total ROU assets$19,997 $23,789 
Liabilities
Current:
Operating lease liabilitiesOther current liabilities$6,892 $7,080 
Noncurrent:
Operating lease liabilitiesOther long-term liabilities7,680 10,215 
Total lease liabilities$14,572 $17,295 
The following table presents supplemental lease information:
Year Ended
20222021
Lease cost
Operating lease cost$8,606 $9,585 
Total lease cost$8,606 $9,585 
Year Ended
20222021
Other information
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases$7,924 $9,506 
ROU assets obtained in exchange for new operating lease liabilities$5,641 $5,322 
Weighted-average remaining lease term—operating leases
2.39 yrs.
2.76 yrs.
Weighted-average discount rate—operating leases3.04 %3.11 %
The following table presents the maturity of the Company’s lease liabilities as of December 31, 2022:
Year ending
2023$7,214 
20245,383 
20251,850 
2026497 
2027120 
Thereafter— 
15,064 
Less: imputed interest(492)
Present value$14,572 
These leases generally provide that property taxes, insurance, and maintenance expenses are the responsibility of the Company. Such expenses are not included in the operating lease amounts outlined in the table above or in the rent expense amounts that follow. The total rent expense was approximately $8,258, $9,830, and $11,199 for the years ended 2022, 2021, and 2020, respectively.
XML 27 R14.htm IDEA: XBRL DOCUMENT v3.22.4
Intangible Assets
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets INTANGIBLE ASSETS
The Company performed its annual goodwill impairment test during the third quarter of 2022. The Company performed a qualitative assessment of each reporting unit and determined that it was not more-likely-than-not that the fair value of any reporting unit was less than its carrying amount. As a result, no impairments of goodwill were recognized in 2022 and 2021.
The Company also performed its annual indefinite-lived intangible asset impairment test during the third quarter of 2022. The Company performed a qualitative assessment of the indefinite-lived intangible assets and determined that it was not more-likely-than-not that the fair value of any indefinite-lived intangible asset was less than the carrying amount. As a result, no impairments of indefinite-lived intangible assets were recognized in 2022 and 2021.
The changes in the carrying amount of goodwill are as follows:
December 31,
2022		January 1,
2022
Balance at beginning of year:
Gross goodwill$17,668 $17,367 
Goodwill as of beginning of year17,668 17,367 
  
Goodwill acquired during the year582 — 
Currency translation adjustment(882)301 
Balance as of end of year
Gross goodwill17,368 17,668 
Goodwill as of end of year$17,368 $17,668 
Intangible assets consist of the following:
As of December 31, 2022
Gross carrying
amount		Accumulated
 amortization		Net carrying
amount		Weighted-average
amortization
period (years)
Amortized intangible assets
Trade name and trademarks$2,285 $(114)$2,171 10
Product formulas8,701 (7,983)718 8
Customer relationships3,313 (414)2,899 4
Non-compete agreements467 (61)406 4
Indefinite-lived intangible assets
Direct sales license26,238 26,238 
   
$41,004 $32,432 
Estimated Amortization Expense: 
 
2023$1,843 
20241,224 
20251,154 
2026692 
2027253 
Thereafter1,028 
 
$6,194 
As of January 1, 2022
Gross carrying
amount		Accumulated
amortization 		Net carrying
amount		Weighted-average
amortization
period (years)
Amortized intangible assets
Trade name and trademarks$4,173 $(4,173)$— 10
Product formulas9,440 (7,462)1,978 8
Indefinite-lived intangible assets
Direct sales license28,464 28,464 
  
$42,077 $30,442 
Aggregate amortization of intangible assets was $1,723, $1,182, and $1,326 for the years ended 2022, 2021, and 2020, respectively.
XML 28 R15.htm IDEA: XBRL DOCUMENT v3.22.4
Other Current Liabilities
 12 Months Ended
Dec. 31, 2022
Other Liabilities Disclosure [Abstract]  
Other Current Liabilities OTHER CURRENT LIABILITIES
Other current liabilities consist of the following:
December 31,
2022		January 1,
2022
Associate incentives$55,688 $53,929 
Accrued employee compensation17,334 32,366 
Deferred revenue20,875 19,635 
Sales taxes11,234 11,330 
Operating lease liabilities6,892 7,080 
Income taxes4,973 5,193 
All other15,788 17,749 
$132,784 $147,282 
XML 29 R16.htm IDEA: XBRL DOCUMENT v3.22.4
Line of Credit
 12 Months Ended
Dec. 31, 2022
Line of Credit Facility [Abstract]  
Line of Credit LINE OF CREDIT
On August 25, 2020, the Company as borrower, and certain of its material subsidiaries as guarantors, entered into the Second Amended and Restated Credit Agreement (the “Credit Agreement”) with Bank of America, N.A. (“Bank of America”) as Administrative Agent, Swingline Lender and Letter of Credit Issuer, and the other lenders party thereto. On August 10, 2022, the Company entered into the Second Amendment to the Second Amended and Restated Credit Agreement ("Restated Credit Agreement"), which replaces the Eurodollar Rate, and LIBOR terms and provisions with the Bloomberg Short-Term Bank Yield Index rate ("BSBY").
The Credit Agreement provides for a revolving credit limit for loans to the Company up to $75,000 (the “Credit Facility”). In addition, at the option of the Company, and subject to certain conditions, the Company may request to increase the aggregate commitment under the Credit Facility up to an additional $200,000.
There was no outstanding debt on the Credit Facility as of December 31, 2022. The obligations of the Company under the Credit Agreement are secured by the pledge of the capital stock of certain subsidiaries of the Company, pursuant to a Security and Pledge Agreement.
Interest on revolving borrowings under the Credit Facility are computed at BSBY, adjusted by features specified in the Credit Agreement. The Credit Agreement covenants require the Company’s rolling four-quarter consolidated EBITDA of $100,000 or greater and its ratio of consolidated funded debt to consolidated EBITDA of equal to or less than 2.0 to 1.0 at the end of each quarter. The Credit Agreement does not include any restrictions on the payment of cash dividends or share repurchases by the Company. Consolidated EBITDA and consolidated funded debt are non-GAAP terms specified in the Credit Agreement.
The Company will be required to pay any balance on this Credit Facility in full at the time of maturity in August 2025.
XML 30 R17.htm IDEA: XBRL DOCUMENT v3.22.4
Commitments and Contingencies
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies COMMITMENTS AND CONTINGENCIES
Unconditional Purchase Obligations
The Company’s unconditional purchase obligations relating to IT-related services and advertising agreements were $7,163 and $6,151, as of December 31, 2022 and January 1, 2022, respectively that are generally paid within one year.
Contingencies
The Company is involved in various lawsuits, claims, and other legal matters from time to time that arise in the ordinary course of conducting business, including matters involving its products, intellectual property, supplier relationships, distributors, competitor relationships, employees and other matters. The Company records a liability when a particular contingency is probable and estimable. The Company faces contingencies that are reasonably possible to occur; however, they cannot currently be estimated. While complete assurance cannot be given as to the outcome of these proceedings, management does not currently believe that any of these matters, individually or in the aggregate, will have a material adverse effect on the Company’s financial condition, liquidity or results of operations. It is reasonably possible that a change in the contingencies could result in a change in the amount recorded by the Company in the future.
Employee Benefit Plan
In the United States, the Company sponsors an employee benefit plan under Section 401(k) of the Internal Revenue Code. This plan covers employees who are at least 18 years of age and have met a one-month service requirement. The Company makes a matching contribution equal to 100 percent of the first one percent of a participant’s compensation that is contributed by the participant, and 50 percent of that deferral that exceeds one percent of the participant’s compensation, not to exceed six percent of the participant’s compensation, subject to the limits of ERISA. In addition, the Company may make a discretionary contribution based on earnings. The Company’s matching contributions cliff vest at two years of service. Contributions made by the Company to the plan in the United States were $2,589, $2,509, and $2,322 for the years ended 2022, 2021, and 2020, respectively.
The Company has employees in international countries that are covered by various defined contribution plans. These plans are administered based upon the legal requirements in the countries in which they are established.
XML 31 R18.htm IDEA: XBRL DOCUMENT v3.22.4
Equity-Based Compensation
 12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Equity-Based Compensation EQUITY-BASED COMPENSATION
Total equity-based compensation expense was $13,485, $14,706, and $14,633 for fiscal years 2022, 2021, and 2020, of which, $154, $408, and $239, was related to liability-classified awards, respectively. The related tax benefit for these periods was $2,556, $2,813, and $2,472, respectively.
The following table shows the remaining unrecognized compensation expense on a pre-tax basis for all types of unvested equity awards outstanding as of December 31, 2022. This table does not include an estimate for future grants that may be issued.
2023$11,273 
20247,781 
20254,117 
2026408 
$23,579 
The remaining unrecognized compensation expense above is expected to be recognized over a weighted-average period of 1.7 years.
The Company's 2015 Equity Incentive Award Plan (the "2015 Plan") is currently the only plan under which equity awards are issued. The 2015 Plan allows for the grant of various equity awards including stock-settled stock
appreciation rights, stock options, restricted stock units, deferred stock units, and other types of equity-based awards to the Company’s officers, key employees, and non-employee directors.
Since the inception of the 2015 Plan, 1,750 shares have been authorized. As of December 31, 2022, 3,877 awards had been granted under the 2015 Plan, of which 2,924 were stock-settled stock appreciation rights, and 953 were restricted stock awards. Also, as of December 31, 2022, a total of 1,088 options and grants had been forfeited, of which 59 awards have been added back to the number of shares available for issuance under the 2015 Plan.
Stock-Settled Stock Appreciation Rights
The Company uses the Black-Scholes option pricing model to estimate the fair value of its stock-settled stock appreciation rights. There were no stock-settled stock appreciation rights granted in 2022. The weighted-average fair value of stock-settled stock appreciation rights granted in 2021 and 2020 was $27.12 and $17.65, respectively.
Stock-settled stock appreciation rights granted to officers and key employees upon hire or promotion to such a position, or annually for existing participants, generally vest 25% each year on the anniversary of the grant date and expire 4.5 years from the date of grant.
Following is a table that includes the weighted-average assumptions that the Company used to calculate fair value of stock-settled stock appreciation rights that were granted during the periods indicated.
Year Ended
202220212020
Expected volatility (1)N/A43.28 %35.23 %
Risk-free interest rate (2)N/A0.33 %1.66 %
Expected life (3)N/A
3.5 yrs
3.5 yrs.
Expected dividend yield (4)N/A0.00 %0.00 %
Weighted-average exercise price (5)N/A$85.19 $63.02 
(1)The Company utilizes historical volatility of the trading price of its common stock.
(2)Risk-free interest rate is based on the U.S. Treasury yield curve with respect to the expected life of the award.
(3)Depending upon the terms of the award, one of two methods will be used to calculate expected life:
(i)a weighted-average that includes historical settlement data of the Company’s equity awards and a hypothetical holding period, or (ii) the simplified method.
(4)The Company historically has not paid and currently has no plan to pay dividends.
(5)Exercise price is the closing price of the Company's common stock on the date of grant.
A summary of the Company’s stock-settled stock appreciation right activity is as follows:
Shares Weighted-average exercise priceWeighted-average remaining
contractual term		Aggregate intrinsic value*
Outstanding at January 1, 2022150 $82.22 2.3$3,596 
Granted— — 
Exercised(2)63.02 
Forfeited— — 
Expired(1)116.06 
Outstanding at December 31, 2022147 $82.16 1.3$— 
Exercisable at December 31, 202272 $90.63 1.1$— 
* Aggregate intrinsic value is defined as the difference between the current market value at the reporting date (the closing price of the Company’s common stock on the last trading day of the period) and the exercise price of awards that were in-the-money. The closing price of the Company’s common stock at December 31, 2022 and January 1, 2022 was $53.20 and $101.20, respectively.
The total intrinsic value of stock-settled stock appreciation rights exercised was $50, $10,337, and $7,881, for the years ended 2022, 2021, and 2020, respectively. The total fair value of stock-settled stock appreciation rights that vested was $983, $3,868, and $3,532, for the years ended 2022, 2021, and 2020, respectively.
During the years ended December 31, 2022, January 1, 2022, and January 2, 2021, certain employees elected to receive a net amount of shares upon the exercise of stock-settled stock appreciation rights in order to satisfy the Company’s tax withholding obligation. There was no reduction to additional paid-in capital for the years ended 2022, 2021, and 2020.
Restricted Stock Awards
Restricted stock awards include stock-settled and cash-settled restricted stock units granted to the Company’s officers and key employees, and deferred stock units granted to non-employee directors. Restricted stock units are granted to officers and key employees upon hire or promotion to such a position, or annually for existing participants, and generally vest 25% each year on the anniversary of the grant date. Awards of deferred stock units granted to non-employee directors generally vest 25% each quarter, commencing on the first vest date anniversary following the final vesting of the previous award. Upon vesting, holders of stock-settled restricted stock units and deferred stock units are entitled to receive shares of the Company’s common stock on a one-for-one basis. Holders of cash-settled restricted stock units are entitled to receive cash payments equivalent to the number of awards held, valued at the closing market price on the vest date. The fair value of restricted stock awards is determined based on the Company’s closing stock price on the date of grant. Cash-settled restricted stock units are accounted for as liability-classified awards and fair value is remeasured to the current fair value, which is the Company's closing stock price, at each reporting date until the award is settled at vesting. Restricted stock awards are full-value shares at the date of grant, vesting over the periods of service, and do not have expiration dates.
A summary of the Company’s stock-settled restricted stock unit activity is as follows:
Shares Weighted-average grant date fair value
Outstanding at January 1, 2022366$80.87 
Granted17091.67 
Vested(142)81.11 
Forfeited(9)83.11 
Outstanding at December 31, 2022385$85.50 
During the year ended December 31, 2022, certain employees elected to receive a net amount of shares upon the release of restricted stock units in order to satisfy the Company’s tax withholding obligation. This resulted in a reduction to additional paid-in capital of $4,706, $3,575, and $2,367 for the years ended 2022, 2021, and 2020, respectively, reflected as a financing activity in the Company’s consolidated statements of cash flows.
The total fair value of restricted stock units that vested was $12,808, $11,378, and $7,732, for the years ended 2022, 2021, and 2020, respectively.
A summary of the Company’s cash-settled restricted stock unit activity is as follows:
Shares Weighted-average grant date fair value
Nonvested at January 1,202212$78.66 
Granted691.53 
Vested(3)79.22 
Forfeited(3)79.67 
Nonvested at December 31,202212$84.72 
The weighted-average fair value of liability-classified awards outstanding was $85, $79, and $76 for the years ended 2022, 2021, and 2020, respectively.
The number of deferred stock units vested and unreleased totaled 8, 19, and 23 for the years ended 2022, 2021, and 2020, respectively. There were no deferred stock units that vested in 2022, 2021, and 2020.
XML 32 R19.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Information
 12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
Segment Information SEGMENT INFORMATION
The Company primarily operates as a global direct-selling nutrition, personal health and wellness company that develops and manufactures high quality, science-based nutritional, and personal care products.
The Company’s operating segments are identified according to how business activities are managed and evaluated by the chief operating decision maker (“CODM”), our CEO. The CODM manages the business, allocates resources, makes operating decisions, and evaluates performance for a geographic region or market based on net sales. The Company aggregates its direct-selling operating segments (“Direct-selling”) into one reportable segment, as management believes that the Company’s Direct-selling segments exhibit similar long-term financial performance and have similar economic characteristics. The CODM does not evaluate operating segments using asset information, accordingly, the Company does not report asset information by segment.
As a result of the Company’s acquisitions during 2022, the Company has operating segments that are not material to the Company’s net sales. These operating segments are included as a component of (“All other”) and are included for purposes of reconciliation of net sales to the Company’s Consolidated Statements of Comprehensive Income.

Year Ended
202220212020
Net sales:
Direct-selling$995,043 $1,186,464 $1,134,644 
All other3,558 — — 
Consolidated Total$998,601 $1,186,464 $1,134,644 
No single Associate accounted for 10% or more of net sales for the periods presented. The table below summarizes the approximate percentage of total product revenue that has been contributed by the Company’s nutritionals, foods, and personal care and skincare products for the periods indicated.
Year Ended
202220212020
USANA Nutritionals87%86%85%
USANA Foods (1)7%7%7%
Personal care and Skincare5%6%7%
All Other1%1%1%
______________________________
(1)Includes the Company’s new Active Nutrition line, which launched in five markets in 2021 and all but two of the remaining markets through the end of 2022.
Selected Financial Information
Financial information, presented by geographic region is listed below:
Year Ended
202220212020
Net Sales to External Customers
Asia Pacific
Greater China$502,486 $563,469 $530,505 
Southeast Asia Pacific190,478 269,803 269,555 
North Asia108,952 129,920 114,964 
Asia Pacific Total801,916 963,192 915,024 
Americas and Europe196,685 223,272 219,620 
Consolidated Total$998,601 $1,186,464 $1,134,644 
December 31,
2022		January 1,
2022
Long-lived Assets
Asia Pacific
Greater China$86,051 $95,965 
Southeast Asia Pacific15,226 15,394 
North Asia3,617 7,395 
Asia Pacific Total104,894 118,754 
Americas and Europe92,373 89,030 
Consolidated Total$197,267 $207,784 
Total Assets
Asia Pacific
Greater China$250,786 $274,002 
Southeast Asia Pacific51,880 62,332 
North Asia22,952 25,592 
Asia Pacific Total325,618 361,926 
Americas and Europe270,931 215,814 
Consolidated Total$596,549 $577,740 
The following table provides further information on markets representing ten percent or more of consolidated net sales and long-lived assets, respectively:
Year Ended
202220212020
Net sales:
China$453,134 $506,103 $470,177 
South Korea$106,391 $125,835 $110,807 
United States$106,087 $110,379 $107,323 
Long-lived Assets:
United States$89,150 $85,350 
China$83,938 $91,530 
XML 33 R20.htm IDEA: XBRL DOCUMENT v3.22.4
Common Stock and Earnings Per Share
 12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Common Stock and Earnings Per Share COMMON STOCK AND EARNINGS PER SHARE
Basic earnings per share (“EPS”) are based on the weighted-average number of shares outstanding for each period. Shares that have been repurchased and retired during the periods specified below have been included in the calculation of the number of weighted-average shares that are outstanding for the calculation of basic EPS based on the time they were outstanding in any period. Diluted EPS are based on shares that are outstanding (computed under basic EPS) and on potentially dilutive shares. Shares that are included in the diluted EPS calculations under the treasury stock method include equity awards that are in-the-money but have not yet been exercised.
The following is a reconciliation of the numerator and denominator used to calculate basic EPS and diluted EPS for the periods indicated:
Year Ended
202220212020
Net earnings available to common shareholders$69,350 $116,505 $124,664 
Weighted average common shares outstanding - basic19,254 20,146 21,156 
Dilutive effect of in-the-money equity awards56 197 100 
Weighted average common shares outstanding - diluted19,310 20,343 21,256 
Earnings per common share from net earnings - basic$3.60 $5.78 $5.89 
Earnings per common share from net earnings - diluted$3.59 $5.73 $5.86 
Equity awards for the following shares were not included in the computation of diluted EPS due to the fact that their effect would be anti-dilutive:
Year Ended
202220212020
35460359
During the years ended 2022, 2021, and 2020, the Company repurchased and retired 288 shares, 1,844 shares, and 785 shares for an aggregate price of $25,382, $177,837, and $57,029, respectively.
XML 34 R21.htm IDEA: XBRL DOCUMENT v3.22.4
Related-Party Transactions
 12 Months Ended
Dec. 31, 2022
Related Party Transactions [Abstract]  
Related-Party Transactions RELATED-PARTY TRANSACTIONSThe Company's Founder and Chairman Emeritus of the Board, Myron W. Wentz, PhD is the sole beneficial owner of the largest shareholder of the Company, Gull Global, Ltd. As of December 31, 2022, Gull Global, Ltd. owned 41.6% of the Company’s issued and outstanding shares. Dr. Wentz retired from the position of Board Chairman and director at the Company's Annual Shareholder Meeting on May 1, 2020. Dr. Wentz devotes much of his personal time, expertise, and resources to a number of business and professional activities outside of USANA. The most significant of these is the Sanoviv Medical Institute, which is a unique, fully integrated health and wellness center located near Rosarito, Mexico that Dr. Wentz founded in 1998. Dr. Wentz’s private entity, Sanoviv S.A. de C.V. (“Sanoviv”), contracts with Amarevita S DE RL DE CV (“Amarevita”), an entity that is owned and operated independently of Dr. Wentz, to conduct the operations of the Sanoviv Medical Institute. Sanoviv leases the medical building to Amarevita and Amarevita carries out all of the operations of the medical institute, which include employing all of the medical and healthcare professionals who provide services at the medical institute. The Amarevita medical and healthcare professionals possess expertise in the fields of human health, digestive health, nutritional medicine, lifestyle medicine and other medical fields that are important to USANA. Amarevita performs research and development of novel product formulations for future development and production by USANA, and they also perform research and development of improvements in existing USANA product formulations. In addition to providing contract research services, Amarevita provides physicians and other medical staff to speak at USANA Associate events. Finally, Amarevita performs health assessments and physical examinations for the Company’s Executives. In consideration for these services, USANA paid Amarevita an immaterial amount in 2022 and 2021, and $175 in 2020. The Company’s agreements with Amarevita were approved by the Audit Committee in advance of the Company’s entry into the agreements. USANA’s collaboration with Amarevita is terminable at will by USANA at any time, without any continuing commitment by USANA.
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule II - Valuation and Qualifying Accounts
 12 Months Ended
Dec. 31, 2022
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule II - Valuation And Qualifying Accounts
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS
(in thousands)
DescriptionBalance at beginning of periodCharged to costs and expensesDeductionsBalance at end of period
December 31, 2022
Allowance for sales returns$547 $6,562 $6,537 $572 
Allowance for doubtful accounts$504 $6 $147 $363 
Valuation allowance - deferred tax assets$99,958 $18,178 $— $118,136 
January 1, 2022
Allowance for sales returns$819 $7,213 $7,485 $547 
Allowance for doubtful accounts$372 $148 $16 $504 
Valuation allowance - deferred tax assets$81,401 $18,557 $— $99,958 
January 2, 2021
Allowance for sales returns$772 $115 $68 $819 
Allowance for doubtful accounts$261 $131 $20 $372 
Valuation allowance - deferred tax assets$64,285 $17,116 $— $81,401 
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.22.4
Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
COVID-19
COVID-19
The COVID-19 pandemic, including the spread of new variants of the virus, has negatively impacted our business in various markets around the world. The ongoing COVID-19 pandemic has created an unpredictable operating environment for us in many of our markets around the world and caused meaningful disruptions in both sales and operations for fiscal 2022, 2021, and 2020. At this time, the Company is unable to predict the impact that COVID-19 will have on its business, financial position and operating results in future periods due to numerous uncertainties and is closely monitoring the impact of the pandemic on all aspects of its business.
The Company
The Company
USANA Health Sciences, Inc. is a global direct-selling, personal health and wellness company that develops and manufactures high quality, science-based nutritional and personal care products.
The Consolidated Financial Statements (the “Financial Statements”) include the accounts and operations of the Company, which are grouped and presented in two geographic regions: (1) Asia Pacific and (2) Americas and Europe. Asia Pacific is further divided into three sub-regions: (i) Greater China, (ii) Southeast Asia Pacific, and (iii) North Asia.
Asia Pacific
(1)Asia Pacific is organized into three sub-regions: Greater China, Southeast Asia Pacific, and North Asia. Markets included in each of these sub-regions are as follows:
(i)Greater China - Hong Kong, Taiwan, and China. Our business in China is conducted by BabyCare
(ii)Southeast Asia Pacific – Australia, New Zealand, Singapore, Malaysia, the Philippines, Thailand, and Indonesia
(iii)North Asia – Japan and South Korea
Americas and Europe
(2)Americas and Europe – United States, Canada, Mexico, Colombia, and Europe (the United Kingdom, France, Germany, Spain, Italy, Romania, Belgium, and the Netherlands)
Principles of Consolidation and Basis of Presentation
Principles of Consolidation and Basis of Presentation
The accompanying Consolidated Financial Statements include the accounts and operations of the Company. All inter-company accounts and transactions have been eliminated in consolidation. The accounting and reporting policies of the Company conform with accounting principles generally accepted in the United States of America (“US GAAP”).
Use of Estimates
Use of Estimates
The preparation of Consolidated Financial Statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. These estimates may be adjusted as more current information becomes available, and any adjustment could be significant.
Fiscal Year
Fiscal Year
The Company operates on a 52/53-week year, ending on the Saturday closest to December 31. Fiscal years 2022 and 2021 were 52-week years. Fiscal year 2020 was a 53-week year. Fiscal year 2022 covered the period January 2, 2022
to December 31, 2022 (hereinafter 2022). Fiscal year 2021 covered the period January 3, 2021 to January 1, 2022 (hereinafter 2021). Fiscal year 2020 covered the period December 29, 2019 to January 2, 2021 (hereinafter 2020).
Fair Value Measurements
Fair Value Measurements
The Company measures at fair value certain of its financial and non-financial assets and liabilities by using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price, based on the highest and best use of the asset or liability. The levels of the fair value hierarchy are:
•Level 1 inputs are quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date.
•Level 2 inputs are from other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly.
•Level 3 inputs are unobservable and are used to measure fair value in situations where there is little, if any, market activity for the asset or liability at the measurement date.
Fair Value of Financial Instruments Fair Value of Financial InstrumentsAs of December 31, 2022 and January 1, 2022, the Company’s financial instruments include cash equivalents, restricted cash, other liabilities, and foreign currency contracts. The recorded values of cash equivalents and restricted cash approximate their fair values, based on their short-term nature.
Translation of Foreign Currencies
Translation of Foreign Currencies
The functional currency of the Company’s foreign subsidiaries is the local currency of their country of domicile. Assets and liabilities of the foreign subsidiaries are translated into U.S. dollar amounts at month-end exchange rates. Revenue and expense accounts are translated at the weighted-average rates for the monthly accounting period to which they relate. Equity accounts are translated at historical rates. Foreign currency translation adjustments are accumulated as a component of other comprehensive income. Gains and losses from foreign currency transactions are included in the “Other, net” component of Other income (expense) in the Company’s consolidated statements of comprehensive income.
Business Combinations
Business Combinations
The Company allocates the purchase price consideration of the assets acquired and liabilities assumed based on the acquisition date fair values. Additionally, the Company records goodwill for the excess of the total consideration given for the acquired business over the fair value of the identifiable net assets of the acquired business. Transaction costs attributable to the acquisition are expensed as incurred.
Cash and Cash Equivalents
Cash and Cash Equivalents
The Company considers all highly liquid investments with an original maturity of three months or less from the date of purchase to be cash equivalents. Cash equivalents as of December 31, 2022 and January 1, 2022 consisted primarily of money market fund investments and amounts receivable from credit card processors.
Amounts receivable from credit card processors and other forms of electronic payment are considered cash equivalents because they are both short-term and highly liquid in nature and are typically converted to cash within three days of the sales transaction.
Restricted Cash
Restricted Cash
The Company is required to maintain cash deposits with banks in certain subsidiary locations for various operating purposes. The most significant of these cash deposits relates to a deposit held at a bank in China, the balance of which was $2,900 as of December 31, 2022, and $3,146 as of January 1, 2022. This deposit is required for the application of direct sales licenses by the Ministry of Commerce and the State Administration of Market Regulation (“SAMR”) of the People’s Republic of China, and will continue to be restricted during the periods while the Company holds these licenses.
Inventories - Current and Noncurrent
Inventories
Inventories are stated at the lower of cost or net realizable value. Cost is determined using a standard costing system, which approximates the first-in, first-out method. The components of inventory cost include raw materials, labor, and overhead. Net realizable value is determined using various assumptions with regard to excess or slow-moving inventories, non-conforming inventories, expiration dates, current and future product demand, production planning, and market conditions. A change in any of these variables could result in an adjustment to inventory.
Noncurrent inventory are inventories not expected to be sold within the normal operating cycle. The Company has defined the operating cycle as 52-weeks. Noncurrent inventory is classified in the "Other assets" line item in the Company's consolidated balance sheets.
Accounts Receivable
Accounts Receivable
Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company maintains an allowance for doubtful accounts for estimated losses inherent in its accounts receivable portfolio. In establishing the
required allowance, management considers historical losses adjusted to take into account current market conditions and our customers’ financial condition, the amount of receivables in dispute, and the current receivables aging and current payment patterns. The Company reviews its allowance for doubtful accounts regularly. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Accounts Receivable is included in the “Prepaid expenses and other current assets” line item in the Company’s consolidated balance sheets.
Income Taxes
Income Taxes
The Company accounts for income taxes using the asset and liability method, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of the differences between the financial statement assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates that are expected to apply to taxable income in the year in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax law is recognized in income in the period that includes the enactment date. Deferred tax expense or benefit is the result of changes in deferred tax assets and liabilities.
The Company evaluates the probability of realizing the future benefits of its deferred tax assets and provides a valuation allowance for the portion of any deferred tax assets where the likelihood of realizing an income tax benefit in the future does not meet the “more-likely-than-not” criteria for recognition. The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the Financial Statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. The Company recognizes interest and penalties related to unrecognized tax benefits in income taxes.
Property and Equipment
Property and Equipment
Property and equipment are recorded at cost. Maintenance, repairs, and renewals, which neither materially add to the value of the property nor appreciably prolong its life, are charged to expense as incurred. Depreciation is provided in amounts sufficient to relate the cost of depreciable assets to operations over the estimated useful lives of the related assets. The straight-line method of depreciation and amortization is followed for financial statement purposes. Leasehold improvements are amortized over the shorter of the life of the respective lease or the useful life of the improvements. Property and equipment are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When property and equipment are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period.
Leases
Leases
With the exception of the Company’s headquarters in Salt Lake City, Utah, and its facilities in New South Wales, Australia, and in Beijing and Tianjin, China, the Company leases its facilities. Each of the facility lease agreements is a non-cancelable operating lease generally structured with renewal options and expires prior to or during 2027. In connection with the production facilities in Beijing and Tianjin, China, the Company has prepaid land use rights, which represents a lease with the associated prepayment recorded as a Right-of-Use (“ROU”) asset. The Company also utilizes equipment under non-cancelable operating leases, expiring through 2026.
At contract inception, the Company determines whether an arrangement is or contains a lease and whether the lease should be classified as an operating or a financing lease. A contract is or contains a lease if the contract conveys the right to control the use of the identified asset for a period of time in exchange for consideration. Control is determined based on the right to obtain all of the economic benefits from use of the identified asset and the right to direct the use of the identified asset. ROU assets for operating leases represent the right to use an underlying asset for the lease term, and operating lease liabilities represent the obligation to make lease payments.
Lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date for leases exceeding 12 months. Minimum lease payments include only the fixed lease component of the agreement, as well as any variable rate payments that depend on an index, initially measured using the
index at the lease commencement date. Non-lease components are accounted for separately from the fixed lease component for all leases. Most of the Company’s leases do not provide an implicit rate that can readily be determined. Therefore, the applied discount rate is based on the Company’s incremental borrowing rate, which is determined using its credit rating and other information available as of the commencement date and is the rate of interest it would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. Lease terms may include options to renew, which the Company factors into the determination of the lease term when it is reasonably certain that the Company will exercise that option. The ROU asset is measured at the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received.
Operating lease expense is recognized on a straight-line basis over the lease term and is included in “Cost of sales” and “Selling, general and administrative” line items in the Company’s consolidated statements of comprehensive income. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases is recognized on a straight-line basis over the lease term.
The Company monitors for events or changes in circumstances that require a reassessment of its leases. When a reassessment results in the remeasurement of a lease liability, a corresponding adjustment is made to the carrying amount of the ROU asset unless doing so would reduce the ROU asset to an amount less than zero, in which case the remaining adjustment would be recorded in the consolidated statements of comprehensive income.
Goodwill GoodwillGoodwill represents the excess of the purchase price over the fair market value of identifiable net assets of acquired companies. Goodwill is not amortized, but rather is tested at the reporting unit level at least annually for impairment or more frequently if triggering events or changes in circumstances indicate impairment. Initially, qualitative factors are considered to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Some of these qualitative factors may include macroeconomic conditions, industry and market considerations, a change in financial performance, entity-specific events, a sustained decrease in share price, and consideration of the difference between the fair value and carrying amount of a reporting unit as determined in the most recent quantitative assessment. If, through this qualitative assessment, the conclusion is made that it is more likely than not that a reporting unit’s fair value is less than its carrying amount, a quantitative impairment analysis is performed. This analysis involves estimating the fair value of a reporting unit using widely accepted valuation methodologies including the income and market approaches, which requires the use of estimates and assumptions. These estimates and assumptions include revenue growth rates, discount rates, and determination of appropriate market comparables. If the fair value of the reporting unit is less than its carrying amount, an impairment loss is recognized in an amount equal to the excess of the carrying amount over the fair value of the reporting unit, not to exceed the carrying amount of the goodwill.
Intangible Assets
Intangible Assets
Intangible assets represent amortized and indefinite-lived intangible assets primarily acquired in connection with business combinations. Amortized intangible assets are amortized over their related useful lives, using a straight-line or accelerated method consistent with the underlying expected future cash flows related to the specific intangible asset. Amortized intangible assets are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When indicators of impairment exist, an estimate of undiscounted net cash flows is used in measuring whether the carrying amount of the asset or related asset group is recoverable. Measurement of the amount of impairment, if any, is based upon the difference between the asset or asset group’s carrying value and fair value. Fair value is determined through various valuation techniques, including market and income approaches as considered necessary.
Indefinite-lived intangible assets are not amortized; however, they are tested at least annually for impairment or more frequently if events or changes in circumstances exist that may indicate impairment. Initially, qualitative factors are considered to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. If, through this qualitative assessment, the conclusion is made that it is more likely than not that an indefinite-lived intangible asset’s fair value is less than its carrying amount, a quantitative impairment analysis is performed by comparing the indefinite-lived intangible asset’s carrying amount to its fair value. The fair value for
indefinite-lived intangible assets is determined through various valuation techniques, including market and income approaches as considered necessary. The amount of any impairment is measured as the difference between the carrying amount and the fair value of the impaired asset.
Investment in Equity Securities
Investment in Equity Securities
Equity securities (“securities”) without readily determinable fair value that are not eligible to be measured in accordance with the net asset value practical expedient qualify for an election to initially estimate fair value using the measurement alternative at its cost. During 2020, the Company entered into a strategic collaboration and made a minority investment in a privately held company, which totaled $20,000 and is included in the “Other assets” line item on the Company’s consolidated balance sheets. The Company, at the time of the investment, elected to apply the measurement alternative, which may be applied to an equity interest on an instrument-by-instrument basis. Dividends received are reported in earnings.
The initial value of the securities are remeasured to fair value if the securities are impaired or if observable price changes occur. These events are continually monitored and assessed at each reporting period. If a readily determinable fair value becomes available for the securities or observable price changes for the identical or a similar investment of the same issuer occur, the securities are measured at fair value as of the date the observable change occurred. Any resulting gains or losses on the securities for which the observable price changes occur will be recorded in net earnings. During 2022 and 2021, no such observable price changes occurred.
At each reporting period a qualitative assessment is made to consider impairment indicators to determine whether the securities are impaired. Impairment indicators may include but are not limited to earnings performance, business prospects by the investee, cash flows from operations, working capital, and noncompliance with debt covenants. If this qualitative assessment indicates impairment, fair value is determined and an impairment loss equal to the difference between the fair value of the investment and its carrying amount is recognized in net income. During 2022 and 2021, no impairment of securities was recorded.
Nonqualified Deferred Compensation Nonqualified Deferred CompensationIn 2021, the Company created a non-qualified deferred compensation plan for a select group of management and highly compensated individuals. The plan permits the deferral of up to 50% of a participant's base salary and/or 80% of a participant's annual incentive bonus. The deferrals are held in an irrevocable rabbi trust (the "Rabbi Trust"), which has been established to administer the plan. The Rabbi Trust is intended to be used as a source of funds to match respective funding obligations to participants. The assets of the trust are subject to the claims of the Company's creditors in the event that the Company becomes insolvent. Consequently, the Rabbi Trust qualifies as a grantor trust for income tax purposes. The Company makes periodic payments into company-owned life insurance policies held in this Rabbi trust to fund the expected obligations arising under this plan. There are no contractual restrictions on the Company's ability to surrender a policy. The assets and liabilities of the plan are included in "Other assets" and "Other long-term liabilities" respectively in the Consolidated Balance Sheets. Changes in the deferred compensation balances are recorded to compensation expense and reflected within the "Selling, general and administrative" line in the Consolidated Statements of Comprehensive Income.
Self-Insurance Self-InsuranceThe Company is self-insured, up to certain limits, for employee group health claims. The Company has purchased stop-loss insurance on both an individual and an aggregate basis, which will reimburse the Company for individual claims in excess of $175 and aggregate claims that are greater than $13,515. A liability is accrued for all unpaid claims.
Derivatives Financial Instruments
Derivative Financial Instruments
The Company’s risk management strategy includes the select use of derivative instruments to reduce the effects of volatility in foreign currency exchange exposure on operating results and cash flows. In accordance with the Company’s
risk management policies, the Company does not hold or issue derivative instruments for trading or speculative purposes. The Company recognizes all derivative instruments as either assets or liabilities in the balance sheet at their respective fair values. When the Company becomes a party to a derivative instrument and intends to apply hedge accounting, the Company formally documents the hedge relationship and the risk management objective for undertaking the hedge, the nature of risk being hedged, and the hedged transaction, which includes designating the instrument for financial reporting purposes as a fair value hedge, a cash flow hedge, or a net investment hedge. The Company also documents how the hedging instrument’s effectiveness in offsetting the hedged risk will be assessed prospectively and retrospectively, and a description of the method used to measure ineffectiveness.
The Company periodically uses derivative instruments to hedge the foreign currency exposure of its net investment in foreign subsidiaries into U.S. dollars. Initially, the Company records derivative assets on a gross basis in its consolidated balance sheets. Subsequently the fair value of derivatives is measured for each reporting period. The effective portion of gains and losses attributable to these net investment hedges is recorded to foreign currency translation adjustment (“FCTA”) within accumulated other comprehensive income (loss) (“AOCI”) to offset the change in the carrying value of the net investment being hedged, and will subsequently be reclassified to net earnings in the period in which the hedged investment is either sold or substantially liquidated.
Common Stock Share Repurchases
Common Stock Share Repurchases
The Company has a stock repurchase plan in place that has been authorized by the Board of Directors. As of December 31, 2022, $82,839 is available to repurchase shares under this plan. The excess of the repurchase price over par value is allocated between additional paid-in capital and retained earnings on a pro-rata basis. There currently is no expiration date on the remaining approved repurchase amount and no requirement for future share repurchases.
Revenue Recognition
Revenue Recognition
Revenue is recognized when, or as, control of a promised product or service transfers to a customer, in an amount that reflects the consideration to which the Company expects to be entitled in exchange for transferring those products or services. Revenue excludes taxes that have been assessed by governmental authorities and that are directly imposed on revenue-producing transactions between the Company and its customers, including sales, use, value-added, and some excise taxes. Revenue recognition is evaluated through the following five-step process:
1)identification of the contract with a customer;
2)identification of the performance obligations in the contract;
3)determination of the transaction price;
4)allocation of the transaction price to the performance obligations in the contract; and
5)recognition of revenue when or as a performance obligation is satisfied.
Product Revenue
A majority of the Company’s sales are for products sold at a point in time and shipped to customers, for which control is transferred to the customer as goods are delivered to the third party carrier for shipment. The Company receives payment, primarily via credit card, for the sale of products at the time customers place orders and payment is required prior to shipment. The Company does not recognize assets associated with costs to obtain or fulfill a contract with a customer.
The Company’s product sales contracts include terms that could cause variability in the transaction price for items such as discounts, product promotions, credits, or sales returns, which are a reduction of revenue. Accordingly, the transaction price for product sales includes estimates of variable consideration to the extent it is probable that a significant reversal of revenue recognized will not occur. At the time of sale, the Company estimates a refund liability for the variable consideration based on historical experience, which is recorded within the “Other current liabilities” line item in the consolidated balance sheets.
Initial product orders with a new customer may include multiple performance obligations related to sales discounts earned under the Company’s initial order reward program. Under this program, the customer receives an option to apply the discounts earned on the initial order to two subsequent Auto Orders, which conveys a material right to the customer. As such, the initial order transaction price is allocated to each separate performance obligation based on its relative standalone selling price and is recognized as revenue as each performance obligation is satisfied.
Associate incentives represent consideration paid to an Associate for distinct services provided in the sale of the Company's products and include all forms of commissions, and other incentives paid to our Associates. The Company may provide Associate incentive promotions which are earned by Associates for distinct services rendered. Associate incentive promotions are recorded as the incentives are earned by the Associates. With the exception of commissions paid to Associates on personal purchases, which are considered a sales discount and are reported as a reduction to net sales, Associate incentives are recorded as an operating expense. The amounts paid to Associates are commensurate with the fair value received for the distinct services rendered by Associates and are recorded as an operating expense when revenue for the goods is recognized.
Shipping and handling activities are performed upon delivery to the third party carrier for shipment. The Company accounts for these activities as fulfillment costs. Therefore, the Company recognizes the costs of these activities when revenue for the goods is recognized. Shipping and handling costs are included in cost of sales for all periods presented.
With respect to will-call orders, the Company periodically assesses the likelihood that customers will exercise their contractual right to pick up orders and revenue is recognized when the likelihood that customers will pick up orders is remote.
Other Revenue
Other types of revenue include fees, which are paid by the customer at the beginning of the service period, for access to online customer service applications and annual account renewal fees for Associates, for which control is transferred over time as services are delivered and are recognized as revenue on a straight-line basis over the term of the respective contracts.
The following table presents Other Revenue for the periods indicated:
Year Ended
202220212020
Other Revenue$3,452 $3,825 $3,805 
Revenue Disaggregation
Disaggregation of revenue by geographical region and major product line is included in Note M – Segment Information.
Contract Balances
When the timing of our provision of goods or services is different from the timing of the payments made by our customers, we recognize either a contract asset (performance precedes contractual due date) or a contract liability (customer payment precedes performance).
Contract liabilities relate to deferred revenue for product sales for customer payments received in advance of shipment, for outstanding material rights under the initial order program, and for services where the performance obligations are satisfied over time as services are delivered. Contract liabilities are recorded as deferred revenue within the "Other current liabilities" line item in the consolidated balance sheets.
Product Return Policy Product Return PolicyAll product orders that are unused and returned within the first 30 days following purchase are refunded at 100% of the sales price. All product orders that are unused and resalable are refunded up to one year from the date of purchase at 100% of the sales price. This standard policy differs in a few of our international markets due to the regulatory environment in those markets. Depending upon the conditions under which product was returned, customers may either receive a refund based on their original form of payment, or credit on account for a product exchange. The Company monitors Associate activity to ensure that all such practices are in line with established Company policies.
Associate Incentives
Associate Incentives
Associate incentives expenses include all forms of commissions, and other incentives paid to our Associates, less commissions paid to Associates on personal purchases, which are considered a sales discount and are reported as a reduction to net sales.
Selling, General and Administrative
Selling, General and Administrative
Selling, general and administrative expenses include wages and benefits, depreciation and amortization, rents and utilities, Associate event costs, advertising and professional fees, marketing, and research and development expenses.
Equity-Based Compensation
Equity-Based Compensation
The Company records compensation expense in the Financial Statements for equity-based awards based on the grant date fair value, which for restricted stock units is the closing market value of the Company’s common stock on the date of the grant. The grant date fair value of each stock-settled stock appreciation right is based upon the Black-Scholes option pricing model. Equity-based compensation expense is recognized under the straight-line method over the period that service is provided, which is generally the vesting term. Further information regarding equity awards can be found in Note L – Equity-Based Compensation.
Advertising AdvertisingAdvertising costs are charged to expense as incurred and are presented as part of the “Selling, general and administrative” line item.
Research and Development Research and DevelopmentResearch and development costs are charged to expense as incurred and are presented as part of the “Selling, general and administrative” line item.
Earnings Per Share
Earnings Per Share
Basic earnings per common share ("EPS") are based on the weighted-average number of common shares that were outstanding during each period. Diluted EPS include the effect of potentially dilutive common shares calculated using the treasury stock method, which include in-the-money, equity-based awards that have been granted but have not been issued. When there is a loss, potential common shares are not included in the computation of diluted EPS, because to do so would be anti-dilutive.
Recent Accounting Pronouncements
Recent Accounting Pronouncements
Issued Accounting Pronouncements Not Yet Adopted
In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. ASU 2021-08 requires an acquirer to recognize and measure contract assets and contract liabilities (deferred revenue) acquired in a business combination in accordance with Revenue from Contracts with Customers (Topic 606). Under this approach, the acquirer applies the revenue model as if it had originated the contracts. This is a departure from the current requirement to measure contract assets and contract liabilities at fair value at the acquisition date. ASU 2021-08 is effective for annual periods beginning after December 15, 2022 and interim periods within those annual periods. ASU 2021-08 should be applied prospectively to business combinations occurring on or after the date of adoption. Evaluation of this new standard is dependent on multiple circumstances including the timing and complexity of completed business combinations. As a result, the Company intends to adopt the provisions of ASU 2021-08 in the first quarter of 2023.
No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements
XML 37 R24.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Fair Value Measurements, Recurring and Nonrecurring
As of December 31, 2022 and January 1, 2022, the following financial assets and liabilities were measured at fair value on a recurring basis using the type of inputs shown:
December 31,
2022		Fair Value Measurements Using
Inputs
Level 1Level 2Level 3
Money market funds included in cash equivalents$211,539 $211,539 $— $— 
Foreign currency contracts included in other current liabilities(3,150)— (3,150)— 
Deferred compensation liabilities
(1,632)— (1,632)— 
Contingent consideration included in other current liabilities of $(338) and other long-term liabilities of $(548)
(886)— — (886)
$205,871 $211,539 $(4,782)$(886)
January 1,
2022		Fair Value Measurements Using
Inputs
Level 1Level 2Level 3
Money market funds included in cash equivalents$163,619 $163,619 $— $— 
Foreign currency contracts included in other current liabilities(461)— (461)— 
$163,158 $163,619 $(461)$— 
Disaggregation of Revenue
The following table presents Other Revenue for the periods indicated:
Year Ended
202220212020
Other Revenue$3,452 $3,825 $3,805 
Contract with Customer, Contract Asset, Contract Liability, and Receivable
The following table provides information about contract liabilities from contracts with customers, including significant changes in the contract liabilities balances during the period.
December 31,
2022		January 1,
2022
Contract liabilities at beginning of period$19,635 $15,952 
Increase due to deferral of revenue at period end20,875 19,635 
Decrease due to beginning contract liabilities recognized as revenue(19,635)(15,952)
Contract liabilities at end of period$20,875 $19,635 
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.22.4
Inventories (Tables)
 12 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
Schedule of Inventory
December 31,
2022		January 1,
2022
Raw materials$21,776 $30,280 
Work in progress4,285 9,586 
Finished goods41,028 58,452 
$67,089 $98,318 
Noncurrent inventories$3,479 $— 
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.22.4
Prepaid Expenses and Other Current Assets (Tables)
 12 Months Ended
Dec. 31, 2022
Prepaid Expense and Other Assets, Current [Abstract]  
Schedule of Prepaid Expenses
Prepaid expenses and other current assets consists of the following:
December 31,
2022		January 1,
2022
Prepaid insurance$2,293 $3,734 
Other prepaid expenses9,089 10,119 
Income taxes receivable2,030 1,579 
Miscellaneous receivables, net5,183 5,584 
Deferred commissions3,157 2,270 
Other current assets7,121 3,681 
$28,873 $26,967 
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Consolidated Income Before Income Taxes
Consolidated earnings before income taxes consists of the following for 2022, 2021, and 2020:
Year Ended
202220212020
U.S.$(23,996)$13,017 $18,838 
Foreign132,617 157,625 159,110 
Total earnings before income taxes$108,621 $170,642 $177,948 
Schedule of Income Tax Expense (Benefit) Included in Income From Continuing Operations
Income tax expense (benefit) included in income from continuing operations consists of the following:
Year Ended
202220212020
Current
Federal$42 $(264)$306 
State297 567 303 
Foreign45,869 56,668 55,147 
Total Current46,208 56,971 55,756 
Deferred
Federal(9,180)(4,088)1,317 
State(331)(40)(47)
Foreign2,574 1,294 (3,742)
Total Deferred(6,937)(2,834)(2,472)
$39,271 $54,137 $53,284 
Schedule of Effective Income Tax Rate
The effective tax rate for 2022, 2021, and 2020 reconciled to the statutory U.S. Federal tax rate is as follows:
Year Ended
202220212020
Statutory U.S. federal income tax rate21.0 %21.0 %21.0 %
State income taxes, net of federal tax benefit0.4 0.4 0.3 
Permanent tax differences0.3 0.1 0.2 
Excess foreign tax credits(16.6)(10.9)(9.9)
Net increase in valuation allowance11.9 10.6 8.2 
Foreign income tax rate differences9.5 1.8 1.7 
Foreign withholding taxes9.7 7.9 7.7 
Uncertain tax position reserve0.5 (0.3)0.8 
All other, net(0.5)1.1 (0.1)
36.2 %31.7 %29.9 %
Schedule of Deferred Taxes
The significant categories of deferred taxes are as follows:
December 31,
2022		January 1,
2022
Deferred tax assets
Inventory$5,872 $5,106 
Accruals not currently deductible8,627 11,634 
Equity-based compensation expense2,746 2,355 
Property and equipment922 1,143 
Intangible assets6,680 7,545 
Foreign currency translation1,448 — 
Capitalized R&D Expenses9,618 2,337 
Tax credit carry forwards115,539 96,635 
Net operating losses1,720 1,401 
Other3,223 4,824 
Gross deferred tax assets156,395 132,980 
Valuation allowance(118,136)(99,958)
Net deferred tax assets38,259 33,022 
Deferred tax liabilities
Property and equipment(5,723)(5,268)
Foreign currency translation— (126)
Prepaid expenses(2,990)(3,596)
Intangible assets(6,680)(7,545)
Withholding tax on unremitted earnings(11,639)(13,556)
Other(5,499)(5,589)
Gross deferred tax liabilities(32,531)(35,680)
Net deferred taxes$5,728 $(2,658)
The components of net deferred taxes on a jurisdiction basis are as follows:
December 31,
2022		January 1,
2022
Net deferred tax assets$9,799 $4,839 
Net deferred tax liabilities(4,071)(7,497)
Net deferred taxes$5,728 $(2,658)
Schedule of Unrecognized Tax Benefits Reconciliation
The following reconciliation provides the changes in unrecognized tax benefits for the years presented:
Year Ended
202220212020
Beginning balance of unrecognized tax benefits$1,008 $1,528 $560 
Increases related to prior year tax positions107 21 775 
Decreases related to prior year tax positions— (330)— 
Increases related to current year tax positions468 424 753 
Decreases for settlements with taxing authorities(133)(635)(560)
Ending balance of unrecognized tax benefits$1,450 $1,008 $1,528 
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.22.4
Property and Equipment (Tables)
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment
Cost of property and equipment and their estimated useful lives is as follows:
YearDecember 31,
2022		January 1,
2022
Buildings39.5$78,071 $80,820 
Laboratory and production equipment
5-7
50,679 47,552 
Air transportation equipment52,952 2,952 
Computer equipment and software
3-5
53,436 53,562 
Furniture and fixtures
3-5
6,198 6,636 
Automobiles
3-5
722 767 
Leasehold improvements
3-5
14,388 15,212 
Land improvements153,271 3,382 
209,717 210,883 
Less accumulated depreciation and amortization124,748 121,590 
84,969 89,293 
Land6,723 6,992 
Deposits and projects in process6,081 5,495 
$97,773 $101,780 
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.22.4
Operating Leases (Tables)
 12 Months Ended
Dec. 31, 2022
Leases, Operating [Abstract]  
Schedule of Classification of ROU Assets and Lease Liabilities
The following table summarizes the classification of ROU assets and lease liabilities in the Company’s consolidated balance sheet:
LeasesClassificationDecember 31,
2022		January 1,
2022
Assets
ROU operating lease assets, netOther assets$19,997 $23,789 
Total ROU assets$19,997 $23,789 
Liabilities
Current:
Operating lease liabilitiesOther current liabilities$6,892 $7,080 
Noncurrent:
Operating lease liabilitiesOther long-term liabilities7,680 10,215 
Total lease liabilities$14,572 $17,295 
Schedule of Supplemental Lease Information
The following table presents supplemental lease information:
Year Ended
20222021
Lease cost
Operating lease cost$8,606 $9,585 
Total lease cost$8,606 $9,585 
Year Ended
20222021
Other information
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases$7,924 $9,506 
ROU assets obtained in exchange for new operating lease liabilities$5,641 $5,322 
Weighted-average remaining lease term—operating leases
2.39 yrs.
2.76 yrs.
Weighted-average discount rate—operating leases3.04 %3.11 %
Schedule of Maturity of Lease Liabilities
The following table presents the maturity of the Company’s lease liabilities as of December 31, 2022:
Year ending
2023$7,214 
20245,383 
20251,850 
2026497 
2027120 
Thereafter— 
15,064 
Less: imputed interest(492)
Present value$14,572 
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.22.4
Intangible Assets (Tables)
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
The changes in the carrying amount of goodwill are as follows:
December 31,
2022		January 1,
2022
Balance at beginning of year:
Gross goodwill$17,668 $17,367 
Goodwill as of beginning of year17,668 17,367 
  
Goodwill acquired during the year582 — 
Currency translation adjustment(882)301 
Balance as of end of year
Gross goodwill17,368 17,668 
Goodwill as of end of year$17,368 $17,668 
Schedule of Intangible Assets
Intangible assets consist of the following:
As of December 31, 2022
Gross carrying
amount		Accumulated
 amortization		Net carrying
amount		Weighted-average
amortization
period (years)
Amortized intangible assets
Trade name and trademarks$2,285 $(114)$2,171 10
Product formulas8,701 (7,983)718 8
Customer relationships3,313 (414)2,899 4
Non-compete agreements467 (61)406 4
Indefinite-lived intangible assets
Direct sales license26,238 26,238 
   
$41,004 $32,432 
As of January 1, 2022
Gross carrying
amount		Accumulated
amortization 		Net carrying
amount		Weighted-average
amortization
period (years)
Amortized intangible assets
Trade name and trademarks$4,173 $(4,173)$— 10
Product formulas9,440 (7,462)1,978 8
Indefinite-lived intangible assets
Direct sales license28,464 28,464 
  
$42,077 $30,442 
Schedule of Amortization Expense
Estimated Amortization Expense: 
 
2023$1,843 
20241,224 
20251,154 
2026692 
2027253 
Thereafter1,028 
 
$6,194 
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.22.4
Other Current Liabilities (Tables)
 12 Months Ended
Dec. 31, 2022
Other Liabilities Disclosure [Abstract]  
Schedule of Other Current Liabilities
Other current liabilities consist of the following:
December 31,
2022		January 1,
2022
Associate incentives$55,688 $53,929 
Accrued employee compensation17,334 32,366 
Deferred revenue20,875 19,635 
Sales taxes11,234 11,330 
Operating lease liabilities6,892 7,080 
Income taxes4,973 5,193 
All other15,788 17,749 
$132,784 $147,282 
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.22.4
Equity-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Remaining Unrecognized Compensation Expense
The following table shows the remaining unrecognized compensation expense on a pre-tax basis for all types of unvested equity awards outstanding as of December 31, 2022. This table does not include an estimate for future grants that may be issued.
2023$11,273 
20247,781 
20254,117 
2026408 
$23,579 
Schedule of Weighted-Average Assumptions Used to Calculate Fair Value of Stock Settled Stock Appreciation Rights
Following is a table that includes the weighted-average assumptions that the Company used to calculate fair value of stock-settled stock appreciation rights that were granted during the periods indicated.
Year Ended
202220212020
Expected volatility (1)N/A43.28 %35.23 %
Risk-free interest rate (2)N/A0.33 %1.66 %
Expected life (3)N/A
3.5 yrs
3.5 yrs.
Expected dividend yield (4)N/A0.00 %0.00 %
Weighted-average exercise price (5)N/A$85.19 $63.02 
(1)The Company utilizes historical volatility of the trading price of its common stock.
(2)Risk-free interest rate is based on the U.S. Treasury yield curve with respect to the expected life of the award.
(3)Depending upon the terms of the award, one of two methods will be used to calculate expected life:
(i)a weighted-average that includes historical settlement data of the Company’s equity awards and a hypothetical holding period, or (ii) the simplified method.
(4)The Company historically has not paid and currently has no plan to pay dividends.
(5)Exercise price is the closing price of the Company's common stock on the date of grant.
Schedule of Stock-Settled Appreciation Right Activity
A summary of the Company’s stock-settled stock appreciation right activity is as follows:
Shares Weighted-average exercise priceWeighted-average remaining
contractual term		Aggregate intrinsic value*
Outstanding at January 1, 2022150 $82.22 2.3$3,596 
Granted— — 
Exercised(2)63.02 
Forfeited— — 
Expired(1)116.06 
Outstanding at December 31, 2022147 $82.16 1.3$— 
Exercisable at December 31, 202272 $90.63 1.1$— 
* Aggregate intrinsic value is defined as the difference between the current market value at the reporting date (the closing price of the Company’s common stock on the last trading day of the period) and the exercise price of awards that were in-the-money. The closing price of the Company’s common stock at December 31, 2022 and January 1, 2022 was $53.20 and $101.20, respectively.
Schedule of Stock-Settled Restricted Stock Unit Activity
A summary of the Company’s stock-settled restricted stock unit activity is as follows:
Shares Weighted-average grant date fair value
Outstanding at January 1, 2022366$80.87 
Granted17091.67 
Vested(142)81.11 
Forfeited(9)83.11 
Outstanding at December 31, 2022385$85.50 
Schedule of Cash-Settled Restricted Stock Unit Activity
A summary of the Company’s cash-settled restricted stock unit activity is as follows:
Shares Weighted-average grant date fair value
Nonvested at January 1,202212$78.66 
Granted691.53 
Vested(3)79.22 
Forfeited(3)79.67 
Nonvested at December 31,202212$84.72 
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Information (Tables)
 12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Operating Segment These operating segments are included as a component of (“All other”) and are included for purposes of reconciliation of net sales to the Company’s Consolidated Statements of Comprehensive Income.
Year Ended
202220212020
Net sales:
Direct-selling$995,043 $1,186,464 $1,134,644 
All other3,558 — — 
Consolidated Total$998,601 $1,186,464 $1,134,644 
Revenue from External Customers by Products and Services The table below summarizes the approximate percentage of total product revenue that has been contributed by the Company’s nutritionals, foods, and personal care and skincare products for the periods indicated.
Year Ended
202220212020
USANA Nutritionals87%86%85%
USANA Foods (1)7%7%7%
Personal care and Skincare5%6%7%
All Other1%1%1%
______________________________
(1)Includes the Company’s new Active Nutrition line, which launched in five markets in 2021 and all but two of the remaining markets through the end of 2022.
Schedule of Revenue by Geographic Region
Financial information, presented by geographic region is listed below:
Year Ended
202220212020
Net Sales to External Customers
Asia Pacific
Greater China$502,486 $563,469 $530,505 
Southeast Asia Pacific190,478 269,803 269,555 
North Asia108,952 129,920 114,964 
Asia Pacific Total801,916 963,192 915,024 
Americas and Europe196,685 223,272 219,620 
Consolidated Total$998,601 $1,186,464 $1,134,644 
December 31,
2022		January 1,
2022
Long-lived Assets
Asia Pacific
Greater China$86,051 $95,965 
Southeast Asia Pacific15,226 15,394 
North Asia3,617 7,395 
Asia Pacific Total104,894 118,754 
Americas and Europe92,373 89,030 
Consolidated Total$197,267 $207,784 
Total Assets
Asia Pacific
Greater China$250,786 $274,002 
Southeast Asia Pacific51,880 62,332 
North Asia22,952 25,592 
Asia Pacific Total325,618 361,926 
Americas and Europe270,931 215,814 
Consolidated Total$596,549 $577,740 
Schedule of Markets Representing Ten Percent Or More of Consolidated Net Sales and Long-Lived Assets
The following table provides further information on markets representing ten percent or more of consolidated net sales and long-lived assets, respectively:
Year Ended
202220212020
Net sales:
China$453,134 $506,103 $470,177 
South Korea$106,391 $125,835 $110,807 
United States$106,087 $110,379 $107,323 
Long-lived Assets:
United States$89,150 $85,350 
China$83,938 $91,530 
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.22.4
Common Stock and Earnings Per Share (Tables)
 12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following is a reconciliation of the numerator and denominator used to calculate basic EPS and diluted EPS for the periods indicated:
Year Ended
202220212020
Net earnings available to common shareholders$69,350 $116,505 $124,664 
Weighted average common shares outstanding - basic19,254 20,146 21,156 
Dilutive effect of in-the-money equity awards56 197 100 
Weighted average common shares outstanding - diluted19,310 20,343 21,256 
Earnings per common share from net earnings - basic$3.60 $5.78 $5.89 
Earnings per common share from net earnings - diluted$3.59 $5.73 $5.86 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
Equity awards for the following shares were not included in the computation of diluted EPS due to the fact that their effect would be anti-dilutive:
Year Ended
202220212020
35460359
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies - Narrative (Details)
 12 Months Ended
Dec. 31, 2022
USD ($)
region
Jan. 01, 2022
USD ($)
Jan. 02, 2021
USD ($)
Jan. 18, 2023
USD ($)
Accounting Policies [Line Items]        
Number of geographic regions | region 2      
Number of sub geographical regions | region 3      
Goodwill, impairment loss $ 0 $ 0 $ 0  
Impairment of intangible assets, indefinite-lived (excluding goodwill) 0 0 0  
Equity securities without readily determinable fair value, amount 0 0    
Equity securities without readily determinable fair value, impairment loss, annual amount $ 0 0    
Non-qualified deferred compensation plan, salary deferred, percentage 0.50      
Non-qualified deferred compensation plan, annual incentive bonus deferral, percentage 0.80      
Life insurance, corporate or bank owned, amount $ 1,622,000 382,000    
Deferred compensation liability, classified, noncurrent, total 1,632,000 390,000    
Minimum amount of individual claims before insurance reimbursement 175,000      
Minimum amount of projected aggregate claims before insurance reimbursement 13,515,000      
Self-insurance expense 13,413,000 12,349,000 $ 11,798,000  
Derivative, notional amount 98,930,000      
Stock repurchase program, remaining authorized repurchase amount 82,839,000      
Contract with customer, asset, after allowance for credit loss, total $ 0 $ 0    
Product return, first time order, duration of return (day) 30 days      
Product return, first time order, percentage refunded 100.00%      
Product return, percentage refunded 100.00%      
Product return, percentage of net sales 0.70% 0.60% 0.70%  
Advertising expense $ 5,053,000 $ 12,399,000 $ 9,853,000  
Research and development expense, total 11,563,000 11,112,000 10,633,000  
Designated as Hedging Instrument        
Accounting Policies [Line Items]        
Derivative assets (liabilities), at fair value, net, total 0 0    
Designated as Hedging Instrument | Subsequent Event        
Accounting Policies [Line Items]        
Derivative, notional amount       $ 81,343,000
Foreign Exchange Option | Designated as Hedging Instrument        
Accounting Policies [Line Items]        
Derivative, notional amount   98,684,000 90,000,000  
Derivative, gain (loss) on derivative, net 4,555,000 1,555,000 $ 846,000  
Other Assets        
Accounting Policies [Line Items]        
Equity securities without readily determinable fair value, amount   20,000,000    
Amounts Receivable from Credit Card Processors        
Accounting Policies [Line Items]        
Cash equivalents, at carrying value, total 8,904,000 11,123,000    
Restricted Cash Deposits in China        
Accounting Policies [Line Items]        
Restricted cash and cash equivalents, noncurrent, total 2,900,000 3,146,000    
Fair Value, Nonrecurring        
Accounting Policies [Line Items]        
Nonfinancial assets, fair value disclosure $ 0 $ 0    
XML 49 R36.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies - Schedule of Assets And Liabilities Measured At Fair Value (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Jan. 01, 2022
Jan. 02, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Deferred compensation liabilities $ (85) $ (79) $ (76)
Business combination, contingent consideration, liability, current 338    
Business combination, contingent consideration, liability, noncurrent (548)    
Fair Value, Recurring      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Foreign currency contracts included in other current liabilities (3,150) (461)  
Deferred compensation liabilities (1,632)    
Contingent consideration included in other current liabilities of $(338) and other long-term liabilities of $(548) (886)    
Total fair value, net asset (liability) 205,871 163,158  
Fair Value, Recurring | Level 1      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Foreign currency contracts included in other current liabilities 0 0  
Deferred compensation liabilities 0    
Contingent consideration included in other current liabilities of $(338) and other long-term liabilities of $(548) 0    
Total fair value, net asset (liability) 211,539 163,619  
Fair Value, Recurring | Level 2      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Foreign currency contracts included in other current liabilities (3,150) (461)  
Deferred compensation liabilities (1,632)    
Contingent consideration included in other current liabilities of $(338) and other long-term liabilities of $(548) 0    
Total fair value, net asset (liability) (4,782) (461)  
Fair Value, Recurring | Level 3      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Foreign currency contracts included in other current liabilities 0 0  
Deferred compensation liabilities 0    
Contingent consideration included in other current liabilities of $(338) and other long-term liabilities of $(548) (886)    
Total fair value, net asset (liability) (886) 0  
Fair Value, Recurring | Money Market Funds      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Money market funds included in cash equivalents 211,539 163,619  
Fair Value, Recurring | Money Market Funds | Level 1      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Money market funds included in cash equivalents 211,539 163,619  
Fair Value, Recurring | Money Market Funds | Level 2      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Money market funds included in cash equivalents 0 0  
Fair Value, Recurring | Money Market Funds | Level 3      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Money market funds included in cash equivalents $ 0 $ 0  
XML 50 R37.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies - Schedule of Other Revenue (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Jan. 02, 2021
Accounting Policies [Abstract]      
Other Revenue $ 3,452 $ 3,825 $ 3,805
XML 51 R38.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies - Schedule of Contract Liabilities From Contract With Customers (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Movement in Contract Liabilities [Roll Forward]    
Contract liabilities at beginning of period $ 19,635 $ 15,952
Increase due to deferral of revenue at period end 20,875 19,635
Decrease due to beginning contract liabilities recognized as revenue (19,635) (15,952)
Contract liabilities at end of period $ 20,875 $ 19,635
XML 52 R39.htm IDEA: XBRL DOCUMENT v3.22.4
Business Combinations and Asset Acquisitions (Details)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jul. 02, 2022
USD ($)
Dec. 31, 2022
USD ($)
period
Dec. 31, 2022
USD ($)
period
Jan. 01, 2022
USD ($)
Jan. 02, 2021
USD ($)
Business Combination, Separately Recognized Transactions [Line Items]          
Goodwill   $ 17,368 $ 17,368 $ 17,668 $ 17,367
Series of Individually Immaterial Business Acquisitions          
Business Combination, Separately Recognized Transactions [Line Items]          
Payments to acquire businesses $ 6,532        
Contingent consideration 886 886 $ 886    
Purchase price allocations to tangible assets 964        
Purchase price allocations to intangible assets 6,065        
Goodwill $ 389        
Increase in goodwill   193      
Decrease in tangible assets   105      
Increase in assumed liabilities   147      
Decrease in consideration, post close net working capital adjustments   $ 59      
Contingent consideration milestone period     3 years    
Number of earnout periods | period   3 3    
Maximum amount of earnouts total   $ 1,500 $ 1,500    
Maximum amount per earnout     $ 500    
XML 53 R40.htm IDEA: XBRL DOCUMENT v3.22.4
Inventories - Schedule of Inventories (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Jan. 01, 2022
Inventory Disclosure [Abstract]    
Raw materials $ 21,776 $ 30,280
Work in progress 4,285 9,586
Finished goods 41,028 58,452
Total inventory, net 67,089 98,318
Noncurrent inventories $ 3,479 $ 0
XML 54 R41.htm IDEA: XBRL DOCUMENT v3.22.4
Inventories - Narrative (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Jan. 01, 2022
Inventory [Line Items]    
Noncurrent inventories $ 3,479 $ 0
XML 55 R42.htm IDEA: XBRL DOCUMENT v3.22.4
Prepaid Expenses and Other Current Assets - Prepaid Expenses and Other Current Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Jan. 01, 2022
Prepaid Expense and Other Assets, Current [Abstract]    
Prepaid insurance $ 2,293 $ 3,734
Other prepaid expenses 9,089 10,119
Income taxes receivable 2,030 1,579
Miscellaneous receivables, net 5,183 5,584
Deferred commissions 3,157 2,270
Other current assets 7,121 3,681
Total prepaid expense and other current assets $ 28,873 $ 26,967
XML 56 R43.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Consolidated Earnings Before Income Taxes (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Jan. 02, 2021
Income Tax Disclosure [Abstract]      
U.S. $ (23,996) $ 13,017 $ 18,838
Foreign 132,617 157,625 159,110
Earnings before income taxes $ 108,621 $ 170,642 $ 177,948
XML 57 R44.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Income Tax Expense (Benefit) Included in Income from Continuing Operations (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Jan. 02, 2021
Current      
Federal $ 42 $ (264) $ 306
State 297 567 303
Foreign 45,869 56,668 55,147
Total Current 46,208 56,971 55,756
Deferred      
Federal (9,180) (4,088) 1,317
State (331) (40) (47)
Foreign 2,574 1,294 (3,742)
Total Deferred (6,937) (2,834) (2,472)
Total income tax expense (benefit) $ 39,271 $ 54,137 $ 53,284
XML 58 R45.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Effective Tax Rate Reconciliation (Details)
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Jan. 02, 2021
Income Tax Disclosure [Abstract]      
Statutory U.S. federal income tax rate 21.00% 21.00% 21.00%
State income taxes, net of federal tax benefit 0.40% 0.40% 0.30%
Permanent tax differences 0.30% 0.10% 0.20%
Excess foreign tax credits (16.60%) (10.90%) (9.90%)
Net increase in valuation allowance 11.90% 10.60% 8.20%
Foreign income tax rate differences 9.50% 1.80% 1.70%
Foreign withholding taxes 9.70% 7.90% 7.70%
Uncertain tax position reserve 0.50% (0.30%) 0.80%
All other, net (0.50%) 1.10% (0.10%)
Total effective income tax rate reconciliation, percent 36.20% 31.70% 29.90%
XML 59 R46.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Significant Categories of Deferred Taxes (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Jan. 01, 2022
Deferred tax assets    
Inventory $ 5,872 $ 5,106
Accruals not currently deductible 8,627 11,634
Equity-based compensation expense 2,746 2,355
Property and equipment 922 1,143
Intangible assets 6,680 7,545
Capitalized R&D Expenses 9,618 2,337
Tax credit carry forwards 115,539 96,635
Net operating losses 1,720 1,401
Other 3,223 4,824
Gross deferred tax assets 156,395 132,980
Valuation allowance (118,136) (99,958)
Net deferred tax assets 38,259 33,022
Deferred tax liabilities    
Property and equipment (5,723) (5,268)
Deferred Tax Liabilities, Unrealized Currency Transaction Gains 0 126
Foreign currency translation (1,448) 0
Prepaid expenses (2,990) (3,596)
Intangible assets (6,680) (7,545)
Withholding tax on unremitted earnings (11,639) (13,556)
Other (5,499) (5,589)
Gross deferred tax liabilities (32,531) (35,680)
Net deferred taxes 5,728  
Net deferred taxes   (2,658)
Net deferred tax assets 9,799 4,839
Net deferred tax liabilities $ (4,071) $ (7,497)
XML 60 R47.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Jan. 02, 2021
Dec. 28, 2019
Income Tax Contingency [Line Items]        
Valuation allowance $ 118,136 $ 99,958    
Deferred tax assets, operating loss carryforwards, foreign 1,666      
Deferred tax assets, operating loss carryforwards, state and local 54      
Valuation allowance, deferred tax asset, increase (decrease), amount 18,178      
Undistributed earnings 4,000      
Incremental taxes 400      
Unrecognized tax benefits 1,450 1,008 $ 1,528 $ 560
Income tax expense related to interest and penalties 201 91    
Other Current Liabilities        
Income Tax Contingency [Line Items]        
Unrecognized tax benefits 66 199    
Unrecognized tax benefits, income tax penalties and interest accrued, total 64 162    
Other Noncurrent Liabilities        
Income Tax Contingency [Line Items]        
Unrecognized tax benefits 1,384 809    
Unrecognized tax benefits, income tax penalties and interest accrued, total 239 $ 63    
Mirrored Deferred Tax Assets Recorded in the U.S. to Offset Deferred Tax Liabilities of Foreign Disregarded Entities        
Income Tax Contingency [Line Items]        
Valuation allowance 1,390      
Foreign Operating Loss Carryforwards        
Income Tax Contingency [Line Items]        
Valuation allowance 1,174      
Other Foreign Deferred Tax Assets        
Income Tax Contingency [Line Items]        
Valuation allowance 118,136      
Foreign Tax Authority        
Income Tax Contingency [Line Items]        
Operating loss carryforwards, total 5,296      
Operating loss carryforwards, not subject to expiration 2,808      
Research Tax Credit Carryforward | Foreign Tax Authority        
Income Tax Contingency [Line Items]        
Tax credit carryforward, amount 111,948      
Research Tax Credit Carryforward | State and Local Jurisdiction | Utah State Tax Commission        
Income Tax Contingency [Line Items]        
Tax credit carryforward, amount 1,568      
Research Tax Credit Carryforward | Domestic Tax Authority        
Income Tax Contingency [Line Items]        
Tax credit carryforward, amount $ 2,023      
XML 61 R48.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Unrecognized Tax Benefits (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Jan. 02, 2021
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Beginning balance of unrecognized tax benefits $ 1,008 $ 1,528 $ 560
Increases related to prior year tax positions 107 21 775
Decreases related to prior year tax positions 0 (330) 0
Increases related to current year tax positions 468 424 753
Decreases for settlements with taxing authorities (133) (635) (560)
Ending balance of unrecognized tax benefits $ 1,450 $ 1,008 $ 1,528
XML 62 R49.htm IDEA: XBRL DOCUMENT v3.22.4
Property and Equipment - Cost of Property and Equipment and Estimated Useful Lives (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 209,717 $ 210,883
Less accumulated depreciation and amortization 124,748 121,590
Property and equipment, net, excluding non-depreciable 84,969 89,293
Property and equipment, net $ 97,773 101,780
Buildings    
Property, Plant and Equipment [Line Items]    
Useful life 39 years 6 months  
Property, plant and equipment, gross $ 78,071 80,820
Laboratory and production equipment    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 50,679 47,552
Laboratory and production equipment | Minimum    
Property, Plant and Equipment [Line Items]    
Useful life 5 years  
Laboratory and production equipment | Maximum    
Property, Plant and Equipment [Line Items]    
Useful life 7 years  
Air transportation equipment    
Property, Plant and Equipment [Line Items]    
Useful life 5 years  
Property, plant and equipment, gross $ 2,952 2,952
Computer equipment and software    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 53,436 53,562
Computer equipment and software | Minimum    
Property, Plant and Equipment [Line Items]    
Useful life 3 years  
Computer equipment and software | Maximum    
Property, Plant and Equipment [Line Items]    
Useful life 5 years  
Furniture and fixtures    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 6,198 6,636
Furniture and fixtures | Minimum    
Property, Plant and Equipment [Line Items]    
Useful life 3 years  
Furniture and fixtures | Maximum    
Property, Plant and Equipment [Line Items]    
Useful life 5 years  
Automobiles    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 722 767
Automobiles | Minimum    
Property, Plant and Equipment [Line Items]    
Useful life 3 years  
Automobiles | Maximum    
Property, Plant and Equipment [Line Items]    
Useful life 5 years  
Leasehold improvements    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 14,388 15,212
Leasehold improvements | Minimum    
Property, Plant and Equipment [Line Items]    
Useful life 3 years  
Leasehold improvements | Maximum    
Property, Plant and Equipment [Line Items]    
Useful life 5 years  
Land improvements    
Property, Plant and Equipment [Line Items]    
Useful life 15 years  
Property, plant and equipment, gross $ 3,271 3,382
Land    
Property, Plant and Equipment [Line Items]    
Property and equipment, net 6,723 6,992
Deposits and projects in process    
Property, Plant and Equipment [Line Items]    
Property and equipment, net $ 6,081 $ 5,495
XML 63 R50.htm IDEA: XBRL DOCUMENT v3.22.4
Property and Equipment - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Jan. 02, 2021
Property, Plant and Equipment [Abstract]      
Depreciation $ 11,351 $ 11,661 $ 12,242
XML 64 R51.htm IDEA: XBRL DOCUMENT v3.22.4
Operating Leases - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Jan. 02, 2021
Leases, Operating [Abstract]      
Rent expense $ 8,258 $ 9,830 $ 11,199
XML 65 R52.htm IDEA: XBRL DOCUMENT v3.22.4
Operating Leases - Classification of Lease Assets and Lease Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Jan. 01, 2022
Assets    
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Other assets Other assets
ROU operating lease assets, net $ 19,997 $ 23,789
Total ROU assets $ 19,997 $ 23,789
Current:    
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Other current liabilities Other current liabilities
Operating lease liabilities $ 6,892 $ 7,080
Noncurrent:    
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other long-term liabilities Other long-term liabilities
Operating lease liabilities $ 7,680 $ 10,215
Total lease liabilities $ 14,572 $ 17,295
XML 66 R53.htm IDEA: XBRL DOCUMENT v3.22.4
Operating Leases - Supplemental Lease Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Leases, Operating [Abstract]    
Operating lease cost $ 8,606 $ 9,585
Total lease cost 8,606 9,585
Cash paid for amounts included in the measurement of lease liabilities    
Operating cash flows from operating leases 7,924 9,506
ROU assets obtained in exchange for new operating lease liabilities $ 5,641 $ 5,322
Weighted-average remaining lease term—operating leases 2 years 4 months 20 days 2 years 9 months 3 days
Weighted-average discount rate—operating leases 3.04% 3.11%
XML 67 R54.htm IDEA: XBRL DOCUMENT v3.22.4
Operating Leases - Maturity of Lease Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Jan. 01, 2022
Leases, Operating [Abstract]    
2023 $ 7,214  
2024 5,383  
2025 1,850  
2026 497  
2027 120  
Thereafter 0  
Total operating lease, liability 15,064  
Less: imputed interest (492)  
Present value $ 14,572 $ 17,295
XML 68 R55.htm IDEA: XBRL DOCUMENT v3.22.4
Intangible Assets - Narrative (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Jan. 02, 2021
Goodwill and Intangible Assets Disclosure [Abstract]      
Goodwill, impairment loss $ 0 $ 0 $ 0
Impairment of intangible assets, indefinite-lived (excluding goodwill) 0 0 0
Amortization of intangible assets, total $ 1,723,000 $ 1,182,000 $ 1,326,000
XML 69 R56.htm IDEA: XBRL DOCUMENT v3.22.4
Intangible Assets - Changes in Carrying Amounts of Goodwill (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Goodwill [Roll Forward]    
Gross goodwill $ 17,668 $ 17,367
Goodwill as of beginning of year 17,668 17,367
Goodwill acquired during the year 582 0
Currency translation adjustment (882) 301
Gross goodwill 17,368 17,668
Goodwill as of end of year $ 17,368 $ 17,668
XML 70 R57.htm IDEA: XBRL DOCUMENT v3.22.4
Intangible Assets - Intangible Assets (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Amortized intangible assets    
Finite-lived intangible assets, net carrying amount $ 6,194  
Indefinite-lived intangible assets    
Intangible assets, gross (excluding goodwill) 41,004 $ 42,077
Intangible assets, net 32,432 30,442
Direct sales license    
Indefinite-lived intangible assets    
Indefinite-lived intangible assets (excluding goodwill), direct sales license 26,238 28,464
Trade name and trademarks    
Amortized intangible assets    
Finite-lived intangible assets, gross carrying amount 2,285 4,173
Finite-lived intangible assets, accumulated amortization (114) (4,173)
Finite-lived intangible assets, net carrying amount $ 2,171 $ 0
Finite-lived intangible asset, weighted-average amortization period (years) 10 years 10 years
Product formulas    
Amortized intangible assets    
Finite-lived intangible assets, gross carrying amount $ 8,701 $ 9,440
Finite-lived intangible assets, accumulated amortization (7,983) (7,462)
Finite-lived intangible assets, net carrying amount $ 718 $ 1,978
Finite-lived intangible asset, weighted-average amortization period (years) 8 years 8 years
Customer relationships    
Amortized intangible assets    
Finite-lived intangible assets, gross carrying amount $ 3,313  
Finite-lived intangible assets, accumulated amortization (414)  
Finite-lived intangible assets, net carrying amount $ 2,899  
Finite-lived intangible asset, weighted-average amortization period (years) 4 years  
Non-compete agreements    
Amortized intangible assets    
Finite-lived intangible assets, gross carrying amount $ 467  
Finite-lived intangible assets, accumulated amortization (61)  
Finite-lived intangible assets, net carrying amount $ 406  
Finite-lived intangible asset, weighted-average amortization period (years) 4 years  
XML 71 R58.htm IDEA: XBRL DOCUMENT v3.22.4
Intangible Assets - Estimated Amortization Expense (Details)
$ in Thousands
Dec. 31, 2022
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
2023 $ 1,843
2024 1,224
2025 1,154
2026 692
2027 253
Thereafter 1,028
Total estimated amortization expense $ 6,194
XML 72 R59.htm IDEA: XBRL DOCUMENT v3.22.4
Other Current Liabilities - Other Current Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Jan. 01, 2022
Other Liabilities Disclosure [Abstract]    
Associate incentives $ 55,688 $ 53,929
Accrued employee compensation 17,334 32,366
Deferred revenue 20,875 19,635
Sales taxes 11,234 11,330
Operating lease liabilities 6,892 7,080
Income taxes 4,973 5,193
All other 15,788 17,749
Total other current liabilities $ 132,784 $ 147,282
XML 73 R60.htm IDEA: XBRL DOCUMENT v3.22.4
Line of Credit - Narrative (Details) - Line of Credit
 12 Months Ended
Dec. 31, 2022
USD ($)
Line of Credit Facility [Line Items]  
Line of credit facility, maximum borrowing capacity $ 75,000,000
Line of credit facility, additional increase in maximum borrowing capacity 200,000,000
Long-term line of credit, total 0
Amended and Restated Credit Agreement  
Line of Credit Facility [Line Items]  
Debt instrument covenant, adjusted earnings before interest taxes, depreciation, and amortization $ 100,000,000
Debt instrument, covenant ratio of consolidated funded debt to adjusted earnings before interest, taxes, depreciation, and amortization 2.0
XML 74 R61.htm IDEA: XBRL DOCUMENT v3.22.4
Commitments and Contingencies - Narrative (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
USD ($)
yr
Jan. 01, 2022
USD ($)
Jan. 02, 2021
USD ($)
Commitments and Contingencies Disclosure [Abstract]      
Unrecorded unconditional purchase obligation, to be paid, year one $ 7,163 $ 6,151  
Defined contribution plan, minimum age of employee | yr 18    
Defined contribution plan, requisite service period (month) 1 month    
Defined contribution plan, employer matching contribution, percent of match 100.00%    
Defined contribution plan, employer matching contribution, percent of employees' gross pay 1.00%    
Defined contribution plan, employer matching contribution, match percent exceeding initial match 50.00%    
Defined contribution plan, maximum annual contributions per employee, percent 6.00%    
Defined benefit plan, cliff vesting period (year) 2 years    
Defined contribution plan, employer contribution amount $ 2,589 $ 2,509 $ 2,322
XML 75 R62.htm IDEA: XBRL DOCUMENT v3.22.4
Equity-Based Compensation - Narrative (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Jan. 02, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Equity based compensation expense $ 13,485,000 $ 14,706,000 $ 14,633,000
Share-based payment arrangement, expense, tax benefit $ 2,556,000 $ 2,813,000 2,472,000
Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition (year) 1 year 8 months 12 days    
Share-based compensation arrangement by share-based payment award, grants in period, gross (in shares) 3,877,000    
Share price (in dollars per share) $ 53.20 $ 101.20  
Share-based payment arrangement, decrease for tax withholding obligation $ 4,706,000 $ 3,575,000 2,367,000
Deferred compensation liabilities 85,000 79,000 76,000
Additional Paid-in Capital      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-based payment arrangement, decrease for tax withholding obligation $ 4,706,000 3,575,000 2,367,000
The 2015 Plan      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-based compensation arrangement by share-based payment award, number of shares authorized (in shares) 1,750,000    
Liability Award      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-based payment arrangement, amount capitalized $ 154,000 $ 408,000 $ 239,000
Stock Appreciation Rights (SARs)      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Granted, shares (in shares) 0    
Granted, weighted-average grant date fair value (in dollars per share)   $ 27.12 $ 17.65
Share-based compensation arrangement by share-based payment award, expiration period (year) 4 years 6 months    
Share-based compensation arrangement by share-based payment award, equity instruments other than options, exercises in period, intrinsic value $ 50,000 $ 10,337,000 $ 7,881,000
Share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period, fair value 983,000 3,868,000 3,532,000
Stock Appreciation Rights (SARs) | Additional Paid-in Capital      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-based payment arrangement, decrease for tax withholding obligation $ 0 0 0
Stock Appreciation Rights (SARs) | Vesting Annually      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage 25.00%    
Stock Appreciation Rights (SARs) | The 2015 Plan      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Granted, shares (in shares) 2,924,000    
Deferred Stock Units      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period, fair value $ 0 $ 0 $ 0
Share based compensation arrangement by share based payment award, equity instruments other than options, vested and unreleased in period (in shares) 8 19 23
Deferred Stock Units | Vesting Each Quarter | Share-based Payment Arrangement, Nonemployee      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage 25.00%    
Restricted Stock      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-based compensation arrangement by share-based payment award, shares issued per award exercised (in shares) 1    
Restricted Stock | The 2015 Plan      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Granted, shares (in shares) 953,000    
Restricted Stock Units (RSUs)      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Granted, shares (in shares) 170,000    
Granted, weighted-average grant date fair value (in dollars per share) $ 91.67    
Share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period, fair value $ 12,808,000 $ 11,378,000 $ 7,732,000
Restricted Stock Units (RSUs) | Additional Paid-in Capital      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Adjustments to additional paid in capital $ 4,706,000 $ 3,575,000 $ 2,367,000
Restricted Stock Units (RSUs) | Vesting Annually      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage 25.00%    
Employee Stock | The 2015 Plan      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-based compensation arrangement by share-based payment award, forfeitures (in shares) 1,088,000    
Share-based compensation arrangement by share-based payment award, number of additional shares authorized (in shares) 59,000    
XML 76 R63.htm IDEA: XBRL DOCUMENT v3.22.4
Equity-Based Compensation - Remaining Unrecognized Compensation Expense (Details)
$ in Thousands
Dec. 31, 2022
USD ($)
Share-Based Payment Arrangement [Abstract]  
2023 $ 11,273
2024 7,781
2025 4,117
2026 408
Total remaining unrecognized compensation expense $ 23,579
XML 77 R64.htm IDEA: XBRL DOCUMENT v3.22.4
Equity-Based Compensation - Weighted-average Assumptions (Details) - Stock Appreciation Rights (SARs) - $ / shares
 12 Months Ended
Jan. 01, 2022
Jan. 02, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expected volatility 43.28% 35.23%
Risk-free interest rate 0.33% 1.66%
Expected life 3 years 6 months 3 years 6 months
Expected dividend yield 0.00% 0.00%
Weighted-average exercise price (in dollars per share) $ 85.19 $ 63.02
XML 78 R65.htm IDEA: XBRL DOCUMENT v3.22.4
Equity-Based Compensation - Summary of Stock-settled Stock Appreciation Right Activity (Details) - Stock Appreciation Rights (SARs) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Shares    
Beginning balance outstanding, shares (in shares) 150  
Granted, shares (in shares) 0  
Exercised, shares (in shares) (2)  
Forfeited, shares (in shares) 0  
Expired, shares (in shares) (1)  
Ending balance outstanding, shares (in shares) 147 150
Exercisable, shares (in shares) 72  
Weighted-average exercise price    
Weighted average exercise price, outstanding (in dollars per share) $ 82.16 $ 82.22
Granted, weighted-average exercise price (in dollars per share) 0  
Exercised, weighted-average exercise price (in dollars per share) 63.02  
Forfeited, weighted-average exercise price (in dollars per share) 0  
Expired, weighted-average exercise price (in dollars per share) 116.06  
Exercisable, weighted-average exercise price (in dollars per share) $ 90.63  
Weighted-average remaining contractual term    
Weighted-average remaining contractual term, outstanding (years) 1 year 3 months 18 days 2 years 3 months 18 days
Exercisable, weighted-average remaining contractual term (years) 1 year 1 month 6 days  
Aggregate Intrinsic Value    
Aggregate intrinsic value, outstanding $ 0 $ 3,596
Exercisable, aggregate intrinsic value $ 0  
XML 79 R66.htm IDEA: XBRL DOCUMENT v3.22.4
Equity-Based Compensation - Summary of Stock-settled Restricted Stock Unit Activity (Details) - Restricted Stock Units (RSUs)
shares in Thousands
 12 Months Ended
Dec. 31, 2022
$ / shares
shares
Shares  
Beginning balance outstanding, shares (in shares) | shares 366
Beginning balance outstanding, weighted-average grant date fair value (in dollars per share) | $ / shares $ 80.87
Granted, shares (in shares) | shares 170
Granted, weighted-average grant date fair value (in dollars per share) | $ / shares $ 91.67
Vested, shares (in shares) | shares (142)
Vested, weighted-average grant date fair value (in dollars per share) | $ / shares $ 81.11
Forfeited, shares (in shares) | shares (9)
Forfeited, weighted-average grant date fair value (in dollars per share) | $ / shares $ 83.11
Ending balance outstanding, shares (in shares) | shares 385
Ending balance outstanding, weighted-average grant date fair value (in dollars per share) | $ / shares $ 85.50
XML 80 R67.htm IDEA: XBRL DOCUMENT v3.22.4
Equity-Based Compensation - Summary of Cash-settled Restricted Stock Unit Activity (Details) - Cash-settled Restricted Stock Units
shares in Thousands
 12 Months Ended
Dec. 31, 2022
$ / shares
shares
Shares  
Beginning balance outstanding, shares (in shares) | shares 12
Beginning balance outstanding, weighted-average grant date fair value (in dollars per share) | $ / shares $ 78.66
Granted, shares (in shares) | shares 6
Granted, weighted-average grant date fair value (in dollars per share) | $ / shares $ 91.53
Vested, shares (in shares) | shares (3)
Vested, weighted-average grant date fair value (in dollars per share) | $ / shares $ 79.22
Forfeited, shares (in shares) | shares (3)
Forfeited, weighted-average grant date fair value (in dollars per share) | $ / shares $ 79.67
Ending balance outstanding, shares (in shares) | shares 12
Ending balance outstanding, weighted-average grant date fair value (in dollars per share) | $ / shares $ 84.72
XML 81 R68.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Information - Schedule of Segment Reporting Information, by Operating Segment (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Jan. 02, 2021
Segment Reporting Information [Line Items]      
Net sales $ 998,601 $ 1,186,464 $ 1,134,644
Operating Segments | Direct-selling      
Segment Reporting Information [Line Items]      
Net sales 995,043 1,186,464 1,134,644
Operating Segments | All Other      
Segment Reporting Information [Line Items]      
Net sales $ 3,558 $ 0 $ 0
XML 82 R69.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Information - Schedule of Revenue Percentage By Product (Details) - Product Concentration Risk - Revenue Benchmark
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Jan. 02, 2021
USANA Nutritionals      
Segment Reporting Information [Line Items]      
Concentration risk, percentage 87.00% 86.00% 85.00%
USANA Foods      
Segment Reporting Information [Line Items]      
Concentration risk, percentage 7.00% 7.00% 7.00%
Personal care and Skincare      
Segment Reporting Information [Line Items]      
Concentration risk, percentage 5.00% 6.00% 7.00%
All Other      
Segment Reporting Information [Line Items]      
Concentration risk, percentage 1.00% 1.00% 1.00%
XML 83 R70.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Information - Consolidated Net Sales and Long Lived Assets (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Jan. 02, 2021
Segment Reporting Information [Line Items]      
Net Sales to External Customers $ 998,601 $ 1,186,464 $ 1,134,644
Long-lived Assets 197,267 207,784  
Total Assets 596,549 577,740  
Asia Pacific Total      
Segment Reporting Information [Line Items]      
Net Sales to External Customers 801,916 963,192 915,024
Long-lived Assets 104,894 118,754  
Total Assets 325,618 361,926  
Greater China      
Segment Reporting Information [Line Items]      
Net Sales to External Customers 502,486 563,469 530,505
Long-lived Assets 86,051 95,965  
Total Assets 250,786 274,002  
Southeast Asia Pacific      
Segment Reporting Information [Line Items]      
Net Sales to External Customers 190,478 269,803 269,555
Long-lived Assets 15,226 15,394  
Total Assets 51,880 62,332  
North Asia      
Segment Reporting Information [Line Items]      
Net Sales to External Customers 108,952 129,920 114,964
Long-lived Assets 3,617 7,395  
Total Assets 22,952 25,592  
Americas and Europe      
Segment Reporting Information [Line Items]      
Net Sales to External Customers 196,685 223,272 $ 219,620
Long-lived Assets 92,373 89,030  
Total Assets $ 270,931 $ 215,814  
XML 84 R71.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Information - Markets Representing Ten Percent Or More Of Consolidated Net Sales and Long-Lived Assets (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Jan. 02, 2021
Segment Reporting Information [Line Items]      
Net sales $ 998,601 $ 1,186,464 $ 1,134,644
Long-lived Assets 197,267 207,784  
China      
Segment Reporting Information [Line Items]      
Net sales 453,134 506,103 470,177
Long-lived Assets 83,938 91,530
South Korea      
Segment Reporting Information [Line Items]      
Net sales 106,391 125,835 110,807
China      
Segment Reporting Information [Line Items]      
Net sales 106,087 110,379 107,323
Long-lived Assets $ 89,150 $ 85,350
XML 85 R72.htm IDEA: XBRL DOCUMENT v3.22.4
Common Stock and Earnings Per Share - Schedule of Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Jan. 02, 2021
Earnings Per Share [Abstract]      
Net earnings available to common shareholders $ 69,350 $ 116,505 $ 124,664
Weighted average common shares outstanding - basic (in shares) 19,254 20,146 21,156
Dilutive effect of in-the-money equity awards (in shares) 56 197 100
Weighted average common shares outstanding - diluted (in shares) 19,310 20,343 21,256
Earnings per common share from net earnings - basic (in dollars per share) $ 3.60 $ 5.78 $ 5.89
Earnings per common share from net earnings - diluted (in dollars per share) $ 3.59 $ 5.73 $ 5.86
XML 86 R73.htm IDEA: XBRL DOCUMENT v3.22.4
Common Stock and Earnings Per Share - Schedule of Shares not Included in the Computation of Diluted EPS (Details) - shares
shares in Thousands
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Jan. 02, 2021
Earnings Per Share [Abstract]      
Antidilutive securities excluded from computation of earnings per share, amount 354 60 359
XML 87 R74.htm IDEA: XBRL DOCUMENT v3.22.4
Common Stock and Earnings Per Share - Narrative (Details) - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Jan. 02, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Stock repurchased and retired during period, shares (in shares) 288 1,844 785
Payments for repurchase of common stock $ 25,382 $ 177,837 $ 57,029
XML 88 R75.htm IDEA: XBRL DOCUMENT v3.22.4
Related-Party Transactions - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Jan. 02, 2021
Gull Global, Ltd.    
Related Party Transaction [Line Items]    
Related party transaction, ownership percentage 41.60%  
Amarevita    
Related Party Transaction [Line Items]    
Related party transaction, expenses from transactions with related party   $ 175
XML 89 R76.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule II - Valuation and Qualifying Accounts - Valuation and Qualifying Accounts (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Jan. 02, 2021
Allowance for sales returns      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at beginning of period $ 547 $ 819 $ 772
Charged to costs and expenses 6,562 7,213 115
Deductions 6,537 7,485 68
Balance at end of period 572 547 819
Allowance for doubtful accounts      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at beginning of period 504 372 261
Charged to costs and expenses 6 148 131
Deductions 147 16 20
Balance at end of period 363 504 372
Valuation allowance - deferred tax assets      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at beginning of period 99,958 81,401 64,285
Charged to costs and expenses 18,178 18,557 17,116
Deductions 0 0 0
Balance at end of period $ 118,136 $ 99,958 $ 81,401
XML 90 usna-20221231_htm.xml IDEA: XBRL DOCUMENT 0000896264 2022-01-02 2022-12-31 0000896264 2022-07-01 0000896264 2023-02-24 0000896264 2022-12-31 0000896264 2022-01-01 0000896264 2021-01-03 2022-01-01 0000896264 2019-12-29 2021-01-02 0000896264 us-gaap:CommonStockMember 2019-12-28 0000896264 us-gaap:AdditionalPaidInCapitalMember 2019-12-28 0000896264 us-gaap:RetainedEarningsMember 2019-12-28 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-28 0000896264 2019-12-28 0000896264 us-gaap:CommonStockMember 2019-12-29 2021-01-02 0000896264 us-gaap:AdditionalPaidInCapitalMember 2019-12-29 2021-01-02 0000896264 us-gaap:RetainedEarningsMember 2019-12-29 2021-01-02 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-29 2021-01-02 0000896264 us-gaap:CommonStockMember 2021-01-02 0000896264 us-gaap:AdditionalPaidInCapitalMember 2021-01-02 0000896264 us-gaap:RetainedEarningsMember 2021-01-02 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-02 0000896264 2021-01-02 0000896264 us-gaap:CommonStockMember 2021-01-03 2022-01-01 0000896264 us-gaap:AdditionalPaidInCapitalMember 2021-01-03 2022-01-01 0000896264 us-gaap:RetainedEarningsMember 2021-01-03 2022-01-01 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-03 2022-01-01 0000896264 us-gaap:CommonStockMember 2022-01-01 0000896264 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 0000896264 us-gaap:RetainedEarningsMember 2022-01-01 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 0000896264 us-gaap:CommonStockMember 2022-01-02 2022-12-31 0000896264 us-gaap:AdditionalPaidInCapitalMember 2022-01-02 2022-12-31 0000896264 us-gaap:RetainedEarningsMember 2022-01-02 2022-12-31 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-02 2022-12-31 0000896264 us-gaap:CommonStockMember 2022-12-31 0000896264 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000896264 us-gaap:RetainedEarningsMember 2022-12-31 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000896264 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2022-12-31 0000896264 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2022-01-01 0000896264 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2021-01-02 0000896264 us-gaap:OtherNoncurrentAssetsMember 2022-12-31 0000896264 us-gaap:OtherNoncurrentAssetsMember 2022-01-01 0000896264 us-gaap:OtherNoncurrentAssetsMember 2021-01-02 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000896264 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000896264 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000896264 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000896264 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 0000896264 us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 0000896264 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 0000896264 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 0000896264 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 0000896264 us-gaap:FairValueMeasurementsNonrecurringMember 2022-12-31 0000896264 us-gaap:FairValueMeasurementsNonrecurringMember 2022-01-01 0000896264 usna:AmountsReceivableFromCreditCardProcessorsMember 2022-12-31 0000896264 usna:AmountsReceivableFromCreditCardProcessorsMember 2022-01-01 0000896264 usna:RestrictedCashDepositsInChinaMember 2022-12-31 0000896264 usna:RestrictedCashDepositsInChinaMember 2022-01-01 0000896264 us-gaap:OtherAssetsMember 2022-01-01 0000896264 us-gaap:ForeignExchangeOptionMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 0000896264 us-gaap:ForeignExchangeOptionMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-02 0000896264 us-gaap:ForeignExchangeOptionMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-02 2022-12-31 0000896264 us-gaap:ForeignExchangeOptionMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-29 2021-01-02 0000896264 us-gaap:ForeignExchangeOptionMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-03 2022-01-01 0000896264 us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 0000896264 us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000896264 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SubsequentEventMember 2023-01-18 0000896264 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2022-04-03 2022-07-02 0000896264 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2022-07-02 0000896264 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2022-07-01 2022-12-31 0000896264 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2022-01-02 2022-12-31 0000896264 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2022-12-31 0000896264 us-gaap:ForeignCountryMember us-gaap:ResearchMember 2022-12-31 0000896264 usna:MirroredDeferredTaxAssetsRecordedInTheUsToOffsetDeferredTaxLiabilitiesOfForeignDisregardedEntitiesMember 2022-12-31 0000896264 us-gaap:StateAndLocalJurisdictionMember usna:UtahStateTaxCommissionMember us-gaap:ResearchMember 2022-12-31 0000896264 us-gaap:DomesticCountryMember us-gaap:ResearchMember 2022-12-31 0000896264 us-gaap:ForeignCountryMember 2022-12-31 0000896264 usna:ForeignOperatingLossCarryforwardsMember 2022-12-31 0000896264 usna:OtherForeignDeferredTaxAssetsMember 2022-12-31 0000896264 us-gaap:OtherCurrentLiabilitiesMember 2022-12-31 0000896264 us-gaap:OtherNoncurrentLiabilitiesMember 2022-12-31 0000896264 us-gaap:OtherCurrentLiabilitiesMember 2022-01-01 0000896264 us-gaap:OtherNoncurrentLiabilitiesMember 2022-01-01 0000896264 us-gaap:BuildingMember 2022-01-02 2022-12-31 0000896264 us-gaap:BuildingMember 2022-12-31 0000896264 us-gaap:BuildingMember 2022-01-01 0000896264 srt:MinimumMember usna:LaboratoryAndProductionEquipmentMember 2022-01-02 2022-12-31 0000896264 srt:MaximumMember usna:LaboratoryAndProductionEquipmentMember 2022-01-02 2022-12-31 0000896264 usna:LaboratoryAndProductionEquipmentMember 2022-12-31 0000896264 usna:LaboratoryAndProductionEquipmentMember 2022-01-01 0000896264 us-gaap:AirTransportationEquipmentMember 2022-01-02 2022-12-31 0000896264 us-gaap:AirTransportationEquipmentMember 2022-12-31 0000896264 us-gaap:AirTransportationEquipmentMember 2022-01-01 0000896264 srt:MinimumMember us-gaap:ComputerEquipmentMember 2022-01-02 2022-12-31 0000896264 srt:MaximumMember us-gaap:ComputerEquipmentMember 2022-01-02 2022-12-31 0000896264 us-gaap:ComputerEquipmentMember 2022-12-31 0000896264 us-gaap:ComputerEquipmentMember 2022-01-01 0000896264 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2022-01-02 2022-12-31 0000896264 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2022-01-02 2022-12-31 0000896264 us-gaap:FurnitureAndFixturesMember 2022-12-31 0000896264 us-gaap:FurnitureAndFixturesMember 2022-01-01 0000896264 srt:MinimumMember us-gaap:AutomobilesMember 2022-01-02 2022-12-31 0000896264 srt:MaximumMember us-gaap:AutomobilesMember 2022-01-02 2022-12-31 0000896264 us-gaap:AutomobilesMember 2022-12-31 0000896264 us-gaap:AutomobilesMember 2022-01-01 0000896264 srt:MinimumMember us-gaap:LeaseholdImprovementsMember 2022-01-02 2022-12-31 0000896264 srt:MaximumMember us-gaap:LeaseholdImprovementsMember 2022-01-02 2022-12-31 0000896264 us-gaap:LeaseholdImprovementsMember 2022-12-31 0000896264 us-gaap:LeaseholdImprovementsMember 2022-01-01 0000896264 us-gaap:LandImprovementsMember 2022-01-02 2022-12-31 0000896264 us-gaap:LandImprovementsMember 2022-12-31 0000896264 us-gaap:LandImprovementsMember 2022-01-01 0000896264 us-gaap:LandMember 2022-12-31 0000896264 us-gaap:LandMember 2022-01-01 0000896264 usna:DepositsAndProjectsInProcessMember 2022-12-31 0000896264 usna:DepositsAndProjectsInProcessMember 2022-01-01 0000896264 us-gaap:TrademarksAndTradeNamesMember 2022-12-31 0000896264 us-gaap:TrademarksAndTradeNamesMember 2022-01-02 2022-12-31 0000896264 us-gaap:TradeSecretsMember 2022-12-31 0000896264 us-gaap:TradeSecretsMember 2022-01-02 2022-12-31 0000896264 us-gaap:CustomerRelationshipsMember 2022-12-31 0000896264 us-gaap:CustomerRelationshipsMember 2022-01-02 2022-12-31 0000896264 us-gaap:NoncompeteAgreementsMember 2022-12-31 0000896264 us-gaap:NoncompeteAgreementsMember 2022-01-02 2022-12-31 0000896264 us-gaap:LicensingAgreementsMember 2022-12-31 0000896264 us-gaap:TrademarksAndTradeNamesMember 2022-01-01 0000896264 us-gaap:TrademarksAndTradeNamesMember 2021-01-03 2022-01-01 0000896264 us-gaap:TradeSecretsMember 2022-01-01 0000896264 us-gaap:TradeSecretsMember 2021-01-03 2022-01-01 0000896264 us-gaap:LicensingAgreementsMember 2022-01-01 0000896264 us-gaap:LineOfCreditMember 2022-12-31 0000896264 us-gaap:LineOfCreditMember usna:AmendedAndRestatedCreditAgreementMember 2022-12-31 0000896264 us-gaap:LineOfCreditMember usna:AmendedAndRestatedCreditAgreementMember 2022-01-02 2022-12-31 0000896264 usna:LiabilityAwardMember 2022-01-02 2022-12-31 0000896264 usna:LiabilityAwardMember 2021-01-03 2022-01-01 0000896264 usna:LiabilityAwardMember 2019-12-29 2021-01-02 0000896264 usna:The2015PlanMember 2022-12-31 0000896264 us-gaap:StockAppreciationRightsSARSMember usna:The2015PlanMember 2022-01-02 2022-12-31 0000896264 us-gaap:RestrictedStockMember usna:The2015PlanMember 2022-01-02 2022-12-31 0000896264 us-gaap:EmployeeStockMember usna:The2015PlanMember 2022-01-02 2022-12-31 0000896264 us-gaap:StockAppreciationRightsSARSMember 2022-01-02 2022-12-31 0000896264 us-gaap:StockAppreciationRightsSARSMember 2021-01-03 2022-01-01 0000896264 us-gaap:StockAppreciationRightsSARSMember 2019-12-29 2021-01-02 0000896264 us-gaap:StockAppreciationRightsSARSMember usna:VestingAnnuallyMember 2022-01-02 2022-12-31 0000896264 us-gaap:StockAppreciationRightsSARSMember 2022-01-01 0000896264 us-gaap:StockAppreciationRightsSARSMember 2021-01-02 0000896264 us-gaap:StockAppreciationRightsSARSMember 2022-12-31 0000896264 us-gaap:StockAppreciationRightsSARSMember us-gaap:AdditionalPaidInCapitalMember 2019-12-29 2021-01-02 0000896264 us-gaap:StockAppreciationRightsSARSMember us-gaap:AdditionalPaidInCapitalMember 2021-01-03 2022-01-01 0000896264 us-gaap:RestrictedStockUnitsRSUMember usna:VestingAnnuallyMember 2022-01-02 2022-12-31 0000896264 usna:DeferredStockUnitsMember us-gaap:ShareBasedPaymentArrangementNonemployeeMember usna:VestingEachQuarterMember 2022-01-02 2022-12-31 0000896264 us-gaap:RestrictedStockMember 2022-12-31 0000896264 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 0000896264 us-gaap:RestrictedStockUnitsRSUMember 2022-01-02 2022-12-31 0000896264 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0000896264 us-gaap:RestrictedStockUnitsRSUMember us-gaap:AdditionalPaidInCapitalMember 2022-01-02 2022-12-31 0000896264 us-gaap:RestrictedStockUnitsRSUMember us-gaap:AdditionalPaidInCapitalMember 2021-01-03 2022-01-01 0000896264 us-gaap:RestrictedStockUnitsRSUMember us-gaap:AdditionalPaidInCapitalMember 2019-12-29 2021-01-02 0000896264 us-gaap:RestrictedStockUnitsRSUMember 2021-01-03 2022-01-01 0000896264 us-gaap:RestrictedStockUnitsRSUMember 2019-12-29 2021-01-02 0000896264 usna:CashSettledRestrictedStockUnitsMember 2022-01-01 0000896264 usna:CashSettledRestrictedStockUnitsMember 2022-01-02 2022-12-31 0000896264 usna:CashSettledRestrictedStockUnitsMember 2022-12-31 0000896264 usna:DeferredStockUnitsMember 2022-01-02 2022-12-31 0000896264 usna:DeferredStockUnitsMember 2021-01-03 2022-01-01 0000896264 usna:DeferredStockUnitsMember 2019-12-29 2021-01-02 0000896264 us-gaap:StockAppreciationRightsSARSMember us-gaap:AdditionalPaidInCapitalMember 2022-01-02 2022-12-31 0000896264 us-gaap:OperatingSegmentsMember usna:DirectSellingMember 2022-01-02 2022-12-31 0000896264 us-gaap:OperatingSegmentsMember usna:DirectSellingMember 2021-01-03 2022-01-01 0000896264 us-gaap:OperatingSegmentsMember usna:DirectSellingMember 2019-12-29 2021-01-02 0000896264 us-gaap:OperatingSegmentsMember usna:AllOtherMember 2022-01-02 2022-12-31 0000896264 us-gaap:OperatingSegmentsMember usna:AllOtherMember 2021-01-03 2022-01-01 0000896264 us-gaap:OperatingSegmentsMember usna:AllOtherMember 2019-12-29 2021-01-02 0000896264 usna:USANANutritionalsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-01-02 2022-12-31 0000896264 usna:USANANutritionalsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-01-03 2022-01-01 0000896264 usna:USANANutritionalsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-12-29 2021-01-02 0000896264 usna:USANAFoodsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-01-02 2022-12-31 0000896264 usna:USANAFoodsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-01-03 2022-01-01 0000896264 usna:USANAFoodsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-12-29 2021-01-02 0000896264 usna:PersonalCareAndSkincareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-01-02 2022-12-31 0000896264 usna:PersonalCareAndSkincareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-01-03 2022-01-01 0000896264 usna:PersonalCareAndSkincareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-12-29 2021-01-02 0000896264 usna:AllOtherMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-01-02 2022-12-31 0000896264 usna:AllOtherMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-01-03 2022-01-01 0000896264 usna:AllOtherMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-12-29 2021-01-02 0000896264 usna:GreaterChinaMember 2022-01-02 2022-12-31 0000896264 usna:GreaterChinaMember 2021-01-03 2022-01-01 0000896264 usna:GreaterChinaMember 2019-12-29 2021-01-02 0000896264 usna:SoutheastAsiaPacificMember 2022-01-02 2022-12-31 0000896264 usna:SoutheastAsiaPacificMember 2021-01-03 2022-01-01 0000896264 usna:SoutheastAsiaPacificMember 2019-12-29 2021-01-02 0000896264 usna:NorthAsiaMember 2022-01-02 2022-12-31 0000896264 usna:NorthAsiaMember 2021-01-03 2022-01-01 0000896264 usna:NorthAsiaMember 2019-12-29 2021-01-02 0000896264 srt:AsiaPacificMember 2022-01-02 2022-12-31 0000896264 srt:AsiaPacificMember 2021-01-03 2022-01-01 0000896264 srt:AsiaPacificMember 2019-12-29 2021-01-02 0000896264 usna:AmericasAndEuropeMember 2022-01-02 2022-12-31 0000896264 usna:AmericasAndEuropeMember 2021-01-03 2022-01-01 0000896264 usna:AmericasAndEuropeMember 2019-12-29 2021-01-02 0000896264 usna:GreaterChinaMember 2022-12-31 0000896264 usna:GreaterChinaMember 2022-01-01 0000896264 usna:SoutheastAsiaPacificMember 2022-12-31 0000896264 usna:SoutheastAsiaPacificMember 2022-01-01 0000896264 usna:NorthAsiaMember 2022-12-31 0000896264 usna:NorthAsiaMember 2022-01-01 0000896264 srt:AsiaPacificMember 2022-12-31 0000896264 srt:AsiaPacificMember 2022-01-01 0000896264 usna:AmericasAndEuropeMember 2022-12-31 0000896264 usna:AmericasAndEuropeMember 2022-01-01 0000896264 country:CN 2022-01-02 2022-12-31 0000896264 country:CN 2021-01-03 2022-01-01 0000896264 country:CN 2019-12-29 2021-01-02 0000896264 country:KR 2022-01-02 2022-12-31 0000896264 country:KR 2021-01-03 2022-01-01 0000896264 country:KR 2019-12-29 2021-01-02 0000896264 country:US 2022-01-02 2022-12-31 0000896264 country:US 2021-01-03 2022-01-01 0000896264 country:US 2019-12-29 2021-01-02 0000896264 country:US 2022-12-31 0000896264 country:US 2022-01-01 0000896264 country:US 2021-01-02 0000896264 country:CN 2022-12-31 0000896264 country:CN 2022-01-01 0000896264 country:CN 2021-01-02 0000896264 usna:GullGlobalLtdMember 2022-01-02 2022-12-31 0000896264 usna:AmarevitaMember 2019-12-29 2021-01-02 0000896264 usna:SecSchedule1209AllowanceSalesReturnsMember 2022-01-01 0000896264 usna:SecSchedule1209AllowanceSalesReturnsMember 2022-01-02 2022-12-31 0000896264 usna:SecSchedule1209AllowanceSalesReturnsMember 2022-12-31 0000896264 us-gaap:AllowanceForCreditLossMember 2022-01-01 0000896264 us-gaap:AllowanceForCreditLossMember 2022-01-02 2022-12-31 0000896264 us-gaap:AllowanceForCreditLossMember 2022-12-31 0000896264 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2022-01-01 0000896264 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2022-01-02 2022-12-31 0000896264 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2022-12-31 0000896264 usna:SecSchedule1209AllowanceSalesReturnsMember 2021-01-02 0000896264 usna:SecSchedule1209AllowanceSalesReturnsMember 2021-01-03 2022-01-01 0000896264 us-gaap:AllowanceForCreditLossMember 2021-01-02 0000896264 us-gaap:AllowanceForCreditLossMember 2021-01-03 2022-01-01 0000896264 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2021-01-02 0000896264 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2021-01-03 2022-01-01 0000896264 usna:SecSchedule1209AllowanceSalesReturnsMember 2019-12-28 0000896264 usna:SecSchedule1209AllowanceSalesReturnsMember 2019-12-29 2021-01-02 0000896264 us-gaap:AllowanceForCreditLossMember 2019-12-28 0000896264 us-gaap:AllowanceForCreditLossMember 2019-12-29 2021-01-02 0000896264 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-12-28 0000896264 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-12-29 2021-01-02 iso4217:USD shares iso4217:USD shares usna:region pure usna:period utr:Y 0000896264 FY false 2022 http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent 10-K true 2022-12-31 --12-31 false 001-35024 USANA HEALTH SCIENCES, INC. UT 87-0500306 3838 West Parkway Blvd. Salt Lake City UT 84120 801 954-7100 Common Stock, Par Value $0.001 per share USNA NYSE Yes No Yes Yes Large Accelerated Filer false false true false 1426392900 19294332 KPMG LLP Salt Lake City, Utah 185 288420000 239832000 67089000 98318000 28873000 26967000 384382000 365117000 97773000 101780000 17368000 17668000 32432000 30442000 9799000 4839000 54795000 57894000 596549000 577740000 11049000 13508000 132784000 147282000 143833000 160790000 4071000 7497000 14173000 14329000 0.001 0.001 50000000 50000000 19206000 19206000 19393000 19393000 19000 19000 55604000 50010000 391636000 344637000 -12787000 458000 434472000 395124000 596549000 577740000 998601000 1186464000 1134644000 193890000 217898000 209111000 804711000 968566000 925533000 434793000 519267000 487856000 262304000 279107000 261186000 697097000 798374000 749042000 107614000 170192000 176491000 3789000 2515000 2535000 192000 57000 507000 -2590000 -2008000 -571000 1007000 450000 1457000 108621000 170642000 177948000 39271000 54137000 53284000 69350000 116505000 124664000 3.60 5.78 5.89 3.59 5.73 5.86 19254000 20146000 21156000 19310000 20343000 21256000 69350000 116505000 124664000 -15126000 2203000 13327000 -1881000 -1880000 3051000 -13245000 4083000 10276000 56105000 120588000 134940000 21655000 22000 59445000 306146000 -13901000 351712000 124664000 124664000 10276000 10276000 14394000 14394000 785000 1000 9012000 48016000 57029000 168000 0 0 2367000 2367000 21038000 21000 62460000 382794000 -3625000 441650000 116505000 116505000 4083000 4083000 14298000 14298000 1844000 2000 23173000 154662000 177837000 199000 0 0 3575000 3575000 19393000 19000 50010000 344637000 458000 395124000 69350000 69350000 -13245000 -13245000 13331000 13331000 288000 0 3031000 22351000 25382000 101000 0 0 4706000 4706000 19206000 19000 55604000 391636000 -12787000 434472000 69350000 116505000 124664000 13393000 13036000 13747000 8017000 9157000 8762000 -141000 -61000 -191000 13331000 14298000 14394000 -7183000 -2970000 -2423000 0 0 510000 -21879000 10501000 16784000 3304000 2331000 5192000 -2656000 -4572000 6076000 -9066000 -11456000 16456000 103902000 121227000 160401000 0 116000 281000 4555000 0 1935000 0 1555000 1089000 0 0 20000000 6532000 0 0 7000 15000 6000 10400000 12763000 15094000 -12370000 -14187000 -33961000 25382000 177837000 57029000 11000000 0 60000000 11000000 0 60000000 4706000 3575000 2367000 0 0 46000 -30088000 -181412000 -59442000 -13777000 2088000 11251000 47667000 -72284000 78249000 243653000 315937000 237688000 291320000 243653000 315937000 288420000 239832000 311917000 0 0 958000 2900000 3821000 3062000 291320000 243653000 315937000 49000 10000 711000 45863000 59524000 53015000 113000 191000 847000 5641000 5322000 6632000 0 0 -3182000 679000 383000 375000 886000 0 0 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">COVID-19</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic, including the spread of new variants of the virus, has negatively impacted our business in various markets around the world. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ongoing COVID-19 pandemic has created an unpredictable operating environment for us in many of our markets around the world and caused meaningful disruptions in both sales and operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for fiscal 2022, 2021, and 2020. At this time, the Company is unable to predict the impact that COVID-19 will have on its business, financial position and operating results in future periods due to numerous uncertainties and is closely monitoring the impact of the pandemic on all aspects of its business.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">The Company</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USANA Health Sciences, Inc. is a global direct-selling, personal health and wellness company that develops and manufactures high quality, science-based nutritional and personal care products. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Financial Statements (the “Financial Statements”) include the accounts and operations of the Company, which are grouped and presented in two geographic regions: (1) Asia Pacific and (2) Americas and Europe. Asia Pacific is further divided into three sub-regions: (i) Greater China, (ii) Southeast Asia Pacific, and (iii) North Asia.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asia Pacific</span></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Asia Pacific is organized into three sub-regions: Greater China, Southeast Asia Pacific, and North Asia. Markets included in each of these sub-regions are as follows:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">Greater China - Hong Kong, Taiwan, and China. Our business in China is conducted by BabyCare</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.8pt">Southeast Asia Pacific – Australia, New Zealand, Singapore, Malaysia, the Philippines, Thailand, and Indonesia</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.03pt">North Asia – Japan and South Korea</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Americas and Europe </span></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Americas and Europe – United States, Canada, Mexico, Colombia, and Europe (the United Kingdom, France, Germany, Spain, Italy, Romania, Belgium, and the Netherlands)</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Principles of Consolidation and Basis of Presentation</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Consolidated Financial Statements include the accounts and operations of the Company. All inter-company accounts and transactions have been eliminated in consolidation. The accounting and reporting policies of the Company conform with accounting principles generally accepted in the United States of America (“US GAAP”).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of Consolidated Financial Statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. These estimates may</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be adjusted as more current information becomes available, and any adjustment could be significant.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fiscal Year</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates on a 52/53-week year, ending on the Saturday closest to December 31. Fiscal years 2022 and 2021 were 52-week years. Fiscal year 2020 was a 53-week year. Fiscal year 2022 covered the period January 2, 2022 </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to December 31, 2022 (hereinafter 2022). Fiscal year 2021 covered the period January 3, 2021 to January 1, 2022 (hereinafter 2021). Fiscal year 2020 covered the period December 29, 2019 to January 2, 2021 (hereinafter 2020).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Measurements</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures at fair value certain of its financial and non-financial assets and liabilities by using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price, based on the highest and best use of the asset or liability. The levels of the fair value hierarchy are:</span></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 inputs are quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date.</span></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 inputs are from other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly.</span></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 inputs are unobservable and are used to measure fair value in situations where there is little, if any, market activity for the asset or liability at the measurement date.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022 and January 1, 2022, the following financial assets and liabilities were measured at fair value on a recurring basis using the type of inputs shown:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inputs</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds included in cash equivalents</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,539 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,539 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts included in other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></div></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,632)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,632)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration included in other current liabilities of $(338) and other long-term liabilities of $(548)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(886)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(886)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,871 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,539 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,782)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(886)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inputs</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds included in cash equivalents</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,619 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,619 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts included in other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(461)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(461)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,158 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,619 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(461)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers of financial assets or liabilities between levels of the fair value hierarchy for the periods indicated.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company’s non-financial assets, which include long-lived assets, are not required to be carried at fair value on a recurring basis. However, if an impairment charge is required, a non-financial asset would be written down to fair value. As of December 31, 2022 and January 1, 2022, there were no non-financial assets measured at fair value on a non-recurring basis.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Value of Financial Instruments</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022 and January 1, 2022, the Company’s financial instruments include cash equivalents, restricted cash, other liabilities, and foreign currency contracts. The recorded values of cash equivalents and restricted cash approximate their fair values, based on their short-term nature. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Translation of Foreign Currencies</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The functional currency of the Company’s foreign subsidiaries is the local currency of their country of domicile. Assets and liabilities of the foreign subsidiaries are translated into U.S. dollar amounts at month-end exchange rates. Revenue and expense accounts are translated at the weighted-average rates for the monthly accounting period to which they relate. Equity accounts are translated at historical rates. Foreign currency translation adjustments are accumulated as a component of other comprehensive income. Gains and losses from foreign currency transactions are included in the “Other, net” component of Other income (expense) in the Company’s consolidated statements of comprehensive income.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Business Combinations</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocates the purchase price consideration of the assets acquired and liabilities assumed based on the acquisition date fair values. Additionally, the Company records goodwill for the excess of the total consideration given for the acquired business over the fair value of the identifiable net assets of the acquired business. Transaction costs attributable to the acquisition are expensed as incurred.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash and Cash Equivalents</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with an original maturity of three months or less from the date of purchase to be cash equivalents. Cash equivalents as of December 31, 2022 and January 1, 2022 consisted primarily of money market fund investments and amounts receivable from credit card processors.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts receivable from credit card processors and other forms of electronic payment are considered cash equivalents because they are both short-term and highly liquid in nature and are typically converted to cash within three days of the sales transaction. Amounts receivable from credit card processors as of December 31, 2022 and January 1, 2022 totaled $8,904 and $11,123, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Cash</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to maintain cash deposits with banks in certain subsidiary locations for various operating purposes. The most significant of these cash deposits relates to a deposit held at a bank in China, the balance of which was $2,900 as of December 31, 2022, and $3,146 as of January 1, 2022. This deposit is required for the application of direct sales licenses by the Ministry of Commerce and the State Administration of Market Regulation (“SAMR”) of the People’s Republic of China, and will continue to be restricted during the periods while the Company holds these licenses.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventories</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value. Cost is determined using a standard costing system, which approximates the first-in, first-out method. The components of inventory cost include raw materials, labor, and overhead. Net realizable value is determined using various assumptions with regard to excess or slow-moving inventories, non-conforming inventories, expiration dates, current and future product demand, production planning, and market conditions. A change in any of these variables could result in an adjustment to inventory.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Noncurrent inventory are inventories not expected to be sold within the normal operating cycle. The Company has defined the operating cycle as 52-weeks. Noncurrent inventory is classified in the "Other assets" line item in the Company's consolidated balance sheets. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounts Receivable</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company maintains an allowance for doubtful accounts for estimated losses inherent in its accounts receivable portfolio. In establishing the </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">required allowance, management considers historical losses adjusted to take into account current market conditions and our customers’ financial condition, the amount of receivables in dispute, and the current receivables aging and current payment patterns. The Company reviews its allowance for doubtful accounts regularly. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Accounts Receivable is included in the “Prepaid expenses and other current assets” line item in the Company’s consolidated balance sheets.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Income Taxes</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes using the asset and liability method, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of the differences between the financial statement assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates that are expected to apply to taxable income in the year in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax law is recognized in income in the period that includes the enactment date. Deferred tax expense or benefit is the result of changes in deferred tax assets and liabilities.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the probability of realizing the future benefits of its deferred tax assets and provides a valuation allowance for the portion of any deferred tax assets where the likelihood of realizing an income tax benefit in the future does not meet the “more-likely-than-not” criteria for recognition. The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the Financial Statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. The Company recognizes interest and penalties related to unrecognized tax benefits in income taxes.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Property and Equipment</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are recorded at cost. Maintenance, repairs, and renewals, which neither materially add to the value of the property nor appreciably prolong its life, are charged to expense as incurred. Depreciation is provided in amounts sufficient to relate the cost of depreciable assets to operations over the estimated useful lives of the related assets. The straight-line method of depreciation and amortization is followed for financial statement purposes. Leasehold improvements are amortized over the shorter of the life of the respective lease or the useful life of the improvements. Property and equipment are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When property and equipment are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Leases</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the exception of the Company’s headquarters in Salt Lake City, Utah, and its facilities in New South Wales, Australia, and in Beijing and Tianjin, China, the Company leases its facilities. Each of the facility lease agreements is a non-cancelable operating lease generally structured with renewal options and expires prior to or during 2027. In connection with the production facilities in Beijing and Tianjin, China, the Company has prepaid land use rights, which represents a lease with the associated prepayment recorded as a Right-of-Use (“ROU”) asset. The Company also utilizes equipment under non-cancelable operating leases, expiring through 2026.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At contract inception, the Company determines whether an arrangement is or contains a lease and whether the lease should be classified as an operating or a financing lease. A contract is or contains a lease if the contract conveys the right to control the use of the identified asset for a period of time in exchange for consideration. Control is determined based on the right to obtain all of the economic benefits from use of the identified asset and the right to direct the use of the identified asset. ROU assets for operating leases represent the right to use an underlying asset for the lease term, and operating lease liabilities represent the obligation to make lease payments.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date for leases exceeding 12 months. Minimum lease payments include only the fixed lease component of the agreement, as well as any variable rate payments that depend on an index, initially measured using the </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">index at the lease commencement date. Non-lease components are accounted for separately from the fixed lease component for all leases. Most of the Company’s leases do not provide an implicit rate that can readily be determined. Therefore, the applied discount rate is based on the Company’s incremental borrowing rate, which is determined using its credit rating and other information available as of the commencement date and is the rate of interest it would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. Lease terms may include options to renew, which the Company factors into the determination of the lease term when it is reasonably certain that the Company will exercise that option. The ROU asset is measured at the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense is recognized on a straight-line basis over the lease term and is included in “Cost of sales” and “Selling, general and administrative” line items in the Company’s consolidated statements of comprehensive income. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases is recognized on a straight-line basis over the lease term.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company monitors for events or changes in circumstances that require a reassessment of its leases. When a reassessment results in the remeasurement of a lease liability, a corresponding adjustment is made to the carrying amount of the ROU asset unless doing so would reduce the ROU asset to an amount less than zero, in which case the remaining adjustment would be recorded in the consolidated statements of comprehensive income.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Goodwill</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase price over the fair market value of identifiable net assets of acquired companies. Goodwill is not amortized, but rather is tested at the reporting unit level at least annually for impairment or more frequently if triggering events or changes in circumstances indicate impairment. Initially, qualitative factors are considered to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Some of these qualitative factors may include macroeconomic conditions, industry and market considerations, a change in financial performance, entity-specific events, a sustained decrease in share price, and consideration of the difference between the fair value and carrying amount of a reporting unit as determined in the most recent quantitative assessment. If, through this qualitative assessment, the conclusion is made that it is more likely than not that a reporting unit’s fair value is less than its carrying amount, a quantitative impairment analysis is performed. This analysis involves estimating the fair value of a reporting unit using widely accepted valuation methodologies including the income and market approaches, which requires the use of estimates and assumptions. These estimates and assumptions include revenue growth rates, discount rates, and determination of appropriate market comparables. If the fair value of the reporting unit is less than its carrying amount, an impairment loss is recognized in an amount equal to the excess of the carrying amount over the fair value of the reporting unit, not to exceed the carrying amount of the goodwill. During 2022, 2021, and 2020, no impairment of goodwill was recorded.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Intangible Assets</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets represent amortized and indefinite-lived intangible assets primarily acquired in connection with business combinations. Amortized intangible assets are amortized over their related useful lives, using a straight-line or accelerated method consistent with the underlying expected future cash flows related to the specific intangible asset. Amortized intangible assets are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When indicators of impairment exist, an estimate of undiscounted net cash flows is used in measuring whether the carrying amount of the asset or related asset group is recoverable. Measurement of the amount of impairment, if any, is based upon the difference between the asset or asset group’s carrying value and fair value. Fair value is determined through various valuation techniques, including market and income approaches as considered necessary.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets are not amortized; however, they are tested at least annually for impairment or more frequently if events or changes in circumstances exist that may indicate impairment. Initially, qualitative factors are considered to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. If, through this qualitative assessment, the conclusion is made that it is more likely than not that an indefinite-lived intangible asset’s fair value is less than its carrying amount, a quantitative impairment analysis is performed by comparing the indefinite-lived intangible asset’s carrying amount to its fair value. The fair value for </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">indefinite-lived intangible assets is determined through various valuation techniques, including market and income approaches as considered necessary. The amount of any impairment is measured as the difference between the carrying amount and the fair value of the impaired asset. During 2022, 2021, and 2020, no impairment of indefinite-lived intangible assets was recorded.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investment in Equity Securities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities (“securities”) without readily determinable fair value that are not eligible to be measured in accordance with the net asset value practical expedient qualify for an election to initially estimate fair value using the measurement alternative at its cost. During 2020, the Company entered into a strategic collaboration and made a minority investment in a privately held company, which totaled $20,000 and is included in the “Other assets” line item on the Company’s consolidated balance sheets. The Company, at the time of the investment, elected to apply the measurement alternative, which may be applied to an equity interest on an instrument-by-instrument basis. Dividends received are reported in earnings.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial value of the securities are remeasured to fair value if the securities are impaired or if observable price changes occur. These events are continually monitored and assessed at each reporting period. If a readily determinable fair value becomes available for the securities or observable price changes for the identical or a similar investment of the same issuer occur, the securities are measured at fair value as of the date the observable change occurred. Any resulting gains or losses on the securities for which the observable price changes occur will be recorded in net earnings. During 2022 and 2021, no such observable price changes occurred.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At each reporting period a qualitative assessment is made to consider impairment indicators to determine whether the securities are impaired. Impairment indicators may include but are not limited to earnings performance, business prospects by the investee, cash flows from operations, working capital, and noncompliance with debt covenants. If this qualitative assessment indicates impairment, fair value is determined and an impairment loss equal to the difference between the fair value of the investment and its carrying amount is recognized in net income. During 2022 and 2021, no impairment of securities was recorded.</span></div><div style="margin-top:10pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nonqualified Deferred Compensation</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the Company created a non-qualified deferred compensation plan for a select group of management and highly compensated individuals. The plan permits the deferral of up to 50% of a participant's base salary and/or 80% of a participant's annual incentive bonus. The deferrals are held in an irrevocable rabbi trust (the "Rabbi Trust"), which has been established to administer the plan. The Rabbi Trust is intended to be used as a source of funds to match respective funding obligations to participants. The assets of the trust are subject to the claims of the Company's creditors in the event that the Company becomes insolvent. Consequently, the Rabbi Trust qualifies as a grantor trust for income tax purposes. The Company makes periodic payments into company-owned life insurance policies held in this Rabbi trust to fund the expected obligations arising under this plan. There are no contractual restrictions on the Company's ability to surrender a policy. The assets and liabilities of the plan are included in "Other assets" and "Other long-term liabilities" respectively in the Consolidated Balance Sheets. Changes in the deferred compensation balances are recorded to compensation expense and reflected within the "Selling, general and administrative" line in the Consolidated Statements of Comprehensive Income. As of December 31, 2022 and January 1, 2022, the trustee held total assets of $1,622 and $382, and deferred compensation liabilities of $1,632, and, $390, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Self-Insurance</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is self-insured, up to certain limits, for employee group health claims. The Company has purchased stop-loss insurance on both an individual and an aggregate basis, which will reimburse the Company for individual claims in excess of $175 and aggregate claims that are greater than $13,515. A liability is accrued for all unpaid claims. Total expense under this self-insurance program was $13,413, $12,349, and $11,798 in 2022, 2021, and 2020, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivative Financial Instruments</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s risk management strategy includes the select use of derivative instruments to reduce the effects of volatility in foreign currency exchange exposure on operating results and cash flows. In accordance with the Company’s </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">risk management policies, the Company does not hold or issue derivative instruments for trading or speculative purposes. The Company recognizes all derivative instruments as either assets or liabilities in the balance sheet at their respective fair values. When the Company becomes a party to a derivative instrument and intends to apply hedge accounting, the Company formally documents the hedge relationship and the risk management objective for undertaking the hedge, the nature of risk being hedged, and the hedged transaction, which includes designating the instrument for financial reporting purposes as a fair value hedge, a cash flow hedge, or a net investment hedge. The Company also documents how the hedging instrument’s effectiveness in offsetting the hedged risk will be assessed prospectively and retrospectively, and a description of the method used to measure ineffectiveness.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company periodically uses derivative instruments to hedge the foreign currency exposure of its net investment in foreign subsidiaries into U.S. dollars. Initially, the Company records derivative assets on a gross basis in its consolidated balance sheets. Subsequently the fair value of derivatives is measured for each reporting period. The effective portion of gains and losses attributable to these net investment hedges is recorded to foreign currency translation adjustment (“FCTA”) within accumulated other comprehensive income (loss) (“AOCI”) to offset the change in the carrying value of the net investment being hedged, and will subsequently be reclassified to net earnings in the period in which the hedged investment is either sold or substantially liquidated.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, the Company settled a forward contract with a notional amount of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$98,930. During 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2020, the Company settled European options with notional amounts of $98,684 and $90,000, respectively. Both the forward contract and the European options were designated as net investment hedges. The Company realized a gain of $4,555 and $846 in 2022 and 2020, respectively, and realized a loss of $1,555 in 2021, recorded to FCTA within AOCI. The Company assessed hedge effectiveness under the forward rate method, determining the hedging instruments were highly effective. As of December 31, 2022 and January 1, 2022, there were no derivatives outstanding for which the Company has applied hedge accounting. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, on January 18, 2023 the Company entered into an option contract designated as a net investment hedge with a notional amount of $81,343.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Common Stock Share Repurchases</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a stock repurchase plan in place that has been authorized by the Board of Directors. As of December 31, 2022, $82,839 is available to repurchase shares under this plan. The excess of the repurchase price over par value is allocated between additional paid-in capital and retained earnings on a pro-rata basis. There currently is no expiration date on the remaining approved repurchase amount and no requirement for future share repurchases.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revenue Recognition</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when, or as, control of a promised product or service transfers to a customer, in an amount that reflects the consideration to which the Company expects to be entitled in exchange for transferring those products or services. Revenue excludes taxes that have been assessed by governmental authorities and that are directly imposed on revenue-producing transactions between the Company and its customers, including sales, use, value-added, and some excise taxes. Revenue recognition is evaluated through the following five-step process:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">identification of the contract with a customer;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">identification of the performance obligations in the contract;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">determination of the transaction price;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">allocation of the transaction price to the performance obligations in the contract; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">recognition of revenue when or as a performance obligation is satisfied.</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Revenue</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A majority of the Company’s sales are for products sold at a point in time and shipped to customers, for which control is transferred to the customer as goods are delivered to the third party carrier for shipment. The Company receives payment, primarily via credit card, for the sale of products at the time customers place orders and payment is required prior to shipment. The Company does not recognize assets associated with costs to obtain or fulfill a contract with a customer.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s product sales contracts include terms that could cause variability in the transaction price for items such as discounts, product promotions, credits, or sales returns, which are a reduction of revenue. Accordingly, the transaction price for product sales includes estimates of variable consideration to the extent it is probable that a significant reversal of revenue recognized will not occur. At the time of sale, the Company estimates a refund liability for the variable consideration based on historical experience, which is recorded within the “Other current liabilities” line item in the consolidated balance sheets.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Initial product orders with a new customer may include multiple performance obligations related to sales discounts earned under the Company’s initial order reward program. Under this program, the customer receives an option to apply the discounts earned on the initial order to two subsequent Auto Orders, which conveys a material right to the customer. As such, the initial order transaction price is allocated to each separate performance obligation based on its relative standalone selling price and is recognized as revenue as each performance obligation is satisfied.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Associate incentives represent consideration paid to an Associate for distinct services provided in the sale of the Company's products and include all forms of commissions, and other incentives paid to our Associates. The Company may provide Associate incentive promotions which are earned by Associates for distinct services rendered. Associate incentive promotions are recorded as the incentives are earned by the Associates. With the exception of commissions paid to Associates on personal purchases, which are considered a sales discount and are reported as a reduction to net sales, Associate incentives are recorded as an operating expense. The amounts paid to Associates are commensurate with the fair value received for the distinct services rendered by Associates and are recorded as an operating expense when revenue for the goods is recognized.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling activities are performed upon delivery to the third party carrier for shipment. The Company accounts for these activities as fulfillment costs. Therefore, the Company recognizes the costs of these activities when revenue for the goods is recognized. Shipping and handling costs are included in cost of sales for all periods presented.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to will-call orders, the Company periodically assesses the likelihood that customers will exercise their contractual right to pick up orders and revenue is recognized when the likelihood that customers will pick up orders is remote.</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Revenue</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other types of revenue include fees, which are paid by the customer at the beginning of the service period, for access to online customer service applications and annual account renewal fees for Associates, for which control is transferred over time as services are delivered and are recognized as revenue on a straight-line basis over the term of the respective contracts.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents Other Revenue for the periods indicated:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Revenue</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,452 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,805 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Disaggregation</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disaggregation of revenue by geographical region and major product line is included in Note M – Segment Information.</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the timing of our provision of goods or services is different from the timing of the payments made by our customers, we recognize either a contract asset (performance precedes contractual due date) or a contract liability (customer payment precedes performance).</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities relate to deferred revenue for product sales for customer payments received in advance of shipment, for outstanding material rights under the initial order program, and for services where the performance obligations are satisfied over time as services are delivered. Contract liabilities are recorded as deferred revenue within the "Other current liabilities" line item in the consolidated balance sheets. The Company typically does not have contract assets based on the payment terms included in the Company’s contracts and the balance of contract assets was $0 at December 31, 2022 and January 1, 2022.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about contract liabilities from contracts with customers, including significant changes in the contract liabilities balances during the period.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities at beginning of period</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,635 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,952 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to deferral of revenue at period end</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,875 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,635 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease due to beginning contract liabilities recognized as revenue</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,635)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,952)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,875 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,635 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Product Return Policy</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All product orders that are unused and returned within the first 30 days following purchase are refunded at 100% of the sales price. All product orders that are unused and resalable are refunded up to one year from the date of purchase at 100% of the sales price. This standard policy differs in a few of our international markets due to the regulatory environment in those markets. Depending upon the conditions under which product was returned, customers may either receive a refund based on their original form of payment, or credit on account for a product exchange. The Company monitors Associate activity to ensure that all such practices are in line with established Company policies. Product returns totaled approximately 0.7%, 0.6%, and 0.7% of net sales in 2022, 2021, and 2020, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Associate Incentives</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Associate incentives expenses include all forms of commissions, and other incentives paid to our Associates, less commissions paid to Associates on personal purchases, which are considered a sales discount and are reported as a reduction to net sales.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Selling, General and Administrative</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses include wages and benefits, depreciation and amortization, rents and utilities, Associate event costs, advertising and professional fees, marketing, and research and development expenses.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Equity-Based Compensation</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records compensation expense in the Financial Statements for equity-based awards based on the grant date fair value, which for restricted stock units is the closing market value of the Company’s common stock on the date of the grant. The grant date fair value of each stock-settled stock appreciation right is based upon the Black-Scholes option pricing model. Equity-based compensation expense is recognized under the straight-line method over the period that service is provided, which is generally the vesting term. Further information regarding equity awards can be found in Note </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a href="#i573ef11f9cdc4355910846a151634a4c_238" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">L</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Equity-Based Compensation.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Advertising</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs are charged to expense as incurred and are presented as part of the “Selling, general and administrative” line item. Advertising expense totaled $5,053, $12,399, and $9,853, in 2022, 2021, and 2020, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Research and Development</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are charged to expense as incurred and are presented as part of the “Selling, general and administrative” line item. Research and development expense totaled $11,563, $11,112, and $10,633 in 2022, 2021, and 2020, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Earnings Per Share</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per common share ("EPS") are based on the weighted-average number of common shares that were outstanding during each period. Diluted EPS include the effect of potentially dilutive common shares calculated using the treasury stock method, which include in-the-money, equity-based awards that have been granted but have not been issued. When there is a loss, potential common shares are not included in the computation of diluted EPS, because to do so would be anti-dilutive.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recent Accounting Pronouncements</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2021-08 requires an acquirer to recognize and measure contract assets and contract liabilities (deferred revenue) acquired in a business combination in accordance with Revenue from Contracts with Customers (Topic 606). Under this approach, the acquirer applies the revenue model as if it had originated the contracts. This is a departure from the current requirement to measure contract assets and contract liabilities at fair value at the acquisition date. ASU 2021-08 is effective for annual periods beginning after December 15, 2022 and interim periods within those annual periods. ASU 2021-08 should be applied prospectively to business combinations occurring on or after the date of adoption. Evaluation of this new standard is dependent on multiple circumstances including the timing and complexity of completed business combinations. As a result, the Company intends to adopt the provisions of ASU 2021-08 in the first quarter of 2023.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">COVID-19</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic, including the spread of new variants of the virus, has negatively impacted our business in various markets around the world. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ongoing COVID-19 pandemic has created an unpredictable operating environment for us in many of our markets around the world and caused meaningful disruptions in both sales and operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for fiscal 2022, 2021, and 2020. At this time, the Company is unable to predict the impact that COVID-19 will have on its business, financial position and operating results in future periods due to numerous uncertainties and is closely monitoring the impact of the pandemic on all aspects of its business.</span></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">The Company</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USANA Health Sciences, Inc. is a global direct-selling, personal health and wellness company that develops and manufactures high quality, science-based nutritional and personal care products. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Financial Statements (the “Financial Statements”) include the accounts and operations of the Company, which are grouped and presented in two geographic regions: (1) Asia Pacific and (2) Americas and Europe. Asia Pacific is further divided into three sub-regions: (i) Greater China, (ii) Southeast Asia Pacific, and (iii) North Asia.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asia Pacific</span></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Asia Pacific is organized into three sub-regions: Greater China, Southeast Asia Pacific, and North Asia. Markets included in each of these sub-regions are as follows:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">Greater China - Hong Kong, Taiwan, and China. Our business in China is conducted by BabyCare</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.8pt">Southeast Asia Pacific – Australia, New Zealand, Singapore, Malaysia, the Philippines, Thailand, and Indonesia</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.03pt">North Asia – Japan and South Korea</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Americas and Europe </span></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Americas and Europe – United States, Canada, Mexico, Colombia, and Europe (the United Kingdom, France, Germany, Spain, Italy, Romania, Belgium, and the Netherlands)</span></div> 2 3 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Principles of Consolidation and Basis of Presentation</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Consolidated Financial Statements include the accounts and operations of the Company. All inter-company accounts and transactions have been eliminated in consolidation. The accounting and reporting policies of the Company conform with accounting principles generally accepted in the United States of America (“US GAAP”).</span></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of Consolidated Financial Statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. These estimates may</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be adjusted as more current information becomes available, and any adjustment could be significant.</span></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fiscal Year</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates on a 52/53-week year, ending on the Saturday closest to December 31. Fiscal years 2022 and 2021 were 52-week years. Fiscal year 2020 was a 53-week year. Fiscal year 2022 covered the period January 2, 2022 </span></div>to December 31, 2022 (hereinafter 2022). Fiscal year 2021 covered the period January 3, 2021 to January 1, 2022 (hereinafter 2021). Fiscal year 2020 covered the period December 29, 2019 to January 2, 2021 (hereinafter 2020). <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Measurements</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures at fair value certain of its financial and non-financial assets and liabilities by using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price, based on the highest and best use of the asset or liability. The levels of the fair value hierarchy are:</span></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 inputs are quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date.</span></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 inputs are from other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly.</span></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 inputs are unobservable and are used to measure fair value in situations where there is little, if any, market activity for the asset or liability at the measurement date.</span></div> <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022 and January 1, 2022, the following financial assets and liabilities were measured at fair value on a recurring basis using the type of inputs shown:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inputs</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds included in cash equivalents</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,539 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,539 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts included in other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></div></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,632)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,632)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration included in other current liabilities of $(338) and other long-term liabilities of $(548)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(886)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(886)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,871 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,539 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,782)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(886)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inputs</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds included in cash equivalents</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,619 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,619 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts included in other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(461)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(461)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,158 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,619 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(461)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 211539000 211539000 0 0 3150000 0 3150000 0 1632000 0 1632000 0 338000 548000 886000 0 0 886000 205871000 211539000 -4782000 -886000 163619000 163619000 0 0 461000 0 461000 0 163158000 163619000 -461000 0 0 0 Fair Value of Financial InstrumentsAs of December 31, 2022 and January 1, 2022, the Company’s financial instruments include cash equivalents, restricted cash, other liabilities, and foreign currency contracts. The recorded values of cash equivalents and restricted cash approximate their fair values, based on their short-term nature. <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Translation of Foreign Currencies</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The functional currency of the Company’s foreign subsidiaries is the local currency of their country of domicile. Assets and liabilities of the foreign subsidiaries are translated into U.S. dollar amounts at month-end exchange rates. Revenue and expense accounts are translated at the weighted-average rates for the monthly accounting period to which they relate. Equity accounts are translated at historical rates. Foreign currency translation adjustments are accumulated as a component of other comprehensive income. Gains and losses from foreign currency transactions are included in the “Other, net” component of Other income (expense) in the Company’s consolidated statements of comprehensive income.</span></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Business Combinations</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocates the purchase price consideration of the assets acquired and liabilities assumed based on the acquisition date fair values. Additionally, the Company records goodwill for the excess of the total consideration given for the acquired business over the fair value of the identifiable net assets of the acquired business. Transaction costs attributable to the acquisition are expensed as incurred.</span></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash and Cash Equivalents</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with an original maturity of three months or less from the date of purchase to be cash equivalents. Cash equivalents as of December 31, 2022 and January 1, 2022 consisted primarily of money market fund investments and amounts receivable from credit card processors.</span></div>Amounts receivable from credit card processors and other forms of electronic payment are considered cash equivalents because they are both short-term and highly liquid in nature and are typically converted to cash within three days of the sales transaction. 8904000 11123000 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Cash</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to maintain cash deposits with banks in certain subsidiary locations for various operating purposes. The most significant of these cash deposits relates to a deposit held at a bank in China, the balance of which was $2,900 as of December 31, 2022, and $3,146 as of January 1, 2022. This deposit is required for the application of direct sales licenses by the Ministry of Commerce and the State Administration of Market Regulation (“SAMR”) of the People’s Republic of China, and will continue to be restricted during the periods while the Company holds these licenses.</span></div> 2900000 3146000 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventories</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value. Cost is determined using a standard costing system, which approximates the first-in, first-out method. The components of inventory cost include raw materials, labor, and overhead. Net realizable value is determined using various assumptions with regard to excess or slow-moving inventories, non-conforming inventories, expiration dates, current and future product demand, production planning, and market conditions. A change in any of these variables could result in an adjustment to inventory.</span></div>Noncurrent inventory are inventories not expected to be sold within the normal operating cycle. The Company has defined the operating cycle as 52-weeks. Noncurrent inventory is classified in the "Other assets" line item in the Company's consolidated balance sheets. <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounts Receivable</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company maintains an allowance for doubtful accounts for estimated losses inherent in its accounts receivable portfolio. In establishing the </span></div>required allowance, management considers historical losses adjusted to take into account current market conditions and our customers’ financial condition, the amount of receivables in dispute, and the current receivables aging and current payment patterns. The Company reviews its allowance for doubtful accounts regularly. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Accounts Receivable is included in the “Prepaid expenses and other current assets” line item in the Company’s consolidated balance sheets. <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Income Taxes</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes using the asset and liability method, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of the differences between the financial statement assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates that are expected to apply to taxable income in the year in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax law is recognized in income in the period that includes the enactment date. Deferred tax expense or benefit is the result of changes in deferred tax assets and liabilities.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the probability of realizing the future benefits of its deferred tax assets and provides a valuation allowance for the portion of any deferred tax assets where the likelihood of realizing an income tax benefit in the future does not meet the “more-likely-than-not” criteria for recognition. The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the Financial Statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. The Company recognizes interest and penalties related to unrecognized tax benefits in income taxes.</span></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Property and Equipment</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are recorded at cost. Maintenance, repairs, and renewals, which neither materially add to the value of the property nor appreciably prolong its life, are charged to expense as incurred. Depreciation is provided in amounts sufficient to relate the cost of depreciable assets to operations over the estimated useful lives of the related assets. The straight-line method of depreciation and amortization is followed for financial statement purposes. Leasehold improvements are amortized over the shorter of the life of the respective lease or the useful life of the improvements. Property and equipment are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When property and equipment are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period.</span></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Leases</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the exception of the Company’s headquarters in Salt Lake City, Utah, and its facilities in New South Wales, Australia, and in Beijing and Tianjin, China, the Company leases its facilities. Each of the facility lease agreements is a non-cancelable operating lease generally structured with renewal options and expires prior to or during 2027. In connection with the production facilities in Beijing and Tianjin, China, the Company has prepaid land use rights, which represents a lease with the associated prepayment recorded as a Right-of-Use (“ROU”) asset. The Company also utilizes equipment under non-cancelable operating leases, expiring through 2026.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At contract inception, the Company determines whether an arrangement is or contains a lease and whether the lease should be classified as an operating or a financing lease. A contract is or contains a lease if the contract conveys the right to control the use of the identified asset for a period of time in exchange for consideration. Control is determined based on the right to obtain all of the economic benefits from use of the identified asset and the right to direct the use of the identified asset. ROU assets for operating leases represent the right to use an underlying asset for the lease term, and operating lease liabilities represent the obligation to make lease payments.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date for leases exceeding 12 months. Minimum lease payments include only the fixed lease component of the agreement, as well as any variable rate payments that depend on an index, initially measured using the </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">index at the lease commencement date. Non-lease components are accounted for separately from the fixed lease component for all leases. Most of the Company’s leases do not provide an implicit rate that can readily be determined. Therefore, the applied discount rate is based on the Company’s incremental borrowing rate, which is determined using its credit rating and other information available as of the commencement date and is the rate of interest it would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. Lease terms may include options to renew, which the Company factors into the determination of the lease term when it is reasonably certain that the Company will exercise that option. The ROU asset is measured at the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense is recognized on a straight-line basis over the lease term and is included in “Cost of sales” and “Selling, general and administrative” line items in the Company’s consolidated statements of comprehensive income. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases is recognized on a straight-line basis over the lease term.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company monitors for events or changes in circumstances that require a reassessment of its leases. When a reassessment results in the remeasurement of a lease liability, a corresponding adjustment is made to the carrying amount of the ROU asset unless doing so would reduce the ROU asset to an amount less than zero, in which case the remaining adjustment would be recorded in the consolidated statements of comprehensive income.</span></div> GoodwillGoodwill represents the excess of the purchase price over the fair market value of identifiable net assets of acquired companies. Goodwill is not amortized, but rather is tested at the reporting unit level at least annually for impairment or more frequently if triggering events or changes in circumstances indicate impairment. Initially, qualitative factors are considered to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Some of these qualitative factors may include macroeconomic conditions, industry and market considerations, a change in financial performance, entity-specific events, a sustained decrease in share price, and consideration of the difference between the fair value and carrying amount of a reporting unit as determined in the most recent quantitative assessment. If, through this qualitative assessment, the conclusion is made that it is more likely than not that a reporting unit’s fair value is less than its carrying amount, a quantitative impairment analysis is performed. This analysis involves estimating the fair value of a reporting unit using widely accepted valuation methodologies including the income and market approaches, which requires the use of estimates and assumptions. These estimates and assumptions include revenue growth rates, discount rates, and determination of appropriate market comparables. If the fair value of the reporting unit is less than its carrying amount, an impairment loss is recognized in an amount equal to the excess of the carrying amount over the fair value of the reporting unit, not to exceed the carrying amount of the goodwill. 0 0 0 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Intangible Assets</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets represent amortized and indefinite-lived intangible assets primarily acquired in connection with business combinations. Amortized intangible assets are amortized over their related useful lives, using a straight-line or accelerated method consistent with the underlying expected future cash flows related to the specific intangible asset. Amortized intangible assets are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When indicators of impairment exist, an estimate of undiscounted net cash flows is used in measuring whether the carrying amount of the asset or related asset group is recoverable. Measurement of the amount of impairment, if any, is based upon the difference between the asset or asset group’s carrying value and fair value. Fair value is determined through various valuation techniques, including market and income approaches as considered necessary.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets are not amortized; however, they are tested at least annually for impairment or more frequently if events or changes in circumstances exist that may indicate impairment. Initially, qualitative factors are considered to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. If, through this qualitative assessment, the conclusion is made that it is more likely than not that an indefinite-lived intangible asset’s fair value is less than its carrying amount, a quantitative impairment analysis is performed by comparing the indefinite-lived intangible asset’s carrying amount to its fair value. The fair value for </span></div>indefinite-lived intangible assets is determined through various valuation techniques, including market and income approaches as considered necessary. The amount of any impairment is measured as the difference between the carrying amount and the fair value of the impaired asset. 0 0 0 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investment in Equity Securities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities (“securities”) without readily determinable fair value that are not eligible to be measured in accordance with the net asset value practical expedient qualify for an election to initially estimate fair value using the measurement alternative at its cost. During 2020, the Company entered into a strategic collaboration and made a minority investment in a privately held company, which totaled $20,000 and is included in the “Other assets” line item on the Company’s consolidated balance sheets. The Company, at the time of the investment, elected to apply the measurement alternative, which may be applied to an equity interest on an instrument-by-instrument basis. Dividends received are reported in earnings.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial value of the securities are remeasured to fair value if the securities are impaired or if observable price changes occur. These events are continually monitored and assessed at each reporting period. If a readily determinable fair value becomes available for the securities or observable price changes for the identical or a similar investment of the same issuer occur, the securities are measured at fair value as of the date the observable change occurred. Any resulting gains or losses on the securities for which the observable price changes occur will be recorded in net earnings. During 2022 and 2021, no such observable price changes occurred.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At each reporting period a qualitative assessment is made to consider impairment indicators to determine whether the securities are impaired. Impairment indicators may include but are not limited to earnings performance, business prospects by the investee, cash flows from operations, working capital, and noncompliance with debt covenants. If this qualitative assessment indicates impairment, fair value is determined and an impairment loss equal to the difference between the fair value of the investment and its carrying amount is recognized in net income. During 2022 and 2021, no impairment of securities was recorded.</span></div> 20000000 0 0 0 0 Nonqualified Deferred CompensationIn 2021, the Company created a non-qualified deferred compensation plan for a select group of management and highly compensated individuals. The plan permits the deferral of up to 50% of a participant's base salary and/or 80% of a participant's annual incentive bonus. The deferrals are held in an irrevocable rabbi trust (the "Rabbi Trust"), which has been established to administer the plan. The Rabbi Trust is intended to be used as a source of funds to match respective funding obligations to participants. The assets of the trust are subject to the claims of the Company's creditors in the event that the Company becomes insolvent. Consequently, the Rabbi Trust qualifies as a grantor trust for income tax purposes. The Company makes periodic payments into company-owned life insurance policies held in this Rabbi trust to fund the expected obligations arising under this plan. There are no contractual restrictions on the Company's ability to surrender a policy. The assets and liabilities of the plan are included in "Other assets" and "Other long-term liabilities" respectively in the Consolidated Balance Sheets. Changes in the deferred compensation balances are recorded to compensation expense and reflected within the "Selling, general and administrative" line in the Consolidated Statements of Comprehensive Income. 0.50 0.80 1622000 382000 1632000 390000 Self-InsuranceThe Company is self-insured, up to certain limits, for employee group health claims. The Company has purchased stop-loss insurance on both an individual and an aggregate basis, which will reimburse the Company for individual claims in excess of $175 and aggregate claims that are greater than $13,515. A liability is accrued for all unpaid claims. 175000 13515000 13413000 12349000 11798000 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivative Financial Instruments</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s risk management strategy includes the select use of derivative instruments to reduce the effects of volatility in foreign currency exchange exposure on operating results and cash flows. In accordance with the Company’s </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">risk management policies, the Company does not hold or issue derivative instruments for trading or speculative purposes. The Company recognizes all derivative instruments as either assets or liabilities in the balance sheet at their respective fair values. When the Company becomes a party to a derivative instrument and intends to apply hedge accounting, the Company formally documents the hedge relationship and the risk management objective for undertaking the hedge, the nature of risk being hedged, and the hedged transaction, which includes designating the instrument for financial reporting purposes as a fair value hedge, a cash flow hedge, or a net investment hedge. The Company also documents how the hedging instrument’s effectiveness in offsetting the hedged risk will be assessed prospectively and retrospectively, and a description of the method used to measure ineffectiveness.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company periodically uses derivative instruments to hedge the foreign currency exposure of its net investment in foreign subsidiaries into U.S. dollars. Initially, the Company records derivative assets on a gross basis in its consolidated balance sheets. Subsequently the fair value of derivatives is measured for each reporting period. The effective portion of gains and losses attributable to these net investment hedges is recorded to foreign currency translation adjustment (“FCTA”) within accumulated other comprehensive income (loss) (“AOCI”) to offset the change in the carrying value of the net investment being hedged, and will subsequently be reclassified to net earnings in the period in which the hedged investment is either sold or substantially liquidated.</span></div> 98930000 98684000 90000000 4555000 846000 1555000 0 0 81343000 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Common Stock Share Repurchases</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a stock repurchase plan in place that has been authorized by the Board of Directors. As of December 31, 2022, $82,839 is available to repurchase shares under this plan. The excess of the repurchase price over par value is allocated between additional paid-in capital and retained earnings on a pro-rata basis. There currently is no expiration date on the remaining approved repurchase amount and no requirement for future share repurchases.</span></div> 82839000 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revenue Recognition</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when, or as, control of a promised product or service transfers to a customer, in an amount that reflects the consideration to which the Company expects to be entitled in exchange for transferring those products or services. Revenue excludes taxes that have been assessed by governmental authorities and that are directly imposed on revenue-producing transactions between the Company and its customers, including sales, use, value-added, and some excise taxes. Revenue recognition is evaluated through the following five-step process:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">identification of the contract with a customer;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">identification of the performance obligations in the contract;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">determination of the transaction price;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">allocation of the transaction price to the performance obligations in the contract; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">recognition of revenue when or as a performance obligation is satisfied.</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Revenue</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A majority of the Company’s sales are for products sold at a point in time and shipped to customers, for which control is transferred to the customer as goods are delivered to the third party carrier for shipment. The Company receives payment, primarily via credit card, for the sale of products at the time customers place orders and payment is required prior to shipment. The Company does not recognize assets associated with costs to obtain or fulfill a contract with a customer.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s product sales contracts include terms that could cause variability in the transaction price for items such as discounts, product promotions, credits, or sales returns, which are a reduction of revenue. Accordingly, the transaction price for product sales includes estimates of variable consideration to the extent it is probable that a significant reversal of revenue recognized will not occur. At the time of sale, the Company estimates a refund liability for the variable consideration based on historical experience, which is recorded within the “Other current liabilities” line item in the consolidated balance sheets.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Initial product orders with a new customer may include multiple performance obligations related to sales discounts earned under the Company’s initial order reward program. Under this program, the customer receives an option to apply the discounts earned on the initial order to two subsequent Auto Orders, which conveys a material right to the customer. As such, the initial order transaction price is allocated to each separate performance obligation based on its relative standalone selling price and is recognized as revenue as each performance obligation is satisfied.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Associate incentives represent consideration paid to an Associate for distinct services provided in the sale of the Company's products and include all forms of commissions, and other incentives paid to our Associates. The Company may provide Associate incentive promotions which are earned by Associates for distinct services rendered. Associate incentive promotions are recorded as the incentives are earned by the Associates. With the exception of commissions paid to Associates on personal purchases, which are considered a sales discount and are reported as a reduction to net sales, Associate incentives are recorded as an operating expense. The amounts paid to Associates are commensurate with the fair value received for the distinct services rendered by Associates and are recorded as an operating expense when revenue for the goods is recognized.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling activities are performed upon delivery to the third party carrier for shipment. The Company accounts for these activities as fulfillment costs. Therefore, the Company recognizes the costs of these activities when revenue for the goods is recognized. Shipping and handling costs are included in cost of sales for all periods presented.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to will-call orders, the Company periodically assesses the likelihood that customers will exercise their contractual right to pick up orders and revenue is recognized when the likelihood that customers will pick up orders is remote.</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Revenue</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other types of revenue include fees, which are paid by the customer at the beginning of the service period, for access to online customer service applications and annual account renewal fees for Associates, for which control is transferred over time as services are delivered and are recognized as revenue on a straight-line basis over the term of the respective contracts.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents Other Revenue for the periods indicated:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Revenue</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,452 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,805 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Disaggregation</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disaggregation of revenue by geographical region and major product line is included in Note M – Segment Information.</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the timing of our provision of goods or services is different from the timing of the payments made by our customers, we recognize either a contract asset (performance precedes contractual due date) or a contract liability (customer payment precedes performance).</span></div>Contract liabilities relate to deferred revenue for product sales for customer payments received in advance of shipment, for outstanding material rights under the initial order program, and for services where the performance obligations are satisfied over time as services are delivered. Contract liabilities are recorded as deferred revenue within the "Other current liabilities" line item in the consolidated balance sheets. <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents Other Revenue for the periods indicated:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Revenue</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,452 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,805 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 3452000 3825000 3805000 0 0 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about contract liabilities from contracts with customers, including significant changes in the contract liabilities balances during the period.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities at beginning of period</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,635 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,952 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to deferral of revenue at period end</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,875 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,635 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease due to beginning contract liabilities recognized as revenue</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,635)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,952)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,875 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,635 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 19635000 15952000 20875000 19635000 19635000 15952000 20875000 19635000 Product Return PolicyAll product orders that are unused and returned within the first 30 days following purchase are refunded at 100% of the sales price. All product orders that are unused and resalable are refunded up to one year from the date of purchase at 100% of the sales price. This standard policy differs in a few of our international markets due to the regulatory environment in those markets. Depending upon the conditions under which product was returned, customers may either receive a refund based on their original form of payment, or credit on account for a product exchange. The Company monitors Associate activity to ensure that all such practices are in line with established Company policies. P30D 1 1 0.007 0.006 0.007 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Associate Incentives</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Associate incentives expenses include all forms of commissions, and other incentives paid to our Associates, less commissions paid to Associates on personal purchases, which are considered a sales discount and are reported as a reduction to net sales.</span></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Selling, General and Administrative</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses include wages and benefits, depreciation and amortization, rents and utilities, Associate event costs, advertising and professional fees, marketing, and research and development expenses.</span></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Equity-Based Compensation</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records compensation expense in the Financial Statements for equity-based awards based on the grant date fair value, which for restricted stock units is the closing market value of the Company’s common stock on the date of the grant. The grant date fair value of each stock-settled stock appreciation right is based upon the Black-Scholes option pricing model. Equity-based compensation expense is recognized under the straight-line method over the period that service is provided, which is generally the vesting term. Further information regarding equity awards can be found in Note </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a href="#i573ef11f9cdc4355910846a151634a4c_238" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">L</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Equity-Based Compensation.</span></div> AdvertisingAdvertising costs are charged to expense as incurred and are presented as part of the “Selling, general and administrative” line item. 5053000 12399000 9853000 Research and DevelopmentResearch and development costs are charged to expense as incurred and are presented as part of the “Selling, general and administrative” line item. 11563000 11112000 10633000 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Earnings Per Share</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per common share ("EPS") are based on the weighted-average number of common shares that were outstanding during each period. Diluted EPS include the effect of potentially dilutive common shares calculated using the treasury stock method, which include in-the-money, equity-based awards that have been granted but have not been issued. When there is a loss, potential common shares are not included in the computation of diluted EPS, because to do so would be anti-dilutive.</span></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recent Accounting Pronouncements</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2021-08 requires an acquirer to recognize and measure contract assets and contract liabilities (deferred revenue) acquired in a business combination in accordance with Revenue from Contracts with Customers (Topic 606). Under this approach, the acquirer applies the revenue model as if it had originated the contracts. This is a departure from the current requirement to measure contract assets and contract liabilities at fair value at the acquisition date. ASU 2021-08 is effective for annual periods beginning after December 15, 2022 and interim periods within those annual periods. ASU 2021-08 should be applied prospectively to business combinations occurring on or after the date of adoption. Evaluation of this new standard is dependent on multiple circumstances including the timing and complexity of completed business combinations. As a result, the Company intends to adopt the provisions of ASU 2021-08 in the first quarter of 2023.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements BUSINESS COMBINATIONS<div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter, the Company acquired assets in business combinations for an aggregate purchase consideration of $6,532 in cash and $886 in contingent consideration. The preliminary purchase price allocations were $964 to tangible assets, $6,065 to intangible assets, and $389 to goodwill. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary reasons for the business combinations are to augment and expand the Company's core competencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amount of revenue and earnings related to the business combinations since the acquisition date is immaterial.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the acquisition date, the Company made certain measurement period adjustments to the preliminary purchase price allocation, which resulted in an increase to goodwill of $193. The increase was due to a $105 decrease of certain tangible assets acquired, an increase to assumed liabilities of $147, and a $59 decrease in the aggregate consideration in connection with post close net working capital adjustments that were finalized in the fourth quarter of 2022.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent consideration liability is based on the achievement of certain milestones over a three-year period. Under the terms of the purchase agreement, the contingent consideration consists of three earn-out periods capped at $500 per earn-out period. The maximum earn-out is $1,500 per the asset purchase agreement. As of the acquisition date, the contingent consideration had a fair value of $886. The estimated fair value of the contingent consideration liability as of the date of acquisition was determined using an option pricing method based upon available information and certain assumptions known and contains key inputs that are unobservable in the market, which represents a Level 3 measurement within the fair value hierarchy. Contingent consideration is included in Fair Value Measures above. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pro forma results of operations have not been presented because the effects of the acquisitions were not material to the Company’s Consolidated Financial Statements.</span></div> 6532000 886000 964000 6065000 389000 193000 -105000 147000 -59000 P3Y 3 500000 1500000 886000 INVENTORIES<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,776 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,280 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,285 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,028 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,452 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,089 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,318 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent inventories</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,479 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>Noncurrent inventory consists of $1,711 of raw materials and $1,768 of finished goods inventory and is included in the “Other assets” line item on the Company’s Consolidated Balance Sheets. <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,776 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,280 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,285 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,028 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,452 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,089 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,318 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent inventories</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,479 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 21776000 30280000 4285000 9586000 41028000 58452000 67089000 98318000 3479000 0 PREPAID EXPENSES AND OTHER CURRENT ASSETS <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consists of the following:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1,<br/>2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,293 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,734 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,089 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,119 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,030 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,579 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Miscellaneous receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,584 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred commissions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,157 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,270 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,121 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,681 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,873 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,967 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consists of the following:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1,<br/>2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,293 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,734 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,089 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,119 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,030 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,579 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Miscellaneous receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,584 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred commissions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,157 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,270 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,121 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,681 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,873 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,967 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2293000 3734000 9089000 10119000 2030000 1579000 5183000 5584000 3157000 2270000 7121000 3681000 28873000 26967000 <div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated earnings before income taxes consists of the following for 2022, 2021, and 2020: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,996)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,017 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,838 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,617 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,625 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,110 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total earnings before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,621 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,642 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,948 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated earnings before income taxes consists of the following for 2022, 2021, and 2020: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,996)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,017 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,838 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,617 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,625 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,110 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total earnings before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,621 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,642 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,948 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense (benefit) included in income from continuing operations consists of the following: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,869 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,668 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,208 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,971 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,756 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,088)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,317 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,574 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,294 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,742)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,937)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,834)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,472)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,271 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,137 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,284 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for 2022, 2021, and 2020 reconciled to the statutory U.S. Federal tax rate is as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory U.S. federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent tax differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess foreign tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign income tax rate differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign withholding taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax position reserve</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for the year ended December 31, 2022 increased compared to the year ended January 1, 2022. The effective tax rate increase is due primarily to a change in the market mix of pre-tax book income.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant categories of deferred taxes are as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,872 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,106 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals not currently deductible</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,627 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,634 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,746 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,143 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,680 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,545 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,448 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized R&amp;D Expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,618 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,337 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit carry forwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,539 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,635 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,720 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,223 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,824 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,395 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,980 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118,136)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99,958)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,259 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,022 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,723)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,268)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,990)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,596)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,680)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,545)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Withholding tax on unremitted earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,639)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,556)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,499)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,589)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,531)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,680)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,728 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,658)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net deferred taxes on a jurisdiction basis are as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1,<br/>2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,799 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,839 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,071)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,497)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,728 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,658)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company had foreign tax credit carryforwards of approximately $111,948. If unused, these carryforwards will expire between 2026 and 2032. The Company has generated excess foreign tax credits since the Tax Cuts and Jobs Act of 2017 was enacted on December 22, 2017. This is due to the U.S. tax rate being lower than most foreign taxing jurisdiction rates where the Company operates. Although the Company can claim foreign tax credits against U.S. source income due to overall domestic losses generated in previous years, the Company does not believe it will be able to use more foreign tax credits than it generates in a single year. The Company believes these foreign tax credit carryforwards will expire unused based on available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, available tax planning strategies, and available carryback opportunities. Similar with prior years, the Company continues to maintain a full valuation allowance on its </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">foreign tax credit carryforwards. Valuation allowances are determined using a more-likely-than-not realization criteria and are based upon all facts and circumstances. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a $1,390 valuation allowance on mirrored deferred tax assets recorded in the United States, which offset deferred tax liabilities of foreign disregarded entities. These mirrored deferred tax assets represent future foreign tax credits. This valuation allowance is necessary because the Company is limited in its ability to utilize future foreign tax credits due to the U.S. tax rate being lower than most foreign taxing jurisdiction rates where the Company operates. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also had $1,568 of Utah research credit carryforwards, and $2,023 of Federal research credit carryforwards as of December 31, 2022. If unused, the Utah research credit carryforwards expire between 2027 and 2036, and the Federal research credits expire between 2036 and 2042. Utah research credits are limited to Utah tax due and the Company has a history of generating more credits than it can use. Federal research credit carryforwards can only be used in a year when U.S. taxes are owed after foreign tax credits have been applied. Due to the lack of sufficient evidence to the contrary, the Company has placed a full valuation allowance on these credit carryforwards. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company had $5,296 of foreign operating loss carry forwards, $2,808 of which have an unlimited carryforward period. The deferred tax asset associated with these losses was $1,666 and a valuation allowance of $1,174 has been applied against this deferred tax asset. The 2022 deferred tax asset for state-tax-loss carryforwards was $54. If unused, some of the state-tax-loss carryforwards will expire between 2032 and 2041 and others can be carried forward indefinitely. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total combined valuation allowance was $118,136 as of December 31, 2022. The 2022 valuation allowance represents a $18,178 net increase from 2021. If the Company determines that there is sufficient evidence to remove the valuation allowances addressed above, the valuation allowance will be released and the provision for income taxes will be reduced. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the cumulative amount of undistributed earnings of the Company’s non-U.S. subsidiaries held for indefinite reinvestment is approximately $4,000. If this amount were repatriated to the United States, the amount of incremental taxes would be approximately $400.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company reported $66 of unrecognized tax benefits in "Other current liabilities" and $1,384 in "Other long-term liabilities" for a combined total of $1,450 in unrecognized tax benefits that would impact the effective tax rate if recognized. This compares to $199 of unrecognized tax benefits in "Other current liabilities" and $809 in "Other long-term liabilities" for a combined total of $1,008 reported as of January 1, 2022. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following reconciliation provides the changes in unrecognized tax benefits for the years presented:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance of unrecognized tax benefits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,528 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">775 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases for settlements with taxing authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(635)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(560)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance of unrecognized tax benefits</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,450 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,528 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for interest and penalties associated with unrecognized tax benefits as a component of income tax expense. For the period ended December 31, 2022 and January 1, 2022, the Company reported $201 and $91, respectively, as income tax expense related to interest and penalties. As of December 31, 2022, the Company recorded $64 of "Other current liabilities" and $239 of "Other long-term liabilities" associated with interest and penalties for </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unrecognized tax benefits. This compares to $162 of "Other current liabilities" and $63 of "Other long-term liabilities" associated with interest and penalties reported as of January 1, 2022.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the United States and foreign jurisdictions. In general, the Company's tax filings are subject to examination for years ended on or after December 31, 2018. However, statutes of limitations in some markets may be as long as ten years for transfer pricing related issues.</span></div> -23996000 13017000 18838000 132617000 157625000 159110000 108621000 170642000 177948000 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense (benefit) included in income from continuing operations consists of the following: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,869 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,668 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,208 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,971 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,756 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,088)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,317 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,574 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,294 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,742)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,937)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,834)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,472)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,271 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,137 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,284 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 42000 -264000 306000 297000 567000 303000 45869000 56668000 55147000 46208000 56971000 55756000 -9180000 -4088000 1317000 -331000 -40000 -47000 2574000 1294000 -3742000 -6937000 -2834000 -2472000 39271000 54137000 53284000 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for 2022, 2021, and 2020 reconciled to the statutory U.S. Federal tax rate is as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory U.S. federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent tax differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess foreign tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign income tax rate differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign withholding taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax position reserve</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 0.210 0.210 0.210 0.004 0.004 0.003 0.003 0.001 0.002 0.166 0.109 0.099 0.119 0.106 0.082 0.095 0.018 0.017 0.097 0.079 0.077 0.005 -0.003 0.008 -0.005 0.011 -0.001 0.362 0.317 0.299 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant categories of deferred taxes are as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,872 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,106 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals not currently deductible</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,627 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,634 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,746 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,143 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,680 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,545 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,448 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized R&amp;D Expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,618 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,337 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit carry forwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,539 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,635 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,720 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,223 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,824 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,395 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,980 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118,136)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99,958)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,259 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,022 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,723)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,268)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,990)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,596)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,680)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,545)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Withholding tax on unremitted earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,639)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,556)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,499)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,589)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,531)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,680)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,728 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,658)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net deferred taxes on a jurisdiction basis are as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1,<br/>2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,799 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,839 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,071)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,497)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,728 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,658)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 5872000 5106000 8627000 11634000 2746000 2355000 922000 1143000 6680000 7545000 1448000 0 9618000 2337000 115539000 96635000 1720000 1401000 3223000 4824000 156395000 132980000 118136000 99958000 38259000 33022000 5723000 5268000 0 126000 2990000 3596000 6680000 7545000 11639000 13556000 5499000 5589000 32531000 35680000 5728000 2658000 9799000 4839000 4071000 7497000 5728000 2658000 111948000 1390000 1568000 2023000 5296000 2808000 1666000 1174000 54000 118136000 18178000 4000000 400000 66000 1384000 1450000 199000 809000 1008000 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following reconciliation provides the changes in unrecognized tax benefits for the years presented:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance of unrecognized tax benefits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,528 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">775 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases for settlements with taxing authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(635)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(560)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance of unrecognized tax benefits</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,450 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,528 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1008000 1528000 560000 107000 21000 775000 0 330000 0 468000 424000 753000 133000 635000 560000 1450000 1008000 1528000 201000 91000 64000 239000 162000 63000 PROPERTY AND EQUIPMENT<div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of property and equipment and their estimated useful lives is as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1,<br/>2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,071 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,820 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory and production equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-7</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,679 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,552 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Air transportation equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-5</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,436 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,562 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-5</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,198 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,636 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Automobiles</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-5</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-5</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,388 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,212 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,271 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,382 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,717 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,883 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,748 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,590 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,969 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,293 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,723 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,992 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits and projects in process</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,081 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,495 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,773 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,780 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation of property and equipment was $11,351, $11,661, and $12,242, for the years ended 2022, 2021, and 2020, respectively.</span></div> <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of property and equipment and their estimated useful lives is as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1,<br/>2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,071 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,820 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory and production equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-7</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,679 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,552 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Air transportation equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-5</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,436 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,562 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-5</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,198 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,636 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Automobiles</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-5</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-5</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,388 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,212 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,271 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,382 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,717 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,883 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,748 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,590 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,969 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,293 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,723 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,992 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits and projects in process</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,081 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,495 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,773 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,780 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> P39Y6M 78071000 80820000 P5Y P7Y 50679000 47552000 P5Y 2952000 2952000 P3Y P5Y 53436000 53562000 P3Y P5Y 6198000 6636000 P3Y P5Y 722000 767000 P3Y P5Y 14388000 15212000 P15Y 3271000 3382000 209717000 210883000 124748000 121590000 84969000 89293000 6723000 6992000 6081000 5495000 97773000 101780000 11351000 11661000 12242000 OPERATING LEASES<div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification of ROU assets and lease liabilities in the Company’s consolidated balance sheet:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU operating lease assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU3M2VmMTFmOWNkYzQzNTU5MTA4NDZhMTUxNjM0YTRjL3NlYzo1NzNlZjExZjljZGM0MzU1OTEwODQ2YTE1MTYzNGE0Y18yMjMvZnJhZzplMTRiYTFmOGI1MmY0YjJhYjA4YjZlZmUyYzU1YzkyZi90YWJsZTozNWZhYTM3ZjVhNTM0ZDI3ODAyNTc0M2RiYTI4MWI3My90YWJsZXJhbmdlOjM1ZmFhMzdmNWE1MzRkMjc4MDI1NzQzZGJhMjgxYjczXzItMi0xLTEtNDM4Ng_d06ef302-907d-408d-800a-795ea96c1db8"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU3M2VmMTFmOWNkYzQzNTU5MTA4NDZhMTUxNjM0YTRjL3NlYzo1NzNlZjExZjljZGM0MzU1OTEwODQ2YTE1MTYzNGE0Y18yMjMvZnJhZzplMTRiYTFmOGI1MmY0YjJhYjA4YjZlZmUyYzU1YzkyZi90YWJsZTozNWZhYTM3ZjVhNTM0ZDI3ODAyNTc0M2RiYTI4MWI3My90YWJsZXJhbmdlOjM1ZmFhMzdmNWE1MzRkMjc4MDI1NzQzZGJhMjgxYjczXzItMi0xLTEtNDM4Ng_def50bc0-a082-48ee-8874-3ab78e803921">Other assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,997 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,789 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ROU assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,997 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,789 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU3M2VmMTFmOWNkYzQzNTU5MTA4NDZhMTUxNjM0YTRjL3NlYzo1NzNlZjExZjljZGM0MzU1OTEwODQ2YTE1MTYzNGE0Y18yMjMvZnJhZzplMTRiYTFmOGI1MmY0YjJhYjA4YjZlZmUyYzU1YzkyZi90YWJsZTozNWZhYTM3ZjVhNTM0ZDI3ODAyNTc0M2RiYTI4MWI3My90YWJsZXJhbmdlOjM1ZmFhMzdmNWE1MzRkMjc4MDI1NzQzZGJhMjgxYjczXzctMi0xLTEtNDM4Ng_370890b8-0a7a-4d3e-acf5-a0a44155e5d2"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU3M2VmMTFmOWNkYzQzNTU5MTA4NDZhMTUxNjM0YTRjL3NlYzo1NzNlZjExZjljZGM0MzU1OTEwODQ2YTE1MTYzNGE0Y18yMjMvZnJhZzplMTRiYTFmOGI1MmY0YjJhYjA4YjZlZmUyYzU1YzkyZi90YWJsZTozNWZhYTM3ZjVhNTM0ZDI3ODAyNTc0M2RiYTI4MWI3My90YWJsZXJhbmdlOjM1ZmFhMzdmNWE1MzRkMjc4MDI1NzQzZGJhMjgxYjczXzctMi0xLTEtNDM4Ng_caed6696-533a-4613-bc52-bf05f30749e3">Other current liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,892 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,080 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU3M2VmMTFmOWNkYzQzNTU5MTA4NDZhMTUxNjM0YTRjL3NlYzo1NzNlZjExZjljZGM0MzU1OTEwODQ2YTE1MTYzNGE0Y18yMjMvZnJhZzplMTRiYTFmOGI1MmY0YjJhYjA4YjZlZmUyYzU1YzkyZi90YWJsZTozNWZhYTM3ZjVhNTM0ZDI3ODAyNTc0M2RiYTI4MWI3My90YWJsZXJhbmdlOjM1ZmFhMzdmNWE1MzRkMjc4MDI1NzQzZGJhMjgxYjczXzktMi0xLTEtNDM4Ng_3e144516-2771-4867-99aa-2e2706eeb690"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU3M2VmMTFmOWNkYzQzNTU5MTA4NDZhMTUxNjM0YTRjL3NlYzo1NzNlZjExZjljZGM0MzU1OTEwODQ2YTE1MTYzNGE0Y18yMjMvZnJhZzplMTRiYTFmOGI1MmY0YjJhYjA4YjZlZmUyYzU1YzkyZi90YWJsZTozNWZhYTM3ZjVhNTM0ZDI3ODAyNTc0M2RiYTI4MWI3My90YWJsZXJhbmdlOjM1ZmFhMzdmNWE1MzRkMjc4MDI1NzQzZGJhMjgxYjczXzktMi0xLTEtNDM4Ng_65ec6c98-01f4-4188-af56-08ff83ab0618">Other long-term liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,680 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,215 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,572 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,295 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental lease information:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,606 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,585 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,606 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,585 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,924 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,506 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,641 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,322 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term—operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.39 yrs.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.76 yrs.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate—operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.04 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the maturity of the Company’s lease liabilities as of December 31, 2022: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,214 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,383 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,850 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,064 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(492)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,572 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These leases generally provide that property taxes, insurance, and maintenance expenses are the responsibility of the Company. Such expenses are not included in the operating lease amounts outlined in the table above or in the rent expense amounts that follow. The total rent expense was approximately $8,258, $9,830, and $11,199 for the years ended 2022, 2021, and 2020, respectively.</span></div> <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification of ROU assets and lease liabilities in the Company’s consolidated balance sheet:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU operating lease assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU3M2VmMTFmOWNkYzQzNTU5MTA4NDZhMTUxNjM0YTRjL3NlYzo1NzNlZjExZjljZGM0MzU1OTEwODQ2YTE1MTYzNGE0Y18yMjMvZnJhZzplMTRiYTFmOGI1MmY0YjJhYjA4YjZlZmUyYzU1YzkyZi90YWJsZTozNWZhYTM3ZjVhNTM0ZDI3ODAyNTc0M2RiYTI4MWI3My90YWJsZXJhbmdlOjM1ZmFhMzdmNWE1MzRkMjc4MDI1NzQzZGJhMjgxYjczXzItMi0xLTEtNDM4Ng_d06ef302-907d-408d-800a-795ea96c1db8"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU3M2VmMTFmOWNkYzQzNTU5MTA4NDZhMTUxNjM0YTRjL3NlYzo1NzNlZjExZjljZGM0MzU1OTEwODQ2YTE1MTYzNGE0Y18yMjMvZnJhZzplMTRiYTFmOGI1MmY0YjJhYjA4YjZlZmUyYzU1YzkyZi90YWJsZTozNWZhYTM3ZjVhNTM0ZDI3ODAyNTc0M2RiYTI4MWI3My90YWJsZXJhbmdlOjM1ZmFhMzdmNWE1MzRkMjc4MDI1NzQzZGJhMjgxYjczXzItMi0xLTEtNDM4Ng_def50bc0-a082-48ee-8874-3ab78e803921">Other assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,997 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,789 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ROU assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,997 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,789 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU3M2VmMTFmOWNkYzQzNTU5MTA4NDZhMTUxNjM0YTRjL3NlYzo1NzNlZjExZjljZGM0MzU1OTEwODQ2YTE1MTYzNGE0Y18yMjMvZnJhZzplMTRiYTFmOGI1MmY0YjJhYjA4YjZlZmUyYzU1YzkyZi90YWJsZTozNWZhYTM3ZjVhNTM0ZDI3ODAyNTc0M2RiYTI4MWI3My90YWJsZXJhbmdlOjM1ZmFhMzdmNWE1MzRkMjc4MDI1NzQzZGJhMjgxYjczXzctMi0xLTEtNDM4Ng_370890b8-0a7a-4d3e-acf5-a0a44155e5d2"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU3M2VmMTFmOWNkYzQzNTU5MTA4NDZhMTUxNjM0YTRjL3NlYzo1NzNlZjExZjljZGM0MzU1OTEwODQ2YTE1MTYzNGE0Y18yMjMvZnJhZzplMTRiYTFmOGI1MmY0YjJhYjA4YjZlZmUyYzU1YzkyZi90YWJsZTozNWZhYTM3ZjVhNTM0ZDI3ODAyNTc0M2RiYTI4MWI3My90YWJsZXJhbmdlOjM1ZmFhMzdmNWE1MzRkMjc4MDI1NzQzZGJhMjgxYjczXzctMi0xLTEtNDM4Ng_caed6696-533a-4613-bc52-bf05f30749e3">Other current liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,892 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,080 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU3M2VmMTFmOWNkYzQzNTU5MTA4NDZhMTUxNjM0YTRjL3NlYzo1NzNlZjExZjljZGM0MzU1OTEwODQ2YTE1MTYzNGE0Y18yMjMvZnJhZzplMTRiYTFmOGI1MmY0YjJhYjA4YjZlZmUyYzU1YzkyZi90YWJsZTozNWZhYTM3ZjVhNTM0ZDI3ODAyNTc0M2RiYTI4MWI3My90YWJsZXJhbmdlOjM1ZmFhMzdmNWE1MzRkMjc4MDI1NzQzZGJhMjgxYjczXzktMi0xLTEtNDM4Ng_3e144516-2771-4867-99aa-2e2706eeb690"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU3M2VmMTFmOWNkYzQzNTU5MTA4NDZhMTUxNjM0YTRjL3NlYzo1NzNlZjExZjljZGM0MzU1OTEwODQ2YTE1MTYzNGE0Y18yMjMvZnJhZzplMTRiYTFmOGI1MmY0YjJhYjA4YjZlZmUyYzU1YzkyZi90YWJsZTozNWZhYTM3ZjVhNTM0ZDI3ODAyNTc0M2RiYTI4MWI3My90YWJsZXJhbmdlOjM1ZmFhMzdmNWE1MzRkMjc4MDI1NzQzZGJhMjgxYjczXzktMi0xLTEtNDM4Ng_65ec6c98-01f4-4188-af56-08ff83ab0618">Other long-term liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,680 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,215 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,572 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,295 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 19997000 23789000 19997000 23789000 6892000 7080000 7680000 10215000 14572000 17295000 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental lease information:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,606 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,585 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,606 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,585 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,924 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,506 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,641 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,322 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term—operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.39 yrs.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.76 yrs.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate—operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.04 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 8606000 9585000 8606000 9585000 7924000 9506000 5641000 5322000 P2Y4M20D P2Y9M3D 0.0304 0.0311 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the maturity of the Company’s lease liabilities as of December 31, 2022: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,214 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,383 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,850 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,064 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(492)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,572 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 7214000 5383000 1850000 497000 120000 0 15064000 492000 14572000 8258000 9830000 11199000 INTANGIBLE ASSETS<div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performed its annual goodwill impairment test during the third quarter of 2022. The Company performed a qualitative assessment of each reporting unit and determined that it was not more-likely-than-not that the fair value of any reporting unit was less than its carrying amount. As a result, no impairments of goodwill were recognized in 2022 and 2021.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also performed its annual indefinite-lived intangible asset impairment test during the third quarter of 2022. The Company performed a qualitative assessment of the indefinite-lived intangible assets and determined that it was not more-likely-than-not that the fair value of any indefinite-lived intangible asset was less than the carrying amount. As a result, no impairments of indefinite-lived intangible assets were recognized in 2022 and 2021.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill are as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1,<br/>2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,668 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,367 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,668 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,367 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(882)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of end of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,368 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,668 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,368 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,668 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of the following:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross carrying<br/>amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/> amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net carrying<br/>amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average<br/>amortization<br/>period (years)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name and trademarks</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,285 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,171 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product formulas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,701 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,983)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(414)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,899 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct sales license</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,238 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,238 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,004 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,432 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Estimated Amortization Expense:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,843 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,224 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,194 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross carrying<br/>amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>amortization </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net carrying<br/>amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average<br/>amortization<br/>period (years)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name and trademarks</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,173 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product formulas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,440 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,462)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,978 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct sales license</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,464 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,464 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,077 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,442 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div>Aggregate amortization of intangible assets was $1,723, $1,182, and $1,326 for the years ended 2022, 2021, and 2020, respectively. 0 0 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill are as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1,<br/>2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,668 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,367 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,668 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,367 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(882)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of end of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,368 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,668 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,368 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,668 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 17668000 17367000 17668000 17367000 582000 0 -882000 301000 17368000 17668000 17368000 17668000 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of the following:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross carrying<br/>amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/> amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net carrying<br/>amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average<br/>amortization<br/>period (years)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name and trademarks</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,285 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,171 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product formulas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,701 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,983)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(414)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,899 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct sales license</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,238 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,238 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,004 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,432 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross carrying<br/>amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>amortization </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net carrying<br/>amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average<br/>amortization<br/>period (years)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name and trademarks</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,173 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product formulas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,440 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,462)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,978 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct sales license</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,464 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,464 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,077 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,442 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table> 2285000 114000 2171000 P10Y 8701000 7983000 718000 P8Y 3313000 414000 2899000 P4Y 467000 61000 406000 P4Y 26238000 26238000 41004000 32432000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Estimated Amortization Expense:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,843 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,224 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,194 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 1843000 1224000 1154000 692000 253000 1028000 6194000 4173000 4173000 0 P10Y 9440000 7462000 1978000 P8Y 28464000 28464000 42077000 30442000 1723000 1182000 1326000 OTHER CURRENT LIABILITIES<div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities consist of the following:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1,<br/>2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Associate incentives</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,688 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,929 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued employee compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,334 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,366 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,875 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,635 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,234 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,330 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,892 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,080 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,973 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,193 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,788 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,749 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,784 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,282 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities consist of the following:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1,<br/>2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Associate incentives</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,688 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,929 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued employee compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,334 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,366 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,875 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,635 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,234 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,330 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,892 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,080 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,973 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,193 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,788 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,749 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,784 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,282 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 55688000 53929000 17334000 32366000 20875000 19635000 11234000 11330000 6892000 7080000 4973000 5193000 15788000 17749000 132784000 147282000 LINE OF CREDIT<div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 25, 2020, the Company as borrower, and certain of its material subsidiaries as guarantors, entered into the Second Amended and Restated Credit Agreement (the “Credit Agreement”) with Bank of America, N.A. (“Bank of America”) as Administrative Agent, Swingline Lender and Letter of Credit Issuer, and the other lenders party thereto. On August 10, 2022, the Company entered into the Second Amendment to the Second Amended and Restated Credit Agreement ("Restated Credit Agreement"), which replaces the Eurodollar Rate, and LIBOR terms and provisions with the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bloomberg Short-Term Bank Yield Index rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">("</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BSBY").</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement provides for a revolving credit limit for loans to the Company up to $75,000 (the “Credit Facility”). In addition, at the option of the Company, and subject to certain conditions, the Company may request to increase the aggregate commitment under the Credit Facility up to an additional $200,000.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no outstanding debt on the Credit Facility as of December 31, 2022. The obligations of the Company under the Credit Agreement are secured by the pledge of the capital stock of certain subsidiaries of the Company, pursuant to a Security and Pledge Agreement. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on revolving borrowings under the Credit Facility are computed at BSBY, adjusted by features specified in the Credit Agreement. The Credit Agreement covenants require the Company’s rolling four-quarter consolidated EBITDA of $100,000 or greater and its ratio of consolidated funded debt to consolidated EBITDA of equal to or less than 2.0 to 1.0 at the end of each quarter. The Credit Agreement does not include any restrictions on the payment of cash dividends or share repurchases by the Company. Consolidated EBITDA and consolidated funded debt are non-GAAP terms specified in the Credit Agreement. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will be required to pay any balance on this Credit Facility in full at the time of maturity in August 2025.</span></div> 75000000 200000000 0 100000000 2.0 COMMITMENTS AND CONTINGENCIES<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Unconditional Purchase Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s unconditional purchase obligations relating to IT-related services and advertising agreements were $7,163 and $6,151, as of December 31, 2022 and January 1, 2022, respectively that are generally paid within one year.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various lawsuits, claims, and other legal matters from time to time that arise in the ordinary course of conducting business, including matters involving its products, intellectual property, supplier relationships, distributors, competitor relationships, employees and other matters. The Company records a liability when a particular contingency is probable and estimable. The Company faces contingencies that are reasonably possible to occur; however, they cannot currently be estimated. While complete assurance cannot be given as to the outcome of these proceedings, management does not currently believe that any of these matters, individually or in the aggregate, will have a material adverse effect on the Company’s financial condition, liquidity or results of operations. It is reasonably possible that a change in the contingencies could result in a change in the amount recorded by the Company in the future. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employee Benefit Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, the Company sponsors an employee benefit plan under Section 401(k) of the Internal Revenue Code. This plan covers employees who are at least 18 years of age and have met a one-month service requirement. The Company makes a matching contribution equal to 100 percent of the first one percent of a participant’s compensation that is contributed by the participant, and 50 percent of that deferral that exceeds one percent of the participant’s compensation, not to exceed six percent of the participant’s compensation, subject to the limits of ERISA. In addition, the Company may make a discretionary contribution based on earnings. The Company’s matching contributions cliff vest at two years of service. Contributions made by the Company to the plan in the United States were $2,589, $2,509, and $2,322 for the years ended 2022, 2021, and 2020, respectively. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has employees in international countries that are covered by various defined contribution plans. These plans are administered based upon the legal requirements in the countries in which they are established.</span></div> 7163000 6151000 18 P1M 1 0.01 0.50 0.06 P2Y 2589000 2509000 2322000 EQUITY-BASED COMPENSATION<div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total equity-based compensation expense w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as $13,485, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$14,706, and $14,633 for fiscal years 2022, 2021, and 2020, of which, $154, $408, and $239, was related to liability-classified awards, respectively. The related tax benefit for these periods w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as $2,556,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $2,813, and $2,472, respectively. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the remaining unrecognized compensation expense on a pre-tax basis for all types of unvested equity awards outstanding as of December 31, 2022. This table does not include an estimate for future grants that may be issued. </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,273 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,781 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,117 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,579 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining unrecognized compensation expense above is expected to be recognized over a weighted-average period of 1.7 years.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's 2015 Equity Incentive Award Plan (the "2015 Plan") is currently the only plan under which equity awards are issued. The 2015 Plan allows for the grant of various equity awards including stock-settled stock </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">appreciation rights, stock options, restricted stock units, deferred stock units, and other types of equity-based awards to the Company’s officers, key employees, and non-employee directors.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the inception of the 2015 Plan, 1,750 shares have been authorized. As of December 31, 2022,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 3,877 awards had been granted under the 2015 Plan, of which 2,924 were stock-settled stock appreciation rights, and 953 were restricted stock awards. Also, as of December 31, 2022, a total of 1,088 options and grants had been forfeited, of which 59 awards have been a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dded back to the number of shares available for issuance under the 2015 Plan. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-Settled Stock Appreciation Rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Black-Scholes option pricing model to estimate the fair value of its stock-settled stock appreciation rights. There were no stock-settled stock appreciation rights granted in 2022. The weighted-average fair value of stock-settled stock appreciation rights granted in 2021 and 2020 w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as $27.12 and $17.65</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-settled stock appreciation rights granted to officers and key employees upon hire or promotion to such a position, or annually for existing participants, generally vest 25% each year on the anniversary of the grant date and expire 4.5 years from the date of grant.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following is a table that includes the weighted-average assumptions that the Company used to calculate fair value of stock-settled stock appreciation rights that were granted during the periods indicated. </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate (2)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.66 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (3)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 yrs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 yrs.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield (4)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average exercise price (5)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.02 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company utilizes historical volatility of the trading price of its common stock.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Risk-free interest rate is based on the U.S. Treasury yield curve with respect to the expected life of the award.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Depending upon the terms of the award, one of two methods will be used to calculate expected life:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">a weighted-average that includes historical settlement data of the Company’s equity awards and a hypothetical holding period, or (ii) the simplified method.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company historically has not paid and currently has no plan to pay dividends.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Exercise price is the closing price of the Company's common stock on the date of grant. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s stock-settled stock appreciation right activity is as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average exercise price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining<br/>contractual term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.22 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,596 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.02 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.06 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.63 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Aggregate intrinsic value is defined as the difference between the current market value at the reporting date (the closing price of the Company’s common stock on the last trading day of the period) and the exercise price of awards that were in-the-money. The closing price of the Company’s common stock at December 31, 2022 and January 1, 2022 was $53.20 and $101.20, respectively. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of stock-settled stock appreciation rights exercised </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was $50,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $10,337, and $7,881, for the years ended 2022, 2021, and 2020, respectively. The total fair value of stock-settled stock appreciation rights that vested </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was $983, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$3,868, and $3,532, for the years ended 2022, 2021, and 2020, respectively. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2022, January 1, 2022, and January 2, 2021, certain employees elected to receive a net amount of shares upon the exercise of stock-settled stock appreciation rights in order to satisfy the Company’s tax withholding obligation. There was no reduction to additional paid-in capital for the years e</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nded 2022, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> an</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d 2020.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock awards include stock-settled and cash-settled restricted stock units granted to the Company’s officers and key employees, and deferred stock units granted to non-employee directors. Restricted stock units are granted to officers and key employees upon hire or promotion to such a position, or annually for existing participants, and generally vest 25% each year on the anniversary of the grant date. Awards of deferred stock units granted to non-employee directors generally vest 25% each quarter, commencing on the first vest date anniversary following the final vesting of the previous award. Upon vesting, holders of stock-settled restricted stock units and deferred stock units are entitled to receive shares of the Company’s common stock on a one-for-one basis. Holders of cash-settled restricted stock units are entitled to receive cash payments equivalent to the number of awards held, valued at the closing market price on the vest date. The fair value of restricted stock awards is determined based on the Company’s closing stock price on the date of grant. Cash-settled restricted stock units are accounted for as liability-classified awards and fair value is remeasured to the current fair value, which is the Company's closing stock price, at each reporting date until the award is settled at vesting. Restricted stock awards are full-value shares at the date of grant, vesting over the periods of service, and do not have expiration dates. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s stock-settled restricted stock unit activity is as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.87 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.50 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, certain employees elected to receive a net amount of shares upon the release of restricted stock units in order to satisfy the Company’s tax withholding obligation. This resulted in a reduction to additional paid-in capi</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tal of $4,706, $3,575</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and $2,367 for the years ended 2022, 2021, and 2020, respectively, reflected as a financing activity in the Company’s consolidated statements of cash flows. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of restricted stock units that vested</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $12,808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$11,378, and $7,732, for the years ended 2022, 2021, and 2020, respectively. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s cash-settled restricted stock unit activity is as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at January 1,2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.66 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.53 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31,2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.72 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average fair value of liability-classified awards outstanding</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $85, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$79, and $76 for the years ended 2022, 2021, and 2020, respectively. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of deferred stock units vested and unreleased to</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">taled 8, 19, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and 23 for the years ended 2022, 2021, and 2020, respectively. There were no deferred stock units that vested in 2022, 2021, and 2020.</span></div> 13485000 14706000 14633000 154000 408000 239000 2556000 2813000 2472000 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the remaining unrecognized compensation expense on a pre-tax basis for all types of unvested equity awards outstanding as of December 31, 2022. This table does not include an estimate for future grants that may be issued. </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,273 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,781 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,117 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,579 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 11273000 7781000 4117000 408000 23579000 P1Y8M12D 1750000 3877000 2924000 953000 1088000 59000 0 27.12 17.65 0.25 P4Y6M <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following is a table that includes the weighted-average assumptions that the Company used to calculate fair value of stock-settled stock appreciation rights that were granted during the periods indicated. </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate (2)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.66 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (3)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 yrs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 yrs.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield (4)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average exercise price (5)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.02 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company utilizes historical volatility of the trading price of its common stock.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Risk-free interest rate is based on the U.S. Treasury yield curve with respect to the expected life of the award.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Depending upon the terms of the award, one of two methods will be used to calculate expected life:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">a weighted-average that includes historical settlement data of the Company’s equity awards and a hypothetical holding period, or (ii) the simplified method.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company historically has not paid and currently has no plan to pay dividends.</span></div>(5)Exercise price is the closing price of the Company's common stock on the date of grant. 0.4328 0.3523 0.0033 0.0166 P3Y6M P3Y6M 0.0000 0.0000 85.19 63.02 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s stock-settled stock appreciation right activity is as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average exercise price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining<br/>contractual term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.22 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,596 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.02 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.06 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.63 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>* Aggregate intrinsic value is defined as the difference between the current market value at the reporting date (the closing price of the Company’s common stock on the last trading day of the period) and the exercise price of awards that were in-the-money. The closing price of the Company’s common stock at December 31, 2022 and January 1, 2022 was $53.20 and $101.20, respectively. 150000 82.22 P2Y3M18D 3596000 0 0 2000 63.02 0 0 1000 116.06 147000 82.16 P1Y3M18D 0 72000 90.63 P1Y1M6D 0 53.20 101.20 50000 10337000 7881000 983000 3868000 3532000 0 0 0.25 0.25 1 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s stock-settled restricted stock unit activity is as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.87 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.50 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 366000 80.87 170000 91.67 142000 81.11 9000 83.11 385000 85.50 4706000 3575000 2367000 12808000 11378000 7732000 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s cash-settled restricted stock unit activity is as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at January 1,2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.66 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.53 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31,2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.72 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 12000 78.66 6000 91.53 3000 79.22 3000 79.67 12000 84.72 85000 79000 76000 8 19 23 0 0 0 0 0 SEGMENT INFORMATION<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company primarily operates as a global direct-selling nutrition, personal health and wellness company that develops and manufactures high quality, science-based nutritional, and personal care products. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s operating segments are identified according to how business activities are managed and evaluated by the chief operating decision maker (“CODM”), our CEO. The CODM manages the business, allocates resources, makes operating decisions, and evaluates performance for a geographic region or market based on net sales. The Company aggregates its direct-selling operating segments (“Direct-selling”) into one reportable segment, as management believes that the Company’s Direct-selling segments exhibit similar long-term financial performance and have similar economic characteristics. The CODM does not evaluate operating segments using asset information, accordingly, the Company does not report asset information by segment. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Company’s acquisitions during 2022, the Company has operating segments that are not material to the Company’s net sales. These operating segments are included as a component of (“All other”) and are included for purposes of reconciliation of net sales to the Company’s Consolidated Statements of Comprehensive Income. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct-selling</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995,043 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186,464 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134,644 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,558 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998,601 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186,464 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134,644 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No single Associate accounted for 10% or more of net sales for the periods presented. The table below summarizes the approximate percentage of total product revenue that has been contributed by the Company’s nutritionals, foods, and personal care and skincare products for the periods indicated. </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USANA Nutritionals</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USANA Foods (1)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care and Skincare</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">______________________________</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes the Company’s new Active Nutrition line, which launched in five markets in 2021 and all but two of the remaining markets through the end of 2022. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selected Financial Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information, presented by geographic region is listed below: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales to External Customers</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502,486 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563,469 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530,505 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southeast Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,478 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,803 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,555 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,964 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801,916 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963,192 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915,024 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas and Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,685 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,620 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998,601 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186,464 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134,644 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-lived Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,051 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,965 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southeast Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,226 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,394 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,617 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,395 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,894 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,754 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas and Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,373 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,030 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Total</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,267 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,784 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,786 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274,002 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southeast Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,880 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,332 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Asia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,952 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,592 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,618 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361,926 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas and Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270,931 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,814 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596,549 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577,740 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides further information on markets representing ten percent or more of consolidated net sales and long-lived assets, respectively: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453,134 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506,103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470,177 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Korea</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,835 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,807 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,087 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,379 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,323 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-lived Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,150 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,350 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,938 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,530 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div> These operating segments are included as a component of (“All other”) and are included for purposes of reconciliation of net sales to the Company’s Consolidated Statements of Comprehensive Income. <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct-selling</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995,043 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186,464 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134,644 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,558 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998,601 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186,464 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134,644 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 995043000 1186464000 1134644000 3558000 0 0 998601000 1186464000 1134644000 The table below summarizes the approximate percentage of total product revenue that has been contributed by the Company’s nutritionals, foods, and personal care and skincare products for the periods indicated. <div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USANA Nutritionals</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USANA Foods (1)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care and Skincare</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">______________________________</span></div>(1)Includes the Company’s new Active Nutrition line, which launched in five markets in 2021 and all but two of the remaining markets through the end of 2022. 0.87 0.86 0.85 0.07 0.07 0.07 0.05 0.06 0.07 0.01 0.01 0.01 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information, presented by geographic region is listed below: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales to External Customers</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502,486 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563,469 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530,505 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southeast Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,478 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,803 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,555 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,964 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801,916 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963,192 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915,024 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas and Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,685 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,620 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998,601 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186,464 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134,644 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-lived Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,051 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,965 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southeast Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,226 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,394 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,617 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,395 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,894 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,754 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas and Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,373 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,030 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Total</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,267 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,784 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,786 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274,002 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southeast Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,880 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,332 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Asia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,952 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,592 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,618 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361,926 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas and Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270,931 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,814 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596,549 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577,740 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 502486000 563469000 530505000 190478000 269803000 269555000 108952000 129920000 114964000 801916000 963192000 915024000 196685000 223272000 219620000 998601000 1186464000 1134644000 86051000 95965000 15226000 15394000 3617000 7395000 104894000 118754000 92373000 89030000 197267000 207784000 250786000 274002000 51880000 62332000 22952000 25592000 325618000 361926000 270931000 215814000 596549000 577740000 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides further information on markets representing ten percent or more of consolidated net sales and long-lived assets, respectively: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453,134 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506,103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470,177 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Korea</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,835 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,807 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,087 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,379 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,323 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-lived Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,150 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,350 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,938 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,530 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div> 453134000 506103000 470177000 106391000 125835000 110807000 106087000 110379000 107323000 89150000 85350000 83938000 91530000 COMMON STOCK AND EARNINGS PER SHARE<div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share (“EPS”) are based on the weighted-average number of shares outstanding for each period. Shares that have been repurchased and retired during the periods specified below have been included in the calculation of the number of weighted-average shares that are outstanding for the calculation of basic EPS based on the time they were outstanding in any period. Diluted EPS are based on shares that are outstanding (computed under basic EPS) and on potentially dilutive shares. Shares that are included in the diluted EPS calculations under the treasury stock method include equity awards that are in-the-money but have not yet been exercised.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the numerator and denominator used to calculate basic EPS and diluted EPS for the periods indicated: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings available to common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,350 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,505 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,664 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,254 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,146 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,156 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of in-the-money equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,310 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,343 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,256 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share from net earnings - basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.60 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.78 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.89 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share from net earnings - diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.59 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.73 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.86 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity awards for the following shares were not included in the computation of diluted EPS due to the fact that their effect would be anti-dilutive: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359</span></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended 2022, 2021, and 2020, the Company repurchased and retired 288 shares, 1,844 shares, and 785 shares for an aggregate price of $25,382, $177,837, and $57,029, respectively.</span></div> <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the numerator and denominator used to calculate basic EPS and diluted EPS for the periods indicated: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings available to common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,350 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,505 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,664 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,254 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,146 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,156 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of in-the-money equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,310 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,343 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,256 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share from net earnings - basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.60 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.78 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.89 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share from net earnings - diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.59 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.73 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.86 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 69350000 116505000 124664000 19254000 20146000 21156000 56000 197000 100000 19310000 20343000 21256000 3.60 5.78 5.89 3.59 5.73 5.86 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity awards for the following shares were not included in the computation of diluted EPS due to the fact that their effect would be anti-dilutive: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359</span></td></tr></table></div> 354000 60000 359000 288000 1844000 785000 25382000 177837000 57029000 RELATED-PARTY TRANSACTIONSThe Company's Founder and Chairman Emeritus of the Board, Myron W. Wentz, PhD is the sole beneficial owner of the largest shareholder of the Company, Gull Global, Ltd. As of December 31, 2022, Gull Global, Ltd. owned 41.6% of the Company’s issued and outstanding shares. Dr. Wentz retired from the position of Board Chairman and director at the Company's Annual Shareholder Meeting on May 1, 2020. Dr. Wentz devotes much of his personal time, expertise, and resources to a number of business and professional activities outside of USANA. The most significant of these is the Sanoviv Medical Institute, which is a unique, fully integrated health and wellness center located near Rosarito, Mexico that Dr. Wentz founded in 1998. Dr. Wentz’s private entity, Sanoviv S.A. de C.V. (“Sanoviv”), contracts with Amarevita S DE RL DE CV (“Amarevita”), an entity that is owned and operated independently of Dr. Wentz, to conduct the operations of the Sanoviv Medical Institute. Sanoviv leases the medical building to Amarevita and Amarevita carries out all of the operations of the medical institute, which include employing all of the medical and healthcare professionals who provide services at the medical institute. The Amarevita medical and healthcare professionals possess expertise in the fields of human health, digestive health, nutritional medicine, lifestyle medicine and other medical fields that are important to USANA. Amarevita performs research and development of novel product formulations for future development and production by USANA, and they also perform research and development of improvements in existing USANA product formulations. In addition to providing contract research services, Amarevita provides physicians and other medical staff to speak at USANA Associate events. Finally, Amarevita performs health assessments and physical examinations for the Company’s Executives. In consideration for these services, USANA paid Amarevita an immaterial amount in 2022 and 2021, and $175 in 2020. The Company’s agreements with Amarevita were approved by the Audit Committee in advance of the Company’s entry into the agreements. USANA’s collaboration with Amarevita is terminable at will by USANA at any time, without any continuing commitment by USANA. 0.416 175000 <div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at beginning of period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Charged to costs and expenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at end of period</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for sales returns</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,562 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,537 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance - deferred tax assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,958 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,178 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,136 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for sales returns</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,485 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance - deferred tax assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,401 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,557 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,958 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 2, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for sales returns</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">772 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance - deferred tax assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,285 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,116 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,401 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 547000 6562000 6537000 572000 504000 6000 147000 363000 99958000 18178000 0 118136000 819000 7213000 7485000 547000 372000 148000 16000 504000 81401000 18557000 0 99958000 772000 115000 68000 819000 261000 131000 20000 372000 64285000 17116000 0 81401000 EXCEL 91 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 92 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 93 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 94 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 255 443 1 false 81 0 false 7 false false R1.htm 0000001 - Document - Document And Entity Information Sheet http://www.usana.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 0000002 - Statement - Consolidated Balance Sheets Sheet http://www.usana.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 0000003 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.usana.com/role/ConsolidatedBalanceSheetsParentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 0000004 - Statement - Consolidated Statements of Comprehensive Income Sheet http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome Consolidated Statements of Comprehensive Income Statements 4 false false R5.htm 0000005 - Statement - Consolidated Statements of Cash Flows Sheet http://www.usana.com/role/ConsolidatedStatementsofCashFlows Consolidated Statements of Cash Flows Statements 5 false false R6.htm 0000006 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 6 false false R7.htm 0000007 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.usana.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 7 false false R8.htm 0000008 - Disclosure - Business Combinations Sheet http://www.usana.com/role/BusinessCombinations Business Combinations Notes 8 false false R9.htm 0000009 - Disclosure - Inventories Sheet http://www.usana.com/role/Inventories Inventories Notes 9 false false R10.htm 0000010 - Disclosure - Prepaid Expenses and Other Current Assets Sheet http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssets Prepaid Expenses and Other Current Assets Notes 10 false false R11.htm 0000011 - Disclosure - Income Taxes Sheet http://www.usana.com/role/IncomeTaxes Income Taxes Notes 11 false false R12.htm 0000012 - Disclosure - Property and Equipment Sheet http://www.usana.com/role/PropertyandEquipment Property and Equipment Notes 12 false false R13.htm 0000013 - Disclosure - Operating Leases Sheet http://www.usana.com/role/OperatingLeases Operating Leases Notes 13 false false R14.htm 0000014 - Disclosure - Intangible Assets Sheet http://www.usana.com/role/IntangibleAssets Intangible Assets Notes 14 false false R15.htm 0000015 - Disclosure - Other Current Liabilities Sheet http://www.usana.com/role/OtherCurrentLiabilities Other Current Liabilities Notes 15 false false R16.htm 0000016 - Disclosure - Line of Credit Sheet http://www.usana.com/role/LineofCredit Line of Credit Notes 16 false false R17.htm 0000017 - Disclosure - Commitments and Contingencies Sheet http://www.usana.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 17 false false R18.htm 0000018 - Disclosure - Equity-Based Compensation Sheet http://www.usana.com/role/EquityBasedCompensation Equity-Based Compensation Notes 18 false false R19.htm 0000019 - Disclosure - Segment Information Sheet http://www.usana.com/role/SegmentInformation Segment Information Notes 19 false false R20.htm 0000020 - Disclosure - Common Stock and Earnings Per Share Sheet http://www.usana.com/role/CommonStockandEarningsPerShare Common Stock and Earnings Per Share Notes 20 false false R21.htm 0000021 - Disclosure - Related-Party Transactions Sheet http://www.usana.com/role/RelatedPartyTransactions Related-Party Transactions Notes 21 false false R22.htm 0000022 - Disclosure - Schedule II - Valuation and Qualifying Accounts Sheet http://www.usana.com/role/ScheduleIIValuationandQualifyingAccounts Schedule II - Valuation and Qualifying Accounts Notes 22 false false R23.htm 0000023 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.usana.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.usana.com/role/SummaryofSignificantAccountingPolicies 23 false false R24.htm 0000024 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.usana.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.usana.com/role/SummaryofSignificantAccountingPolicies 24 false false R25.htm 0000025 - Disclosure - Inventories (Tables) Sheet http://www.usana.com/role/InventoriesTables Inventories (Tables) Tables http://www.usana.com/role/Inventories 25 false false R26.htm 0000026 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) Sheet http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsTables Prepaid Expenses and Other Current Assets (Tables) Tables http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssets 26 false false R27.htm 0000027 - Disclosure - Income Taxes (Tables) Sheet http://www.usana.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.usana.com/role/IncomeTaxes 27 false false R28.htm 0000028 - Disclosure - Property and Equipment (Tables) Sheet http://www.usana.com/role/PropertyandEquipmentTables Property and Equipment (Tables) Tables http://www.usana.com/role/PropertyandEquipment 28 false false R29.htm 0000029 - Disclosure - Operating Leases (Tables) Sheet http://www.usana.com/role/OperatingLeasesTables Operating Leases (Tables) Tables http://www.usana.com/role/OperatingLeases 29 false false R30.htm 0000030 - Disclosure - Intangible Assets (Tables) Sheet http://www.usana.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://www.usana.com/role/IntangibleAssets 30 false false R31.htm 0000031 - Disclosure - Other Current Liabilities (Tables) Sheet http://www.usana.com/role/OtherCurrentLiabilitiesTables Other Current Liabilities (Tables) Tables http://www.usana.com/role/OtherCurrentLiabilities 31 false false R32.htm 0000032 - Disclosure - Equity-Based Compensation (Tables) Sheet http://www.usana.com/role/EquityBasedCompensationTables Equity-Based Compensation (Tables) Tables http://www.usana.com/role/EquityBasedCompensation 32 false false R33.htm 0000033 - Disclosure - Segment Information (Tables) Sheet http://www.usana.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.usana.com/role/SegmentInformation 33 false false R34.htm 0000034 - Disclosure - Common Stock and Earnings Per Share (Tables) Sheet http://www.usana.com/role/CommonStockandEarningsPerShareTables Common Stock and Earnings Per Share (Tables) Tables http://www.usana.com/role/CommonStockandEarningsPerShare 34 false false R35.htm 0000035 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details) Sheet http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails Summary of Significant Accounting Policies - Narrative (Details) Details 35 false false R36.htm 0000036 - Disclosure - Summary of Significant Accounting Policies - Schedule of Assets And Liabilities Measured At Fair Value (Details) Sheet http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails Summary of Significant Accounting Policies - Schedule of Assets And Liabilities Measured At Fair Value (Details) Details 36 false false R37.htm 0000037 - Disclosure - Summary of Significant Accounting Policies - Schedule of Other Revenue (Details) Sheet http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherRevenueDetails Summary of Significant Accounting Policies - Schedule of Other Revenue (Details) Details 37 false false R38.htm 0000038 - Disclosure - Summary of Significant Accounting Policies - Schedule of Contract Liabilities From Contract With Customers (Details) Sheet http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofContractLiabilitiesFromContractWithCustomersDetails Summary of Significant Accounting Policies - Schedule of Contract Liabilities From Contract With Customers (Details) Details 38 false false R39.htm 0000039 - Disclosure - Business Combinations and Asset Acquisitions (Details) Sheet http://www.usana.com/role/BusinessCombinationsandAssetAcquisitionsDetails Business Combinations and Asset Acquisitions (Details) Details 39 false false R40.htm 0000040 - Disclosure - Inventories - Schedule of Inventories (Details) Sheet http://www.usana.com/role/InventoriesScheduleofInventoriesDetails Inventories - Schedule of Inventories (Details) Details 40 false false R41.htm 0000041 - Disclosure - Inventories - Narrative (Details) Sheet http://www.usana.com/role/InventoriesNarrativeDetails Inventories - Narrative (Details) Details 41 false false R42.htm 0000042 - Disclosure - Prepaid Expenses and Other Current Assets - Prepaid Expenses and Other Current Assets (Details) Sheet http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails Prepaid Expenses and Other Current Assets - Prepaid Expenses and Other Current Assets (Details) Details 42 false false R43.htm 0000043 - Disclosure - Income Taxes - Consolidated Earnings Before Income Taxes (Details) Sheet http://www.usana.com/role/IncomeTaxesConsolidatedEarningsBeforeIncomeTaxesDetails Income Taxes - Consolidated Earnings Before Income Taxes (Details) Details 43 false false R44.htm 0000044 - Disclosure - Income Taxes - Income Tax Expense (Benefit) Included in Income from Continuing Operations (Details) Sheet http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails Income Taxes - Income Tax Expense (Benefit) Included in Income from Continuing Operations (Details) Details 44 false false R45.htm 0000045 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details) Sheet http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails Income Taxes - Effective Tax Rate Reconciliation (Details) Details 45 false false R46.htm 0000046 - Disclosure - Income Taxes - Significant Categories of Deferred Taxes (Details) Sheet http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails Income Taxes - Significant Categories of Deferred Taxes (Details) Details 46 false false R47.htm 0000047 - Disclosure - Income Taxes - Narrative (Details) Sheet http://www.usana.com/role/IncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 47 false false R48.htm 0000048 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details) Sheet http://www.usana.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails Income Taxes - Unrecognized Tax Benefits (Details) Details 48 false false R49.htm 0000049 - Disclosure - Property and Equipment - Cost of Property and Equipment and Estimated Useful Lives (Details) Sheet http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails Property and Equipment - Cost of Property and Equipment and Estimated Useful Lives (Details) Details 49 false false R50.htm 0000050 - Disclosure - Property and Equipment - Narrative (Details) Sheet http://www.usana.com/role/PropertyandEquipmentNarrativeDetails Property and Equipment - Narrative (Details) Details 50 false false R51.htm 0000051 - Disclosure - Operating Leases - Narrative (Details) Sheet http://www.usana.com/role/OperatingLeasesNarrativeDetails Operating Leases - Narrative (Details) Details 51 false false R52.htm 0000052 - Disclosure - Operating Leases - Classification of Lease Assets and Lease Liabilities (Details) Sheet http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails Operating Leases - Classification of Lease Assets and Lease Liabilities (Details) Details 52 false false R53.htm 0000053 - Disclosure - Operating Leases - Supplemental Lease Information (Details) Sheet http://www.usana.com/role/OperatingLeasesSupplementalLeaseInformationDetails Operating Leases - Supplemental Lease Information (Details) Details 53 false false R54.htm 0000054 - Disclosure - Operating Leases - Maturity of Lease Liabilities (Details) Sheet http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails Operating Leases - Maturity of Lease Liabilities (Details) Details 54 false false R55.htm 0000055 - Disclosure - Intangible Assets - Narrative (Details) Sheet http://www.usana.com/role/IntangibleAssetsNarrativeDetails Intangible Assets - Narrative (Details) Details 55 false false R56.htm 0000056 - Disclosure - Intangible Assets - Changes in Carrying Amounts of Goodwill (Details) Sheet http://www.usana.com/role/IntangibleAssetsChangesinCarryingAmountsofGoodwillDetails Intangible Assets - Changes in Carrying Amounts of Goodwill (Details) Details 56 false false R57.htm 0000057 - Disclosure - Intangible Assets - Intangible Assets (Details) Sheet http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails Intangible Assets - Intangible Assets (Details) Details 57 false false R58.htm 0000058 - Disclosure - Intangible Assets - Estimated Amortization Expense (Details) Sheet http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails Intangible Assets - Estimated Amortization Expense (Details) Details 58 false false R59.htm 0000059 - Disclosure - Other Current Liabilities - Other Current Liabilities (Details) Sheet http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails Other Current Liabilities - Other Current Liabilities (Details) Details 59 false false R60.htm 0000060 - Disclosure - Line of Credit - Narrative (Details) Sheet http://www.usana.com/role/LineofCreditNarrativeDetails Line of Credit - Narrative (Details) Details 60 false false R61.htm 0000061 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://www.usana.com/role/CommitmentsandContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 61 false false R62.htm 0000062 - Disclosure - Equity-Based Compensation - Narrative (Details) Sheet http://www.usana.com/role/EquityBasedCompensationNarrativeDetails Equity-Based Compensation - Narrative (Details) Details 62 false false R63.htm 0000063 - Disclosure - Equity-Based Compensation - Remaining Unrecognized Compensation Expense (Details) Sheet http://www.usana.com/role/EquityBasedCompensationRemainingUnrecognizedCompensationExpenseDetails Equity-Based Compensation - Remaining Unrecognized Compensation Expense (Details) Details 63 false false R64.htm 0000064 - Disclosure - Equity-Based Compensation - Weighted-average Assumptions (Details) Sheet http://www.usana.com/role/EquityBasedCompensationWeightedaverageAssumptionsDetails Equity-Based Compensation - Weighted-average Assumptions (Details) Details 64 false false R65.htm 0000065 - Disclosure - Equity-Based Compensation - Summary of Stock-settled Stock Appreciation Right Activity (Details) Sheet http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails Equity-Based Compensation - Summary of Stock-settled Stock Appreciation Right Activity (Details) Details 65 false false R66.htm 0000066 - Disclosure - Equity-Based Compensation - Summary of Stock-settled Restricted Stock Unit Activity (Details) Sheet http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails Equity-Based Compensation - Summary of Stock-settled Restricted Stock Unit Activity (Details) Details 66 false false R67.htm 0000067 - Disclosure - Equity-Based Compensation - Summary of Cash-settled Restricted Stock Unit Activity (Details) Sheet http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails Equity-Based Compensation - Summary of Cash-settled Restricted Stock Unit Activity (Details) Details 67 false false R68.htm 0000068 - Disclosure - Segment Information - Schedule of Segment Reporting Information, by Operating Segment (Details) Sheet http://www.usana.com/role/SegmentInformationScheduleofSegmentReportingInformationbyOperatingSegmentDetails Segment Information - Schedule of Segment Reporting Information, by Operating Segment (Details) Details 68 false false R69.htm 0000069 - Disclosure - Segment Information - Schedule of Revenue Percentage By Product (Details) Sheet http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails Segment Information - Schedule of Revenue Percentage By Product (Details) Details 69 false false R70.htm 0000070 - Disclosure - Segment Information - Consolidated Net Sales and Long Lived Assets (Details) Sheet http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails Segment Information - Consolidated Net Sales and Long Lived Assets (Details) Details 70 false false R71.htm 0000071 - Disclosure - Segment Information - Markets Representing Ten Percent Or More Of Consolidated Net Sales and Long-Lived Assets (Details) Sheet http://www.usana.com/role/SegmentInformationMarketsRepresentingTenPercentOrMoreOfConsolidatedNetSalesandLongLivedAssetsDetails Segment Information - Markets Representing Ten Percent Or More Of Consolidated Net Sales and Long-Lived Assets (Details) Details 71 false false R72.htm 0000072 - Disclosure - Common Stock and Earnings Per Share - Schedule of Earnings Per Share (Details) Sheet http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofEarningsPerShareDetails Common Stock and Earnings Per Share - Schedule of Earnings Per Share (Details) Details 72 false false R73.htm 0000073 - Disclosure - Common Stock and Earnings Per Share - Schedule of Shares not Included in the Computation of Diluted EPS (Details) Sheet http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofSharesnotIncludedintheComputationofDilutedEPSDetails Common Stock and Earnings Per Share - Schedule of Shares not Included in the Computation of Diluted EPS (Details) Details 73 false false R74.htm 0000074 - Disclosure - Common Stock and Earnings Per Share - Narrative (Details) Sheet http://www.usana.com/role/CommonStockandEarningsPerShareNarrativeDetails Common Stock and Earnings Per Share - Narrative (Details) Details 74 false false R75.htm 0000075 - Disclosure - Related-Party Transactions - Narrative (Details) Sheet http://www.usana.com/role/RelatedPartyTransactionsNarrativeDetails Related-Party Transactions - Narrative (Details) Details 75 false false R76.htm 0000076 - Disclosure - Schedule II - Valuation and Qualifying Accounts - Valuation and Qualifying Accounts (Details) Sheet http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails Schedule II - Valuation and Qualifying Accounts - Valuation and Qualifying Accounts (Details) Details 76 false false All Reports Book All Reports usna-20221231.htm exhibit231.htm subsidiaries-exhibit21.htm usna-20221231.xsd usna-20221231_cal.xml usna-20221231_def.xml usna-20221231_lab.xml usna-20221231_pre.xml usna-20221231xex311.htm usna-20221231xex312.htm usna-20221231xex321.htm usna-20221231xex322.htm usna-20221231_g1.jpg http://fasb.org/srt/2022 http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 96 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "usna-20221231.htm": { "axisCustom": 0, "axisStandard": 31, "baseTaxonomies": { "http://fasb.org/srt/2022": 1, "http://fasb.org/us-gaap/2022": 1061, "http://xbrl.sec.gov/dei/2022": 36 }, "contextCount": 255, "dts": { "calculationLink": { "local": [ "usna-20221231_cal.xml" ] }, "definitionLink": { "local": [ "usna-20221231_def.xml" ] }, "inline": { "local": [ "usna-20221231.htm" ] }, "labelLink": { "local": [ "usna-20221231_lab.xml" ] }, "presentationLink": { "local": [ "usna-20221231_pre.xml" ] }, "schema": { "local": [ "usna-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 677, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 6, "http://xbrl.sec.gov/dei/2022": 4, "total": 10 }, "keyCustom": 64, "keyStandard": 379, "memberCustom": 27, "memberStandard": 53, "nsprefix": "usna", "nsuri": "http://www.usana.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Document And Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.usana.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000010 - Disclosure - Prepaid Expenses and Other Current Assets", "menuCat": "Notes", "order": "10", "role": "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssets", "shortName": "Prepaid Expenses and Other Current Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000011 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "11", "role": "http://www.usana.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000012 - Disclosure - Property and Equipment", "menuCat": "Notes", "order": "12", "role": "http://www.usana.com/role/PropertyandEquipment", "shortName": "Property and Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000013 - Disclosure - Operating Leases", "menuCat": "Notes", "order": "13", "role": "http://www.usana.com/role/OperatingLeases", "shortName": "Operating Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000014 - Disclosure - Intangible Assets", "menuCat": "Notes", "order": "14", "role": "http://www.usana.com/role/IntangibleAssets", "shortName": "Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000015 - Disclosure - Other Current Liabilities", "menuCat": "Notes", "order": "15", "role": "http://www.usana.com/role/OtherCurrentLiabilities", "shortName": "Other Current Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000016 - Disclosure - Line of Credit", "menuCat": "Notes", "order": "16", "role": "http://www.usana.com/role/LineofCredit", "shortName": "Line of Credit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000017 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "17", "role": "http://www.usana.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000018 - Disclosure - Equity-Based Compensation", "menuCat": "Notes", "order": "18", "role": "http://www.usana.com/role/EquityBasedCompensation", "shortName": "Equity-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000019 - Disclosure - Segment Information", "menuCat": "Notes", "order": "19", "role": "http://www.usana.com/role/SegmentInformation", "shortName": "Segment Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000002 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://www.usana.com/role/ConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AssetsCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000020 - Disclosure - Common Stock and Earnings Per Share", "menuCat": "Notes", "order": "20", "role": "http://www.usana.com/role/CommonStockandEarningsPerShare", "shortName": "Common Stock and Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000021 - Disclosure - Related-Party Transactions", "menuCat": "Notes", "order": "21", "role": "http://www.usana.com/role/RelatedPartyTransactions", "shortName": "Related-Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000022 - Disclosure - Schedule II - Valuation and Qualifying Accounts", "menuCat": "Notes", "order": "22", "role": "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccounts", "shortName": "Schedule II - Valuation and Qualifying Accounts", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "usna:COVID19PolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000023 - Disclosure - Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "23", "role": "http://www.usana.com/role/SignificantAccountingPoliciesPolicies", "shortName": "Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "usna:COVID19PolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000024 - Disclosure - Summary of Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "24", "role": "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000025 - Disclosure - Inventories (Tables)", "menuCat": "Tables", "order": "25", "role": "http://www.usana.com/role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000026 - Disclosure - Prepaid Expenses and Other Current Assets (Tables)", "menuCat": "Tables", "order": "26", "role": "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsTables", "shortName": "Prepaid Expenses and Other Current Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000027 - Disclosure - Income Taxes (Tables)", "menuCat": "Tables", "order": "27", "role": "http://www.usana.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000028 - Disclosure - Property and Equipment (Tables)", "menuCat": "Tables", "order": "28", "role": "http://www.usana.com/role/PropertyandEquipmentTables", "shortName": "Property and Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "usna:AssetsAndLiabilitiesLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000029 - Disclosure - Operating Leases (Tables)", "menuCat": "Tables", "order": "29", "role": "http://www.usana.com/role/OperatingLeasesTables", "shortName": "Operating Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "usna:AssetsAndLiabilitiesLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000003 - Statement - Consolidated Balance Sheets (Parentheticals)", "menuCat": "Statements", "order": "3", "role": "http://www.usana.com/role/ConsolidatedBalanceSheetsParentheticals", "shortName": "Consolidated Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000030 - Disclosure - Intangible Assets (Tables)", "menuCat": "Tables", "order": "30", "role": "http://www.usana.com/role/IntangibleAssetsTables", "shortName": "Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000031 - Disclosure - Other Current Liabilities (Tables)", "menuCat": "Tables", "order": "31", "role": "http://www.usana.com/role/OtherCurrentLiabilitiesTables", "shortName": "Other Current Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000032 - Disclosure - Equity-Based Compensation (Tables)", "menuCat": "Tables", "order": "32", "role": "http://www.usana.com/role/EquityBasedCompensationTables", "shortName": "Equity-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000033 - Disclosure - Segment Information (Tables)", "menuCat": "Tables", "order": "33", "role": "http://www.usana.com/role/SegmentInformationTables", "shortName": "Segment Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000034 - Disclosure - Common Stock and Earnings Per Share (Tables)", "menuCat": "Tables", "order": "34", "role": "http://www.usana.com/role/CommonStockandEarningsPerShareTables", "shortName": "Common Stock and Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "div", "usna:TheCompanyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "usna:NumberOfGeographicRegions", "reportCount": 1, "unique": true, "unitRef": "region", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000035 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)", "menuCat": "Details", "order": "35", "role": "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails", "shortName": "Summary of Significant Accounting Policies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "usna:TheCompanyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "usna:NumberOfGeographicRegions", "reportCount": 1, "unique": true, "unitRef": "region", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000036 - Disclosure - Summary of Significant Accounting Policies - Schedule of Assets And Liabilities Measured At Fair Value (Details)", "menuCat": "Details", "order": "36", "role": "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails", "shortName": "Summary of Significant Accounting Policies - Schedule of Assets And Liabilities Measured At Fair Value (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OtherIncome", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000037 - Disclosure - Summary of Significant Accounting Policies - Schedule of Other Revenue (Details)", "menuCat": "Details", "order": "37", "role": "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherRevenueDetails", "shortName": "Summary of Significant Accounting Policies - Schedule of Other Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OtherIncome", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i10627b90ea344620a3ae10df64e29176_I20220101", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000038 - Disclosure - Summary of Significant Accounting Policies - Schedule of Contract Liabilities From Contract With Customers (Details)", "menuCat": "Details", "order": "38", "role": "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofContractLiabilitiesFromContractWithCustomersDetails", "shortName": "Summary of Significant Accounting Policies - Schedule of Contract Liabilities From Contract With Customers (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i0fc5098e0dcd43c88a57a3da64892aa4_I20210102", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000039 - Disclosure - Business Combinations and Asset Acquisitions (Details)", "menuCat": "Details", "order": "39", "role": "http://www.usana.com/role/BusinessCombinationsandAssetAcquisitionsDetails", "shortName": "Business Combinations and Asset Acquisitions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i31df8cde69ad4644801de3e95309dc90_D20220403-20220702", "decimals": "-3", "lang": "en-US", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000004 - Statement - Consolidated Statements of Comprehensive Income", "menuCat": "Statements", "order": "4", "role": "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome", "shortName": "Consolidated Statements of Comprehensive Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000040 - Disclosure - Inventories - Schedule of Inventories (Details)", "menuCat": "Details", "order": "40", "role": "http://www.usana.com/role/InventoriesScheduleofInventoriesDetails", "shortName": "Inventories - Schedule of Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryNoncurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000041 - Disclosure - Inventories - Narrative (Details)", "menuCat": "Details", "order": "41", "role": "http://www.usana.com/role/InventoriesNarrativeDetails", "shortName": "Inventories - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R42": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PrepaidInsurance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000042 - Disclosure - Prepaid Expenses and Other Current Assets - Prepaid Expenses and Other Current Assets (Details)", "menuCat": "Details", "order": "42", "role": "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails", "shortName": "Prepaid Expenses and Other Current Assets - Prepaid Expenses and Other Current Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PrepaidInsurance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000043 - Disclosure - Income Taxes - Consolidated Earnings Before Income Taxes (Details)", "menuCat": "Details", "order": "43", "role": "http://www.usana.com/role/IncomeTaxesConsolidatedEarningsBeforeIncomeTaxesDetails", "shortName": "Income Taxes - Consolidated Earnings Before Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000044 - Disclosure - Income Taxes - Income Tax Expense (Benefit) Included in Income from Continuing Operations (Details)", "menuCat": "Details", "order": "44", "role": "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails", "shortName": "Income Taxes - Income Tax Expense (Benefit) Included in Income from Continuing Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000045 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details)", "menuCat": "Details", "order": "45", "role": "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails", "shortName": "Income Taxes - Effective Tax Rate Reconciliation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsInventory", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000046 - Disclosure - Income Taxes - Significant Categories of Deferred Taxes (Details)", "menuCat": "Details", "order": "46", "role": "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails", "shortName": "Income Taxes - Significant Categories of Deferred Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsInventory", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000047 - Disclosure - Income Taxes - Narrative (Details)", "menuCat": "Details", "order": "47", "role": "http://www.usana.com/role/IncomeTaxesNarrativeDetails", "shortName": "Income Taxes - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i10627b90ea344620a3ae10df64e29176_I20220101", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000048 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)", "menuCat": "Details", "order": "48", "role": "http://www.usana.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails", "shortName": "Income Taxes - Unrecognized Tax Benefits (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000049 - Disclosure - Property and Equipment - Cost of Property and Equipment and Estimated Useful Lives (Details)", "menuCat": "Details", "order": "49", "role": "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails", "shortName": "Property and Equipment - Cost of Property and Equipment and Estimated Useful Lives (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000005 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "5", "role": "http://www.usana.com/role/ConsolidatedStatementsofCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000050 - Disclosure - Property and Equipment - Narrative (Details)", "menuCat": "Details", "order": "50", "role": "http://www.usana.com/role/PropertyandEquipmentNarrativeDetails", "shortName": "Property and Equipment - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000051 - Disclosure - Operating Leases - Narrative (Details)", "menuCat": "Details", "order": "51", "role": "http://www.usana.com/role/OperatingLeasesNarrativeDetails", "shortName": "Operating Leases - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "usna:AssetsAndLiabilitiesLesseeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000052 - Disclosure - Operating Leases - Classification of Lease Assets and Lease Liabilities (Details)", "menuCat": "Details", "order": "52", "role": "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails", "shortName": "Operating Leases - Classification of Lease Assets and Lease Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "usna:AssetsAndLiabilitiesLesseeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000053 - Disclosure - Operating Leases - Supplemental Lease Information (Details)", "menuCat": "Details", "order": "53", "role": "http://www.usana.com/role/OperatingLeasesSupplementalLeaseInformationDetails", "shortName": "Operating Leases - Supplemental Lease Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000054 - Disclosure - Operating Leases - Maturity of Lease Liabilities (Details)", "menuCat": "Details", "order": "54", "role": "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails", "shortName": "Operating Leases - Maturity of Lease Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "us-gaap:GoodwillImpairmentLoss", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:GoodwillImpairmentLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000055 - Disclosure - Intangible Assets - Narrative (Details)", "menuCat": "Details", "order": "55", "role": "http://www.usana.com/role/IntangibleAssetsNarrativeDetails", "shortName": "Intangible Assets - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i10627b90ea344620a3ae10df64e29176_I20220101", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:GoodwillGross", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000056 - Disclosure - Intangible Assets - Changes in Carrying Amounts of Goodwill (Details)", "menuCat": "Details", "order": "56", "role": "http://www.usana.com/role/IntangibleAssetsChangesinCarryingAmountsofGoodwillDetails", "shortName": "Intangible Assets - Changes in Carrying Amounts of Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i0fc5098e0dcd43c88a57a3da64892aa4_I20210102", "decimals": "-3", "lang": "en-US", "name": "us-gaap:GoodwillGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000057 - Disclosure - Intangible Assets - Intangible Assets (Details)", "menuCat": "Details", "order": "57", "role": "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails", "shortName": "Intangible Assets - Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "usna:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000058 - Disclosure - Intangible Assets - Estimated Amortization Expense (Details)", "menuCat": "Details", "order": "58", "role": "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails", "shortName": "Intangible Assets - Estimated Amortization Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "usna:AssociateIncentivesPayable", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000059 - Disclosure - Other Current Liabilities - Other Current Liabilities (Details)", "menuCat": "Details", "order": "59", "role": "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails", "shortName": "Other Current Liabilities - Other Current Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "usna:AssociateIncentivesPayable", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "ie59ab57504c24482bd9de1e1d52767bb_I20191228", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000006 - Statement - Consolidated Statements of Stockholders' Equity", "menuCat": "Statements", "order": "6", "role": "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity", "shortName": "Consolidated Statements of Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "ie59ab57504c24482bd9de1e1d52767bb_I20191228", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "ifddf32277cab40ffbb02444e10bc2637_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000060 - Disclosure - Line of Credit - Narrative (Details)", "menuCat": "Details", "order": "60", "role": "http://www.usana.com/role/LineofCreditNarrativeDetails", "shortName": "Line of Credit - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "ifddf32277cab40ffbb02444e10bc2637_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000061 - Disclosure - Commitments and Contingencies - Narrative (Details)", "menuCat": "Details", "order": "61", "role": "http://www.usana.com/role/CommitmentsandContingenciesNarrativeDetails", "shortName": "Commitments and Contingencies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "usna:EquityBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000062 - Disclosure - Equity-Based Compensation - Narrative (Details)", "menuCat": "Details", "order": "62", "role": "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "shortName": "Equity-Based Compensation - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "usna:EquityBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "usna:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAmountDueYearOne", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000063 - Disclosure - Equity-Based Compensation - Remaining Unrecognized Compensation Expense (Details)", "menuCat": "Details", "order": "63", "role": "http://www.usana.com/role/EquityBasedCompensationRemainingUnrecognizedCompensationExpenseDetails", "shortName": "Equity-Based Compensation - Remaining Unrecognized Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2f07c97faf2c49f3a6013f2be43c19cf_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "usna:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAmountDueYearOne", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i695d9faf7196463c990c7ed29a364b9c_D20210103-20220101", "decimals": "4", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000064 - Disclosure - Equity-Based Compensation - Weighted-average Assumptions (Details)", "menuCat": "Details", "order": "64", "role": "http://www.usana.com/role/EquityBasedCompensationWeightedaverageAssumptionsDetails", "shortName": "Equity-Based Compensation - Weighted-average Assumptions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i695d9faf7196463c990c7ed29a364b9c_D20210103-20220101", "decimals": "4", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i1c4dc195ae6a4c82a1625d906ed46613_I20220101", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000065 - Disclosure - Equity-Based Compensation - Summary of Stock-settled Stock Appreciation Right Activity (Details)", "menuCat": "Details", "order": "65", "role": "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails", "shortName": "Equity-Based Compensation - Summary of Stock-settled Stock Appreciation Right Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "ibbd57269f9334d1e8210e223dd6af356_D20220102-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2b93fbae703348359005b12b1d9b5fe5_I20220101", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000066 - Disclosure - Equity-Based Compensation - Summary of Stock-settled Restricted Stock Unit Activity (Details)", "menuCat": "Details", "order": "66", "role": "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails", "shortName": "Equity-Based Compensation - Summary of Stock-settled Restricted Stock Unit Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2b93fbae703348359005b12b1d9b5fe5_I20220101", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "iea18f62b910e4638a87877c18c6a0337_I20220101", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000067 - Disclosure - Equity-Based Compensation - Summary of Cash-settled Restricted Stock Unit Activity (Details)", "menuCat": "Details", "order": "67", "role": "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "shortName": "Equity-Based Compensation - Summary of Cash-settled Restricted Stock Unit Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "iea18f62b910e4638a87877c18c6a0337_I20220101", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000068 - Disclosure - Segment Information - Schedule of Segment Reporting Information, by Operating Segment (Details)", "menuCat": "Details", "order": "68", "role": "http://www.usana.com/role/SegmentInformationScheduleofSegmentReportingInformationbyOperatingSegmentDetails", "shortName": "Segment Information - Schedule of Segment Reporting Information, by Operating Segment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i2bcd34ce2a034481bc7ee58698519ea2_D20220102-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "idfed7d790c5241bb842f4aeb110a3d1f_D20220102-20221231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000069 - Disclosure - Segment Information - Schedule of Revenue Percentage By Product (Details)", "menuCat": "Details", "order": "69", "role": "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails", "shortName": "Segment Information - Schedule of Revenue Percentage By Product (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "idfed7d790c5241bb842f4aeb110a3d1f_D20220102-20221231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000007 - Disclosure - Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "7", "role": "http://www.usana.com/role/SummaryofSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000070 - Disclosure - Segment Information - Consolidated Net Sales and Long Lived Assets (Details)", "menuCat": "Details", "order": "70", "role": "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails", "shortName": "Segment Information - Consolidated Net Sales and Long Lived Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i51ab9988267b400c8ec3f5f15a2b990c_D20220102-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000071 - Disclosure - Segment Information - Markets Representing Ten Percent Or More Of Consolidated Net Sales and Long-Lived Assets (Details)", "menuCat": "Details", "order": "71", "role": "http://www.usana.com/role/SegmentInformationMarketsRepresentingTenPercentOrMoreOfConsolidatedNetSalesandLongLivedAssetsDetails", "shortName": "Segment Information - Markets Representing Ten Percent Or More Of Consolidated Net Sales and Long-Lived Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "ieda192d70e5f4a9397efba57bbc45e12_D20220102-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000072 - Disclosure - Common Stock and Earnings Per Share - Schedule of Earnings Per Share (Details)", "menuCat": "Details", "order": "72", "role": "http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofEarningsPerShareDetails", "shortName": "Common Stock and Earnings Per Share - Schedule of Earnings Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000073 - Disclosure - Common Stock and Earnings Per Share - Schedule of Shares not Included in the Computation of Diluted EPS (Details)", "menuCat": "Details", "order": "73", "role": "http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofSharesnotIncludedintheComputationofDilutedEPSDetails", "shortName": "Common Stock and Earnings Per Share - Schedule of Shares not Included in the Computation of Diluted EPS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodShares", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000074 - Disclosure - Common Stock and Earnings Per Share - Narrative (Details)", "menuCat": "Details", "order": "74", "role": "http://www.usana.com/role/CommonStockandEarningsPerShareNarrativeDetails", "shortName": "Common Stock and Earnings Per Share - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R75": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i78d8c790c346419bb92ef8fee557d55d_D20220102-20221231", "decimals": "4", "first": true, "lang": "en-US", "name": "usna:RelatedPartyTransactionOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000075 - Disclosure - Related-Party Transactions - Narrative (Details)", "menuCat": "Details", "order": "75", "role": "http://www.usana.com/role/RelatedPartyTransactionsNarrativeDetails", "shortName": "Related-Party Transactions - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i78d8c790c346419bb92ef8fee557d55d_D20220102-20221231", "decimals": "4", "first": true, "lang": "en-US", "name": "usna:RelatedPartyTransactionOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "ia764a4cf3ccf448eb4a50e212cd07148_I20220101", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000076 - Disclosure - Schedule II - Valuation and Qualifying Accounts - Valuation and Qualifying Accounts (Details)", "menuCat": "Details", "order": "76", "role": "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails", "shortName": "Schedule II - Valuation and Qualifying Accounts - Valuation and Qualifying Accounts (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "iabba022fad6e4c1799f2d8fdf6203d60_I20191228", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000008 - Disclosure - Business Combinations", "menuCat": "Notes", "order": "8", "role": "http://www.usana.com/role/BusinessCombinations", "shortName": "Business Combinations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000009 - Disclosure - Inventories", "menuCat": "Notes", "order": "9", "role": "http://www.usana.com/role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "usna-20221231.htm", "contextRef": "i96dd5e757ec5407ca8bd1f5cbc825d26_D20220102-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 81, "tag": { "country_CN": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CHINA", "terseLabel": "China" } } }, "localname": "CN", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationMarketsRepresentingTenPercentOrMoreOfConsolidatedNetSalesandLongLivedAssetsDetails" ], "xbrltype": "domainItemType" }, "country_KR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "KOREA, REPUBLIC OF", "terseLabel": "South Korea" } } }, "localname": "KR", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationMarketsRepresentingTenPercentOrMoreOfConsolidatedNetSalesandLongLivedAssetsDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "China" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationMarketsRepresentingTenPercentOrMoreOfConsolidatedNetSalesandLongLivedAssetsDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r695", "r696", "r697" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID", "terseLabel": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r695", "r696", "r697" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r695", "r696", "r697" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r695", "r696", "r697" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r698" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r693" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r693" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r693" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r699" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r693" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r693" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r693" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r693" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r695", "r696", "r697" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r692" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r694" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region of Asia Pacific.", "label": "Asia Pacific [Member]", "terseLabel": "Asia Pacific Total" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r256", "r306", "r318", "r319", "r320", "r321", "r322", "r324", "r328", "r376", "r377", "r378", "r379", "r381", "r382", "r384", "r386", "r387", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r748", "r749", "r810", "r811" ], "lang": { "en-us": { "role": { "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.", "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofSegmentReportingInformationbyOperatingSegmentDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r256", "r306", "r318", "r319", "r320", "r321", "r322", "r324", "r328", "r376", "r377", "r378", "r379", "r381", "r382", "r384", "r386", "r387", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r748", "r749", "r810", "r811" ], "lang": { "en-us": { "role": { "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.", "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofSegmentReportingInformationbyOperatingSegmentDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r372", "r373", "r374", "r375", "r440", "r583", "r609", "r633", "r634", "r674", "r682", "r691", "r750", "r801", "r802", "r803", "r804", "r805", "r806" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r372", "r373", "r374", "r375", "r440", "r583", "r609", "r633", "r634", "r674", "r682", "r691", "r750", "r801", "r802", "r803", "r804", "r805", "r806" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r330", "r585", "r675", "r689", "r745", "r746", "r752", "r808" ], "lang": { "en-us": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r330", "r585", "r675", "r689", "r745", "r746", "r752", "r808" ], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r372", "r373", "r374", "r375", "r432", "r440", "r471", "r472", "r473", "r582", "r583", "r609", "r633", "r634", "r674", "r682", "r691", "r744", "r750", "r802", "r803", "r804", "r805", "r806" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r372", "r373", "r374", "r375", "r432", "r440", "r471", "r472", "r473", "r582", "r583", "r609", "r633", "r634", "r674", "r682", "r691", "r744", "r750", "r802", "r803", "r804", "r805", "r806" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": { "auth_ref": [ "r263", "r645" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]", "terseLabel": "Schedule II - Valuation And Qualifying Accounts" } } }, "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccounts" ], "xbrltype": "textBlockItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r331", "r332", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r635", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r676", "r690", "r752" ], "lang": { "en-us": { "role": { "documentation": "Geographical area.", "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails", "http://www.usana.com/role/SegmentInformationMarketsRepresentingTenPercentOrMoreOfConsolidatedNetSalesandLongLivedAssetsDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r331", "r332", "r617", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r635", "r636", "r676", "r690", "r752" ], "lang": { "en-us": { "role": { "documentation": "Information by geographical components.", "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails", "http://www.usana.com/role/SegmentInformationMarketsRepresentingTenPercentOrMoreOfConsolidatedNetSalesandLongLivedAssetsDetails" ], "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]" } } }, "localname": "ValuationAndQualifyingAccountsAbstract", "nsuri": "http://fasb.org/srt/2022", "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]" } } }, "localname": "ValuationAndQualifyingAccountsDisclosureLineItems", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsDisclosureTable": { "auth_ref": [ "r257", "r258", "r259", "r261", "r262", "r645" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]" } } }, "localname": "ValuationAndQualifyingAccountsDisclosureTable", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r17", "r688" ], "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r2", "r190", "r201" ], "calculation": { "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "verboseLabel": "Income taxes" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r97", "r222" ], "calculation": { "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails": { "order": 2.0, "parentTag": "usna_PropertyPlantAndEquipmentNetExcludingNondepreciable", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "terseLabel": "Less accumulated depreciation and amortization" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r27", "r29", "r30", "r227", "r605", "r614", "r615" ], "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive income (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive income (loss), net of tax:" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r26", "r30", "r157", "r571", "r610", "r611", "r710", "r711", "r712", "r724", "r725", "r726" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r8" ], "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r481", "r482", "r483", "r724", "r725", "r726", "r792" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation", "negatedLabel": "Tax withholding for net-share settled equity awards", "terseLabel": "Share-based payment arrangement, decrease for tax withholding obligation" } } }, "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).", "label": "Adjustments to Additional Paid in Capital, Other", "terseLabel": "Adjustments to additional paid in capital" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r118", "r119", "r442" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Equity-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net earnings to net cash provided by (used in) operating activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r486" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising Cost [Policy Text Block]", "terseLabel": "Advertising" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r487" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Advertising Expense", "terseLabel": "Advertising expense" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AirTransportationEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment used for the primary purpose of air transportation.", "label": "Air Transportation Equipment [Member]", "terseLabel": "Air transportation equipment" } } }, "localname": "AirTransportationEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AllowanceForCreditLossMember": { "auth_ref": [ "r719", "r720", "r721", "r722", "r723" ], "lang": { "en-us": { "role": { "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForCreditLossMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r53", "r84", "r91" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of intangible assets, total" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r291" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities excluded from computation of earnings per share, amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofSharesnotIncludedintheComputationofDilutedEPSDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Assets": { "auth_ref": [ "r188", "r200", "r226", "r251", "r314", "r320", "r326", "r342", "r376", "r377", "r379", "r380", "r381", "r383", "r385", "r387", "r388", "r529", "r531", "r545", "r688", "r748", "r749", "r799" ], "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets", "verboseLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS", "verboseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r217", "r231", "r251", "r342", "r376", "r377", "r379", "r380", "r381", "r383", "r385", "r387", "r388", "r529", "r531", "r545", "r688", "r748", "r749", "r799" ], "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AutomobilesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vehicles that are used primarily for transporting people.", "label": "Automobiles [Member]", "terseLabel": "Automobiles" } } }, "localname": "AutomobilesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r446", "r447", "r448", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r470", "r471", "r472", "r473", "r474" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails", "http://www.usana.com/role/EquityBasedCompensationWeightedaverageAssumptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows", "http://www.usana.com/role/IncomeTaxesNarrativeDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r164", "r167" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows", "http://www.usana.com/role/IncomeTaxesNarrativeDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r96" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "Buildings" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r525", "r680", "r681" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/BusinessCombinationsandAssetAcquisitionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r138", "r139", "r525", "r680", "r681" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/BusinessCombinationsandAssetAcquisitionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": { "auth_ref": [ "r150" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.", "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High", "terseLabel": "Maximum amount of earnouts total" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/BusinessCombinationsandAssetAcquisitionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [ "r147", "r148", "r528" ], "calculation": { "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails": { "order": 2.0, "parentTag": "us-gaap_FairValueNetAssetLiability", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.", "label": "Business Combination, Contingent Consideration, Liability", "negatedTerseLabel": "Contingent consideration included in other current liabilities of $(338) and other long-term liabilities of $(548)", "terseLabel": "Contingent consideration" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/BusinessCombinationsandAssetAcquisitionsDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": { "auth_ref": [ "r147", "r149" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.", "label": "Business Combination, Contingent Consideration, Liability, Current", "terseLabel": "Business combination, contingent consideration, liability, current" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": { "auth_ref": [ "r147", "r149" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.", "label": "Business Combination, Contingent Consideration, Liability, Noncurrent", "negatedTerseLabel": "Business combination, contingent consideration, liability, noncurrent" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r151", "r526" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Business Combinations" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/BusinessCombinations" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment": { "auth_ref": [ "r141" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to property, plant, and equipment acquired in connection with a business combination for which the initial accounting was incomplete.", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment", "negatedTerseLabel": "Decrease in tangible assets" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/BusinessCombinationsandAssetAcquisitionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r140" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "terseLabel": "Purchase price allocations to tangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/BusinessCombinationsandAssetAcquisitionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r140" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Purchase price allocations to intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/BusinessCombinationsandAssetAcquisitionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Combination, Separately Recognized Transactions [Line Items]", "terseLabel": "Business Combination, Separately Recognized Transactions [Line Items]" } } }, "localname": "BusinessCombinationSeparatelyRecognizedTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/BusinessCombinationsandAssetAcquisitionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable": { "auth_ref": [ "r137" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing the disclosures related to transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination by type of transaction.", "label": "Business Combination, Separately Recognized Transactions [Table]", "terseLabel": "Business Combination, Separately Recognized Transactions [Table]" } } }, "localname": "BusinessCombinationSeparatelyRecognizedTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/BusinessCombinationsandAssetAcquisitionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [ "r136" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.", "label": "Business Combinations Policy [Policy Text Block]", "terseLabel": "Business Combinations" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r58", "r59", "r60" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Capital Expenditures Incurred but Not yet Paid", "terseLabel": "Accrued purchases of property and equipment" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r55", "r220", "r655" ], "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash and cash equivalents", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAxis": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Information by type of cash and cash equivalent balance.", "label": "Cash and Cash Equivalents [Axis]", "terseLabel": "Cash and Cash Equivalents [Axis]" } } }, "localname": "CashAndCashEquivalentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails": { "order": 4.0, "parentTag": "us-gaap_FairValueNetAssetLiability", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Money market funds included in cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r56", "r187" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Restricted Cash" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r49", "r55", "r61" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "totalLabel": "Total cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]", "terseLabel": "Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r49", "r55", "r61" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period", "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect [Abstract]", "terseLabel": "Cash paid during the period for:" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r49", "r181" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r701" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash Equivalents, at Carrying Value", "terseLabel": "Cash equivalents, at carrying value, total" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r100", "r369", "r371", "r620", "r747" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r724", "r725", "r792" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par or stated value per share (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares, issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r7", "r104" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)", "terseLabel": "Common stock, shares, outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r7", "r688" ], "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.001 par value; Authorized -- 50,000 shares, issued and outstanding 19,206 as of December\u00a031, 2022 and 19,393 as of January\u00a01, 2022" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r31", "r234", "r236", "r242", "r601", "r606" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]", "terseLabel": "Comprehensive income:" } } }, "localname": "ComprehensiveIncomeNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]", "terseLabel": "Computer equipment and software" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r67", "r68", "r179", "r180", "r334", "r619" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r67", "r68", "r179", "r180", "r334", "r616", "r619" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r67", "r68", "r179", "r180", "r334", "r619", "r809" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r67", "r68", "r179", "r180", "r334" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk, percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r67", "r68", "r179", "r180", "r334", "r619" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r155", "r662" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation and Basis of Presentation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r751" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.", "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]", "terseLabel": "Contract with Customer, Contract Asset, Contract Liability, and Receivable" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetNet": { "auth_ref": [ "r416", "r418", "r429" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Contract with Customer, Asset, after Allowance for Credit Loss", "terseLabel": "Contract with customer, asset, after allowance for credit loss, total" } } }, "localname": "ContractWithCustomerAssetNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r416", "r417", "r429" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "periodEndLabel": "Contract liabilities at end of period", "periodStartLabel": "Contract liabilities at beginning of period" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofContractLiabilitiesFromContractWithCustomersDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r430" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "negatedLabel": "Decrease due to beginning contract liabilities recognized as revenue" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofContractLiabilitiesFromContractWithCustomersDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r36", "r585" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of sales" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r718", "r785", "r787" ], "calculation": { "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails": { "order": 3.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Current Federal Tax Expense (Benefit)", "verboseLabel": "Federal" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r718", "r785" ], "calculation": { "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails": { "order": 1.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense (Benefit)", "verboseLabel": "Foreign" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r135", "r509", "r517", "r718" ], "calculation": { "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "totalLabel": "Total Current" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Current" } } }, "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r718", "r785", "r787" ], "calculation": { "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails": { "order": 2.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Current State and Local Tax Expense (Benefit)", "verboseLabel": "State" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r144" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r102", "r250", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r405", "r412", "r413", "r414" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Line of Credit" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/LineofCredit" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r1", "r2", "r3", "r189", "r192", "r199", "r256", "r389", "r390", "r391", "r392", "r393", "r395", "r401", "r402", "r403", "r404", "r406", "r407", "r408", "r409", "r410", "r411", "r557", "r669", "r670", "r671", "r672", "r673", "r716" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r22", "r256", "r389", "r390", "r391", "r392", "r393", "r395", "r401", "r402", "r403", "r404", "r406", "r407", "r408", "r409", "r410", "r411", "r557", "r669", "r670", "r671", "r672", "r673", "r716" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).", "label": "Deferred Compensation Liability, Classified, Noncurrent", "terseLabel": "Deferred compensation liability, classified, noncurrent, total" } } }, "localname": "DeferredCompensationLiabilityClassifiedNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent": { "auth_ref": [], "calculation": { "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails": { "order": 1.0, "parentTag": "us-gaap_FairValueNetAssetLiability", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements. Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.", "label": "Deferred Compensation Liability, Current and Noncurrent", "negatedTerseLabel": "Deferred compensation liabilities", "terseLabel": "Deferred compensation liabilities" } } }, "localname": "DeferredCompensationLiabilityCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.", "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]", "terseLabel": "Schedule of Prepaid Expenses" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredCostsCurrent": { "auth_ref": [ "r708" ], "calculation": { "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer.", "label": "Deferred Costs, Current", "terseLabel": "Deferred commissions" } } }, "localname": "DeferredCostsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r718", "r786", "r787" ], "calculation": { "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred Federal Income Tax Expense (Benefit)", "verboseLabel": "Federal" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r135", "r718", "r786" ], "calculation": { "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense (Benefit)", "verboseLabel": "Foreign" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r491", "r492" ], "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0 }, "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails_1": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Deferred tax assets", "verboseLabel": "Net deferred tax assets" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r53", "r135", "r510", "r516", "r517", "r718" ], "calculation": { "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "totalLabel": "Total Deferred" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Deferred" } } }, "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r4", "r5", "r191", "r198", "r503" ], "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 }, "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails_1": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "negatedTotalLabel": "Gross deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r491", "r492" ], "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 }, "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 }, "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails_1": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "negatedTerseLabel": "Net deferred tax liabilities", "terseLabel": "Deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "auth_ref": [ "r54" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.", "label": "Deferred Income Taxes and Tax Credits", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxesAndTaxCredits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r704" ], "calculation": { "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue, Current", "verboseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r718", "r786", "r787" ], "calculation": { "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "verboseLabel": "State" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetDomain": { "auth_ref": [ "r128" ], "lang": { "en-us": { "role": { "documentation": "Identification of the deferred tax asset for which a valuation reserve exists.", "label": "Deferred Tax Asset [Domain]", "terseLabel": "Deferred Tax Asset [Domain]" } } }, "localname": "DeferredTaxAssetDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": { "auth_ref": [], "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "order": 8.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.", "label": "Deferred Tax Assets, Goodwill and Intangible Assets", "verboseLabel": "Intangible assets" } } }, "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r504" ], "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Gross deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGrossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Gross [Abstract]", "terseLabel": "Deferred tax assets" } } }, "localname": "DeferredTaxAssetsGrossAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": { "auth_ref": [ "r132", "r784" ], "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "order": 9.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.", "label": "Deferred Tax Assets, in Process Research and Development", "verboseLabel": "Capitalized R&D Expenses" } } }, "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInventory": { "auth_ref": [ "r132", "r784" ], "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.", "label": "Deferred Tax Assets, Inventory", "verboseLabel": "Inventory" } } }, "localname": "DeferredTaxAssetsInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r783" ], "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets, Net", "totalLabel": "Net deferred taxes" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r783" ], "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": -1.0 }, "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails_1": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Net deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r132", "r784" ], "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "terseLabel": "Net operating losses" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": { "auth_ref": [ "r132", "r784" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign", "terseLabel": "Deferred tax assets, operating loss carryforwards, foreign" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": { "auth_ref": [ "r132", "r784" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local", "terseLabel": "Deferred tax assets, operating loss carryforwards, state and local" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r132", "r784" ], "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred Tax Assets, Other", "verboseLabel": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": { "auth_ref": [], "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.", "label": "Deferred Tax Assets, Property, Plant and Equipment", "verboseLabel": "Property and equipment" } } }, "localname": "DeferredTaxAssetsPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "auth_ref": [ "r130", "r132", "r784" ], "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.", "label": "Deferred Tax Assets, Tax Credit Carryforwards", "terseLabel": "Tax credit carry forwards" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r132", "r784" ], "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost", "verboseLabel": "Equity-based compensation expense" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": { "auth_ref": [ "r132", "r784" ], "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals", "terseLabel": "Accruals not currently deductible" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses": { "auth_ref": [ "r132", "r784" ], "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "order": 10.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses on foreign currency transactions.", "label": "Deferred Tax Assets, Unrealized Currency Losses", "negatedTerseLabel": "Foreign currency translation" } } }, "localname": "DeferredTaxAssetsUnrealizedCurrencyLosses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r505" ], "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance", "terseLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails", "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r122", "r783" ], "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities, Net", "negatedTotalLabel": "Net deferred taxes" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Gross [Abstract]", "terseLabel": "Deferred tax liabilities" } } }, "localname": "DeferredTaxLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": { "auth_ref": [ "r132", "r784" ], "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.", "label": "Deferred Tax Liabilities, Intangible Assets", "negatedTerseLabel": "Intangible assets" } } }, "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesOther": { "auth_ref": [ "r132", "r784" ], "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.", "label": "Deferred Tax Liabilities, Other", "negatedTerseLabel": "Other" } } }, "localname": "DeferredTaxLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesPrepaidExpenses": { "auth_ref": [], "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.", "label": "Deferred Tax Liabilities, Prepaid Expenses", "negatedTerseLabel": "Prepaid expenses" } } }, "localname": "DeferredTaxLiabilitiesPrepaidExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "auth_ref": [ "r132", "r784" ], "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.", "label": "Deferred Tax Liabilities, Property, Plant and Equipment", "negatedTerseLabel": "Property and equipment" } } }, "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains": { "auth_ref": [ "r132", "r784" ], "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from unrealized gains on foreign currency transactions.", "label": "Deferred Tax Liabilities, Unrealized Currency Transaction Gains", "terseLabel": "Deferred Tax Liabilities, Unrealized Currency Transaction Gains" } } }, "localname": "DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.", "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay", "terseLabel": "Defined contribution plan, employer matching contribution, percent of employees' gross pay" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage employer matches of the employee's percentage contribution matched.", "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match", "terseLabel": "Defined contribution plan, employer matching contribution, percent of match" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.", "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent", "terseLabel": "Defined contribution plan, maximum annual contributions per employee, percent" } } }, "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r53", "r95" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r53", "r309" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet": { "auth_ref": [ "r159" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.", "label": "Derivative Assets (Liabilities), at Fair Value, Net", "terseLabel": "Derivative assets (liabilities), at fair value, net, total" } } }, "localname": "DerivativeAssetsLiabilitiesAtFairValueNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r791" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "terseLabel": "Derivative, gain (loss) on derivative, net" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r165", "r166", "r168", "r169", "r661" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r789", "r790" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Derivative, notional amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r160", "r161", "r162", "r163", "r170", "r255" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivatives Financial Instruments" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Designated as Hedging Instrument" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r752" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Disaggregation of Revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r445", "r477", "r478", "r480", "r485", "r683" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-Based Payment Arrangement [Text Block]", "terseLabel": "Equity-Based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Tax Authority [Member]", "terseLabel": "Domestic Tax Authority" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings per common share" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r243", "r269", "r270", "r271", "r272", "r273", "r277", "r280", "r287", "r289", "r290", "r294", "r535", "r536", "r602", "r607", "r665" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Earnings per share, basic (in dollars per share)", "verboseLabel": "Earnings per common share from net earnings - basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofEarningsPerShareDetails", "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r243", "r269", "r270", "r271", "r272", "r273", "r280", "r287", "r289", "r290", "r294", "r535", "r536", "r602", "r607", "r665" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Earnings per share, diluted (in dollars per share)", "verboseLabel": "Earnings per common share from net earnings - diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofEarningsPerShareDetails", "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r64", "r65" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r291", "r292", "r293", "r295" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Common Stock and Earnings Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r794" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r494" ], "calculation": { "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "totalLabel": "Total effective income tax rate reconciliation, percent" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r253", "r494", "r519" ], "calculation": { "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "order": 8.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Statutory U.S. federal income tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r781", "r788" ], "calculation": { "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "order": 9.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "terseLabel": "Net increase in valuation allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r781", "r788" ], "calculation": { "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "order": 5.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent", "terseLabel": "Foreign income tax rate differences" } } }, "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "auth_ref": [ "r781", "r788" ], "calculation": { "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "order": 7.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent", "terseLabel": "All other, net" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r781", "r788" ], "calculation": { "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "order": 2.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "terseLabel": "State income taxes, net of federal tax benefit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies": { "auth_ref": [ "r781", "r788" ], "calculation": { "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "order": 3.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.", "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Percent", "terseLabel": "Uncertain tax position reserve" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign": { "auth_ref": [ "r781", "r788" ], "calculation": { "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "order": 6.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent", "negatedLabel": "Excess foreign tax credits" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsForeign", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r19" ], "calculation": { "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Accrued employee compensation" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": { "auth_ref": [ "r476" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost capitalized for award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Amount Capitalized", "terseLabel": "Share-based payment arrangement, amount capitalized" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r479" ], "calculation": { "http://www.usana.com/role/EquityBasedCompensationRemainingUnrecognizedCompensationExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "totalLabel": "Total remaining unrecognized compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationRemainingUnrecognizedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r479" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition (year)" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": { "auth_ref": [ "r475" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Expense, Tax Benefit", "terseLabel": "Share-based payment arrangement, expense, tax benefit" } } }, "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock [Member]", "terseLabel": "Employee Stock" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r104", "r214", "r238", "r239", "r240", "r264", "r265", "r266", "r268", "r274", "r276", "r297", "r343", "r415", "r481", "r482", "r483", "r512", "r513", "r534", "r547", "r548", "r549", "r550", "r551", "r553", "r571", "r610", "r611", "r612" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": { "auth_ref": [ "r339" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Amount", "terseLabel": "Equity securities without readily determinable fair value, amount" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount": { "auth_ref": [ "r340" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of impairment loss on investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount", "terseLabel": "Equity securities without readily determinable fair value, impairment loss, annual amount" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment in equity security without readily determinable fair value, which does not qualify for practical expedient to estimate fair value using net asset value per share. Includes, but is not limited to, information considered for determining upward and downward adjustment from observable price change.", "label": "Equity Securities without Readily Determinable Fair Value [Policy Text Block]", "terseLabel": "Investment in Equity Securities" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r537", "r538", "r543" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "auth_ref": [ "r172", "r173", "r174", "r175", "r176" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r403", "r433", "r434", "r435", "r436", "r437", "r438", "r538", "r579", "r580", "r581", "r670", "r671", "r677", "r678", "r679" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r537", "r538", "r539", "r540", "r544" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r403", "r433", "r438", "r538", "r579", "r677", "r678", "r679" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r403", "r433", "r438", "r538", "r580", "r670", "r671", "r677", "r678", "r679" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r403", "r433", "r434", "r435", "r436", "r437", "r438", "r538", "r581", "r670", "r671", "r677", "r678", "r679" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r403", "r433", "r434", "r435", "r436", "r437", "r438", "r579", "r580", "r581", "r670", "r671", "r677", "r678", "r679" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsNonrecurringMember": { "auth_ref": [ "r537", "r538", "r539", "r540", "r541", "r544" ], "lang": { "en-us": { "role": { "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.", "label": "Fair Value, Nonrecurring [Member]", "terseLabel": "Fair Value, Nonrecurring" } } }, "localname": "FairValueMeasurementsNonrecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r542", "r544" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueNetAssetLiability": { "auth_ref": [], "calculation": { "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of asset after deduction of liability.", "label": "Fair Value, Net Asset (Liability)", "totalLabel": "Total fair value, net asset (liability)" } } }, "localname": "FairValueNetAssetLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r177", "r178" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Finite-lived intangible asset, weighted-average amortization period (years)" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r224", "r363" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Finite-lived intangible assets, accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "calculation": { "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r92" ], "calculation": { "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "verboseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.", "label": "Finite-Lived Intangible Assets Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Amortization Expense" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r92" ], "calculation": { "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r92" ], "calculation": { "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "verboseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r92" ], "calculation": { "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "verboseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r92" ], "calculation": { "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "verboseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r360", "r362", "r363", "r365", "r586", "r587" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r90", "r587" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Finite-lived intangible assets, gross carrying amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r85", "r89" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r90", "r586" ], "calculation": { "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "terseLabel": "Finite-lived intangible assets, net carrying amount", "totalLabel": "Total estimated amortization expense" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails", "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net [Abstract]", "terseLabel": "Amortized intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiscalPeriod": { "auth_ref": [ "r152" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.", "label": "Fiscal Period, Policy [Policy Text Block]", "terseLabel": "Fiscal Year" } } }, "localname": "FiscalPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]", "terseLabel": "Foreign Tax Authority" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails": { "order": 3.0, "parentTag": "us-gaap_FairValueNetAssetLiability", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.", "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure", "negatedTerseLabel": "Foreign currency contracts included in other current liabilities" } } }, "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r555" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Translation of Foreign Currencies" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignExchangeOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An option that allows the holder to buy (if call) or sell (if put) an underlying currency at a fixed exercise rate, expressed as an exchange, during a specified period (an American option) or at a specified date (a European option).", "label": "Foreign Exchange Option [Member]", "terseLabel": "Foreign Exchange Option" } } }, "localname": "ForeignExchangeOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]", "terseLabel": "Furniture and fixtures" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r53" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "negatedLabel": "(Gain) loss on sale of property and equipment" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r223", "r347", "r600", "r668", "r688", "r731", "r738" ], "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Goodwill as of end of year", "periodStartLabel": "Goodwill as of beginning of year", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/BusinessCombinationsandAssetAcquisitionsDetails", "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/IntangibleAssetsChangesinCarryingAmountsofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r350", "r668" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill, Acquired During Period", "terseLabel": "Goodwill acquired during the year" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsChangesinCarryingAmountsofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r94" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "auth_ref": [ "r358", "r359", "r668" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.", "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": { "auth_ref": [ "r87" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.", "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r354" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "verboseLabel": "Currency translation adjustment" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsChangesinCarryingAmountsofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillGross": { "auth_ref": [ "r349", "r356", "r668" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Gross", "periodEndLabel": "Gross goodwill", "periodStartLabel": "Gross goodwill" } } }, "localname": "GoodwillGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsChangesinCarryingAmountsofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r53", "r348", "r353", "r358", "r668" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impairment Loss", "terseLabel": "Goodwill, impairment loss" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsNarrativeDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillPeriodIncreaseDecrease": { "auth_ref": [ "r739" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Period Increase (Decrease)", "terseLabel": "Increase in goodwill" } } }, "localname": "GoodwillPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/BusinessCombinationsandAssetAcquisitionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsChangesinCarryingAmountsofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GranteeStatusAxis": { "auth_ref": [ "r441", "r443", "r446", "r447", "r448", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r470", "r471", "r472", "r473", "r474" ], "lang": { "en-us": { "role": { "documentation": "Information by status of recipient to whom award is granted.", "label": "Grantee Status [Axis]", "terseLabel": "Grantee Status [Axis]" } } }, "localname": "GranteeStatusAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GranteeStatusDomain": { "auth_ref": [ "r441", "r443", "r446", "r447", "r448", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r470", "r471", "r472", "r473", "r474" ], "lang": { "en-us": { "role": { "documentation": "Status of recipient to whom award is granted.", "label": "Grantee Status [Domain]", "terseLabel": "Grantee Status [Domain]" } } }, "localname": "GranteeStatusDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r35", "r251", "r314", "r319", "r325", "r328", "r342", "r376", "r377", "r379", "r380", "r381", "r383", "r385", "r387", "r388", "r545", "r666", "r748" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r162", "r533" ], "lang": { "en-us": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": { "auth_ref": [ "r715", "r742" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.", "label": "Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)", "terseLabel": "Impairment of intangible assets, indefinite-lived (excluding goodwill)" } } }, "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsNarrativeDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r252", "r518" ], "calculation": { "http://www.usana.com/role/IncomeTaxesConsolidatedEarningsBeforeIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "verboseLabel": "U.S." } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesConsolidatedEarningsBeforeIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r32", "r186", "r195", "r208", "r314", "r319", "r325", "r328", "r603", "r666" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 }, "http://www.usana.com/role/IncomeTaxesConsolidatedEarningsBeforeIncomeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Earnings before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.usana.com/role/IncomeTaxesConsolidatedEarningsBeforeIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r252", "r518" ], "calculation": { "http://www.usana.com/role/IncomeTaxesConsolidatedEarningsBeforeIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "verboseLabel": "Foreign" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesConsolidatedEarningsBeforeIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r124" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityNameAxis": { "auth_ref": [ "r124" ], "lang": { "en-us": { "role": { "documentation": "Information by name of taxing authority.", "label": "Income Tax Authority, Name [Axis]", "terseLabel": "Income Tax Authority, Name [Axis]" } } }, "localname": "IncomeTaxAuthorityNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority, Name [Domain]", "terseLabel": "Income Tax Authority, Name [Domain]" } } }, "localname": "IncomeTaxAuthorityNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxContingencyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Tax Contingency [Line Items]", "terseLabel": "Income Tax Contingency [Line Items]" } } }, "localname": "IncomeTaxContingencyLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxContingencyTable": { "auth_ref": [ "r125", "r126", "r127", "r134" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.", "label": "Income Tax Contingency [Table]", "terseLabel": "Income Tax Contingency [Table]" } } }, "localname": "IncomeTaxContingencyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r253", "r495", "r501", "r508", "r514", "r520", "r522", "r523", "r524" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r254", "r275", "r276", "r312", "r493", "r515", "r521", "r608" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 }, "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income taxes", "totalLabel": "Total income tax expense (benefit)" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r237", "r489", "r490", "r501", "r502", "r507", "r511" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r50", "r57" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "verboseLabel": "Income taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Taxes Paid, Net [Abstract]", "terseLabel": "Cash received during the period for:" } } }, "localname": "IncomeTaxesPaidNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxesReceivable": { "auth_ref": [ "r194", "r206", "r705" ], "calculation": { "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails": { "order": 4.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.", "label": "Income Taxes Receivable, Current", "terseLabel": "Income taxes receivable" } } }, "localname": "IncomeTaxesReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r52" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r52" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities, net of acquisitions:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "auth_ref": [ "r52" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Liabilities", "terseLabel": "Other liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r52" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r281", "r282", "r283", "r290", "r444" ], "calculation": { "http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofEarningsPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "terseLabel": "Dilutive effect of in-the-money equity awards (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r361", "r364" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-Lived Intangible Assets [Axis]", "terseLabel": "Indefinite-lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r93" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "terseLabel": "Indefinite-lived intangible assets (excluding goodwill), direct sales license" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract]", "terseLabel": "Indefinite-lived intangible assets" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r86", "r93" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [ "r223" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "terseLabel": "Intangible assets, gross (excluding goodwill)" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r83", "r88" ], "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r182", "r197", "r241", "r308", "r556" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r245", "r247", "r249" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryCurrentTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.", "label": "Inventory, Current [Table]", "terseLabel": "Inventory, Current [Table]" } } }, "localname": "InventoryCurrentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/InventoriesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r346" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r81", "r658" ], "calculation": { "http://www.usana.com/role/InventoriesScheduleofInventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/InventoriesScheduleofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Inventory [Line Items]", "terseLabel": "Inventory [Line Items]" } } }, "localname": "InventoryLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/InventoriesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r229", "r656", "r688" ], "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.usana.com/role/InventoriesScheduleofInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories", "totalLabel": "Total inventory, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/InventoriesScheduleofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNoncurrent": { "auth_ref": [ "r703" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.", "label": "Inventory, Noncurrent", "terseLabel": "Noncurrent inventories" } } }, "localname": "InventoryNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/InventoriesNarrativeDetails", "http://www.usana.com/role/InventoriesScheduleofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r219", "r228", "r296", "r344", "r345", "r346", "r584", "r663" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "terseLabel": "Inventories - Current and Noncurrent" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "auth_ref": [ "r81", "r660" ], "calculation": { "http://www.usana.com/role/InventoriesScheduleofInventoriesDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.", "label": "Inventory, Raw Materials, Net of Reserves", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterialsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/InventoriesScheduleofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r81", "r659" ], "calculation": { "http://www.usana.com/role/InventoriesScheduleofInventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work in progress" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/InventoriesScheduleofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r38", "r307" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to real estate held.", "label": "Land Improvements [Member]", "terseLabel": "Land improvements" } } }, "localname": "LandImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LandMember": { "auth_ref": [ "r753" ], "lang": { "en-us": { "role": { "documentation": "Part of earth's surface not covered by water.", "label": "Land [Member]", "terseLabel": "Land" } } }, "localname": "LandMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r568", "r687" ], "calculation": { "http://www.usana.com/role/OperatingLeasesSupplementalLeaseInformationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "totalLabel": "Total lease cost" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesSupplementalLeaseInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r796" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Schedule of Supplemental Lease Information" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r96" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesOperatingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases, Operating [Abstract]" } } }, "localname": "LeasesOperatingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r562" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r797" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Schedule of Maturity of Lease Liabilities" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r569" ], "calculation": { "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total operating lease, liability" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r569" ], "calculation": { "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "verboseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r569" ], "calculation": { "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "verboseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r569" ], "calculation": { "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "verboseLabel": "2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r569" ], "calculation": { "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "verboseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r569" ], "calculation": { "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "verboseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r569" ], "calculation": { "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "verboseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r569" ], "calculation": { "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails_1": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedTerseLabel": "Less: imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r570" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Operating Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r12", "r193", "r204", "r688", "r717", "r729", "r793" ], "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r21", "r218", "r251", "r342", "r376", "r377", "r379", "r380", "r381", "r383", "r385", "r387", "r388", "r530", "r531", "r532", "r545", "r688", "r748", "r799", "r800" ], "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LicensingAgreementsMember": { "auth_ref": [ "r145" ], "lang": { "en-us": { "role": { "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).", "label": "Licensing Agreements [Member]", "terseLabel": "Direct sales license" } } }, "localname": "LicensingAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LifeInsuranceCorporateOrBankOwnedAmount": { "auth_ref": [ "r80", "r702" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the amount that could be realized under a life insurance contract or contracts owned by the Entity as of the date of the statement of financial position. Such Entity-owned life insurance policies are commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).", "label": "Life Insurance, Corporate or Bank Owned, Amount", "terseLabel": "Life insurance, corporate or bank owned, amount" } } }, "localname": "LifeInsuranceCorporateOrBankOwnedAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r3", "r192", "r199" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-Term Line of Credit", "terseLabel": "Long-term line of credit, total" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Line of Credit Facility [Abstract]" } } }, "localname": "LineOfCreditFacilityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]", "terseLabel": "Line of Credit Facility [Line Items]" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r18" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Line of credit facility, maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r18", "r716" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]", "terseLabel": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Line of Credit" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r754" ], "lang": { "en-us": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]", "terseLabel": "Money Market Funds" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MovementInValuationAllowancesAndReservesRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]", "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]" } } }, "localname": "MovementInValuationAllowancesAndReservesRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r246" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r246" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r49", "r51", "r54" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r33", "r54", "r196", "r207", "r216", "r232", "r235", "r240", "r251", "r267", "r269", "r270", "r271", "r272", "r275", "r276", "r284", "r314", "r319", "r325", "r328", "r342", "r376", "r377", "r379", "r380", "r381", "r383", "r385", "r387", "r388", "r536", "r545", "r666", "r748" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net earnings", "totalLabel": "Net earnings" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows", "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r269", "r270", "r271", "r272", "r277", "r278", "r286", "r290", "r314", "r319", "r325", "r328", "r666" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "terseLabel": "Net earnings available to common shareholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofEarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash Investing and Financing Items [Abstract]", "terseLabel": "Non-cash investing and financing activities:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1": { "auth_ref": [ "r58", "r59", "r60" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value of an asset or business acquired in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Noncash or Part Noncash Acquisition, Value of Assets Acquired", "terseLabel": "Contingent consideration given to acquire assets" } } }, "localname": "NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncompeteAgreementsMember": { "auth_ref": [ "r143" ], "lang": { "en-us": { "role": { "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.", "label": "Noncompete Agreements [Member]", "terseLabel": "Non-compete agreements" } } }, "localname": "NoncompeteAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NoncurrentAssets": { "auth_ref": [ "r332" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.", "label": "Long-Lived Assets", "terseLabel": "Long-lived Assets" } } }, "localname": "NoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails", "http://www.usana.com/role/SegmentInformationMarketsRepresentingTenPercentOrMoreOfConsolidatedNetSalesandLongLivedAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r39" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Other income (expense), net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r314", "r319", "r325", "r328", "r666" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Earnings from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r563", "r687" ], "calculation": { "http://www.usana.com/role/OperatingLeasesSupplementalLeaseInformationDetails": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesSupplementalLeaseInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r795" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "terseLabel": "Rent expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r559" ], "calculation": { "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails_1": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "totalLabel": "Total lease liabilities", "verboseLabel": "Present value" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails", "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r559" ], "calculation": { "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails", "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r560" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.", "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r559" ], "calculation": { "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r560" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.", "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r561", "r564" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Operating cash flows from operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesSupplementalLeaseInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r558" ], "calculation": { "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails": { "order": 1.0, "parentTag": "usna_LeaseRightOfUseAsset", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "ROU operating lease assets, net" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r715" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Operating Lease, Right-of-Use Asset, Amortization Expense", "terseLabel": "Right-of-use asset amortization" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r560" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.", "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r567", "r687" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted-average discount rate\u2014operating leases" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesSupplementalLeaseInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r566", "r687" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted-average remaining lease term\u2014operating leases" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesSupplementalLeaseInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r130" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "Operating loss carryforwards, total" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r318", "r319", "r320", "r321", "r322", "r328" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofSegmentReportingInformationbyOperatingSegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r62", "r63", "r72", "r158" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.", "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetImpairmentCharges": { "auth_ref": [ "r715", "r743" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.", "label": "Other Asset Impairment Charges", "terseLabel": "(Gain) loss on impairment on other assets" } } }, "localname": "OtherAssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r230", "r688" ], "calculation": { "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r164", "r171" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other Assets [Member]", "terseLabel": "Other Assets" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r225" ], "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": { "auth_ref": [ "r25", "r27" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax", "terseLabel": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": { "auth_ref": [ "r25", "r28", "r546", "r552" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax", "negatedLabel": "Tax benefit (expense) related to foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r153", "r154", "r156", "r233", "r236" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "terseLabel": "Other comprehensive income (loss), net of tax", "totalLabel": "Other comprehensive income (loss), net of tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentAssetsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other current assets.", "label": "Other Current Assets [Text Block]", "terseLabel": "Prepaid Expenses And Other Current Assets" } } }, "localname": "OtherCurrentAssetsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherCurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current liabilities.", "label": "Other Current Liabilities [Member]", "terseLabel": "Other Current Liabilities" } } }, "localname": "OtherCurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherCurrentLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of other current liabilities.", "label": "Other Current Liabilities [Table Text Block]", "terseLabel": "Schedule of Other Current Liabilities" } } }, "localname": "OtherCurrentLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OtherCurrentLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherIncome": { "auth_ref": [ "r209" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue and income classified as other.", "label": "Other Income", "terseLabel": "Other Revenue" } } }, "localname": "OtherIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r19", "r688" ], "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "terseLabel": "Other current liabilities", "totalLabel": "Total other current liabilities" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities, Current [Abstract]", "terseLabel": "Current:" } } }, "localname": "OtherLiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities Disclosure [Abstract]" } } }, "localname": "OtherLiabilitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other liabilities.", "label": "Other Liabilities Disclosure [Text Block]", "terseLabel": "Other Current Liabilities" } } }, "localname": "OtherLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OtherCurrentLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r23" ], "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other long-term liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities, Noncurrent [Abstract]", "terseLabel": "Noncurrent:" } } }, "localname": "OtherLiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherNoncurrentAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent assets.", "label": "Other Noncurrent Assets [Member]", "terseLabel": "Other Noncurrent Assets" } } }, "localname": "OtherNoncurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Member]", "terseLabel": "Other Noncurrent Liabilities" } } }, "localname": "OtherNoncurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r40" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other, net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPrepaidExpenseCurrent": { "auth_ref": [ "r707", "r730" ], "calculation": { "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails": { "order": 5.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Other Prepaid Expense, Current", "terseLabel": "Other prepaid expenses" } } }, "localname": "OtherPrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivablesNetCurrent": { "auth_ref": [], "calculation": { "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.", "label": "Other Receivables, Net, Current", "terseLabel": "Miscellaneous receivables, net" } } }, "localname": "OtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherSundryLiabilitiesCurrent": { "auth_ref": [ "r19", "r101" ], "calculation": { "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.", "label": "Other Sundry Liabilities, Current", "verboseLabel": "All other" } } }, "localname": "OtherSundryLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForHedgeInvestingActivities": { "auth_ref": [ "r248", "r714" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.", "label": "Payments for Hedge, Investing Activities", "negatedLabel": "Payments for net investment hedge" } } }, "localname": "PaymentsForHedgeInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r46" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchase of common stock", "terseLabel": "Payments for repurchase of common stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareNarrativeDetails", "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r48" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedLabel": "Payments for debt issuance costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r244" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "negatedLabel": "Payments related to tax withholding for net-share settled equity awards" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r43", "r527" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Payments to acquire businesses" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/BusinessCombinationsandAssetAcquisitionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r43" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedTerseLabel": "Payments to acquire businesses" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r44" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment": { "auth_ref": [ "r714" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire securities classified as trading securities and held for investment purposes. Excludes payments for trading securities purchased and held principally for the purpose of selling them in the near term (thus held for only a short period of time).", "label": "Payments to Acquire Trading Securities Held-for-investment", "negatedTerseLabel": "Payments for investment in equity securities" } } }, "localname": "PaymentsToAcquireTradingSecuritiesHeldforinvestment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r780" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r780" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r709" ], "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets", "totalLabel": "Total prepaid expense and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Prepaid Expense and Other Assets, Current [Abstract]" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.", "label": "Prepaid Expenses and Other Current Assets [Member]", "terseLabel": "Prepaid Expenses and Other Current Assets" } } }, "localname": "PrepaidExpensesAndOtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "domainItemType" }, "us-gaap_PrepaidInsurance": { "auth_ref": [ "r657", "r667", "r730" ], "calculation": { "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails": { "order": 6.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Insurance", "terseLabel": "Prepaid insurance" } } }, "localname": "PrepaidInsurance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromCollectionOfNotesReceivable": { "auth_ref": [ "r41" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from Collection of Notes Receivable", "terseLabel": "Receipts on notes receivable" } } }, "localname": "ProceedsFromCollectionOfNotesReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromHedgeInvestingActivities": { "auth_ref": [ "r248", "r713" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.", "label": "Proceeds from Hedge, Investing Activities", "terseLabel": "Proceeds from the settlement of net investment hedges" } } }, "localname": "ProceedsFromHedgeInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIncomeTaxRefunds": { "auth_ref": [ "r51", "r57" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash received during the period as refunds for the overpayment of taxes.", "label": "Proceeds from Income Tax Refunds", "terseLabel": "Income tax refund" } } }, "localname": "ProceedsFromIncomeTaxRefunds", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLinesOfCredit": { "auth_ref": [ "r45", "r716" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Proceeds from Lines of Credit", "terseLabel": "Borrowings on line of credit" } } }, "localname": "ProceedsFromLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r42" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from Sale of Property, Plant, and Equipment", "terseLabel": "Proceeds from sale of property and equipment" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductConcentrationRiskMember": { "auth_ref": [ "r66" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.", "label": "Product Concentration Risk [Member]", "terseLabel": "Product Concentration Risk" } } }, "localname": "ProductConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r98" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r99", "r621", "r622", "r623" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PropertyandEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r96", "r221" ], "calculation": { "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails": { "order": 1.0, "parentTag": "usna_PropertyPlantAndEquipmentNetExcludingNondepreciable", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property, plant and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r98", "r205", "r604", "r688" ], "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r98", "r621", "r622" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r98" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Schedule of Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r96" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Useful life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_PublicUtilitiesInventoryAxis": { "auth_ref": [ "r706" ], "lang": { "en-us": { "role": { "documentation": "Information by type of inventory held.", "label": "Inventory [Axis]", "terseLabel": "Inventory [Axis]" } } }, "localname": "PublicUtilitiesInventoryAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/InventoriesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PublicUtilitiesInventoryRawMaterialsMember": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Basic goods that are to be consumed directly or indirectly in the production of finished goods or services.", "label": "Raw Materials [Member]", "terseLabel": "Raw Materials" } } }, "localname": "PublicUtilitiesInventoryRawMaterialsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/InventoriesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PublicUtilitiesInventoryTypeDomain": { "auth_ref": [ "r706" ], "lang": { "en-us": { "role": { "documentation": "Tangible personal property that is held for sale in the ordinary course of business, in process of production for such sale or is to be currently consumed in the production of goods or services to be available for sale.", "label": "Inventory [Domain]", "terseLabel": "Inventory [Domain]" } } }, "localname": "PublicUtilitiesInventoryTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/InventoriesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]", "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]" } } }, "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r439", "r574", "r575" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/RelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": { "auth_ref": [ "r183" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Expenses from Transactions with Related Party", "terseLabel": "Related party transaction, expenses from transactions with related party" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/RelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/RelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r439", "r574", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r798" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/RelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r572", "r573", "r575", "r576", "r577" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related-Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLinesOfCredit": { "auth_ref": [ "r47", "r716" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Repayments of Lines of Credit", "negatedTerseLabel": "Payments on line of credit" } } }, "localname": "RepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r121", "r210", "r807" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development expense, total" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r121" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Expense, Policy [Policy Text Block]", "terseLabel": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchMember": { "auth_ref": [ "r131" ], "lang": { "en-us": { "role": { "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.", "label": "Research Tax Credit Carryforward [Member]", "terseLabel": "Research Tax Credit Carryforward" } } }, "localname": "ResearchMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashAndCashEquivalents": { "auth_ref": [ "r55", "r61", "r187", "r202", "r220" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents", "periodEndLabel": "Restricted cash" } } }, "localname": "RestrictedCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Domain]", "terseLabel": "Cash and Cash Equivalents [Domain]" } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsNoncurrent": { "auth_ref": [ "r55", "r61", "r618" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents, Noncurrent", "terseLabel": "Restricted cash and cash equivalents, noncurrent, total" } } }, "localname": "RestrictedCashAndCashEquivalentsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r64" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Restricted Stock" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock Units (RSUs)" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r9", "r105", "r203", "r613", "r615", "r688" ], "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r214", "r264", "r265", "r266", "r268", "r274", "r276", "r343", "r481", "r482", "r483", "r512", "r513", "r534", "r610", "r612" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r305", "r306", "r318", "r323", "r324", "r330", "r331", "r334", "r427", "r428", "r585" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Net sales", "verboseLabel": "Net Sales to External Customers" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails", "http://www.usana.com/role/SegmentInformationMarketsRepresentingTenPercentOrMoreOfConsolidatedNetSalesandLongLivedAssetsDetails", "http://www.usana.com/role/SegmentInformationScheduleofSegmentReportingInformationbyOperatingSegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r431", "r664" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r565", "r687" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "ROU assets obtained in exchange for new operating lease liabilities" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OperatingLeasesSupplementalLeaseInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesAndExciseTaxPayableCurrent": { "auth_ref": [ "r17" ], "calculation": { "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Sales and Excise Tax Payable, Current", "terseLabel": "Sales taxes" } } }, "localname": "SalesAndExciseTaxPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r334", "r728" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Revenue Benchmark" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r64" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r64" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r133" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of Income Tax Expense (Benefit) Included in Income From Continuing Operations" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r129" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Schedule of Deferred Taxes" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r727" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of Effective Income Tax Rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": { "auth_ref": [ "r76" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.", "label": "Revenue from External Customers by Products and Services [Table Text Block]", "terseLabel": "Revenue from External Customers by Products and Services" } } }, "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r85", "r89", "r586" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r668", "r731", "r732", "r733", "r734", "r735", "r736", "r737", "r738", "r739", "r740", "r741" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Schedule of Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r718" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]", "terseLabel": "Schedule of Consolidated Income Before Income Taxes" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r0", "r14", "r15", "r16" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of Inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": { "auth_ref": [ "r113" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.", "label": "Schedule of Nonvested Share Activity [Table Text Block]", "terseLabel": "Schedule of Cash-Settled Restricted Stock Unit Activity" } } }, "localname": "ScheduleOfNonvestedShareActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r98" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r184", "r185" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/RelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock": { "auth_ref": [ "r34", "r77" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]", "terseLabel": "Schedule of Revenue by Geographic Region" } } }, "localname": "ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": { "auth_ref": [ "r34", "r78" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]", "terseLabel": "Schedule of Markets Representing Ten Percent Or More of Consolidated Net Sales and Long-Lived Assets" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r73", "r74", "r75", "r82" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails", "http://www.usana.com/role/SegmentInformationMarketsRepresentingTenPercentOrMoreOfConsolidatedNetSalesandLongLivedAssetsDetails", "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails", "http://www.usana.com/role/SegmentInformationScheduleofSegmentReportingInformationbyOperatingSegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r73", "r74", "r75", "r82" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Segment Reporting Information, by Operating Segment" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r441", "r443", "r446", "r447", "r448", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r470", "r471", "r472", "r473", "r474" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "terseLabel": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails", "http://www.usana.com/role/EquityBasedCompensationWeightedaverageAssumptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r106" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Schedule of Stock-Settled Restricted Stock Unit Activity" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock": { "auth_ref": [ "r106" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year.", "label": "Share-Based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]", "terseLabel": "Schedule of Stock-Settled Appreciation Right Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r116" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of Weighted-Average Assumptions Used to Calculate Fair Value of Stock Settled Stock Appreciation Rights" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock": { "auth_ref": [ "r117" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost [Table Text Block]", "terseLabel": "Schedule of Remaining Unrecognized Compensation Expense" } } }, "localname": "ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "auth_ref": [ "r686", "r782" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in unrecognized tax benefits.", "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]", "terseLabel": "Schedule of Unrecognized Tax Benefits Reconciliation" } } }, "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r302", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r328", "r334", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r367", "r368", "r668", "r808" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofSegmentReportingInformationbyOperatingSegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r302", "r303", "r304", "r314", "r317", "r322", "r326", "r327", "r328", "r329", "r330", "r333", "r334", "r335" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails", "http://www.usana.com/role/SegmentInformationMarketsRepresentingTenPercentOrMoreOfConsolidatedNetSalesandLongLivedAssetsDetails", "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails", "http://www.usana.com/role/SegmentInformationScheduleofSegmentReportingInformationbyOperatingSegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SelfInsuranceReservePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for self-insurance reserves, including, but not limited to incurred but not reported reserves (IBNR).", "label": "Self Insurance Reserve [Policy Text Block]", "terseLabel": "Self-Insurance" } } }, "localname": "SelfInsuranceReservePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r37" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.", "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]", "terseLabel": "Selling, General and Administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": { "auth_ref": [ "r139" ], "lang": { "en-us": { "role": { "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.", "label": "Series of Individually Immaterial Business Acquisitions [Member]", "terseLabel": "Series of Individually Immaterial Business Acquisitions" } } }, "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/BusinessCombinationsandAssetAcquisitionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r52" ], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "verboseLabel": "Equity-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Forfeited, shares (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited, weighted-average grant date fair value (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r461" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted, shares (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r461" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted, weighted-average grant date fair value (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r458", "r459" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Ending balance outstanding, shares (in shares)", "periodStartLabel": "Beginning balance outstanding, shares (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r458", "r459" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Ending balance outstanding, weighted-average grant date fair value (in dollars per share)", "periodStartLabel": "Beginning balance outstanding, weighted-average grant date fair value (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": { "auth_ref": [ "r115" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms", "terseLabel": "Weighted-average remaining contractual term, outstanding (years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r462" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedTerseLabel": "Vested, shares (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "auth_ref": [ "r465" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value", "terseLabel": "Share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period, fair value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r462" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested, weighted-average grant date fair value (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price", "terseLabel": "Weighted-average exercise price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationWeightedaverageAssumptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r472" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Expected dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationWeightedaverageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r471" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationWeightedaverageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r473" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationWeightedaverageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails", "http://www.usana.com/role/EquityBasedCompensationWeightedaverageAssumptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Number of non-option equity instruments exercised by participants.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised", "negatedTerseLabel": "Exercised, shares (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations": { "auth_ref": [ "r112" ], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations", "negatedTerseLabel": "Expired, shares (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": { "auth_ref": [ "r111" ], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures", "negatedTerseLabel": "Forfeited, shares (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "auth_ref": [ "r109" ], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted", "terseLabel": "Granted, shares (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r107", "r108" ], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "periodEndLabel": "Ending balance outstanding, shares (in shares)", "periodStartLabel": "Beginning balance outstanding, shares (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized", "terseLabel": "Share-based compensation arrangement by share-based payment award, number of additional shares authorized (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r685" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "terseLabel": "Share-based compensation arrangement by share-based payment award, number of shares authorized (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted-average exercise price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r446", "r447", "r448", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r470", "r471", "r472", "r473", "r474" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails", "http://www.usana.com/role/EquityBasedCompensationWeightedaverageAssumptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r449", "r468", "r469", "r470", "r471", "r474", "r484", "r485" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-Based Payment Arrangement [Policy Text Block]", "terseLabel": "Equity-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedPaymentArrangementNonemployeeMember": { "auth_ref": [ "r441", "r446", "r447", "r448", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r470", "r471", "r472", "r473", "r474" ], "lang": { "en-us": { "role": { "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor does not exercise nor has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Excludes nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.", "label": "Share-Based Payment Arrangement, Nonemployee [Member]", "terseLabel": "Share-based Payment Arrangement, Nonemployee" } } }, "localname": "ShareBasedPaymentArrangementNonemployeeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price (in dollars per share)" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r755" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "terseLabel": "Share-based compensation arrangement by share-based payment award, award vesting rights, percentage" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract]", "terseLabel": "Aggregate Intrinsic Value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding", "terseLabel": "Aggregate intrinsic value, outstanding" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r684" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period", "terseLabel": "Share-based compensation arrangement by share-based payment award, expiration period (year)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r470" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected life" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationWeightedaverageAssumptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.", "label": "State and Local Jurisdiction [Member]", "terseLabel": "State and Local Jurisdiction" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r215", "r302", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r328", "r334", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r366", "r367", "r368", "r668", "r808" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofSegmentReportingInformationbyOperatingSegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r24", "r104", "r214", "r238", "r239", "r240", "r264", "r265", "r266", "r268", "r274", "r276", "r297", "r343", "r415", "r481", "r482", "r483", "r512", "r513", "r534", "r547", "r548", "r549", "r550", "r551", "r553", "r571", "r610", "r611", "r612" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows", "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r264", "r265", "r266", "r297", "r585" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows", "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockAppreciationRightsSARSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.", "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)" } } }, "localname": "StockAppreciationRightsSARSMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails", "http://www.usana.com/role/EquityBasedCompensationWeightedaverageAssumptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r6", "r7", "r104", "r105" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Common stock issued under entity award plans (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r6", "r7", "r105", "r114" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Common stock issued under equity award plans" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount remaining of a stock repurchase plan authorized.", "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount", "terseLabel": "Stock repurchase program, remaining authorized repurchase amount" } } }, "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "auth_ref": [ "r6", "r7", "r104", "r105" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased and retired during the period.", "label": "Stock Repurchased and Retired During Period, Shares", "negatedLabel": "Common stock repurchased and retired (in shares)", "terseLabel": "Stock repurchased and retired during period, shares (in shares)" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareNarrativeDetails", "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": { "auth_ref": [ "r6", "r7", "r104", "r105" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).", "label": "Stock Repurchased and Retired During Period, Value", "negatedLabel": "Common stock repurchased and retired" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r7", "r10", "r11", "r79", "r688", "r717", "r729", "r793" ], "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders' equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityPolicyTextBlock": { "auth_ref": [ "r103" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.", "label": "Stockholders' Equity, Policy [Policy Text Block]", "terseLabel": "Common Stock Share Repurchases" } } }, "localname": "StockholdersEquityPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r554", "r578" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareNarrativeDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r554", "r578" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareNarrativeDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r554", "r578" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareNarrativeDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosures of cash flow information" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardAmount": { "auth_ref": [ "r130" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Tax Credit Carryforward, Amount", "terseLabel": "Tax credit carryforward, amount" } } }, "localname": "TaxCreditCarryforwardAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxCreditCarryforwardAxis": { "auth_ref": [ "r131" ], "lang": { "en-us": { "role": { "documentation": "Information by specific tax credit related to an unused tax credit.", "label": "Tax Credit Carryforward [Axis]", "terseLabel": "Tax Credit Carryforward [Axis]" } } }, "localname": "TaxCreditCarryforwardAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardNameDomain": { "auth_ref": [ "r131" ], "lang": { "en-us": { "role": { "documentation": "The name of the tax credit carryforward.", "label": "Tax Credit Carryforward, Name [Domain]", "terseLabel": "Tax Credit Carryforward, Name [Domain]" } } }, "localname": "TaxCreditCarryforwardNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r211", "r212", "r213", "r336", "r337", "r338" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts Receivable [Policy Text Block]", "terseLabel": "Accounts Receivable" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TradeSecretsMember": { "auth_ref": [ "r146" ], "lang": { "en-us": { "role": { "documentation": "Information generally known to only a limited number of the entity's employees, such as a formula, pattern, machine, technology, and production process that may give an entity a competitive advantage.", "label": "Trade Secrets [Member]", "terseLabel": "Product formulas" } } }, "localname": "TradeSecretsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TrademarksAndTradeNamesMember": { "auth_ref": [ "r142" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trademarks and Trade Names [Member]", "terseLabel": "Trade name and trademarks" } } }, "localname": "TrademarksAndTradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UndistributedEarnings": { "auth_ref": [ "r285", "r288" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The earnings that is allocated to common stock and participating securities to the extent that each security may share in earnings as if all of the earnings for the period had been distributed.", "label": "Undistributed Earnings, Basic", "terseLabel": "Undistributed earnings" } } }, "localname": "UndistributedEarnings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r488", "r497" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Ending balance of unrecognized tax benefits", "periodStartLabel": "Beginning balance of unrecognized tax benefits", "terseLabel": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails", "http://www.usana.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r498" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions", "negatedLabel": "Decreases related to prior year tax positions" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": { "auth_ref": [ "r500" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities", "negatedLabel": "Decreases for settlements with taxing authorities" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r496" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Unrecognized tax benefits, income tax penalties and interest accrued, total" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": { "auth_ref": [ "r496" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense", "terseLabel": "Income tax expense related to interest and penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [ "r499" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.", "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions", "terseLabel": "Increases related to current year tax positions" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r498" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions", "terseLabel": "Increases related to prior year tax positions" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary": { "auth_ref": [ "r370" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year One", "terseLabel": "Unrecorded unconditional purchase obligation, to be paid, year one" } } }, "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r69", "r70", "r71", "r298", "r299", "r300", "r301" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceByDeferredTaxAssetAxis": { "auth_ref": [ "r128" ], "lang": { "en-us": { "role": { "documentation": "Information by type of deferred tax consequences attributable to deductible temporary differences.", "label": "Valuation Allowance by Deferred Tax Asset [Axis]", "terseLabel": "Valuation Allowance by Deferred Tax Asset [Axis]" } } }, "localname": "ValuationAllowanceByDeferredTaxAssetAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r506" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "terseLabel": "Valuation allowance, deferred tax asset, increase (decrease), amount" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": { "auth_ref": [ "r719", "r720", "r721", "r722", "r723" ], "lang": { "en-us": { "role": { "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.", "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]", "terseLabel": "Valuation allowance - deferred tax assets" } } }, "localname": "ValuationAllowanceOfDeferredTaxAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowancesAndReservesBalance": { "auth_ref": [ "r257", "r262" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount", "periodEndLabel": "Balance at end of period", "periodStartLabel": "Balance at beginning of period" } } }, "localname": "ValuationAllowancesAndReservesBalance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": { "auth_ref": [ "r260" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense", "terseLabel": "Charged to costs and expenses" } } }, "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDeductions": { "auth_ref": [ "r261" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction", "terseLabel": "Deductions" } } }, "localname": "ValuationAllowancesAndReservesDeductions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDomain": { "auth_ref": [ "r257", "r258", "r259", "r261", "r262" ], "lang": { "en-us": { "role": { "documentation": "Valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]" } } }, "localname": "ValuationAllowancesAndReservesDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowancesAndReservesTypeAxis": { "auth_ref": [ "r257", "r258", "r259", "r261", "r262" ], "lang": { "en-us": { "role": { "documentation": "Information by valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]" } } }, "localname": "ValuationAllowancesAndReservesTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VestingAxis": { "auth_ref": [ "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r780" ], "lang": { "en-us": { "role": { "documentation": "Information by vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Axis]", "terseLabel": "Vesting [Axis]" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [ "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r780" ], "lang": { "en-us": { "role": { "documentation": "Vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Domain]", "terseLabel": "Vesting [Domain]" } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r279", "r290" ], "calculation": { "http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofEarningsPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average common shares outstanding - diluted (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofEarningsPerShareDetails", "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Weighted average common shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r277", "r290" ], "calculation": { "http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofEarningsPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted average common shares outstanding - basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofEarningsPerShareDetails", "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "sharesItemType" }, "usna_AccountingPoliciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounting Policies", "label": "Accounting Policies [Line Items]", "terseLabel": "Accounting Policies [Line Items]" } } }, "localname": "AccountingPoliciesLineItems", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "usna_AccountingPoliciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounting Policies", "label": "Accounting Policies [Table]", "terseLabel": "Accounting Policies [Table]" } } }, "localname": "AccountingPoliciesTable", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "usna_AllOtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to all other.", "label": "All Other [Member]", "terseLabel": "All Other" } } }, "localname": "AllOtherMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails", "http://www.usana.com/role/SegmentInformationScheduleofSegmentReportingInformationbyOperatingSegmentDetails" ], "xbrltype": "domainItemType" }, "usna_AmarevitaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Amarevita.", "label": "Amarevita [Member]", "terseLabel": "Amarevita" } } }, "localname": "AmarevitaMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/RelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "usna_AmendedAndRestatedCreditAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to amended and restated credit agreement.", "label": "Amended And Restated Credit Agreement [Member]", "terseLabel": "Amended and Restated Credit Agreement" } } }, "localname": "AmendedAndRestatedCreditAgreementMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "xbrltype": "domainItemType" }, "usna_AmericasAndEuropeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to Americas and Europe.", "label": "Americas And Europe [Member]", "terseLabel": "Americas and Europe" } } }, "localname": "AmericasAndEuropeMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails" ], "xbrltype": "domainItemType" }, "usna_AmountsReceivableFromCreditCardProcessorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents amounts receivable from credit card processors.", "label": "Amounts Receivable From Credit Card Processors [Member]", "terseLabel": "Amounts Receivable from Credit Card Processors" } } }, "localname": "AmountsReceivableFromCreditCardProcessorsMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "usna_AssetsAndLiabilitiesLesseeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's assets and liabilities.", "label": "Assets And Liabilities, Lessee [Table Text Block]", "terseLabel": "Schedule of Classification of ROU Assets and Lease Liabilities" } } }, "localname": "AssetsAndLiabilitiesLesseeTableTextBlock", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/OperatingLeasesTables" ], "xbrltype": "textBlockItemType" }, "usna_AssociateIncentives": { "auth_ref": [], "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses related to commissions and other incentives earned by independent associates. Commissions are earned based on direct and indirect commissionable product sales. Other incentives including bonuses and contests and promotions are based on pay-for-performance and earned when associates achieve the required performance measures.", "label": "Associate Incentives", "terseLabel": "Associate incentives" } } }, "localname": "AssociateIncentives", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "usna_AssociateIncentivesPayable": { "auth_ref": [], "calculation": { "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred and payable for associate incentives.", "label": "Associate Incentives Payable", "verboseLabel": "Associate incentives" } } }, "localname": "AssociateIncentivesPayable", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "usna_AssociateIncentivesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for associate incentives.", "label": "Associate Incentives [Policy Text Block]", "terseLabel": "Associate Incentives" } } }, "localname": "AssociateIncentivesPolicyTextBlock", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "usna_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValuePerArrangementHigh": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of maximum earn-out per period.", "label": "Business Combination, Contingent Consideration Arrangements, Range Of Outcomes, Value Per Arrangement, High", "terseLabel": "Maximum amount per earnout" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValuePerArrangementHigh", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/BusinessCombinationsandAssetAcquisitionsDetails" ], "xbrltype": "monetaryItemType" }, "usna_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssumedLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assumed Liabilities", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assumed Liabilities", "terseLabel": "Increase in assumed liabilities" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssumedLiabilities", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/BusinessCombinationsandAssetAcquisitionsDetails" ], "xbrltype": "monetaryItemType" }, "usna_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapital": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Working Capital", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Working Capital", "negatedLabel": "Decrease in consideration, post close net working capital adjustments" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapital", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/BusinessCombinationsandAssetAcquisitionsDetails" ], "xbrltype": "monetaryItemType" }, "usna_COVID19PolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "COVID-19 Policy", "label": "COVID-19 Policy [Policy Text Block]", "terseLabel": "COVID-19" } } }, "localname": "COVID19PolicyPolicyTextBlock", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "usna_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash Paid For Amounts Included In The Measurement Of Lease Liabilities", "label": "Cash Paid For Amounts Included In The Measurement Of Lease Liabilities [Abstract]", "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities" } } }, "localname": "CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/OperatingLeasesSupplementalLeaseInformationDetails" ], "xbrltype": "stringItemType" }, "usna_CashSettledRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents cash-settled restricted stock units.", "label": "Cash-Settled Restricted Stock Units [Member]", "terseLabel": "Cash-settled Restricted Stock Units" } } }, "localname": "CashSettledRestrictedStockUnitsMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails" ], "xbrltype": "domainItemType" }, "usna_ContingentConsiderationMilestonePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contingent Consideration Milestone Period", "label": "Contingent Consideration Milestone Period", "terseLabel": "Contingent consideration milestone period" } } }, "localname": "ContingentConsiderationMilestonePeriod", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/BusinessCombinationsandAssetAcquisitionsDetails" ], "xbrltype": "durationItemType" }, "usna_DebtInstrumentCovenantAdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of debt instrument covenant for adjusted earnings before interest taxes, depreciation, and amortization.", "label": "Debt Instrument Covenant Adjusted Earnings Before Interest Taxes Depreciation And Amortization", "terseLabel": "Debt instrument covenant, adjusted earnings before interest taxes, depreciation, and amortization" } } }, "localname": "DebtInstrumentCovenantAdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "usna_DebtInstrumentCovenantRatioOfConsolidatedFundedDebtToAdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The covenant ratio of consolidated debt to adjusted earnings before interest, taxes, depreciation, and amortization for a debt instrument.", "label": "Debt Instrument Covenant Ratio Of Consolidated Funded Debt To Adjusted Earnings Before Interest Taxes Depreciation And Amortization", "terseLabel": "Debt instrument, covenant ratio of consolidated funded debt to adjusted earnings before interest, taxes, depreciation, and amortization" } } }, "localname": "DebtInstrumentCovenantRatioOfConsolidatedFundedDebtToAdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "xbrltype": "pureItemType" }, "usna_DeferredStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents deferred stock units.", "label": "Deferred Stock Units [Member]", "terseLabel": "Deferred Stock Units" } } }, "localname": "DeferredStockUnitsMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "usna_DeferredTaxLiabilitiesWithholdingTaxOnUnremittedEarnings": { "auth_ref": [], "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from withholding tax on unremitted earnings.", "label": "Deferred Tax Liabilities Withholding Tax On Unremitted Earnings", "negatedLabel": "Withholding tax on unremitted earnings" } } }, "localname": "DeferredTaxLiabilitiesWithholdingTaxOnUnremittedEarnings", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "usna_DefinedBenefitPlanCliffVestingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum amount of service time before matching contributions will cliff vest.", "label": "Defined Benefit Plan Cliff Vesting Period", "terseLabel": "Defined benefit plan, cliff vesting period (year)" } } }, "localname": "DefinedBenefitPlanCliffVestingPeriod", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "usna_DefinedContributionPlanEmployerContributionAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contributions made by an employer to a defined contribution plan.", "label": "Defined Contribution Plan Employer Contribution Amount", "terseLabel": "Defined contribution plan, employer contribution amount" } } }, "localname": "DefinedContributionPlanEmployerContributionAmount", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "usna_DefinedContributionPlanEmployerMatchingContributionMatchPercentExceedingInitialMatch": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percent exceeding the initial matching percent that the employer matches contributions under the defined contribution plan.", "label": "Defined Contribution Plan Employer Matching Contribution Match Percent Exceeding Initial Match", "terseLabel": "Defined contribution plan, employer matching contribution, match percent exceeding initial match" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionMatchPercentExceedingInitialMatch", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "usna_DefinedContributionPlanMinimumAgeOfEmployee": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum age of employee required to participate in the defined contribution plan", "label": "Defined Contribution Plan Minimum Age Of Employee", "terseLabel": "Defined contribution plan, minimum age of employee" } } }, "localname": "DefinedContributionPlanMinimumAgeOfEmployee", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "usna_DefinedContributionPlanRequisiteServicePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The requisite service period of the defined contribution plan.", "label": "Defined Contribution Plan Requisite Service Period", "terseLabel": "Defined contribution plan, requisite service period (month)" } } }, "localname": "DefinedContributionPlanRequisiteServicePeriod", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "usna_DepositsAndProjectsInProcessMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents deposits and projects in process.", "label": "Deposits and Projects In Process [Member]", "terseLabel": "Deposits and projects in process" } } }, "localname": "DepositsAndProjectsInProcessMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "usna_DirectSellingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Direct Selling", "label": "Direct Selling [Member]", "terseLabel": "Direct-selling" } } }, "localname": "DirectSellingMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofSegmentReportingInformationbyOperatingSegmentDetails" ], "xbrltype": "domainItemType" }, "usna_EquityBasedCompensationExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value of equity based compensation expenses under share-based payment arrangement.", "label": "Equity Based Compensation Expense", "terseLabel": "Equity based compensation expense" } } }, "localname": "EquityBasedCompensationExpense", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "usna_ExercisableAggregateIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of exercisable award under share-based payment arrangement. Excludes share and unit options.", "label": "Exercisable, Aggregate Intrinsic Value", "terseLabel": "Exercisable, aggregate intrinsic value" } } }, "localname": "ExercisableAggregateIntrinsicValue", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "xbrltype": "monetaryItemType" }, "usna_ExercisableSharesInShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options exercisable.", "label": "Exercisable, Shares (In Shares)", "terseLabel": "Exercisable, shares (in shares)" } } }, "localname": "ExercisableSharesInShares", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "xbrltype": "sharesItemType" }, "usna_ExercisableWeightedAverageExercisePriceInDollarsPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average exercise price of exercisable award under share-based payment arrangement. Excludes share and unit options.", "label": "Exercisable, Weighted-Average Exercise Price (In Dollars Per Share)", "terseLabel": "Exercisable, weighted-average exercise price (in dollars per share)" } } }, "localname": "ExercisableWeightedAverageExercisePriceInDollarsPerShare", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "xbrltype": "perShareItemType" }, "usna_ExercisableWeightedAverageRemainingContractualTermYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for equity-based awards excluding options that are exercisable, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Exercisable, Weighted-Average Remaining Contractual Term (Year)", "terseLabel": "Exercisable, weighted-average remaining contractual term (years)" } } }, "localname": "ExercisableWeightedAverageRemainingContractualTermYear", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "xbrltype": "durationItemType" }, "usna_ExercisedWeightedAverageExercisePriceInDollarsPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average exercise price of award exercised in period under share-based payment arrangement. Excludes share and unit options.", "label": "Exercised, Weighted-Average Exercise Price (In Dollars Per Share)", "terseLabel": "Exercised, weighted-average exercise price (in dollars per share)" } } }, "localname": "ExercisedWeightedAverageExercisePriceInDollarsPerShare", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "xbrltype": "perShareItemType" }, "usna_ExpiredWeightedAverageExercisePriceInDollarsPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average exercise price of award expired during the period under share-based payment arrangement. Excludes share and unit options.", "label": "Expired, Weighted-Average Exercise Price (In Dollars Per Share)", "terseLabel": "Expired, weighted-average exercise price (in dollars per share)" } } }, "localname": "ExpiredWeightedAverageExercisePriceInDollarsPerShare", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "xbrltype": "perShareItemType" }, "usna_FinishedGoodsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Finished Goods", "label": "Finished Goods [Member]", "terseLabel": "Finished Goods" } } }, "localname": "FinishedGoodsMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/InventoriesNarrativeDetails" ], "xbrltype": "domainItemType" }, "usna_ForeignOperatingLossCarryforwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents foreign operating loss carryforwards.", "label": "Foreign Operating Loss Carryforwards [Member]", "terseLabel": "Foreign Operating Loss Carryforwards" } } }, "localname": "ForeignOperatingLossCarryforwardsMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "usna_ForeignWithholdingTaxes": { "auth_ref": [], "calculation": { "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "order": 1.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax withholdings.", "label": "Foreign Withholding Taxes", "terseLabel": "Foreign withholding taxes" } } }, "localname": "ForeignWithholdingTaxes", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "usna_ForfeitedWeightedAverageExercisePriceInDollarsPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average exercise price of award forfeited during the period under share-based payment arrangement. Excludes share and unit options.", "label": "Forfeited, Weighted-Average Exercise Price (In Dollars Per Share)", "terseLabel": "Forfeited, weighted-average exercise price (in dollars per share)" } } }, "localname": "ForfeitedWeightedAverageExercisePriceInDollarsPerShare", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "xbrltype": "perShareItemType" }, "usna_GrantedWeightedAverageExercisePriceInDollarsPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average exercise price of award granted during the period under share-based payment arrangement. Excludes share and unit options.", "label": "Granted, Weighted-Average Exercise Price (In Dollars Per Share)", "terseLabel": "Granted, weighted-average exercise price (in dollars per share)" } } }, "localname": "GrantedWeightedAverageExercisePriceInDollarsPerShare", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "xbrltype": "perShareItemType" }, "usna_GreaterChinaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to Greater China.", "label": "Greater China [Member]", "terseLabel": "Greater China" } } }, "localname": "GreaterChinaMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails" ], "xbrltype": "domainItemType" }, "usna_GullGlobalLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Gull Global, Ltd.", "label": "Gull Global, Ltd. [Member]", "terseLabel": "Gull Global, Ltd." } } }, "localname": "GullGlobalLtdMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/RelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "usna_IncreaseDueToDeferralOfRevenueAtPeriodEnd": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of increase (decrease) in contract with customer liability due to deferred revenue.", "label": "Increase Due To Deferral Of Revenue At Period End", "terseLabel": "Increase due to deferral of revenue at period end" } } }, "localname": "IncreaseDueToDeferralOfRevenueAtPeriodEnd", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofContractLiabilitiesFromContractWithCustomersDetails" ], "xbrltype": "monetaryItemType" }, "usna_IncrementalTaxes": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of incremental taxes for the reporting period.", "label": "Incremental Taxes", "terseLabel": "Incremental taxes" } } }, "localname": "IncrementalTaxes", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "usna_LaboratoryAndProductionEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents laboratory and production equipment.", "label": "Laboratory And Production Equipment [Member]", "terseLabel": "Laboratory and production equipment" } } }, "localname": "LaboratoryAndProductionEquipmentMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "usna_LeaseRightOfUseAsset": { "auth_ref": [], "calculation": { "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under lease.", "label": "Lease Right Of Use Asset", "totalLabel": "Total ROU assets" } } }, "localname": "LeaseRightOfUseAsset", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "usna_LiabilityAwardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents liability award.", "label": "Liability Award [Member]", "terseLabel": "Liability Award" } } }, "localname": "LiabilityAwardMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "usna_LineOfCreditFacilityAdditionalIncreaseInMaximumBorrowingCapacity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity due to additional increase under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility", "label": "Line Of Credit Facility Additional Increase In Maximum Borrowing Capacity", "terseLabel": "Line of credit facility, additional increase in maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityAdditionalIncreaseInMaximumBorrowingCapacity", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "usna_MinimumAmountOfIndividualClaimsBeforeInsuranceReimbursement": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The minimum amount of individual claims required before insurance will reimburse.", "label": "Minimum Amount Of Individual Claims Before Insurance Reimbursement", "terseLabel": "Minimum amount of individual claims before insurance reimbursement" } } }, "localname": "MinimumAmountOfIndividualClaimsBeforeInsuranceReimbursement", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "usna_MinimumAmountOfProjectedAggregateClaimsBeforeInsuranceReimbursement": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The minimum amount of projected aggregate claims required before insurance will reimburse.", "label": "Minimum Amount Of Projected Aggregate Claims Before Insurance Reimbursement", "terseLabel": "Minimum amount of projected aggregate claims before insurance reimbursement" } } }, "localname": "MinimumAmountOfProjectedAggregateClaimsBeforeInsuranceReimbursement", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "usna_MirroredDeferredTaxAssetsRecordedInTheUsToOffsetDeferredTaxLiabilitiesOfForeignDisregardedEntitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents mirrored deferred tax assets recorded in the U.S. to offset deferred tax liabilities of foreign disregarded entities.", "label": "Mirrored Deferred Tax Assets Recorded in the U.S. to Offset Deferred Tax Liabilities of Foreign Disregarded Entities [Member]", "terseLabel": "Mirrored Deferred Tax Assets Recorded in the U.S. to Offset Deferred Tax Liabilities of Foreign Disregarded Entities" } } }, "localname": "MirroredDeferredTaxAssetsRecordedInTheUsToOffsetDeferredTaxLiabilitiesOfForeignDisregardedEntitiesMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "usna_MovementInContractLiabilitiesRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Movement In Contract Liabilities", "label": "Movement In Contract Liabilities [Roll Forward]", "terseLabel": "Movement in Contract Liabilities [Roll Forward]" } } }, "localname": "MovementInContractLiabilitiesRollForward", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofContractLiabilitiesFromContractWithCustomersDetails" ], "xbrltype": "stringItemType" }, "usna_NonCashChangeInRightOfUseAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash change in right-of-use asset.", "label": "Non-Cash Change In Right-Of-Use Assets", "terseLabel": "Non-cash change in right-of-use assets" } } }, "localname": "NonCashChangeInRightOfUseAssets", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "usna_NonQualifiedDeferredCompensationPlanAnnualIncentiveBonusDeferredPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non-Qualified Deferred Compensation Plan, Annual Incentive Bonus Deferred, Percentage", "label": "Non-Qualified Deferred Compensation Plan, Annual Incentive Bonus Deferred, Percentage", "terseLabel": "Non-qualified deferred compensation plan, annual incentive bonus deferral, percentage" } } }, "localname": "NonQualifiedDeferredCompensationPlanAnnualIncentiveBonusDeferredPercentage", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "pureItemType" }, "usna_NonQualifiedDeferredCompensationPlanSalaryDeferredPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non-Qualified Deferred Compensation Plan, Salary Deferred, Percentage", "label": "Non-Qualified Deferred Compensation Plan, Salary Deferred, Percentage", "terseLabel": "Non-qualified deferred compensation plan, salary deferred, percentage" } } }, "localname": "NonQualifiedDeferredCompensationPlanSalaryDeferredPercentage", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "pureItemType" }, "usna_NonfinancialAssetsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of nonfinancial assets measured at fair value.", "label": "Nonfinancial Assets Fair Value Disclosure", "terseLabel": "Nonfinancial assets, fair value disclosure" } } }, "localname": "NonfinancialAssetsFairValueDisclosure", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "usna_NonqualifiedDeferredCompensationPlanPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy related to the Company's nonqualified deferred compensation plan.", "label": "Nonqualified Deferred Compensation Plan Policy [Policy Text Block]", "terseLabel": "Nonqualified Deferred Compensation" } } }, "localname": "NonqualifiedDeferredCompensationPlanPolicyPolicyTextBlock", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "usna_NorthAsiaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to north Asia.", "label": "North Asia [Member]", "terseLabel": "North Asia" } } }, "localname": "NorthAsiaMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails" ], "xbrltype": "domainItemType" }, "usna_NumberOfEarnoutPeriods": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of earn-out periods.", "label": "Number Of Earnout Periods", "terseLabel": "Number of earnout periods" } } }, "localname": "NumberOfEarnoutPeriods", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/BusinessCombinationsandAssetAcquisitionsDetails" ], "xbrltype": "integerItemType" }, "usna_NumberOfGeographicRegions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of geographic regions in which the company operates.", "label": "Number Of Geographic Regions", "terseLabel": "Number of geographic regions" } } }, "localname": "NumberOfGeographicRegions", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "usna_NumberOfSubGeographicalRegions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of sub-geographical regions the company operates in.", "label": "Number Of Sub Geographical Regions", "terseLabel": "Number of sub geographical regions" } } }, "localname": "NumberOfSubGeographicalRegions", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "usna_OperatingLossCarryforwardsNotSubjectToExpiration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws, that are not subject to expiration.", "label": "Operating Loss Carryforwards Not Subject To Expiration", "terseLabel": "Operating loss carryforwards, not subject to expiration" } } }, "localname": "OperatingLossCarryforwardsNotSubjectToExpiration", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "usna_OtherForeignDeferredTaxAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents other foreign deferred tax assets.", "label": "Other Foreign Deferred Tax Assets [Member]", "terseLabel": "Other Foreign Deferred Tax Assets" } } }, "localname": "OtherForeignDeferredTaxAssetsMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "usna_PermanentTaxDifferences": { "auth_ref": [], "calculation": { "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "order": 4.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to permanent tax differences.", "label": "Permanent Tax Differences", "terseLabel": "Permanent tax differences" } } }, "localname": "PermanentTaxDifferences", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "usna_PersonalCareAndSkincareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to personal care and skincare.", "label": "Personal Care And Skincare [Member]", "terseLabel": "Personal care and Skincare" } } }, "localname": "PersonalCareAndSkincareMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails" ], "xbrltype": "domainItemType" }, "usna_ProductReturnFirstTimeOrderDurationOfReturn": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The duration of the return on first-time product orders.", "label": "Product Return First Time Order Duration Of Return", "terseLabel": "Product return, first time order, duration of return (day)" } } }, "localname": "ProductReturnFirstTimeOrderDurationOfReturn", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "usna_ProductReturnFirstTimeOrderPercentageRefunded": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage refunded on first-time orders for product returns.", "label": "Product Return First Time Order Percentage Refunded", "terseLabel": "Product return, first time order, percentage refunded" } } }, "localname": "ProductReturnFirstTimeOrderPercentageRefunded", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "usna_ProductReturnPercentageOfNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of net sales that had product returns during the period.", "label": "Product Return Percentage Of Net Sales", "terseLabel": "Product return, percentage of net sales" } } }, "localname": "ProductReturnPercentageOfNetSales", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "usna_ProductReturnPercentageRefunded": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of refund on product returns.", "label": "Product Return Percentage Refunded", "terseLabel": "Product return, percentage refunded" } } }, "localname": "ProductReturnPercentageRefunded", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "usna_ProductReturnPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for product returns.", "label": "Product Return [Policy Text Block]", "terseLabel": "Product Return Policy" } } }, "localname": "ProductReturnPolicyTextBlock", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "usna_PropertyPlantAndEquipmentNetExcludingNondepreciable": { "auth_ref": [], "calculation": { "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale, excluding non-depreciable amounts.", "label": "Property Plant And Equipment Net Excluding Nondepreciable", "totalLabel": "Property and equipment, net, excluding non-depreciable" } } }, "localname": "PropertyPlantAndEquipmentNetExcludingNondepreciable", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "xbrltype": "monetaryItemType" }, "usna_RelatedPartyTransactionOwnershipPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The ownership percentage by the related party.", "label": "Related Party Transaction Ownership Percentage", "terseLabel": "Related party transaction, ownership percentage" } } }, "localname": "RelatedPartyTransactionOwnershipPercentage", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/RelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "percentItemType" }, "usna_RestrictedCashDepositsInChinaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents restricted cash deposits in China.", "label": "Restricted Cash Deposits in China [Member]", "terseLabel": "Restricted Cash Deposits in China" } } }, "localname": "RestrictedCashDepositsInChinaMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "usna_RightOfUseAssetsObtainedInExchangeForLeaseObligations": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of right of use asset obtained in exchange for operating lease liability classified as a noncash transaction.", "label": "Right-Of-Use Assets Obtained In Exchange For Lease Obligations", "terseLabel": "Right-of-use assets obtained in exchange for lease obligations" } } }, "localname": "RightOfUseAssetsObtainedInExchangeForLeaseObligations", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "usna_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for finite lived and indefinite lived intangible assets.", "label": "Schedule Of Finite And Indefinite Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Intangible Assets" } } }, "localname": "ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "usna_SecSchedule1209AllowanceSalesReturnsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Allowance for sales returns.", "label": "SEC Schedule, 12-09, Allowance, Sales Returns [Member]", "terseLabel": "Allowance for sales returns" } } }, "localname": "SecSchedule1209AllowanceSalesReturnsMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "usna_SelfInsuranceExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The expense in the period incurred for claims for which no insurance coverage exists.", "label": "Self Insurance Expense", "terseLabel": "Self-insurance expense" } } }, "localname": "SelfInsuranceExpense", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "usna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The intrinsic value of award exercised under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement By Share-based Payment Award Equity Instruments Other Than Options Exercises In Period Intrinsic Value", "terseLabel": "Share-based compensation arrangement by share-based payment award, equity instruments other than options, exercises in period, intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodIntrinsicValue", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "usna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndUnreleasedInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares vested and unreleased in the period of non-option equity instruments under share based payment arrangement.", "label": "Share-based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Unreleased In Period", "terseLabel": "Share based compensation arrangement by share based payment award, equity instruments other than options, vested and unreleased in period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndUnreleasedInPeriod", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "usna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average exercise price of award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement By Share-based Payment Award Equity Instruments Other Than Options Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price, outstanding (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "xbrltype": "perShareItemType" }, "usna_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeitures": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares under equity instrument agreements that were cancelled as a result of occurrence of a terminating event.", "label": "Share-based Compensation Arrangement By Share-based Payment Award Forfeitures", "terseLabel": "Share-based compensation arrangement by share-based payment award, forfeitures (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeitures", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "usna_ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of awards granted during the period.", "label": "Share-based Compensation Arrangement By Share-based Payment Award Grants In Period Gross", "terseLabel": "Share-based compensation arrangement by share-based payment award, grants in period, gross (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantsInPeriodGross", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "usna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedPerAwardExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued per each one award upon exercise of award under share based payment arrangement.", "label": "Share-based Compensation Arrangement By Share-based Payment Award Shares Issued Per Award Exercised", "terseLabel": "Share-based compensation arrangement by share-based payment award, shares issued per award exercised (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedPerAwardExercised", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "usna_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAmountDueYearFour": { "auth_ref": [], "calculation": { "http://www.usana.com/role/EquityBasedCompensationRemainingUnrecognizedCompensationExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement to be recognized in year four.", "label": "Share-based Payment Arrangement Nonvested Award Cost Not Yet Recognized Amount Due Year Four", "verboseLabel": "2026" } } }, "localname": "ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAmountDueYearFour", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationRemainingUnrecognizedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "usna_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAmountDueYearOne": { "auth_ref": [], "calculation": { "http://www.usana.com/role/EquityBasedCompensationRemainingUnrecognizedCompensationExpenseDetails": { "order": 4.0, "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement to be recognized in year one", "label": "Share-based Payment Arrangement Nonvested Award Cost Not Yet Recognized Amount Due Year One", "verboseLabel": "2023" } } }, "localname": "ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAmountDueYearOne", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationRemainingUnrecognizedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "usna_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAmountDueYearThree": { "auth_ref": [], "calculation": { "http://www.usana.com/role/EquityBasedCompensationRemainingUnrecognizedCompensationExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement to be recognized in year three.", "label": "Share-based Payment Arrangement Nonvested Award Cost Not Yet Recognized Amount Due Year Three", "verboseLabel": "2025" } } }, "localname": "ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAmountDueYearThree", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationRemainingUnrecognizedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "usna_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAmountDueYearTwo": { "auth_ref": [], "calculation": { "http://www.usana.com/role/EquityBasedCompensationRemainingUnrecognizedCompensationExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement to be recognized in year two.", "label": "Share-based Payment Arrangement Nonvested Award Cost Not Yet Recognized Amount Due Year Two", "verboseLabel": "2024" } } }, "localname": "ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAmountDueYearTwo", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationRemainingUnrecognizedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "usna_SoutheastAsiaPacificMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to Southeast Asia Pacific.", "label": "Southeast Asia Pacific [Member]", "terseLabel": "Southeast Asia Pacific" } } }, "localname": "SoutheastAsiaPacificMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails" ], "xbrltype": "domainItemType" }, "usna_The2015PlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the 2015 Equity Incentive Award Plan.", "label": "The 2015 Plan [Member]", "terseLabel": "The 2015 Plan" } } }, "localname": "The2015PlanMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "usna_TheCompanyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Company", "label": "The Company [Policy Text Block]", "terseLabel": "The Company" } } }, "localname": "TheCompanyPolicyTextBlock", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "usna_USANAFoodsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to USANA Foods.", "label": "USANA Foods [Member]", "terseLabel": "USANA Foods" } } }, "localname": "USANAFoodsMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails" ], "xbrltype": "domainItemType" }, "usna_USANANutritionalsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to USANA Nutritionals.", "label": "USANA Nutritionals [Member]", "terseLabel": "USANA Nutritionals" } } }, "localname": "USANANutritionalsMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails" ], "xbrltype": "domainItemType" }, "usna_UtahStateTaxCommissionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the Utah state tax commission.", "label": "Utah State Tax Commission [Member]", "terseLabel": "Utah State Tax Commission" } } }, "localname": "UtahStateTaxCommissionMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "usna_VestingAnnuallyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents vesting annually.", "label": "Vesting Annually [Member]", "terseLabel": "Vesting Annually" } } }, "localname": "VestingAnnuallyMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "usna_VestingEachQuarterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents vesting each quarter.", "label": "Vesting Each Quarter [Member]", "terseLabel": "Vesting Each Quarter" } } }, "localname": "VestingEachQuarterMember", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "usna_WeightedAverageRemainingContractualTermAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted-Average Remaining Contractual Term", "label": "Weighted-Average Remaining Contractual Term [Abstract]", "terseLabel": "Weighted-average remaining contractual term" } } }, "localname": "WeightedAverageRemainingContractualTermAbstract", "nsuri": "http://www.usana.com/20221231", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "xbrltype": "stringItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21459-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(4)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=SL65897772-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "b", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(3)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=d3e5291-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126966630&loc=d3e41228-113958", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "2C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498348-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.5(c))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.4)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3581-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column B))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column D))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column E))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "66", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2814-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "https://asc.fasb.org/topic&trid=2122394", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r635": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r636": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r637": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column B", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r638": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column C", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r639": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column D", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column E", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r641": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column F", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r642": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column G", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r643": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column H", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r644": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column I", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r645": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "09", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r646": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(i)", "Subsection": "01", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r647": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(i)", "Subsection": "02", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r648": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(A)", "Subsection": "01", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r649": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(A)", "Subsection": "02", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(B)", "Subsection": "01", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r651": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(B)", "Subsection": "02", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r652": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(C)", "Subsection": "02", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r653": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "01", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r654": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "02", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(1)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r692": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r693": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r694": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r695": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r696": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r697": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r698": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r699": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column B))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r72": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column D))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column E))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r747": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "325", "URI": "https://asc.fasb.org/extlink&oid=6384206&loc=d3e41899-111602", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r810": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(ii)", "Subsection": "01", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r811": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)", "Subsection": "01", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "https://asc.fasb.org/topic&trid=2144416", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 97 0000896264-23-000004-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000896264-23-000004-xbrl.zip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�A&;1%5M5X$3E<=SJX-IT2J#- MI9\=&8'Y*GQZ^D4YOP="#O3P-J:

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ʋ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�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Ǜ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